
<html lang="en"     class="pb-page"  data-request-id="23d05b14-6cea-4739-9344-7c8816a6de64"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm201331s;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2012.55.issue-5"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure-Based Design of Novel Class II c-Met Inhibitors: 2. SAR and Kinase Selectivity Profiles of the Pyrazolone Series" /></meta><meta name="dc.Creator" content="Longbin  Liu" /></meta><meta name="dc.Creator" content="Mark H.  Norman" /></meta><meta name="dc.Creator" content="Matthew  Lee" /></meta><meta name="dc.Creator" content="Ning  Xi" /></meta><meta name="dc.Creator" content="Aaron  Siegmund" /></meta><meta name="dc.Creator" content="Alessandro A.  Boezio" /></meta><meta name="dc.Creator" content="Shon  Booker" /></meta><meta name="dc.Creator" content="Debbie  Choquette" /></meta><meta name="dc.Creator" content="Noel D.  D’Angelo" /></meta><meta name="dc.Creator" content="Julie  Germain" /></meta><meta name="dc.Creator" content="Kevin  Yang" /></meta><meta name="dc.Creator" content="Yajing  Yang" /></meta><meta name="dc.Creator" content="Yihong  Zhang" /></meta><meta name="dc.Creator" content="Steven F.  Bellon" /></meta><meta name="dc.Creator" content="Douglas A.  Whittington" /></meta><meta name="dc.Creator" content="Jean-Christophe  Harmange" /></meta><meta name="dc.Creator" content="Celia  Dominguez" /></meta><meta name="dc.Creator" content="Tae-Seong  Kim" /></meta><meta name="dc.Creator" content="Isabelle  Dussault" /></meta><meta name="dc.Description" content="As part of our effort toward developing an effective therapeutic agent for c-Met-dependent tumors, a pyrazolone-based class II c-Met inhibitor, N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)-3-fluorophenyl..." /></meta><meta name="Description" content="As part of our effort toward developing an effective therapeutic agent for c-Met-dependent tumors, a pyrazolone-based class II c-Met inhibitor, N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)-3-fluorophenyl..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 24, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm201331s" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm201331s" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm201331s" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm201331s" /></link>
        
    
    

<title>Structure-Based Design of Novel Class II c-Met Inhibitors: 2. SAR and Kinase Selectivity Profiles of the Pyrazolone Series | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm201331s" /></meta><meta property="og:title" content="Structure-Based Design of Novel Class II c-Met Inhibitors: 2. SAR and Kinase Selectivity Profiles of the Pyrazolone Series" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0005.jpeg" /></meta><meta property="og:description" content="As part of our effort toward developing an effective therapeutic agent for c-Met-dependent tumors, a pyrazolone-based class II c-Met inhibitor, N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)-3-fluorophenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide (1), was identified. Knowledge of the binding mode of this molecule in both c-Met and VEGFR-2 proteins led to a novel strategy for designing more selective analogues of 1. Along with detailed SAR information, we demonstrate that the low kinase selectivity associated with class II c-Met inhibitors can be improved significantly. This work resulted in the discovery of potent c-Met inhibitors with improved selectivity profiles over VEGFR-2 and IGF-1R that could serve as useful tools to probe the relationship between kinase selectivity and in vivo efficacy in tumor xenograft models. Compound 59e (AMG 458) was ultimately advanced into preclinical safety studies." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm201331s"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm201331s">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm201331s&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm201331s&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm201331s&amp;href=/doi/10.1021/jm201331s" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 1868-1897</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm201330u" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm201376w" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure-Based Design of Novel Class II c-Met Inhibitors: 2. SAR and Kinase Selectivity Profiles of the Pyrazolone Series</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Longbin++Liu">Longbin Liu</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+H.++Norman">Mark H. Norman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew++Lee">Matthew Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ning++Xi">Ning Xi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aaron++Siegmund">Aaron Siegmund</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alessandro+A.++Boezio">Alessandro A. Boezio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shon++Booker">Shon Booker</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Debbie++Choquette">Debbie Choquette</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Noel+D.++D%E2%80%99Angelo">Noel D. D’Angelo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julie++Germain">Julie Germain</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Yang">Kevin Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yajing++Yang">Yajing Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yihong++Zhang">Yihong Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+F.++Bellon">Steven F. Bellon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Douglas+A.++Whittington">Douglas A. Whittington</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Christophe++Harmange">Jean-Christophe Harmange</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Celia++Dominguez">Celia Dominguez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tae-Seong++Kim">Tae-Seong Kim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Isabelle++Dussault">Isabelle Dussault</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Departments of Medicinal Chemistry, <sup>‡</sup>Oncology Research, and <sup>§</sup>Molecular Structure, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States </span></div><div class="aff-info" id="aff2"><span class="aff-text"><sup>∥</sup>Departments of Medicinal Chemistry and <sup>⊥</sup>Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States </span></div><div class="corresp-info"><strong>*</strong>Phone: 805-447-3442. Fax: 805-480-1337. E-mail: <a href="/cdn-cgi/l/email-protection#4e2222273b0e2f23292b20602d2123"><span class="__cf_email__" data-cfemail="aec2c2c7dbeecfc3c9cbc080cdc1c3">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm201331s&amp;href=/doi/10.1021%2Fjm201331s" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 1868–1897</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 9, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 October 2011</li><li><span class="item_label"><b>Published</b> online</span>24 February 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 March 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm201331s" title="DOI URL">https://doi.org/10.1021/jm201331s</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1868%26pageCount%3D30%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLongbin%2BLiu%252C%2BMark%2BH.%2BNorman%252C%2BMatthew%2BLee%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D5%26contentID%3Djm201331s%26title%3DStructure-Based%2BDesign%2Bof%2BNovel%2BClass%2BII%2Bc-Met%2BInhibitors%253A%2B2.%2BSAR%2Band%2BKinase%2BSelectivity%2BProfiles%2Bof%2Bthe%2BPyrazolone%2BSeries%26numPages%3D30%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1897%26publicationDate%3DMarch%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm201331s"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3766</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">53</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm201331s" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure-Based Design of Novel Class II c-Met Inhibitors: 2. SAR and Kinase Selectivity Profiles of the Pyrazolone Series&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Longbin&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;H. Norman&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Ning&quot;,&quot;last_name&quot;:&quot;Xi&quot;},{&quot;first_name&quot;:&quot;Aaron&quot;,&quot;last_name&quot;:&quot;Siegmund&quot;},{&quot;first_name&quot;:&quot;Alessandro&quot;,&quot;last_name&quot;:&quot;A. Boezio&quot;},{&quot;first_name&quot;:&quot;Shon&quot;,&quot;last_name&quot;:&quot;Booker&quot;},{&quot;first_name&quot;:&quot;Debbie&quot;,&quot;last_name&quot;:&quot;Choquette&quot;},{&quot;first_name&quot;:&quot;Noel&quot;,&quot;last_name&quot;:&quot;D. D’Angelo&quot;},{&quot;first_name&quot;:&quot;Julie&quot;,&quot;last_name&quot;:&quot;Germain&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Yajing&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Yihong&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;F. Bellon&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;A. Whittington&quot;},{&quot;first_name&quot;:&quot;Jean-Christophe&quot;,&quot;last_name&quot;:&quot;Harmange&quot;},{&quot;first_name&quot;:&quot;Celia&quot;,&quot;last_name&quot;:&quot;Dominguez&quot;},{&quot;first_name&quot;:&quot;Tae-Seong&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Isabelle&quot;,&quot;last_name&quot;:&quot;Dussault&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;1868-1897&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm201331s&quot;},&quot;abstract&quot;:&quot;As part of our effort toward developing an effective therapeutic agent for c-Met-dependent tumors, a pyrazolone-based class II c-Met inhibitor, N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)-3-fluorophenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide (1), was identified. Knowledge of the binding mode of this molecule in both c-Met and VEGFR-2 proteins led to a novel strategy for designing more selective analogues of 1. Along with detailed SAR information, we demonstrate that the low kinase selectivity associated with class II c-Met inhibitors can be improved significantly. This work resulted in the discovery of potent c-Met inhibitors with improved selectivity profiles over VEGFR-2 and IGF-1R that could serve as useful tools to probe the relationship between kinase selectivity and in vivo efficacy in tumor xenograft models. Compound 59e (AMG 458) was ultimately advanced into preclinical safety studies.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201331s&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201331s" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201331s&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201331s" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201331s&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201331s" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm201331s&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201331s&amp;href=/doi/10.1021/jm201331s" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm201331s" /></input><a href="/doi/pdf/10.1021/jm201331s" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm201331s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm201331s%26sid%3Dliteratum%253Aachs%26pmid%3D22320327%26genre%3Darticle%26aulast%3DLiu%26date%3D2012%26atitle%3DStructure-Based%2BDesign%2Bof%2BNovel%2BClass%2BII%2Bc-Met%2BInhibitors%253A%2B2.%2BSAR%2Band%2BKinase%2BSelectivity%2BProfiles%2Bof%2Bthe%2BPyrazolone%2BSeries%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D5%26spage%3D1868%26epage%3D1897%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291465" title="Structure activity relationship">Structure activity relationship</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292349" title="Alkyls">Alkyls</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jmcmar.2012.55.issue-5/production/jmcmar.2012.55.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">As part of our effort toward developing an effective therapeutic agent for c-Met-dependent tumors, a pyrazolone-based class II c-Met inhibitor, <i>N</i>-(4-((6,7-dimethoxyquinolin-4-yl)oxy)-3-fluorophenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>1</b>), was identified. Knowledge of the binding mode of this molecule in both c-Met and VEGFR-2 proteins led to a novel strategy for designing more selective analogues of <b>1</b>. Along with detailed SAR information, we demonstrate that the low kinase selectivity associated with class II c-Met inhibitors can be improved significantly. This work resulted in the discovery of potent c-Met inhibitors with improved selectivity profiles over VEGFR-2 and IGF-1R that could serve as useful tools to probe the relationship between kinase selectivity and in vivo efficacy in tumor xenograft models. Compound <b>59e</b> (AMG 458) was ultimately advanced into preclinical safety studies.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote withdrawn"><h4><span></span> Accession Codes</h4><p class="last">The cocrystal structure data for VEGFR-2 + <b>1</b> and c-Met + (<i>R</i>)-<b>58a</b> have been deposited in the Protein Data Bank with PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3U6J">3U6J</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3U6I">3U6I</a>, respectively.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58067" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58067" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The receptor tyrosine kinase (RTK) c-Met is mainly expressed by epithelial cells. Activation of c-Met is regulated by its ligand, hepatocyte growth factor (HGF), also known as scatter factor (SF).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Upon binding of HGF at the extracellular domain, c-Met receptor undergoes dimerization that results in transphosphorylation of the intracellular tyrosine residues (Y1234, Y1235) within the catalytic site.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Further phosphorylation of residues Y1349 and Y1356 mobilizes the intracellular C-terminal docking domain that recruits and subsequently activates a wide range of downstream signaling molecules (e.g., Grb2, Gab1, PI3K, Akt, Ras, Erk, and STAT3) that modulate the survival, proliferation, migration, and invasion of cells. As such, normal HGF/c-Met signaling plays an important role during embryogenesis and tissue injury repair.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> On the other hand, dysregulation of this pathway (through, e.g., either overexpression of HGF/c-Met or activating mutation of <i>MET</i> gene) can render many cellular processes unchecked and promote tumorigenesis. It has been established that aberrant signaling of the HGF/c-Met pathway correlates with aggressive tumor growth and poor prognosis in cancer patients.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Different approaches to inhibition of the HGF/c-Met pathway in cancer cells have been documented.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> These include antagonistic ligands to c-Met, antibodies against either HGF or c-Met, and small molecule kinase inhibitors targeting the intracellular kinase domain. Numerous c-Met kinase inhibitors have been reported in the literature.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> These inhibitors can be categorized into either class I or class II based on their binding mode in the c-Met kinase domain (vide infra). While class I molecules tend to be very selective for c-Met, thus far, a majority of the class II molecules are multikinase inhibitors. Improving the selectivity of class II c-Met inhibitors has been a significant challenge. In fact, until recently, no selective class II c-Met inhibitors have been reported and little is known as to whether the kinase selectivity profiles of class II c-Met inhibitors can be improved. Schroeder et al. reported the design of a pyridone-based c-Met inhibitor that was selective over a number of kinases, including IGF-1R.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The selectivity over VEGFR-2 was modest (46-fold). We postulated that knowledge from kinase structural analysis coupled with SAR and X-ray crystallography studies on c-Met complexes would enable us to better understand and optimize kinase selectivity within this family of class II c-Met inhibitors. <a href="https://doi.org/10.1021/jm201330u">In the preceding paper</a>, we reported the structure-based design of a class II c-Met inhibitor that led to compound <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), which represented the most potent c-Met inhibitor in that series (<i>K</i><sub>i</sub> = 1.0 nM).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In this paper, we will detail our efforts toward enhancing the kinase selectivity profile of compound <b>1</b> by modifying the quinoline (A), the fluorophenyl (B), and particularly the pyrazolone (C) regions of the molecule.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure and activity of compound <b>1</b>, a pyrazolone-based class II c-Met inhibitor (numbering conventions used in the text for the quinoline and the pyrazolone rings are shown).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Structural Basis for SAR Exploration of the Pyrazolone Ring</h3><div class="NLM_p">In general, the extended structure of class II c-Met inhibitors beyond the ATP binding pocket in the c-Met kinase domain tends to render them less selective over other kinases.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Mindful of this observation, pyrazolone <b>1</b> was tested for selectivity against a panel of tyrosine and serine/threonine kinases. In addition to the potent inhibition of c-Met and RON, a member of the MET proto-oncogene family,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> pyrazolone <b>1</b> also showed activity toward a number of other kinases.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In particular, it was a potent inhibitor of VEGFR-2 (<i>K</i><sub>i</sub> = 8 nM), itself an important and clinically proven cancer therapy target,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and of the insulin-like growth factor 1 receptor (IGF-1R, <i>K</i><sub>i</sub> = 32 nM), another RTK that is upregulated in both primary and metastatic cancers.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> To develop these types of inhibitors as potential probes for c-Met driven tumors, higher levels of selectivity over other kinases were desired. Given the extensive structural information of inhibitor-bound VEGFR-2 available in the literature, we set out to identify structural differences between c-Met and VEGFR-2 within the kinase binding pockets as a means of enhancing selectivity.</div><div class="NLM_p">Examination of publicly available VEGFR-2 crystal structures indicated that this protein, like most other kinases, lacked the presence of a hydrophobic pocket equivalent to the Ile1145 pocket in c-Met. This suggested that <b>1</b> would bind VEGFR-2 in a well-established binding mode in which the inhibitor would induce the protein to adopt a DFG-out conformation by replacing the cognate phenylalanine of the DFG motif with the <i>N</i>-phenyl ring of the pyrazolone, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Moreover, because our structural analysis of the kinome suggested that the Ile1145 pocket may be unique to c-Met, we hypothesized that <b>1</b> would adopt the same DFG-out binding mode in other kinases as well. Subsequent X-ray crystallography studies of <b>1</b> bound to VEGFR-2 confirmed this prediction and clearly showed the expected DFG-out binding mode (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). Specifically, the quinoline and the fluorophenyl ring of the inhibitor assume essentially the same orientation in VEGFR-2 as seen in c-Met (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In contrast, the pyrazolone carboxyl amide rotates 180° away from the C-helix of VEGFR-2, displacing the DFG-Phe1047 residue with the <i>N</i>-phenyl group. In this orientation, the oxygen atom of the carboxyl amide forms a hydrogen bond to catalytic Lys868 and the pyrazolone carbonyl group forms a hydrogen bond to the backbone NH of Asp1046 from the DFG sequence. The N(1)-Me group on the pyrazolone ring resides ∼3.6 Å away from Ile888 on the C-helix, forming a close van der Waals contact. The difference between the two binding modes (c-Met vs VEGFR-2) is highlighted by an overlay of the two crystal structures (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Model of <b>1</b> in VEGFR-2 indicating key contacts. Hydrogen bonds are colored in green and key van der Waals contacts in black. Distances are in Å. (B) X-ray cocrystal structure of <b>1</b> in VEGFR-2 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3U6J">3U6J</a>). Phe1047 of the DFG-motif adopts a DFG-out conformation as predicted. (C) Overlay of c-Met (blue) and VEGFR-2 (gray) cocrystal structures showing the relative orientations of <b>1</b> and the 3–4 Å “movement” of the C-helix.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The DFG-out conformation of VEGFR-2 bound to <b>1</b> suggested that the pyrazolone ring in <b>1</b> could be exploited as a selectivity handle. For example, due to the close proximity of the C(5)-Me and N(1)-Me of the pyrazolone ring to the γ carbons of Glu885 and Ile888, respectively, substitutions (especially large, polar ones) at these positions should create unfavorable interactions with the C-helix of VEGFR-2 and most other kinases. On the other hand, these same substitutions were expected to be well tolerated upon binding to c-Met based on the X-ray crystal structure of the <b>1</b> bound to c-Met.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The binding mode in c-Met showed the N(1)-Me projecting out toward a largely solvent accessible region of the protein where there would be opportunities for introducing additional contacts with the protein (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C). Additionally, the C(5)-Me was observed to project directly toward Phe1223 of the DFG sequence, which had been shown from previous crystal structures to be capable of adopting a DFG-out conformation, indicating that c-Met could tolerate a larger C(5)-substituents.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p last">On the basis of this understanding of the structural differences between c-Met and VEGFR-2, modification of the pyrazolone ring (region C, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) represented a logical approach to enhancing the selectivity profile of the pyrazolone-based class II c-Met inhibitors against VEGFR-2 and other kinases. Additionally, our SAR efforts in other parts of the molecule (i.e., A, B regions, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) aimed at improving the physicochemical properties of <b>1</b> also uncovered subtle influences of modifications on selectivity profiles. To better assess selectivity/off-target liability over other RTKs, a second counterscreen target, IGF-1R, was chosen along with VEGFR-2 in this study. Following discussion of the chemical synthesis of various analogues, we will briefly highlight the SAR investigations in the quinoline (A) and in the central <i>F</i>-phenyl ring (B) of <b>1</b>. We then present our major SAR work in the pyrazolone core (C) as guided by the aforementioned hypotheses.</div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63118" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63118" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Analogues with substitution at the 6-position of the quinoline were prepared as shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The requisite quinoline ring was constructed following the protocol of Lin and Loo.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Thus, 4-bromo-3-methoxybenzenamine <b>2</b> was condensed with diethyl ethoxymethylenemalonate at 100 °C followed by cyclization in diphenyl ether at 245 °C to give ethyl 6-bromo-4-hydroxy-7-methoxyquinoline-3-carboxylate (<b>3a</b>). This crude material was subjected to hydrolysis followed by decarboxylation over a short reaction time (to minimize the <i>O</i>-demethylation during prolonged heating) to yield 6-bromo-7-methoxyquinolin-4-ol (<b>3b</b>), which was converted to chloride <b>4</b> using POCl<sub>3</sub>. Biaryl ether-formation with <b>4</b> and 2-fluoro-4-nitrophenol (<b>5</b>) was best achieved in chlorobenzene to give 6-bromo-4-(2-fluoro-4-nitrophenoxy)-7-methoxyquinoline <b>6</b>.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The latter was converted to either the 6-methyl or the 6-vinylquinoline derivatives (<b>7</b> and <b>8</b>) under the Negishi<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> or the Molander<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> protocols, respectively. Alternatively, selective reduction of the nitro group in <b>6</b> with SnCl<sub>2</sub> provided bromoaniline <b>9a</b>, whereas hydrogenation over Pd catalyst led to the <i>des</i>-bromo aniline <b>9d</b>. Similarly, hydrogenation of the nitro groups in <b>7</b> and <b>8</b>, with concomitant hydrogenolysis of the vinyl group in <b>8</b>, afforded alkyl anilines <b>9b</b> and <b>9c</b>. Amide coupling of <b>9a</b>–<b>d</b> with 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (<b>10</b>)<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> in the presence of HATU furnished analogues <b>11a</b>–<b>d</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0016.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) diethyl ethoxymethylenemalonate, 100 °C, 17 h, (2) Ph<sub>2</sub>O, 245 °C, 2 h; (b) (1) NaOH (aq), 100 °C, 50 min, HCl, (2) Ph<sub>2</sub>O, reflux, 30 min; (c) POCl<sub>3</sub>, 110 °C, 2 h; (d) PhCl, 140 °C, 16 h; (e) Me<sub>2</sub>Zn, Pd(dppf)Cl<sub>2</sub>, dioxane, 105 °C; (f) (CH<sub>2</sub>═CH)BF<sub>3</sub>K, Pd(dppf)Cl<sub>2</sub>, PrOH, 95 °C; (g) SnCl<sub>2</sub>, EtOH, 70 °C; (h) H<sub>2</sub>, Pd(OH)<sub>2</sub>/C (20%), EtOH; (i) HATU, DCM.</p></p></figure><div class="NLM_p">The syntheses of analogues with modifications in the central “B-ring” region are shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Thus 6,7-dimethoxyquinoline-based anilines 2-chloro-4-(6,7-dimethoxyquinolin-4-yloxy)aniline (<b>12</b>),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> 6-(6,7-dimethoxyquinolin-4-yloxy)pyridin-3-amine (<b>13</b>),<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and 5-(6,7-dimethoxyquinolin-4-yloxy)pyridin-2-amine (<b>14</b>)<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> were coupled with either 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (<b>10</b>) or its acid chloride to give dimethoxyquinolines <b>15a</b>–<b>c</b>.Monomethoxyl quinoline-based aniline 5-(7-methoxyquinolin-4-yloxy)pyridin-2-amine (<b>16</b>) was prepared as described previously.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Biaryl ether formation from 4-chloro-7-methoxyquinoline (<b>17</b>)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and 3-methoxy-4-nitrophenol under SN<sub>Ar</sub> conditions gave nitro derivative <b>18a</b>, which was reduced to aniline <b>18b</b>. A modified Ullmann coupling followed by benzoylation allowed for the conversion of 2-amino-5-iodopyrimidine <b>19</b> to <b>20a</b>.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a><i>O</i>-Debenzylation of the latter to <b>20b</b>, followed by SN<sub>Ar</sub> biaryl ether formation to <b>21a</b>, and final debenzoylation afforded aminopyrimidine <b>21b</b>. Amide coupling of <b>16</b>, <b>18b</b>, and <b>21b</b> with <b>10</b> provided monomethoxyquinolines <b>22a</b>–<b>c</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0017.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>10</b>, HATU, Et<sub>3</sub>N, DCM; (b) <b>10</b>, (CO)<sub>2</sub>Cl<sub>2</sub>, DMF, DCM; (c) 3-methoxy-4-nitrophenol, PhCl, reflux; (d) H<sub>2</sub>, Pd/C (20%), EtOAc; (e) BnOH, Cs<sub>2</sub>CO<sub>3</sub>, CuI, 1,10-phenanthroline, 110 °C; (f) BzCl, pyridine, DCM; (g) H<sub>2</sub>, Pd/C (10%), MeOH; (h) <b>17</b>, PPTS, 2-BuOH, 100 °C; (i) NaOH, MeOH, 70 °C.</p></p></figure><div class="NLM_p">Several synthetic routes were developed for C(5)-substituted pyrazolones. In the first method, simple amino groups at the C-5 carbon were installed via the bromide intermediate <b>24</b>, which was readily prepared via bromination<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> of methyl 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate <b>23</b><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Substitution of the bromine with either sodium azide, followed by reduction, or secondary amines led to the formation of esters <b>25a</b>–<b>d</b>. Saponification and amide coupling with either <b>9d</b> or <b>16</b> afforded compounds <b>26a</b>–<b>d</b> and <b>27</b>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0018.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, CHCl<sub>3</sub>; (b) (1) NaN<sub>3</sub>, DMF, (2) PPh<sub>3</sub>, THF, H<sub>2</sub>O; (3) Boc<sub>2</sub>O, DCM; (c) R<sub>1</sub>R<sub>2</sub>NH, DCM; (d) NaOH, H<sub>2</sub>O, MeOH, 80 °C; (e) HATU, <b>9d</b> or <b>16</b>, DMF or DCM.</p></p></figure><div class="NLM_p">In the second method, the C(5)-substituents were introduced via de novo pyrazolone synthesis featuring an amido Dieckmann condensation (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Thus, Boc-protected amino acids <b>28a</b>–<b>b</b> were coupled with phenyl hydrazine to give <b>29a</b>–<b>b</b>. The β-NH of the acyl hydrazides were protected as N(Cbz) (<b>30a</b>–<b>b</b>), setting the stage for methylation at the α-NH to give hydrazides <b>31a</b>–<b>b</b>. After removal of the Cbz groups, the β-NH’s of <b>32a</b>–<b>b</b> were acylated with ethyl malonoyl chloride. The resulting intermediates <b>33a</b>–<b>b</b> were subjected to sodium ethoxide-mediated cyclization followed by in situ saponification to furnish C-5 substituted pyrazolone-4-carboxylic acids <b>34a</b>–<b>b</b>. Amide coupling as described earlier with anilines <b>9d</b> and <b>16</b> afforded <b>35a</b>–<b>b</b> and <b>36</b> after removal of the Boc-protecting groups.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0019.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HOBt, EDCI, Et<sub>3</sub>N, PhNHNH<sub>2</sub>, DCM; (b) BnOC(O)Cl, NaOH (aq), THF; (c) NaH, DMF; MeI, 0 °C → rt; (d) H<sub>2</sub>, Pd/C, MeOH; (e) DMAP, ethyl malonoyl chloride, DCM, 0 °C → rt; (f) NaOEt, EtOH, 90 °C; NaOH, MeOH, 90 °C; (g) <b>9d</b> or <b>16</b>, <sup><i>i</i></sup>Pr<sub>2</sub>NEt, HATU, DMF or DCM; (h) TFA, DCM.</p></p></figure><div class="NLM_p">In the final method (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>), ketoesters that were either commercially available (<b>38g</b>–<b>i</b>) or readily accessible from acids <b>37a</b>–<b>f</b> under the Masomune conditions (<b>38a</b>–<b>f</b>)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> were subjected to Knorr condensations with methyl-2-phenylhydrazine<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> to give pyrazolones <b>39a</b>–<b>i</b>. Subsequent Vilsmeier formylation<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and Pinnick<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> oxidation at C(4) furnished pyrazolone-4-carboxylic acids <b>41a</b>–<b>i</b>. HATU-mediated amide coupling with aniline <b>9d</b> or <b>16</b> yielded analogues <b>42a</b>–<b>c</b> and <b>43c</b>–<b>i</b>.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0020.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CDI, methyl malonate potassium salt, MgCl<sub>2</sub>, THF; (b) PhNHNHMe, HOAc, pyridine, 100 °C; (c) DMF, POCl<sub>3</sub>; (d) NaClO<sub>2</sub>, 2-methylbut-2-ene, NaH<sub>2</sub>PO<sub>4</sub>, <sup><i>t</i></sup>BuOH, 0→20 °C; (e) <b>9d</b> or <b>16,</b> HATU or EDCI-HOAt, DMF, or DCM.</p></p></figure><div class="NLM_p">Alkyl substitutions at the pyrazolone N(1) position were installed by the direct <i>N</i>-alkylation of 5-methyl-2-phenyl-1<i>H</i>-pyrazol-3(2<i>H</i>)-one (<b>44</b>) at fusion temperatures (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>). This reaction worked best with either alkyl iodides or alkyl tosylates. Vilsmeier formylation of pyrazolones <b>45a</b>–<b>c</b> and subsequent oxidation of aldehydes <b>46a</b>–<b>c</b> provided the carboxylic acids <b>47a</b>–<b>c</b>. The methylallyl group in <b>47c</b> was readily converted to the saturated derivative <b>47d</b> via hydrogenation. Amide coupling with either <b>9d</b> or <b>16</b> afforded final products <b>48a</b>–<b>d</b>, <b>49a</b>, and <b>50b</b>. At the early stage of our work, the olefin <b>48c</b> served as a precursor to hydroxylated analogues. Thus, the 2-methylallyl function in <b>48c</b> was further transformed, via intermediates <b>51</b> and <b>52</b>, to the 2-hydroxypropyl analogue <b>53</b>.</div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0021.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) RX (X = I, OTs, or Br), Δ; (b) POCl<sub>3</sub>, DMF, 50 °C; (c) NaClO<sub>2</sub>, KH<sub>2</sub>PO<sub>4</sub>, 2-methyl-2-butene, <sup><i>t</i></sup>BuOH, H<sub>2</sub>O, 0 °C → rt; (d) H<sub>2</sub>, Pd/C, EtOAc; (e) <b>9d</b> or <b>16</b>, Et<sub>3</sub>N, HATU, DMF; (f) OsO<sub>4</sub>, NMO, <sup><i>t</i></sup>BuOH–H<sub>2</sub>O; (g) NaIO<sub>4</sub>, <sup><i>t</i></sup>BuOH–H<sub>2</sub>O; (h) NaBH<sub>4</sub>, MeOH.</p></p></figure><div class="NLM_p">To expedite efforts on the synthesis of N(1)-modified analogues containing a β-hydroxyl ethyl moiety, we developed a general method for the selective hydroxyethylation of pyrazolone <b>54</b> with oxarines <b>55</b> (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The resulting benzyl esters <b>56a</b>–<b>e</b> were cleaved under hydrogenolysis conditions to acids <b>57a</b>–<b>e</b> that were in turn coupled with aniline <b>9d</b> or <b>16</b> to give the desired products. Using this methodology, both the racemic and the enantiomers of <b>53</b> [(<i>R</i>)-<b>58a</b>, (<i>S</i>)-<b>58a</b>] were readily prepared. Similarly, a variety of β-hydroxyl ethyl derivatives such as primary (<b>58b</b>, <b>59b</b>), secondary (<b>58c</b>, <b>58d</b>, <b>59a</b>), and tertiary (<b>58e</b>, <b>59e</b>) alcohols were synthesized. Additionally, the primary alcohol <b>58b</b> was converted through the Mitsunobu reaction to amine <b>61</b> via phthalimide <b>60</b>.</div><figure id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0022.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Mg(ClO<sub>4</sub>)<sub>2</sub> or AlCl<sub>3</sub>, ACN; (b) Pd/C, H<sub>2</sub>, EtOAc; (c) <b>9d</b> or <b>16</b>, HATU, Et<sub>3</sub>N, DMF; (d) phthalimide, Ph<sub>3</sub>P, DEAD, DCM; (e) hydrazine, EtOH/H<sub>2</sub>O, 50 °C.</p></p></figure><div class="NLM_p">Modification of the alcohols obtained from the oxirane opening was also explored to expand the structural diversity at N(1) (Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>). Thus, alcohol <b>56b</b> was treated with TMS-diazomethane to afford methyl ether <b>62a</b>, which was then converted, via acid <b>62b</b>, to analogue <b>63</b>. For the synthesis of 3-amino-2-hydroxypropyl substituted pyrazolones at N(1), the 3-chloro-2-hydroxypropyl derivative <b>64</b><a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> was converted via the azido intermediate (<b>65a</b>) to amino alcohol <b>65b</b>. Boc-protection of the free amine (to <b>66a</b>) and <i>O</i>-debenzylation (to <b>66b</b>) followed by amide coupling afforded, after deprotection, the amino alcohol analogue <b>67</b>. In addition, <b>65b</b> was sequentially converted to intermediates <b>68a</b>–<b>b</b> and the final oxazolidinone analogue <b>69</b>.</div><figure id="sch8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0023.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) TMSCHN<sub>2</sub>, HBF<sub>4</sub>, DCM; (b) H<sub>2</sub>, Pd/C, EtOAc; (c) <b>9b</b> or <b>16</b>, HATU, Et<sub>3</sub>N, DMF; (d) NaN<sub>3</sub>, DMF/water, 90 °C, 18 h; (e) HSC<sub>3</sub>H<sub>6</sub>SH, DIEA, MeOH, 23 °C, 48 h; (f) Boc<sub>2</sub>O, DCM; (g) disuccinimidyl carbonate (DSC), DBU, 1,4-dioxane, 23 °C, 2 h; (h) TFA, DCM.</p></p></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> SAR of the Quinoline 6-MeO Group (A-Region)</h3><div class="NLM_p">Di- or trimethoxy substituted aryl appendages are commonly employed in the linker strand region of the ATP binding site to boost the potency of kinase inhibitors.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> While useful for SAR purposes, these poly methoxy-substituted aryls often introduce metabolic instabilities. In the case of <b>1</b>, we recognized that the <i>ortho</i>-dimethoxy quinoline represented a latent <i>ortho</i>-quinone surrogate that might lead to undesired safety complications.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> To mitigate this concern, we elected to first investigate monomethoxy substituted quinolines in the linker strand region.</div><div class="NLM_p">As shown from the crystal structure in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> the 7-methoxy group of <b>1</b> is buried in the ATP-binding pocket and forms numerous van der Waals contacts with the linker strand of the protein. In contrast, the 6-methoxy group is more exposed to the solvent and forms only two protein contacts, including one with Phe1089 at the tip of the P-loop, a residue known to be flexible and likely less important for inhibitor potency. We speculated that modifications at the 6-position would likely have less of an impact on potency than those at the 7-position.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Additionally, replacing the 6-methoxy group would also eliminate the possibility of both <i>ortho</i>-quinone and <i>para</i>-quinone-imine formations in vivo.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Consistent with our structural understanding, as indicated in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, the 6-methoxy group in <b>1</b> could be replaced with a halogen (<b>11a</b>), small alkyls (<b>11b</b>, <b>11c</b>), or even completely eliminated (<b>11d</b>) with minimal loss of biochemical activity (<5-fold). However, the cellular activity in PC3 cells was significantly reduced in most cases (<b>11a</b>–<b>c</b>), with the exception of the 6-H analogue (<b>11d</b>) where marginal impact was observed. With respect to kinase selectivity, replacing the 6-methoxy group generally resulted in a 2-fold improvement in selectivity over VEGFR-2. Although the bromo- and alkyl analogues <b>11a</b>–<b>c</b> showed no impact on the selectivity over IGF-1R, the <i>des</i>-methoxy analogue <b>11d</b> exhibited an improved selectivity over IGF-1R (>150-fold), representing about a 5-fold improvement from <b>1</b>.</div><figure id="fig3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray structure of <b>1</b> bound to c-Met highlighting key interactions of the 6- (right-hand side) and 7- (left-hand side) methoxyl groups of the quinoline ring (A-region). Hydrogen bonds are colored in green and key van der Waals contacts in black. Distances are in Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Modification of the Quinoline Ring<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0024.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center">c-Met</th><th class="rowsep1 colsep0" colspan="2" align="center">VEGFR-2</th><th class="rowsep1 colsep0" colspan="2" align="center">IGF-1R</th><th class="rowsep1 colsep0" align="center">PC3</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub></th><th class="colsep0 rowsep0" align="center">fold</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub></th><th class="colsep0 rowsep0" align="center">fold</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">7.8</td><td class="colsep0 rowsep0" align="center">8</td><td class="colsep0 rowsep0" align="center">32.1</td><td class="colsep0 rowsep0" align="center">32</td><td class="colsep0 rowsep0" align="center">20.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="center">5.1</td><td class="colsep0 rowsep0" align="center">78.9</td><td class="colsep0 rowsep0" align="center">16</td><td class="colsep0 rowsep0" align="center">149</td><td class="colsep0 rowsep0" align="center">29</td><td class="colsep0 rowsep0" align="center">652</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="center">3.4</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">146</td><td class="colsep0 rowsep0" align="center">43</td><td class="colsep0 rowsep0" align="center">461</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11c</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="center">2.4</td><td class="colsep0 rowsep0" align="center">38</td><td class="colsep0 rowsep0" align="center">16</td><td class="colsep0 rowsep0" align="center">70.2</td><td class="colsep0 rowsep0" align="center">29</td><td class="colsep0 rowsep0" align="center">534</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">1.1</td><td class="colsep0 rowsep0" align="center">23.7</td><td class="colsep0 rowsep0" align="center">22</td><td class="colsep0 rowsep0" align="center">178</td><td class="colsep0 rowsep0" align="center">162</td><td class="colsep0 rowsep0" align="center">37.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub> (nM): inhibitory constant for the phosphorylation of gastrin by c-Met, VEGFR-2, or IGF-1R. Fold: ratio of <i>K</i><sub>i</sub>(kinase)/<i>K</i><sub>i</sub>(c-Met). PC3 IC<sub>50</sub> (nM): inhibitory concentration for HGF-mediated c-Met phosphorylation in PC3 cells. Both <i>K</i><sub>i</sub> and IC<sub>50</sub> values are reported as an average for <i>n</i> > 2. See <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a> for standard deviations.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> SAR of the Central Fluorophenyl Ring (B-Region)</h3><div class="NLM_p">In the c-Met-bound form, the central fluorophenyl ring in <b>1</b> connecting the quinoline and the pyrazolone carboxyamide resides between the gatekeeper Leu1157 and the P-loop Phe1089. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, the fluorine atom occupies a shallow hydrophobic nitch demarcated by the Val1092 isopropyl side chain, indicating there is little room for substitution at this position. Replacing the CF group in <b>1</b> with a nitrogen atom resulted in 50-fold loss of activity (<b>15b</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). This change not only removed occupancy of the Val1092 cavity but perhaps more significantly imparted a dramatic change in the conformational preferences of the molecule. Modeling studies indicated that this nitrogen atom prefers to form an intramolecular CH–N hydrogen bond with C(3) of the quinoline ring, thereby bringing the two rings into a coplanar conformation in the ground state and destabilizing the bound-state orthogonal conformation. Therefore, we explored modifying the adjacent position (Y in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> structure). It was found that bulkier groups such as chlorine (<b>15a</b>) or methoxy (<b>22b</b>) reduces the potency of <b>1</b> by ∼10–15-fold. This is likely a result from both the loss of occupancy of the Val1092 cavity and a slight steric clash with the δ carbon of Lys1110 that resides ∼3.9 Å from position Y. In contrast to <b>15b</b>, the isomeric pyridine (<b>15c</b>) still maintained the bound-state conformational preference and led to only a minor loss of activity. Notably, the pyridine analogue <b>15c</b> effected an unanticipated improvement in selectivity over IGF-1R (>4-fold) relative to the fluorophenyl analogue <b>1</b>. Combination of this feature with the superior selectivity associated with the mono methoxyquinoline (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <b>11d</b>) led to analogue <b>22a</b>, which had the best overall activity and selectivity up to this point. In addition, we recognized that this pyridine-based central ring not only conferred better physicochemical characteristics to the molecule (e.g., lower logP, molecular weight, and protein binding) but also significantly reduced potential metabolic liabilities associated with the <i>para</i>-aminophenol moiety.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> For the SAR purposes, both the fluorophenyl- (e.g., <b>1</b>) and the pyridine- (e.g., <b>15c</b>, <b>22a</b>) based central rings are included in subsequent discussions. Interestingly, the pyrimidine analogue (<b>22c</b>) with a nitrogen at both Y- and Z-positions showed 13-fold reduced c-Met activity relative to the pyridine derivative. One possible explanation is that by forcing a nitrogen atom into the Z-position, the carboxylate of Asp1222, which is 3.6 Å away, may experience electrostatic repulsion.</div><figure id="fig4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray structure of <b>1</b> bound to c-Met highlighting key interactions of the central fluorophenyl ring (B-region). Hydrogen bonds are colored in green and key van der Waals contacts in black. Distances are in Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of the Central Ring<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0025.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center">c-Met</th><th class="rowsep1 colsep0" colspan="2" align="center">VEGFR-2</th><th class="rowsep1 colsep0" colspan="2" align="center">IGF-1R</th><th class="rowsep1 colsep0" align="center">PC3</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">Z</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub></th><th class="colsep0 rowsep0" align="center">fold</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub></th><th class="colsep0 rowsep0" align="center">fold</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">CF</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">7.8</td><td class="colsep0 rowsep0" align="center">8</td><td class="colsep0 rowsep0" align="center">32.1</td><td class="colsep0 rowsep0" align="center">32</td><td class="colsep0 rowsep0" align="center">20.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15b</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="center">53.5</td><td class="colsep0 rowsep0" align="center">1980</td><td class="colsep0 rowsep0" align="center">37</td><td class="colsep0 rowsep0" align="center">1570</td><td class="colsep0 rowsep0" align="center">29</td><td class="colsep0 rowsep0" align="center">417</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15a</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CCl</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="center">15.8</td><td class="colsep0 rowsep0" align="center">35.9</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">26.5</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">177</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">COMe</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="center">12.8</td><td class="colsep0 rowsep0" align="center">702</td><td class="colsep0 rowsep0" align="center">55</td><td class="colsep0 rowsep0" align="center">93.6</td><td class="colsep0 rowsep0" align="center">7</td><td class="colsep0 rowsep0" align="center">114</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15c</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="center">1.9</td><td class="colsep0 rowsep0" align="center">18.4</td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="center">233</td><td class="colsep0 rowsep0" align="center">123</td><td class="colsep0 rowsep0" align="center">71.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="center">1.2</td><td class="colsep0 rowsep0" align="center">42.0</td><td class="colsep0 rowsep0" align="center">35</td><td class="colsep0 rowsep0" align="center">618</td><td class="colsep0 rowsep0" align="center">515</td><td class="colsep0 rowsep0" align="center">83.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22c</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="center">16.7</td><td class="colsep0 rowsep0" align="center">1630</td><td class="colsep0 rowsep0" align="center">97</td><td class="colsep0 rowsep0" align="center">217</td><td class="colsep0 rowsep0" align="center">13</td><td class="colsep0 rowsep0" align="center">–</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub> (nM): inhibitory constant for the phosphorylation of gastrin by c-Met, VEGFR-2, or IGF-1R. Fold: ratio of <i>K</i><sub>i</sub>(kinase)/<i>K</i><sub>i</sub>(c-Met). PC3 IC<sub>50</sub> (nM): inhibitory concentration for HGF-mediated c-Met phosphorylation in PC3 cells. Both <i>K</i><sub>i</sub> and IC<sub>50</sub> values are reported as an average for <i>n</i> > 2. See <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a> for standard deviations.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> C-Region Overview</h3><div class="NLM_p">In parallel to establishing SAR in the A- and B-regions, we focused much of our medicinal chemistry efforts in the C-region, where our structural analysis suggested a path for improving kinase selectivity. Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> illustrates the three different areas of the C-region that we investigated: (i) the Ile1145 pocket, occupied by the N(2)-phenyl ring of <b>1</b>, (ii) the solvent channel, slightly accessed by the N(1)-methyl group of <b>1</b>, and (iii) a DFG-out pocket, occluded by c-Met’s DFG-in motif in complex with <b>1</b>.</div><figure id="fig5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0011.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. C-region of X-ray structure of <b>1</b> bound to c-Met, with three distinct areas annotated. Note that the side chain of Glu1127, between the solvent channel and Ile1145 pocket, was not resolved and is treated artificially in this surface representation as an alanine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">With the N(2) SAR shown <a href="https://doi.org/10.1021/jm201330u">in the preceding paper</a>,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> we found the hydrophobic Ile1145 pocket to be best accommodated by aryl rings. As previously discussed, our structural analysis had suggested that most kinases lack an equivalent to the Ile1145 pocket but that some may have the ability to tolerate N(2)-aryl rings by placing them in the DFG-out pocket. Thus, the finding that N(2)-aryl rings also engendered affinity in other kinases was not surprising because these aryl rings were predicted and subsequently observed to bind DFG-out. With the N(2)-substitution putatively occupying an altogether different pocket in off-target kinases, further exploration of the N(2)-substitution offered the potential to exploit these structural differences. However, both the Ile1145 pocket of c-Met and the DFG-out pockets of other kinases demonstrated a preference for aromatic rings. A more promising approach to enhance kinase selectivity in this series appeared to involve preservation of the N(2)-phenyl group with concomitant functionalization of either N(1) into the solvent channel or C(5) into an induced DFG-out pocket.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> SAR at C(5)</h3><div class="NLM_p">The effects of targeting the DFG-out pocket with C(5) substitutions on c-Met activity as well as on selectivity against VEGFR-2 and IGF1-R are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. As described earlier (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), we predicted that C(5)-substitutions, particularly polar groups, were less likely to be tolerated in VEGFR-2. This is because VEGFR-2 (and other kinases) would only be able to accommodate compounds from this series in a DFG-out binding mode in which bulky C(5)-substitution would disrupt a well conserved salt-bridge between a glutamic acid on the C-helix and the catalytic lysine. Moreover, our prior experience with kinases found to be capable of forsaking this lysine–glutamate salt bridge suggested that the resultant opening would be hydrophobic, thus incompatible with polar groups. Consistent with this analysis, a simple amino methyl group at C(5) was well tolerated in c-Met (<b>26b</b>: <i>K</i><sub>i</sub> = 1.4 nM; PC3 cell, 42 nM) and led to significant loss of activity in VEGFR-2 and IGF-1R relative to <b>11d</b>, resulting in 378- and 649-fold selectivity over the two kinases. Capping the amine of <b>26b</b> with the bulky Boc group further attenuated the off-target activity but also resulted in a 20-fold loss of c-Met activity (<b>26a</b>). However, less drastic size increases of C(5), as in the dialkyl aminomethyl (<b>26c</b>) and cyclic dialkyl aminomethyl groups (<b>26d</b>, <b>27</b>), were well tolerated in c-Met and maintained robust selectivity against VEGFR-2 and IGF-1R. These data confirmed the prediction that branched (up to six heavy atoms) basic groups at C(5) could enhance selectivity over VEGFR-2 and IGF-1R.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effects of C5-Substituents on Selectivity Profiles<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0001.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0002.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last"><i>K</i><sub>i</sub> (nM): inhibitory constant for the phosphorylation of gastrin by c-Met, VEGFR-2, or IGF-1R. Fold: ratio of <i>K</i><sub>i</sub>(kinase)/<i>K</i><sub>i</sub>(c-Met). PC3 IC<sub>50</sub> (nM): inhibitory concentration for HGF-mediated c-Met phosphorylation in PC3 cells. Both <i>K</i><sub>i</sub> and IC<sub>50</sub> values are reported as an average for <i>n</i> > 2. See <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a> for standard deviations.</p></div></div><div></div></div><div class="NLM_p">Distinct from most kinases, the DFG-out pocket of c-Met was predicted to adopt a more open shape that would tolerate modest polarity at C(5). While Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> largely corroborates this idea, it shows that small α-branched basic NH groups were not well tolerated. Loss of c-Met activity was observed in the cases of the <i>gem</i>-dimethyl derivative (<b>35a</b>) and the 2′-pyrrolidinyl derivatives (<b>35b</b>, <b>36</b>). Molecular modeling suggests that compounds <b>26b</b>–<b>d</b> and <b>27</b>, which are unsubstituted at the α-position, are able to position their basic amines in well solvated areas of the C-region. In contrast, their α-branched derivatives (<b>35a</b>–<b>b</b> and <b>36</b>) show a significant conformational preference to form an intramolecular hydrogen bond between the basic amine and the amide carbonyl, as illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>. The conformational impact of α-branching is likely driven by sterics: while the α-unsubstituted molecule can place its lone β-heavy atom out of plane with the pyrazolone, the α-branched molecule is unable to simultaneously position both β-heavy atoms away from the N(1)-methyl of the pyrazolone and the amide carbonyl. The energetically favorable option for the α-branched molecules is then to form an intramolecular hydrogen bond. While such intramolecular hydrogen bonding leads to the most favorable conformer in the unbound state, this conformation would interfere with the ligand’s ability to bind in c-Met’s DFG-out pocket. Consistent with the well-established DFG-out binding mode of kinases, in order for the α-branched <b>35a</b>–<b>b</b> and <b>36</b> to bind, these ligands must provide the DFG-out Asp1222-NH with a hydrogen bond acceptor. While the ground state conformation of these compounds precludes this interaction, the predicted energetic penalty of breaking the intramolecular hydrogen bond to satisfy the Asp1222-NH with the amide carbonyl is qualitatively in agreement with the observed loss of potency. When the pyrrolidine ring in <b>35b</b> was replaced with a furan ring as in <b>42a</b>–<b>b</b>, thereby excluding possible intramolecular hydrogen-bond formation, the c-Met activity was recovered. Pyrans <b>42c</b> and <b>43c</b> were also potent in c-Met enzyme (<i>K</i><sub>i</sub> < 2 nM) and cell (IC<sub>50</sub> < 40 nM) assays, and were selective over VEGFR-2.</div><figure id="fig6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0012.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Impact of α-branching of C(5)-substitution on conformational preferences. The conformation of the α-<i>unbranched</i> fragment is dictated by the strong preference of the sp<sup>3</sup> carbon to place the nitrogen atom <i>orthogonal</i> to the pyrazolone plane. In contrast, the ground state conformer for the α-branched fragment forms an intramolecular H-bond between the β-NH and the amide carbonyl, thereby interrupting its ability to satisfy the DFG motif-Asp1222 backbone amide-NH and rendering it incompatible with binding to c-Met. α-Branched molecules presumably pay a conformational penalty to bind in a different higher energy conformation that does not interfere with DFG-out binding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To mimic the phenylalanine of c-Met, heteroaromatic groups at C(5) were also investigated. Introducing a 4-pyridinyl ring at C(5) improved the c-Met activity at both the biochemical and cellular levels (<b>43d</b> vs <b>22a</b>). In addition, the selectivity over VEGFR-2 was enhanced by >100-fold, although selectivity over IGF-1R dropped by 9-fold. The position of the pyridine attachment at C(5) did not affect the activity or selectivity profiles (cf., <b>43e</b> and <b>43f</b>), nor did the introduction of another nitrogen atom to the pyridine ring (cf., pyrazine <b>43g</b>). Five-membered heteroaryl groups at C(5) such as 5-methylisoxazol-3-yl (<b>43h</b>) and 2-methylthiazol-4-yl (<b>43i</b>) behaved similarly in their c-Met activity and selectivity over VEGFR-2 and IGF-1R.</div><div class="NLM_p last">In summarizing our C(5) exploration, we found that high selectivity over VEGFR-2 could be achieved with both aryl and alkyl groups at C(5) containing polar functionality, while the selectivity over IGF-1R was generally lower with an aryl substituent than with an alkyl substituent.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> SAR at N(1)</h3><div class="NLM_p">The effect of targeting the solvent channel as depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, through N(1)-substitution, on c-Met activity and selectivity over VEGFR-2 and IGF-1R is shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. For this purpose, the SAR is limited to the 7-methoxyquinoline based linker binder as represented by <b>11d</b>. As discussed earlier (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), we anticipated that modifications at N(1) would provide a means for improving kinase selectivity by introducing unfavorable steric overlap with the C-helix of the VEGFR-2 protein and other kinases in the traditional DFG-out binding mode. The most conservative change, replacing the methyl group at N(1) with an ethyl group (<b>48a</b>), effectively increased the VEGFR-2 selectivity by 4-fold but led to a 2–3-fold decrease in c-Met enzymatic and cellular potency. Consistent with results on the analogues described earlier, the central pyridine ring (<b>49a</b>) enhanced selectivity over both VEGFR-2 and IGF-1R by an additional 2-fold. Extending further into the solvent channel through homologation to the <i>n</i>-propyl analogues (<b>48b</b> and <b>50b</b>) slightly improved the c-Met enzymatic and cellular potency by ∼1.5-fold over the ethyl analogues (<b>48a</b> and <b>49a</b>) to the same level as in the unsubstituted parent <b>11d</b>. The additional γ carbons of <b>48b</b> and <b>50b</b> also appeared to have enhanced, by an additional 1.5–2-fold over the ethyl, selectivities over VEGFR-2 and IGF-1R now at >150- and >400-fold, respectively. However, attaching a second γ carbon as in the isobutyl analogue (<b>48d</b>) was accompanied by significant loss of c-Met activity (>7-fold), possibly reflecting unfavorable desolvation penalty associated with the increased hydrophobicity. Interestingly, the loss of c-Met activity in <b>48d</b> was recovered by simply removing the sp<sup>3</sup>-center at the branching point, as shown with the 2-methylallyl analogue (<b>48c</b>). Nevertheless, the β-branched analogues (<b>48d</b> and <b>48c</b>) clearly showed that the selectivities begin to taper off. Overall, among simple alkyl derivatives, the <i>n</i>-propyl analogues offered the best combination of potency and selectivity.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Effects of N1-Substituents on Selectivity Profiles<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0003.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0004.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last"><i>K</i><sub>i</sub> (nM): inhibitory constant for the phosphorylation of gastrin by c-Met, VEGFR-2, or IGF-1R. Fold: ratio of <i>K</i><sub>i</sub>(kinase)/<i>K</i><sub>i</sub>(c-Met). PC3 IC<sub>50</sub> (nM): inhibitory concentration for HGF-mediated c-Met phosphorylation in PC3 cells. Both <i>K</i><sub>i</sub> and IC<sub>50</sub> values are reported as an average for <i>n</i> > 2. See <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a> for standard deviations.</p></div></div><div></div></div><div class="NLM_p">Encouraged by the SAR of simple alkyl groups at the N(1) position of the pyrazolone ring, polar functionalities were introduced to better satisfy this highly solvated area as well as to modulate the overall physicochemical properties of the molecules. A terminal amino group on the ethyl chain (<b>61</b>) caused a 4-fold loss in c-Met activity in both the enzyme and the cellular assays. Compound <b>61</b> was also ∼2-fold less selective over IGF-1R. On the other hand, the corresponding hydroxyl analogue (<b>58b</b>) was better tolerated in c-Met and was more selective over IGF-1R. With the pyridine central ring, the β-hydroxyl analogue <b>59b</b> showed an increased selectivity over both VEGFR-2 (3-fold) and IGF-1R (6-fold) when compared to the ethyl analogue (<b>49a</b>). Capping the hydroxyl group in <b>59</b> as a methoxy (<b>63</b>) led to slight decrease in both c-Met activity and selectivity over VEGFR-2. These results suggested that a β-hydroxyl group was the optimal polar group in the N(1) region. Having already established that the optimal hydrocarbon chain length was an <i>n</i>-propyl group (cf., <b>48b</b> vs <b>48a</b>), combining these two structural features at the N(1) position was examined next. While the racemic 2-hydroxypropyl analogue with a central fluorophenyl ring (<b>53</b>) showed similar potency and selectivity when compared to either the hydroxyethyl or the propyl derivatives (<b>58b</b> and <b>48b</b>, respectively), the analogue with a central pyridine ring (<b>59a</b>) showed the highest selectivity over VEGFR-2 (1200-fold) to this point. Compound <b>59a</b> was also more selective over IGF-1R (1670-fold) than the propyl analogue <b>50b</b> (685-fold). The chirality of hydroxyl group (or derivatives thereof) had little effect on c-Met activity or selectivity: both the (<i>R</i>)- and the (<i>S</i>)- enantiomers of <b>53</b> [(<i>R</i>)-<b>58a</b>, (<i>S</i>)<b>-58a</b>] showed similar c-Met activities and selectivities over VEGFR-2 and IGF-1R.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The <i>R</i>-enantiomer, (<i>R</i>)-<b>58a</b>, was cocrystallized with c-Met and the structure was solved at 2.0-Å resolution (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>A). The structure showed that the carbinol chain occupied the solvent channel as anticipated, with the secondary hydroxyl protruding out from the pyrazolone ring, flanked above by Glu-1127 from the C-Helix and below by the backbone carbonyl groups of Phe-1223 and Gly-1224 (of the DFG motif). The X-ray structure also suggested that the region surrounding the methyl group of the propyl chain could accommodate substitution (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>B). Indeed, compounds with groups flanking the secondary hydroxyl such as ethyl (<b>58c</b>) and isopropyl (<b>58d</b>) derivatives were well tolerated and selective. The amino alcohol function as in <b>67</b> was also tolerated but led to 5-fold loss in selectivity over IGF-1R. When the amino alcohol in <b>67</b> was cyclized as the oxazolidinone <b>69</b>, erosion in both c-Met activity and the selectivity over VEGFR-2 were observed.</div><figure id="fig7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0013.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. X-ray cocrystal structure of (<i>R</i>)-<b>58a</b> bound to c-Met (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3U6I">3U6I</a>). (A) Key interactions of the pyrazolone region with the protein. Hydrogen bond (green dashed lines) distances are in Å; (B) surface of the c-Met active site pocket. The surfaces of Phe1089, Asp1222, Phe1223, and Gly1224 are not depicted for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Discovery of <b>59e</b> (AMG 458)<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></h3><div class="NLM_p">The superior activity/selectivity profile provided by the hydroxypropyl side chain prompted extensive investigations of (<i>R</i>)-<b>58a</b> in vivo. It was found that in rat and mouse, the secondary hydroxyl group in (<i>R</i>)-<b>58a</b> was prone to oxidation to the corresponding ketone which was subsequently shown to be nonselective over VEGFR-2.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Therefore, it was concluded that 2-hydroxyl propyl derivatives were not viable candidates for in vivo studies. However, the observation that chirality of the 2-hydroxyl group had little influence on activity/selectivity, combined with our understanding of the structural information, led us to believe that a tertiary hydroxyl group would be tolerated in c-Met and potentially resistant to biotransformations. It was further hypothesized that good selectivity would be retained based on the selectivity data from the isobutyl analogue (<b>48d</b>). Indeed, this was the case; both tertiary alcohols <b>58e</b> and <b>59e</b> showed c-Met activities similar to the 2-hydroxylpropyl derivative (<b>53</b>, <b>59a</b>). In addition, they were more selective against VEGFR-2 (2–3-fold) than the secondary alcohols. On the basis of these results, both <b>58e</b> and <b>59e</b> were selected for in vivo pharmacological evaluations.<a onclick="showRef(event, 'ref9 ref38'); return false;" href="javascript:void(0);" class="ref ref9 ref38">(9, 38)</a> Overall, compound <b>59e</b> was the most selective class II c-Met inhibitor we had synthesized. The broad spectrum kinase profile of <b>59e</b> is represented in the form of heat map in Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a> using internal IC<sub>50</sub> data for kinases that have been counterscreened against. On the basis of the excellent selectivity profile, as well as favorable PK profiles in both the rodent and primate species, compound <b>59e</b> was advanced into preclinical safety studies.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><figure id="fig8" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0014.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Heat map of kinase activity (IC<sub>50</sub>) of compounds <b>1</b> and <b>59e</b> (activity units are in micromolar).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec99" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Summary</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71322" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71322" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In summary, we demonstrated that the selectivity profiles of class II c-Met inhibitors can be dramatically improved. Through extensive molecular modeling studies and X-ray structural analysis of the lead structure <b>1</b>, we uncovered a number of factors that govern the kinase selectivity profiles of this series using VEGFR-2 and IGF-1R as examples. Specifically, we showed that: (1) both the 6-desmethoxy quinoline in the linker region (A) and the pyridine in the central ring (B) enhanced selectivity, but more so over IGF-1R than over VEGFR-2, (2) polarity at C(5) of the pyrazolone (C) was essential for good selectivity over VEGFR-2, whereas steric bulk was important for selectivity over IGF-1R, and (3) a 2-hydroxypropyl side chain at N(1) was optimal for overall selectivity and activity. These efforts ultimately led to the identification of <b>59e</b> which was >2000-fold selective over VEGFR-2 and IGF-1R and significantly more selective over other kinases than the initial lead compound (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>).</div><figure id="fig9" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0015.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structural evolution from <b>1</b> to <b>59e</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Experimental Section<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30675" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30675" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General</h3><div class="NLM_p last">Unless otherwise noted, all materials were obtained from commercial suppliers and used without further purification. Anhydrous solvents were obtained from Aldrich, Acros, or EM Science and used directly. All reactions involving air or moisture sensitive reagents were performed under a N<sub>2</sub> or Ar atmosphere. Microwave-assisted reactions were conducted either with an Initiator from Biotage, Uppsala, Sweden, or Explorer from CEM, Matthews, North Carolina. Silica gel chromatography was performed using either glass columns packed with silica gel (200–400 mesh, Aldrich Chemical) or prepacked silica gel cartridges (Biotage or Redisep) mounted on a medium pressure liquid chromatography instrument from ISCO [MPLC (ISCO)]. All final compounds were purified to >95% purity as determined by LC/MS obtained on an Agilent 1100 spectrometer using a Phenomenex Synergi column (MAX-RP, 50 mm × 2.0 mm, 4μ, 40 °C). The solvent systems were A, 0.1% TFA in H<sub>2</sub>O; B, 0.1% TFA in MeCN; 0.8 mL/min. The method was as follows: 0.0–0.2 min, 10% B; 0.2–3.0 min, 10–100% B; 3.0–4.5 min, 100% B; 4.5–5.0 min, 100–10%; 3.0 μL injection; 215, 254 nm detection; MSD, positive mode. Low-resolution mass spectral (MS) data were obtained at the same time of the purity determination on the LC/MS instrument using ES ionization mode (positive). NMR spectra were determined with a Bruker 300 MHz or DRX 400 MHz spectrometer. Chemical shifts were reported in parts per million (ppm, δ units). Elemental analyses (C, H, N) were obtained from Atlantic Microlab in Norcross, Georgia.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Method for Amide Coupling between 1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>10</b>) and Anilines</h3><div class="NLM_p last">A mixture of an aniline (1.0 equiv), acid <b>10</b> (1.5 equiv), Et<sub>3</sub>N (1.5 equiv), and HATU (1.5 equiv) in DCM or DMF (substrate [c] ∼0.1 M) was stirred at rt for 24 h. The mixture was either filtered, and the filtrate was concentrated (when DCM was the solvent) or partitioned between EtOAc and H<sub>2</sub>O (when DMF was the solvent). The organic residue was purified by silica gel chromatography (eluent: MeOH in DCM or MeOH in EtOAc) to afford the title compounds.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i>-(4-(6-Bromo-7-methoxyquinolin-4-yloxy)-3-fluorophenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>11a</b>)</h3><div id="sec3_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (A) Ethyl 6-Bromo-4-hydroxy-7-methoxyquinoline-3-carboxylate (<b>3a</b>)</h4><div class="NLM_p last">A mixture of diethyl ethoxymethylenemalonate (22 mL, 102 mmol) and 4-bromo-3-methoxybenzenamine <b>2</b> (20.2 g, 100 mmol) was heated at 100 °C in a sand bath under N<sub>2</sub> for 17 h. Ph<sub>2</sub>O (100 mL) was added, and the mixture was heated with a heating gun at ∼245 °C (internal probe). After 5 min, the boiling red solution turned cloudy. After 2 h, the mixture was allowed to cool to rt, diluted with hexanes (100 mL), and filtered. The solid was washed with hexanes (2 × 100 mL) to give the crude product (28 g, 84%), which was used directly in the next step.</div></div><div id="sec3_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (B) 6-Bromo-7-methoxyquinolin-4-ol (<b>3b</b>)</h4><div class="NLM_p last">A mixture of ethyl 6-bromo-4-hydroxy-7-methoxyquinoline-3-carboxylate (28 g, 86 mmol) and NaOH (15 g, 375 mmol) in H<sub>2</sub>O (150 mL) was heated at 100 °C in an oil bath for 50 min. The solution was allowed to cool to rt and was acidified with HCl (concd). The slurry was filtered, and the resulting solid was washed with H<sub>2</sub>O and air-dried to give the acid intermediate. The acid was suspended in Ph<sub>2</sub>O (150 mL) and was heated with a heating gun. At 120 °C, rapid foaming occurred, which continued until after the internal temperature reached 140 °C; thereafter rapid rises in temperature were observed. The mixture was heated at reflux for 30 min, cooled to rt, and diluted with hexanes (100 mL). The mixture was filtered hot (60 °C), and the residue was washed with hexanes (3×). The solid was suspended in H<sub>2</sub>O (150 mL) and treated with NaOH (5 N, 25 mL). After being heated at 100 °C for 20 min, the dark mixture was filtered hot. The filtrate was quenched with HCl (5 N, 20 mL) and the resulting slurry was let cool to rt before it was filtered and the resulting solid residue was washed with H<sub>2</sub>O (20 mL). The solid contained the desired product plus the side-product resulting from <i>O</i>-demethylation (>50:1 ratio, >96% pure at 215 nm). MS (ESI pos ion) calcd for C<sub>10</sub>H<sub>8</sub>BrNO<sub>2</sub>, 253.0/255.0; found, 254.0/256.0 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.93 (s, 3 H), 5.99 (d, <i>J</i> = 7.4 Hz, 1 H), 7.06 (s, 1 H), 7.87 (d, <i>J</i> = 7.4 Hz, 1 H), 8.11–8.21 (m, 1 H).</div></div><div id="sec3_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (C) 6-Bromo-4-chloro-7-methoxyquinoline (<b>4</b>)</h4><div class="NLM_p last">A mixture of 6-bromo-7-methoxyquinolin-4-ol (2.2 g, 8.7 mmol) and POCl<sub>3</sub> (15 mL, 161 mmol) was heated at 110 °C in an oil bath for 2 h. The reaction mixture was allowed to cool to rt and concentrated. The residue was washed with hot EtOAc (2 × 15 mL) and dried in the air to give a brown powder (2.6 g, 97% as HCl salt). MS (ESI pos ion) calcd for C<sub>10</sub>H<sub>7</sub>BrClNO, 270.9/272.9/274.9; found, 271.9/273.9/275.9 (M + H). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.87 (bd, 1 H), 8.42 (s, 1 H), 7.73 (s, 1 H), 7.64 (bd, 1 H), 4.06 (s, 3 H).</div></div><div id="sec3_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (D) 6-Bromo-4-(2-fluoro-4-nitrophenoxy)-7-methoxyquinoline (<b>6</b>)</h4><div class="NLM_p last">A mixture of 6-bromo-4-chloro-7-methoxyquinoline-HCl (600 mg, 1942 μmol) and 2-fluoro-4-nitrophenol (915 mg, 5825 μmol) in chlorobenzene (5 mL) was heated to reflux (140 °C oil bath). After 16 h, the solution was allowed to cool to rt and the mixture was diluted with ether (10 mL) to form a white slurry that was filtered through a fritted funnel. The solid residue was suspended in NaOH (3 N, 15 mL), and the mixture was stirred for 20 min. The solid was collected and washed first with MeOH/H<sub>2</sub>O (1:8) and then with ether to give a light-yellow solid (490 mg, >95% pure). MS (ESI pos ion) calcd for C<sub>16</sub>H<sub>10</sub>BrFN<sub>2</sub>O<sub>4</sub>, 392.0/394.0; found, 393.0/395.0 (M + H). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 4.07 (s, 3 H), 6.51 (d, <i>J</i> = 5.1 Hz, 1 H), 7.39 (t, <i>J</i> = 8.2 Hz, 1 H), 7.49 (s, 1 H), 8.18 (t, <i>J</i> = 10.6 Hz, 2 H), 8.52 (s, 1 H), 8.69 (d, <i>J</i> = 5.1 Hz, 1 H).</div></div><div id="sec3_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (E) 4-(6-Bromo-7-methoxyquinolin-4-yloxy)-3-fluorobenzenamine (<b>9a</b>)</h4><div class="NLM_p last">A mixture of 6-bromo-4-(2-fluoro-4-nitrophenoxy)-7-methoxyquinoline (100 mg, 254 μmol) in EtOH (6 mL) was treated with tin(II) chloride dihydrate (140 mg, 615 μmol). The resulting brown slurry was heated at 70 °C for 4 h. The orange mixture was allowed to cool to rt and diluted with NaOH (1 N, 10 mL). The mixture was extracted with EtOAc (3 × 10 mL), and the combined organic layers were washed with NaOH (1 N, 10 mL), H<sub>2</sub>O, and brine. After drying over Na<sub>2</sub>SO<sub>4</sub>, filtering, and concentrating of the organic phase, the resulting yellow solid (92.4 mg, 100%) was used directly in the next step. MS (ESI pos ion) calcd for C<sub>16</sub>H<sub>12</sub>BrFN<sub>2</sub>O<sub>2</sub>, 362.0/364.0; found, 363.0/365.0 (M + H).</div></div><div id="sec3_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (F) <i>N</i>-(4-(6-Bromo-7-methoxyquinolin-4-yloxy)-3-fluorophenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>11a</b>)</h4><div class="NLM_p last">A mixture of 4-(6-bromo-7-methoxyquinolin-4-yloxy)-3-fluorobenzenamine (9a, 92.4 mg, 254 μmol), 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (10, 85 mg, 366 μmol), and HATU (135 mg, 356 μmol) in CHCl<sub>3</sub> (5 mL) was heated at 70 °C for 2 d. During this period, more reagents were added to drive the reaction to completion. The mixture was allowed to cool to rt and diluted with EtOAc (15 mL). The mixture was washed with NaOH (0.5 N, 2×), H<sub>2</sub>O, brine, and dried over Na<sub>2</sub>SO<sub>4</sub>. The organic phase was filtered and concentrated. The residue was purified by chromatography on silica gel with (2 N NH<sub>3</sub>-MeOH)–DCM (4%) as eluents. The major, less polar fraction was collected to give a crystalline solid that was further triturated with EtOAc/hexanes (1:1) to give a brown powder (30 mg, 20%). MS (ESI pos ion) calcd for C<sub>28</sub>H<sub>22</sub>BrFN<sub>4</sub>O<sub>4</sub>, 576.1/578.1; found, 577.0/579.0 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.81 (s, 3 H), 3.38 (s, 3 H), 4.05 (s, 3 H), 6.42 (d, <i>J</i> = 5.1 Hz, 1 H), 7.17 (t, <i>J</i> = 8.6 Hz, 1 H), 7.31 (d, <i>J</i> = 8.8 Hz, 1 H), 7.37 (d, <i>J</i> = 7.4 Hz, 2 H), 7.47 (t, <i>J</i> = 7.5 Hz, 1 H), 7.44 (s, 1 H), 7.57 (t, <i>J</i> = 7.8 Hz, 2 H), 7.93 (dd, <i>J</i> = 1.7, 12.5 Hz, 1 H), 8.6 (m, 2 H), 10.9 (s, 1 H).</div></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>N</i>-(3-Fluoro-4-(7-methoxy-6-methylquinolin-4-yloxy)phenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>11b</b>)</h3><div id="sec3_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (A) 4-(2-Fluoro-4-nitrophenoxy)-7-methoxy-6-methylquinoline (<b>7</b>)</h4><div class="NLM_p last">In a 25 mL round-bottomed flask was added Pd(dppf)Cl<sub>2</sub>–DCM (6.2 mg, 7.6 μmol), 6-bromo-4-(2-fluoro-4-nitrophenoxy)-7-methoxyquinoline (100 mg,254 μmol), and dioxane (2 mL) under Ar. Dimethylzinc (1.0 M in heptane, 509 μL, 509 μmol) was then added. After gas evolution ceased, the mixture was heated at 105 °C. After 18 h, more dimethylzinc (509 μL, 509 μmol) was added. After an additional 3 h, the reaction was allowed to cool to rt. The mixture was quenched with MeOH (0.1 mL) and diluted with DCM (5 mL)–MeOH (1 mL). The mixture was filtrated, and the resulting solids were washed with MeOH–DCM (10%). The combined filtrates were concentrated. The residue was purified by chromatography on silica gel with EtOAc as eluent to afford a white solid (54 mg, 65%). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>17</sub>H<sub>13</sub>FN<sub>2</sub>O<sub>4</sub>, 328.1; found, 329.2 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.42 (s, 3 H), 4.01 (s, 3 H), 6.54 (d, <i>J</i> = 4.6 Hz, 1 H), 7.29 (m, 1 H), 7.41 (s, 1 H), 7.95 (s, 1 H), 8.12 (d, <i>J</i> = 9.0 Hz, 1 H), 8.18 (d, <i>J</i> = 9.8 Hz, 1 H), 8.64 (d, <i>J</i> = 4.7 Hz, 1 H).</div></div><div id="sec3_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (B) 3-Fluoro-4-(7-methoxy-6-methylquinolin-4-yloxy)aniline (<b>9b</b>)</h4><div class="NLM_p last">A mixture of 4-(2-fluoro-4-nitrophenoxy)-7-methoxy-6-methylquinoline (50 mg, 152 μmol) and Pd(OH)<sub>2</sub>/C (20%, 80 mg) in EtOH (15 mL) was purged with H<sub>2</sub> (3×). The mixture was stirred at rt under an atmosphere of H<sub>2</sub> (balloon) for 6 h. The mixture was filtered, and the filtrate was concentrated. The crude product was used immediately in the next step. MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>17</sub>H<sub>15</sub>FN<sub>2</sub>O<sub>2</sub>, 298.1; found, 299.1 (M + H).</div></div><div id="sec3_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (C) <i>N</i>-(3-Fluoro-4-(7-methoxy-6-methylquinolin-4-yloxy)phenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>11b</b>)</h4><div class="NLM_p last">A mixture of 3-fluoro-4-(7-methoxy-6-methylquinolin-4-yloxy)benzenamine (50 mg, 168 μmol), 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (65 mg, 280 μmol), and HATU (127 mg, 335 μmol) in DCM (4 mL) was stirred at 40 °C for 20 h. During this period, more HATU (127 mg, 335 μmol) was added. The mixture was diluted with EtOAc (15 mL) and washed with NaOH (1 N, 10 mL), H<sub>2</sub>O (5 mL), and brine. The organic layer was dried with Na<sub>2</sub>SO<sub>4,</sub> filtered, and concentrated. The residue was purified by chromatography on silica gel using (2 N NH<sub>3</sub> in MeOH)/EtOAc (0 to 4%) as eluents to give an off-white solid (20 mg, 23%). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>29</sub>H<sub>25</sub>FN<sub>4</sub>O<sub>4</sub>, 512.2; found, 513.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.42 (s, 3 H), 2.80 (s, 3 H), 3.38 (s, 3 H), 3.99 (s, 3 H), 6.40 (d, <i>J</i> = 5.0 Hz, 1 H), 7.16 (t, <i>J</i> = 8.6 Hz, 1 H), 7.28 (m, 1 H), 7.37 (m, 3 H), 7.48 (t, <i>J</i> = 6.6 Hz, 1 H), 7.57 (t, <i>J</i> = 7.2 Hz, 2 H), 7.92 (d, <i>J</i> = 12.3 Hz, 1 H), 8.10 (s, 1 H), 8.53 (d, <i>J</i> = 5.3 Hz, 1 H), 10.88 (s, 1 H).</div></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-(4-(6-Ethyl-7-methoxyquinolin-4-yloxy)-3-fluorophenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>11c</b>)</h3><div id="sec3_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (A) 4-(2-Fluoro-4-nitrophenoxy)-7-methoxy-6-vinylquinoline (<b>8</b>)</h4><div class="NLM_p last">In a 25 mL round-bottomed flask was charged Pd(dppf)Cl<sub>2</sub>–DCM (48 mg, 66 μmol), potassium vinyltrifluoroborate (220 mg, 1642 μmol), 6-bromo-4-(2-fluoro-4-nitrophenoxy)-7-methoxyquinoline (520 mg, 1323 μmol), and Et<sub>3</sub>N (300 μL, 2135 μmol) in 1-propanol (4 mL). The mixture was heated at 90 °C under Ar for 15 h. The reaction mixture was allowed to cool to rt and was diluted with EtOAc (15 mL). The mixture was filtered through a pad of Celite, and the solid residue was washed with MeOH–DCM (1%). The filtrate was concentrated, and the residue was purified by chromatography on silica gel using MeOH–DCM (0–2%) as eluent to afford a mixture of the desired product and the debromination byproduct (5:1). MS (ESI pos ion) calcd for C<sub>18</sub>H<sub>13</sub>FN<sub>2</sub>O<sub>4</sub>, 340.1; found, 341.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.02 (s, 3 H), 5.45 (d, <i>J</i> = 11.4 Hz, 1 H), 5.97 (d, <i>J</i> = 17.6 Hz, 1 H), 6.51 (d, <i>J</i> = 5.1 Hz, 1 H), 7.16 (dd, <i>J</i> = 17.6, 11.2 Hz, 1 H), 7.38 (t, <i>J</i> = 8.2 Hz, 1 H), 7.45 (s, 1 H), 8.12–8.24 (m, 2 H), 8.31 (s, 1 H), 8.64 (d, <i>J</i> = 5.3 Hz, 1 H).</div></div><div id="sec3_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (B) 4-(6-Ethyl-7-methoxyquinolin-4-yloxy)-3-fluoroaniline (<b>9c</b>)</h4><div class="NLM_p last">To a solution of 4-(2-fluoro-4-nitrophenoxy)-7-methoxy-6-vinylquinoline (130 mg, 382 μmol) in a mixture of EtOH (20 mL) and EtOAc (25 mL) under N<sub>2</sub> was added Pd(OH)<sub>2</sub>/C (20%, 105 mg, 748 μmol). The mixture was purged with H<sub>2</sub> and stirred under an atmosphere of H<sub>2</sub> (balloon) for 23 h. The mixture was filtered through a pad of Celite, and the solid residue was washed with EtOAc. The filtrate was concentrated, and the residue was purified by chromatography on silica gel gel using MeOH/EtOAc (0 to 5%) as eluents to afford the product (65 mg, 100%) containing ∼30% <i>des</i>-ethyl derivative (carried through from the last step). MS (ESI pos ion) calcd for C<sub>18</sub>H<sub>17</sub>FN<sub>2</sub>O<sub>2</sub>, 312.1; found, 313.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.32 (t, <i>J</i> = 7.3 Hz, 3 H), 2.83 (q, <i>J</i> = 7.4 Hz, 2 H), 3.99 (s, 3 H), 6.37 (d, <i>J</i> = 5.3 Hz, 1 H), 6.50 (dd, <i>J</i> = 8.5, 2.6 Hz, 1 H), 6.57 (dd, <i>J</i> = 11.7, 2.5 Hz, 1 H), 7.03 (t, <i>J</i> = 8.6 Hz, 1 H), 7.37 (s, 1 H), 8.10 (s, 1 H), 8.52 (d, <i>J</i> = 5.1 Hz, 1 H).</div></div><div id="sec3_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (C) <i>N</i>-(4-(6-Ethyl-7-methoxyquinolin-4-yloxy)-3-fluorophenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>11c</b>)</h4><div class="NLM_p last">A mixture of 4-(6-ethyl-7-methoxyquinolin-4-yloxy)-3-fluorobenzenamine (65 mg, 208 μmol), 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (97 mg, 416 μmol), and HATU (180 mg, 473 μmol) in DCM (5 mL) was stirred overnight. More HATU (180 mg, 473 μmol) and Et<sub>3</sub>N (0.5 mL) were added. After 4 d, the mixture was diluted with EtOAc (15 mL) and washed with NaOH (0.5 N, 10 mL), NaHCO<sub>3</sub> (saturated), dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to a red oil. The product mixture after chromatography on silica gel using MeOH/EtOAc (0–4%) as eluent was further purified on HPLC (10–90% gradient/15 min). The product fractions were concentrated and the residue was neutralized with NaOH (1N). The aqueous layer was saturated with NaHCO<sub>3</sub> and extracted with DCM to afford the product (30 mg, 27%). MS (ESI pos ion) calcd for C<sub>30</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>4</sub>, 526.2; found, 527.2 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.32 (t, <i>J</i> = 7.5 Hz, 3 H), 2.81 (s, 3 H), 2.84 (m, 2 H), 3.38 (s, 3 H), 3.99 (s, 3 H), 6.39 (d, <i>J</i> = 4.9 Hz, 1 H), 7.17 (t, <i>J</i> = 8.8 Hz, 1 H), 7.32 (d, 1 H), 7.37 (m, 2 H), 7.48 (t, <i>J</i> = 7.2 Hz, 1 H), 7.57 (t, <i>J</i> = 7.5 Hz, 2 H), 7.92 (dd, <i>J</i> = 2.0, 13.8 Hz, 1 H), 8.09 (s, 1 H), 8.54 (d, <i>J</i> = 5.1 Hz, 1 H), 10.88 (1 H).</div></div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>N</i>-(4-(6-Bromo-7-methoxyquinolin-4-yloxy)-3-fluorophenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>11d</b>)</h3><div id="sec3_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (A) 3-Fluoro-4-(7-methoxyquinolin-4-yloxy)aniline (<b>9d</b>)<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></h4><div class="NLM_p last">A mixture of 6-bromo-4-(2-fluoro-4-nitrophenoxy)-7-methoxyquinoline (440 mg, 1119 μmol) and Pd(OH)<sub>2</sub>/C (20%, 200 mg) in EtOH (30 mL) was purged with H<sub>2</sub> and stirred under an atmosphere of H<sub>2</sub> for 20 h. The reaction content was purged with N<sub>2</sub>, filtered through a pad of Celite, and concentrated to a brown residue. Because of the potential oxidative decomposition of the highly electron rich system, the crude product was carried directly into the next step. MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>16</sub>H<sub>13</sub>FN<sub>2</sub>O<sub>2</sub>, 284.1; found, 285.1 (M + H).</div></div><div id="sec3_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (B) <i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>11d</b>)</h4><div class="NLM_p last">A mixture of 3-fluoro-4-(7-methoxyquinolin-4-yloxy)benzenamine (318 mg, 1119 μmol), 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (390 mg, 1678 μmol), and HATU (638 mg, 1678 μmol) in DCM (9 mL)–DMF (3 mL) was stirred for 4 h. Et<sub>3</sub>N (0.5 mL) was added and the mixture was stirred overnight. The mixture was diluted with EtOAc (30 mL) and washed with NaOH (1 N, 20 mL), H<sub>2</sub>O, and saturated NaHCO<sub>3</sub>. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by chromatography on silica gel with MeOH/EtOAc (0–4%) as eluent to give the desired product as a white solid (190 mg, 34%). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>28</sub>H<sub>23</sub>FN<sub>4</sub>O<sub>4</sub>, 498.1; found, 499.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.80 (s, 3 H), 3.38 (s, 3 H), 3.97 (s, 3 H), 6.41 (d, <i>J</i> = 5.3 Hz, 1 H), 7.17 (t, <i>J</i> = 8.6 Hz, 2 H), 7.22 (dd, <i>J</i> = 2.4, 9.2 Hz, 1 H), 7.29 (d, 1 H), 7.37 (d, <i>J</i> = 7.6 Hz, 2 H), 7.41 (d, <i>J</i> = 2.4 Hz, 1 H), 7.48 (t, <i>J</i> = 7.4 Hz, 1 H), 7.57 (t, <i>J</i> = 7.8 Hz, 2 H), 7.92 (dd, <i>J</i> = 2.1, 12.5 Hz, 1 H), 8.27 (d, <i>J</i> = 9.2 Hz, 1 H), 8.58 (d, <i>J</i> = 5.7 Hz, 1 H), 10.88 (s, 1 H).</div></div></div><div id="sec3_6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>N</i>-(2-Chloro-4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>15a</b>)</h3><div class="NLM_p last">To a solution of 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (0.04 g, 0.2 mmol) in DCM was added oxalyl chloride (0.02 mL, 0.2 mmol) followed by a drop of DMF. The mixture was stirred at rt for 4 h, and the solvent was evaporated. The crude material was added to a solution of 2-chloro-4-(6,7-dimethoxyquinolin-4-yloxy)benzenamine<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (0.05 g, 0.2 mmol) in DCM (1 mL), followed by the addition of Et<sub>3</sub>N (0.02 mL, 0.2 mmol). The mixture was stirred at rt for 3 d. Water was added, and the mixture was extracted with DCM. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The residue was purified by preparative TLC using MeOH–DCM (5%) as eluent to give the desired product (35 mg, 40%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>29</sub> H<sub>25</sub>ClN<sub>4</sub>O<sub>5</sub>, 544.2; found, 545.0 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.81 (s, 3 H), 3.37 (s, 3 H), 3.48 (s, 1 H), 4.04 (s, 3 H), 4.07 (s, 3 H), 6.55 (d, <i>J</i> = 3.9 Hz, 1 H), 7.11 (dd, <i>J</i> = 9.3, 1.9 Hz, 1 H), 7.38 (d, <i>J</i> = 7.3 Hz, 2 H), 7.43–7.63 (m, 5 H), 8.50 (d, <i>J</i> = 5.4 Hz, 1 H), 8.70 (d, <i>J</i> = 8.8 Hz, 1 H), 11.12 (s, 1 H).</div></div><div id="sec3_6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>N</i>-(6-(6,7-Dimethoxyquinolin-4-yloxy)pyridin-3-yl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>15b</b>)</h3><div class="NLM_p last">To a solution of 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (0.046 g, 0.20 mmol) in DCM (2 mL) was added oxalyl chloride (0.017 mL, 0.20 mmol) followed by a drop of DMF. The mixture was stirred at rt for 4 h, and the solvent was evaporated. A solution of 6-(6,7-dimethoxyquinolin-4-yloxy)pyridin-3-amine (0.04 g, 0.1 mmol) in DCM (2 mL) was added followed by Et<sub>3</sub>N (0.03 mL, 0.2 mmol). The resulting mixture was stirred at rt overnight. Water was added, and the mixture was extracted with DCM. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The residue was purified by preparative TLC using MeOH–DCM (5%) as eluent to give the desired product (25 mg, 36%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>28</sub> H<sub>25</sub> N<sub>5</sub>O<sub>5</sub>, 511.2; found, 512.1 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.71 (s, 3 H), 3.38 (s, 3 H), 3.89 (s, 3 H), 3.95 (s, 3 H), 6.84 (d, <i>J</i> = 5.2 Hz, 1 H), 7.31 (d, <i>J</i> = 8.7 Hz, 1 H), 7.7–7.38 (m, 7 H), 8.27 (dd, <i>J</i> = 2.9, 5.8 Hz, 1 H), 8.50 (d, <i>J</i> = 2.6 Hz, 1 H), 8.56 (d, <i>J</i> = 5.0 Hz, 1 H), 10.86 (s, 1 H).</div></div><div id="sec3_6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>N</i>-(5-(6,7-Dimethoxyquinolin-4-yloxy)pyridin-2-yl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>15c</b>)</h3><div class="NLM_p last">A mixture of 5-(6,7-dimethoxyquinolin-4-yloxy)pyridin-2-amine (130 mg, 437 μmol), 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (120 mg, 517 μmol), HATU (280 mg, 736 μmol), and Et<sub>3</sub>N (1.0 mL) in DCM (5 mL) was stirred at rt for 24 h to give, after aqueous workup and purification by chromatography on silica gel with MeOH–DCM (4–6%) as eluent, the desired product as a white solid (37 mg, 17%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>28</sub> H<sub>25</sub> N<sub>5</sub>O<sub>5</sub>, 511.2; found, 512.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.81 (s, 3 H), 3.38 (s, 3 H), 4.06 (s, 6 H), 6.46 (d, <i>J</i> = 5.23 Hz, 1 H), 7.38 (d, <i>J</i> = 8.2 Hz, 2 H), 7.41–7.58 (m, 6 H), 8.25 (d, <i>J</i> = 2.7 Hz, 1 H), 8.38 (d, <i>J</i> = 9.0 Hz, 1 H), 8.46–8.54 (m, 1 H), 11.28 (s, 1 H).</div></div><div id="sec3_6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>N</i>-(5-(7-Methoxyquinolin-4-yloxy)pyridin-2-yl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>22a</b>)</h3><div class="NLM_p last">A mixture of 5-(7-methoxyquinolin-4-yloxy)pyridin-2-amine (<b>16</b>, 400 mg, 1497 μmol), 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (521 mg, 2245 μmol), Et<sub>3</sub>N (1.0 mL), and HATU (854 mg, 2245 μmol) in DCM (3 mL)–DMF (3 mL) was stirred at rt. After 20 h, more 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (521 mg, 2245 μmol) was added, and the mixture was heated at 65 °C for 3 h. The mixture was allowed to cool to rt, diluted with EtOAc (20 mL), and stirred overnight. The mixture was filtered, and the solid was washed with Et<sub>2</sub>O/EtOAc (1:1), aqueous NaOH (1 N, 5 mL), and lyophilized to give the product as a white power (606 mg, 84%). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>27</sub>H<sub>23</sub>N<sub>5</sub>O<sub>4</sub>, 481.2; found, 482.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.80 (s, 3 H), 3.37 (s, 3 H), 3.97 (s, 3 H), 6.42 (d, <i>J</i> = 5.1 Hz, 1 H), 7.23 (dd, <i>J</i> = 2.4, 9.7 Hz, 1 H), 7.37 (d, <i>J</i> = 7.4 Hz, 2 H), 7.41 (m, 1 H), 7.47 (m, 1 H), 7.53 (m, 3 H), 8.23 (m, 2 H), 8.38 (d, <i>J</i> = 9.0 Hz, 1 H), 8.60 (d, <i>J</i> = 5.1 Hz, 1 H), 11.27 (s, 1 H).</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>N</i>-(2-Methoxy-4-(7-methoxyquinolin-4-yloxy)phenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>22b</b>)</h3><div id="sec3_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (A) 7-Methoxy-4-(3-methoxy-4-nitrophenoxy)quinoline (<b>18a</b>)</h4><div class="NLM_p last">To a solution of 3-methoxy-4-nitrophenol (0.51 g, 3.0 mmol) in chlorobenzene (15 mL) was added 4-chloro-7-methoxyquinoline <b>17</b> (0.70 g, 3.6 mmol). The reaction mixture was heated at reflux under N<sub>2</sub> for 20 h. The reaction mixture was allowed to cool to rt, diluted with H<sub>2</sub>O, and basified to pH ∼8 with NaOH (5 N). The resulting mixture was extracted with EtOAc (3 × 50 mL). The combined organic layers were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified by chromatography on silica gel using EtOAc in hexanes (30 to 70%) as eluent to obtain the product as pale-yellow solid (430 mg, 44%). (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>14</sub>N<sub>2</sub>O<sub>5</sub>, 326.1; found, 326.8. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 3.96 (s, 3 H), 3.99 (s, 3 H), 6.78 (d, <i>J</i> = 5.3 Hz, 1 H), 6.88 (dd, <i>J</i> = 8.85, 2.3 Hz, 1 H), 7.21 (d, <i>J</i> = 2.3 Hz, 1 H), 7.31 (dd, <i>J</i> = 9.2, 2.4 Hz, 1 H), 7.40 (d, <i>J</i> = 2.4 Hz, 1 H), 8.01 (d, <i>J</i> = 9.0 Hz, 1 H), 8.21 (d, <i>J</i> = 9.2 Hz, 1 H), 8.65 (d, <i>J</i> = 5.3 Hz, 1 H).</div></div><div id="sec3_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (B) 2-Methoxy-4-(7-methoxyquinolin-4-yloxy)aniline (<b>18b</b>)</h4><div class="NLM_p last">To a solution of 7-methoxy-4-(3-methoxy-4-nitrophenoxy)quinoline (0.43 g, 1.3 mmol) in EtOAc (15 mL) under N<sub>2</sub> was added Pd/C (10%, 0.042 g). The reaction mixture was purged with N<sub>2</sub> (3×) and was exposed to H<sub>2</sub> in a balloon. After 20 h at rt, the solvent was separated by filtration and evaporated. The crude product was purified by chromatography on silica gelusing MeOH–DCM (3:97) as eluent to obtain the product as brown foam. MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>16</sub>N<sub>2</sub>O<sub>3</sub>, 296.1; found, 296.9. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 3.84 (bs, OMe and NH<sub>2</sub>, 5 H), 3.97 (s, 3 H), 6.43 (d, <i>J</i> = 5.3 Hz, 1 H), 6.58–6.69 (m, 2 H), 6.72–6.82 (m, 1 H), 7.21 (dd, <i>J</i> = 9.1, 2.5 Hz, 1 H), 7.40 (d, <i>J</i> = 2.4 Hz, 1 H), 8.26 (d, <i>J</i> = 9.0 Hz, 1 H), 8.56 (d, <i>J</i> = 5.3 Hz, 1 H).</div></div><div id="sec3_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (C) <i>N</i>-(2-Methoxy-4-(7-methoxyquinolin-4-yloxy)phenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>22b</b>)</h4><div class="NLM_p last">To a solution of 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (0.11 g, 0.48 mmol) in DMF (10 mL) was added 2-methoxy-4-(7-methoxyquinolin-4-yloxy)benzenamine (0.095 g, 0.32 mmol), 1<i>H</i>-benzo[<i>d</i>][1,2,3]triazol-1-ol hydrate (0.074 g, 0.48 mmol), EDCI-HCl (0.068 g, 0.35 mmol), and <sup>i</sup>Pr<sub>2</sub>NEt (0.11 mL, 0.64 mmol). The reaction was heated at 60 °C for 20 h and then partitioned between EtOAc and saturated NaHCO<sub>3</sub>. The aqueous layer was extracted with EtOAc (2 × 50 mL). The combined organic layers were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified by chromatography on silica gel using MeOH–DCM (5:95) as eluent to give the product as an off-white solid (110 mg, 67%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>26</sub>N<sub>4</sub>O<sub>5</sub>, 510.2; found, 511.2. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.82 (s, 3 H), 3.35 (s, 3 H), 3.88 (s, 3 H), 3.98 (s, 3 H), 6.50 (d, <i>J</i> = 5.3 Hz, 1 H), 6.73 (d, <i>J</i> = 2.4 Hz, 1 H), 6.79 (dd, <i>J</i> = 8.7, 2.45 Hz, 1 H), 7.22 (dd, <i>J</i> = 9.2, 2.4 Hz, 1 H), 7.38 (s, 1 H), 7.39–7.44 (m, 2 H), 7.47 (d, <i>J</i> = 7.4 Hz, 1 H), 7.55 (t, <i>J</i> = 7.4 Hz, 2 H), 8.25 (d, <i>J</i> = 9.0 Hz, 1 H), 8.59 (d, <i>J</i> = 5.3 Hz, 1 H), 8.62 (d, <i>J</i> = 8.8 Hz, 1 H), 10.96 (s, 1 H).</div></div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>N</i>-(5-(7-Methoxyquinolin-4-yloxy)pyrimidin-2-yl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>22c</b>)</h3><div id="sec3_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (A) <i>N</i>-(5-(Benzyloxy)pyrimidin-2-yl)benzamide (<b>20a</b>)</h4><div class="NLM_p">A mixture of CuI (861.8 mg, 4525 μmol), 2-amino-5-iodopyrimidine (1000 mg, 4525 μmol), Cs<sub>2</sub>CO<sub>3</sub> (2949 mg, 9050 μmol), and 1,10-phenanthroline (815.4 mg, 4525 μmol) in benzyl alcohol (4696 μL, 45249 μmol) in a 50 mL sealed tube under N<sub>2</sub> was stirred and heated at 110 °C. After 1 h, the reaction mixture was directly purified by chromatography on silica gel with [NH<sub>3</sub>/MeOH (1%)]–DCM (0–10%) to afford the title compound contaminated with 1,10-phenanthroline. This material was used without further purification in the next step. MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>11</sub>N<sub>3</sub>O, 201.1; found, 202.0 (M + H).</div><div class="NLM_p last">In a 50 mL round-bottomed flask was added 5-(benzyloxy)pyrimidin-2-amine (910 mg, 4522 μmol) and DCM (10 mL) followed by pyridine (3658 μL, 45223 μmol) and benzoyl chloride (1575 μL, 13567 μmol). After stirring at rt for 3 h, the reaction mixture was evaporated and the residue was purified by chromatography on silica gel with MeOH–DCM (0–10%) as eluent to afford the title compound. MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>15</sub>N<sub>3</sub>O<sub>2</sub>, 305.1; found, 306.1 (M + H).</div></div><div id="sec3_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (B) <i>N</i>-(5-Hydroxypyrimidin-2-yl)benzamide (<b>20b</b>)</h4><div class="NLM_p last">In a 50 mL round-bottomed flask under N<sub>2</sub> was added <i>N</i>-(5-(benzyloxy)pyrimidin-2-yl)benzamide (322 mg, 1055 μmol) and a suspension of Pd/C (10%, 112 mg) in MeOH (4 mL). The reaction mixture was purged with H<sub>2</sub> and stirred under an atmosphere of H<sub>2</sub> (balloon). After 4 h, the reaction mixture was purged with N<sub>2</sub> and then filtered over Celite and concentrated under reduced pressure. The crude product was used without further purification in the next step. MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>9</sub>N<sub>3</sub>O<sub>2</sub>, 215.1; found, 215.9 (M + H).</div></div><div id="sec3_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (C) <i>N</i>-(5-(7-Methoxyquinolin-4-yloxy)pyrimidin-2-yl)benzamide (<b>21a</b>)</h4><div class="NLM_p last">In a 50 mL sealed tube under N<sub>2</sub> were added 4-chloro-7-methoxyquinoline (254 mg, 1313 μmol), <i>N</i>-(5-hydroxypyrimidin-2-yl)benzamide (226 mg, 1050 μmol), PPTS (330 mg, 1313 μmol), and 2-BuOH (4 mL). The mixture was stirred and heated at 100 °C for1 h. After cooling to rt, the reaction mixture was diluted with DCM and neutralized with NaOH (1 N). The aqueous phase was extracted with DCM–MeOH (90:10, 3×). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude mixture was purified by chromatography on silica gel with MeOH–DCM (0–5%) as eluent to afford the title compound (163 mg, 41.7%) as yellow oil. MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>16</sub>N<sub>4</sub>O<sub>3</sub>, 372.1; found, 373.0 (M + H).</div></div><div id="sec3_8_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (D) 5-(7-Methoxyquinolin-4-yloxy)pyrimidin-2-amine (<b>21b</b>)</h4><div class="NLM_p last">A mixture of <i>N</i>-(5-(7-methoxyquinolin-4-yloxy)pyrimidin-2-yl)benzamide (163 mg, 438 μmol), MeOH (10 mL), and NaOH (1N, 10 mL) in a 50 mL sealed tube was heated at 70 °C. After 1 h, the reaction mixture was diluted with DCM and neutralized with NH<sub>4</sub>Cl (saturated). The aqueous phase was extracted with DCM–MeOH (90:10, 3×). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude mixture was purified by chromatography on silica gel with MeOH–DCM (0 to 5%) as eluent to afford the title compound (57 mg, 49%) as a white solid. MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>12</sub>N<sub>4</sub>O<sub>2</sub>, 268.1; found, 269.0 (M + H).</div></div><div id="sec3_8_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (E) <i>N</i>-(5-(7-Methoxyquinolin-4-yloxy)pyrimidin-2-yl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>22c</b>)</h4><div class="NLM_p last">In a 10 mL sealed tube under N<sub>2</sub> was added 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (36 mg, 157 μmol), DCM (1 mL), and a catalytical amount of DMF, followed by oxalyl chloride (46 μL, 522 μmol). The reaction mixture was stirred at rt for 30 min and then evaporated under high vacuum for 2 h. The resulting acyl chloride was dissolved in DCM and transferred to a flask containing 5-(7-methoxyquinolin-4-yloxy)pyrimidin-2-amine (28 mg, 104 μmol). <i><sup>i</sup></i>Pr<sub>2</sub>NEt (55 μL, 313 μmol) was added, and the mixture was heated at 50 °C for 3 h. The crude reaction mixture was directly purified by chromatography on silica gel with MeOH/EtOAc (20:80) as eluent to afford the title compound. MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>22</sub>N<sub>6</sub>O<sub>4</sub>, 482.2; found, 483.1 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>/CDCl<sub>3</sub>) δ 2.72 (s, 3 H), 3.38 (s, 3 H), 3.95 (s, 3 H), 6.65–6.74 (m, 1 H), 7.28–7.36 (m, 1 H), 7.40–7.46 (m, 3 H), 7.48–7.54 (m, 1 H), 7.55–7.62 (m, 2 H), 8.22–8.28 (m, 1 H), 8.64–8.69 (m, 1 H), 8.71 (s, 2 H), 11.50 (s, 1 H).</div></div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> <i>tert</i>-Butyl (4-((3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)carbamoyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-5-yl)methylcarbamate (<b>26a</b>)</h3><div id="sec3_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (A) Methyl 5-(Bromomethyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (<b>24</b>)</h4><div class="NLM_p last">Methyl 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (7.82 g, 31.8 mmol) was dissolved in CHCl<sub>3</sub> (150 mL), and NBS (6.91 g, 38.8 mmol) was added. After 1.5 h at rt, more NBS (6.23 g, 35.2 mmol) was added. After stirring for 1 h, the reaction mixture was filtered, and the solid was washed with CHCl<sub>3</sub>. The filtrate was concentrated, treated with DCM, and filtered. The filtrate was concentrated, and purified again by chromatography on silica gel using MeOH–DCM (0–10%) as eluent to give the desired product (4.11 g, 33%). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>13</sub>H<sub>13</sub>BrN<sub>2</sub>O<sub>3</sub>, 324.0; found, 325.0 (M + H). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 3.46 (s, 3 H), 3.85 (s, 3 H), 4.99 (s, 2 H), 7.38–7.42 (m, 2 H), 7.56–7.64 (m, 3 H).</div></div><div id="sec3_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (B) Methyl 5-(Azidomethyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate</h4><div class="NLM_p last">Methyl 5-(bromomethyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (3.494 g, 10.75 mmol) was dissolved in DMF (20 mL) and cooled in an ice–water bath under N<sub>2</sub>. Then, sodium azide (842 mg, 12.96 mmol) was added and the reaction was allowed to warm to rt and stirred for 50 min. The mixture was quenched with H<sub>2</sub>O (70 mL), stirred overnight, and extracted with DCM (3 × 75 mL). The organic phases were combined, washed with H<sub>2</sub>O (6 × 100 mL), brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was dried under high vacuum to afford the title compound (2.592 g, 61%). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>13</sub>H<sub>13</sub>N<sub>5</sub>O<sub>3</sub>, 287.1; found, 288.1 (M + H).</div></div><div id="sec3_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (C) Methyl 5-(Aminomethyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (<b>25b</b>)</h4><div class="NLM_p last">Methyl 5-(azidomethyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (1.802 g, 6.27 mmol) was dissolved in THF (60 mL) and H<sub>2</sub>O (2.0 mL). Triphenyl phosphine (1.913 g, 7.29 mmol) was added over 5 min, resulting in gas evolution. After stirring under N<sub>2</sub> at rt overnight, the mixture was concentrated. The residue was purified by chromatography on silica gel [MeOH–DCM (1:50 to 1:20), then (2 N NH<sub>3</sub> in MeOH)–DCM (1:10 to 1:5)] to afford the title compound (1.245 g, 66%). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>13</sub>H<sub>15</sub>N<sub>3</sub>O<sub>3</sub>, 261.1; found, 262.1 (M + H). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 3.43 (s, 3 H), 3.89 (s, 3 H), 4.15 (s, 2 H), 7.33 (d, <i>J</i> = 9.0 Hz, 2 H), 7.41 (t, <i>J</i> = 7.3 Hz, 1 H), 7.50 (d, <i>J</i> = 8.0 Hz, 2 H).</div></div><div id="sec3_9_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (D) Methyl 5-((<i>tert</i>-Butoxycarbonyl)methyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (<b>25a</b>)</h4><div class="NLM_p last">To a solution of methyl 5-(aminomethyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (1.214 g, 4.65 mmol) in DCM (40 mL), cooled in an ice water bath, was added a solution of di-<i>tert</i>-butyl dicarbonate (1.175 g, 5.38 mmol) in DCM (5 mL), followed by DCM rinsing (∼2 mL). After about 30 min, the reaction was allowed to warm to rt and stirred for another 30 min. The reaction mixture was poured into H<sub>2</sub>O (30 mL), and the layers were separated. The aqueous phase was extracted with DCM (30 mL). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford the title compound. MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>18</sub>H<sub>23</sub>N<sub>3</sub>O<sub>5</sub>, 361.2; found, 362.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.46 (s, 9 H), 3.57 (s, 3 H), 3.89 (s, 3 H), 4.50 (d, <i>J</i> = 6.6 Hz, 2 H), 5.83 (br s, 1 H), 7.30 (d, <i>J</i> = 7.4 Hz, 2 H), 7.39–7.46 (m, 1 H), 7.47–7.58 (m, 2 H).</div></div><div id="sec3_9_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (E) 5-((<i>tert</i>-Butoxycarbonyl)methyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic Acid</h4><div class="NLM_p last">A mixture of methyl 5-((<i>tert</i>-butoxycarbonyl)methyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate in MeOH (25 mL) and NaOH (1 N, 6.0 mL) was stirred at rt. After 70 min, NaOH pellets (0.683 g, 17.1 mmol) were added. After stirring for 1 h at rt, the flask was fitted with a reflux condenser and placed in a preheated oil bath (80 °C). After 45 min, the mixture was allowed to cool to rt and treated with HCl (10%) to adjust the pH to about 2–4. The mixture was concentrated. The residue was treated with DCM–MeOH (1:1), and the resultant suspension was filtered. The filtrate was concentrated and the solid was again treated with DCM–MeOH (1:1), and the suspension was filtered. The filtrate was concentrated and the residue was dried under high vacuum to afford the title compound (1.573 g, 97%). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>17</sub>H<sub>21</sub>N<sub>3</sub>O<sub>5</sub>, 347.2; found, 348.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.45 (s, 9 H), 3.63 (s, 3 H), 4.53 (d, <i>J</i> = 6.6 Hz, 2 H), 6.03 (br s, 1 H), 7.34 (d, <i>J</i> = 1.2 Hz, 2 H), 7.48–7.62 (m, 3 H), 12.03 (br s, 1 H).</div></div><div id="sec3_9_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> (F) <i>tert</i>-Butyl (4-((3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)carbamoyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-5-yl)methylcarbamate (<b>26a</b>)</h4><div class="NLM_p last">The general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines was followed to prepare the title compound (1.197 g, 31%). Part of this material (0.5 g) was further purified on HPLC (10–95% MeCN/H<sub>2</sub>O with 0.1% TFA) to provide an analytically pure sample. MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>33</sub>H<sub>32</sub>FN<sub>5</sub>O<sub>6</sub>, 613.2; found, 614.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.47 (s, 9 H), 3.66 (s, 3 H), 4.09 (s, 3 H), 4.62 (d, <i>J</i> = 6.6 Hz, 2 H), 6.11 (t, <i>J</i> = 6.6 Hz, 1 H), 6.72 (d, <i>J</i> = 6.5 Hz, 1 H), 7.19–7.25 (m, 1 H), 7.38 (d, <i>J</i> = 7.6 Hz, 3 H), 7.44 (dd, <i>J</i> = 9.4, 2.2 Hz, 1 H), 7.55–7.63 (m, 3 H), 7.95–8.13 (m, 2 H), 8.41 (d, <i>J</i> = 9.2 Hz, 1 H), 8.81 (d, <i>J</i> = 6.6 Hz, 1 H), 10.96 (s, 1 H).</div></div></div><div id="sec3_9_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 5-(Aminomethyl)-<i>N</i>-(3-fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>26b</b>)</h3><div class="NLM_p last"><i>tert</i>-Butyl (4-((3-fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)carbamoyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-5-yl)methylcarbamate (667 mg, 1.09 mmol) was dissolved in DCM (10 mL), and TFA (0.50 mL, 6.5 mmol) was added. The mixture was stirred in a water bath under N<sub>2</sub> for 90 min, and then more TFA (0.50 mL, 6.5 mmol) was added, and stirring was continued. After 3.5 h, the reaction mixture was concentrated, treated with NH<sub>3</sub> in MeOH (2 N, 10 mL), and concentrated. The residue was purified by chromatography on silica gel [MeOH–DCM (1:50), then (2 N NH<sub>3</sub> in MeOH)–DCM (1:10 to 1:5)] to afford the title compound (336 mg, 60%). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>28</sub>H<sub>24</sub>FN<sub>5</sub>O<sub>4</sub>, 513.2; found, 514.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.01 (br s, 2 H), 3.51 (s, 3 H), 3.98 (s, 3 H), 4.30, (s, 2 H), 6.43 (d, <i>J</i> = 5.3 Hz, 1 H), 7.16–7.26 (m, 2 H), 7.32 (d, <i>J</i> = 8.4 Hz, 1 H), 7.39 (d, <i>J</i> = 8.0 Hz, 2 H), 7.44 (s, 1 H), 7.48–7.54 (m, 1 H), 7.56–7.64 (m, 2 H), 7.92 (d, <i>J</i> = 12.3 Hz, 1 H), 8.28 (d, <i>J</i> = 9.0 Hz, 1 H), 8.61 (d, <i>J</i> = 5.1 Hz, 1 H), 10.93 (s, 1 H).</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 5-((Ethyl(methyl)amino)methyl)-<i>N</i>-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>26c</b>)</h3><div id="sec3_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> (A) Methyl 5-((Ethyl(methyl)amino)methyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (<b>25c</b>)</h4><div class="NLM_p last">Methyl 5-(bromomethyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (368 mg, 1.13 mmol) was suspended in DCM (8 mL), and <i>N</i>-ethylmethylamine (0.12 mL, 1.4 mmol) was added. The mixture was stirred under N<sub>2</sub> at rt for 75 min, and then more <i>N</i>-ethylmethylamine (0.03 mL, 0.04 mmol) was added. After 2.5 h, the mixture was concentrated and the residue was purified by chromatography on silica gel [MeOH–DCM (25:1) to (2 N NH<sub>3</sub> in MeOH)–DCM (10:1)] to afford the title compound (331 mg) that was taken directly to the next step. MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>16</sub>H<sub>21</sub>N<sub>3</sub>O<sub>3</sub>, 303.2; found, 304.1 (M + H). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 1.11 (t, <i>J</i> = 7.1 Hz, 3 H), 2.30 (s, 3 H), 2.57 (q, <i>J</i> = 7.1 Hz, 2 H), 3.48 (s, 3 H), 3.85 (s, 3 H), 3.98 (s, 2 H), 7.29–7.33 (m, 2 H), 7.37–7.43 (m, 1 H), 7.47–7.53 (m, 2 H).</div></div><div id="sec3_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> (B) 5-((Ethyl(methyl)amino)methyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic Acid</h4><div class="NLM_p last">Methyl 5-((ethyl(methyl)amino)methyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (331 mg, 1.09 mmol) was dissolved in MeOH (6 mL). Aqueous NaOH (1 N, 0.6 mL) and solid NaOH (96 mg, 2.42 mmol) were added. The flask was fitted with a reflux condenser and placed in a preheated oil bath (90 °C) and stirred for 1.5 h. The mixture was allowed to cool to rt, partially concentrated, and treated with HCl (concd) to lower the pH to ∼5. The mixture was concentrated, triturated with MeOH–DCM (1:1), and filtered. The filtrate was concentrated, and the residue was dried under high vacuum to afford the title compound (366.5 mg) that was taken to the next step. MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>15</sub>H<sub>19</sub>N<sub>3</sub>O<sub>3</sub>, 289.1; found, 290.1 (M + H).</div></div><div id="sec3_10_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> (C) 5-((Ethyl(methyl)amino)methyl)-<i>N</i>-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>26c</b>)</h4><div class="NLM_p last">The general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines was followed to prepare the title compound (42 mg, 7% over 3 steps from the methyl ester). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>31</sub>H<sub>30</sub>FN<sub>5</sub>O<sub>4</sub>, 555.2; found, 555.8 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.15 (t, <i>J</i> = 7.0 Hz, 3 H), 2.37 (s, 3 H), 2.63 (q,<i>J</i> = 6.8 Hz, 2 H), 3.58 (s, 3 H), 3.98 (s, 3 H), 4.22 (s, 2 H), 6.41 (d, <i>J</i> = 5.1 Hz, 1 H), 7.15–7.19 (m, 1 H), 7.21–7.33 (m, 2 H), 7.36–7.43 (m, 3 H), 7.47–7.54 (m, 1 H), 7.55–7.61 (m, 2 H), 7.92 (d, <i>J</i> = 11.9 Hz, 1 H), 8.28 (d, <i>J</i> = 9.2 Hz, 1 H), 8.59 (d, <i>J</i> = 4.9 Hz, 1 H), 11.06 (s, 1 H).</div></div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-methyl-3-oxo-2-phenyl-5-(pyrrolidin-1-ylmethyl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>26d</b>)</h3><div id="sec3_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> (A) Methyl 1-Methyl-3-oxo-2-phenyl-5-(pyrrolidin-1-ylmethyl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (<b>25d</b>)</h4><div class="NLM_p last">Methyl 5-(bromomethyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (1.266 g, 3.89 mmol) was dissolved in DCM (30 mL), and pyrrolidine (0.40 mL, 4.8 mmol) was added via syringe. The mixture was stirred under N<sub>2</sub> at rt. After 20 min, more pyrrolidine (0.090 mL, 1.1 mmol) was added, and stirring was continued for 3.5 h. The mixture was concentrated, and the residue was purified by chromatography on silica gel [MeOH–DCM (1:50 to 1:25),(2 N NH<sub>3</sub> in MeOH)–DCM (1:15)] to give the title compound (1.182 g, 67%). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>17</sub>H<sub>21</sub>N<sub>3</sub>O<sub>3</sub>, 315.2; found, 316.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.81 (dt, <i>J</i> = 6.5, 3.1 Hz, 4 H), 2.65 (t, <i>J</i> = 6.0 Hz, 4 H), 3.48 (s, 3 H), 3.86 (s, 3 H), 4.12 (s, 2 H), 7.32 (d, <i>J</i> = 7.4 Hz, 2 H), 7.38–7.44 (m, 1 H), 7.48–7.54 (m, 2 H).</div></div><div id="sec3_11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> (B) 1-Methyl-3-oxo-2-phenyl-5-(pyrrolidin-1-ylmethyl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic Acid</h4><div class="NLM_p last">Methyl 1-methyl-3-oxo-2-phenyl-5-(pyrrolidin-1-ylmethyl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (1.182 g, 3.7 mmol) was dissolved in MeOH (17 mL). Aqueous NaOH (1.0 M, 4.2 mL, 4.2 mmol) and solid NaOH (282 mg, 7.05 mmol) were added. The mixture was stirred at rt for 3 h and then stirred at 90 °C for 1 h. The mixture was then cooled to rt and treated with a solution of HCl (10%) to lower the pH to ∼2. The mixture was concentrated, treated with MeOH–DCM (1:1), and filtered. The filtrate was concentrated to give the title compound (1.342 g, 93%). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>16</sub>H<sub>19</sub>N<sub>3</sub>O<sub>3</sub>, 301.1; found, 302.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.17–2.23 (m, 4 H), 3.45–3.55 (m, 4 H), 3.83 (s, 3 H), 4.75 (s, 2 H), 7.44–7.49 (m, 2 H), 7.51–7.61 (m, 3 H).</div></div><div id="sec3_11_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> (C) <i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-methyl-3-oxo-2-phenyl-5-(pyrrolidin-1-ylmethyl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>26d</b>)</h4><div class="NLM_p last">The general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines was followed to prepare the title compound (81 mg, 8%). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>32</sub>H<sub>30</sub>FN<sub>5</sub>O<sub>4</sub>, 567.2; found, 568.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.84 (br s, 4 H), 2.72 (br s, 4 H), 3.58 (s, 3 H), 3.98 (s, 3 H), 4.28–4.40 (m, 2 H), 6.41 (d, <i>J</i> = 5.3 Hz, 1 H), 7.10–7.20 (m, 1 H), 7.20–7.34 (m, 2 H), 7.36–7.44 (m, 3 H), 7.47–7.54 (m, 1 H), 7.55–7.65 (m, 2 H), 7.93 (d, <i>J</i> = 13.1 Hz, 1 H), 8.28 (d, <i>J</i> = 9.0 Hz, 1 H), 8.60 (d, <i>J</i> = 5.1 Hz, 1 H), 11.06 (s, 1 H).</div></div></div><div id="sec3_11_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> <i>N</i>-(5-(7-Methoxyquinolin-4-yloxy)pyridin-2-yl)-1-methyl-3-oxo-2-phenyl-5-(pyrrolidin-1-ylmethyl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>27</b>)</h3><div class="NLM_p last">The general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines was followed to prepare the title compound (90 mg, 8%). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>31</sub>H<sub>30</sub>N<sub>6</sub>O<sub>4</sub>, 550.2; found, 551.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.84 (br s, 4 H), 2.73 (br s, 4 H), 3.57 (s, 3 H), 3.98 (s, 3 H), 4.35 (s, 2 H), 6.43 (d, <i>J</i> = 5.1 Hz, 1 H), 7.24 (d, <i>J</i> = 9.0 Hz, 1 H), 7.36–7.63 (m, 7 H), 8.22–8.28 (m., 2 H), 8.37 (d, <i>J</i> = 9.00 Hz, 1 H), 8.61 (d, <i>J</i> = 5.3 Hz, 1 H), 11.44 (s, 1 H).</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 5-(2-Aminopropan-2-yl)-<i>N</i>-(3-fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>35a</b>)</h3><div id="sec3_12_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> (A) <i>tert</i>-Butyl 2-Methyl-1-oxo-1-(2-phenylhydrazinyl)propan-2-ylcarbamate (<b>29a</b>)</h4><div class="NLM_p last">The title compound was prepared from 2-(<i>tert</i>-butoxycarbonylamino)-2-methylpropanoic acid <b>28a</b> (5.26 g, 25.90 mmol) according to the procedure described for <b>29b</b> (5.92 g, 78%). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>15</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>, 293.2; found, 316.1 (M + Na). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.49 (s, 9 H), 1.57 (s, 6 H), 4.87 (br s, 1 H), 6.04 (d, <i>J</i> = 4.3 Hz, 1 H), 6.89 (d, <i>J</i> = 7.6 Hz, 3 H), 7.23 (t, <i>J</i> = 7.9 Hz, 2 H), 8.48 (br s, 1 H).</div></div><div id="sec3_12_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> (B) Benzyl 2-(2-(<i>tert</i>-Butoxycarbonylamino)-2-methylpropanoyl)-1-phenylhydrazinecarboxylate (<b>30a</b>)</h4><div class="NLM_p last">The title compound was prepared from <i>tert</i>-butyl 2-methyl-1-oxo-1-(2-phenylhydrazinyl)propan-2-ylcarbamate (5.88 g, 20.0 mmol) according to the procedure described for <b>30b</b> (7.540 g, 81%). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>29</sub>N<sub>3</sub>O<sub>5</sub>, 427.2; found, 450.0 (M + Na). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.24 (br s, 6 H), 1.36 (s, 9 H), 5.13 (s, 2 H), 7.04–7.11 (m, 2 H), 7.26 (t, <i>J</i> = 7.6 Hz, 2 H), 7.30–7.39 (m, 6 H), 7.52 (br s, 1 H), 10.47 (s, 1 H).</div></div><div id="sec3_12_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> (C) Benzyl 2-(2-(<i>tert</i>-Butoxycarbonylamino)-2-methylpropanoyl)-2-methyl-1-phenylhydrazinecarboxylate (<b>31a</b>)</h4><div class="NLM_p last">The title compound was prepared from benzyl 2-(2-(<i>tert</i>-butoxycarbonylamino)-2-methylpropanoyl)-1-phenylhydrazinecarboxylate (4.033 g, 9.43 mmol) according to the procedure described for <b>31b</b> and was used directly in the next step. MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>31</sub>N<sub>3</sub>O<sub>5</sub>, 441.2; found, 342.1 (M-Boc + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.37 (s, 15 H), 3.28 (s, 3 H), 5.14 (s, 2 H), 7.10–7.14 (m, 1 H), 7.21–7.43 (m, 8 H), 7.47–7.57 (br s, 1 H), 7.62 (s, 1 H).</div></div><div id="sec3_12_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> (D) <i>tert</i>-Butyl 2-Methyl-1-(1-methyl-2-phenylhydrazinyl)-1-oxopropan-2-ylcarbamate (<b>32a</b>)</h4><div class="NLM_p last">The title compound was prepared according to the procedure described for <b>32b</b> to give 3.306 g (86% over 2 steps). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>16</sub>H<sub>25</sub>N<sub>3</sub>O<sub>3</sub>, 307.2; found, 252.1 (M-C<sub>4</sub>H<sub>8</sub> + H).</div></div><div id="sec3_12_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> (E) 5-(2-(<i>tert</i>-Butoxycarbonyl)propan-2-yl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>34a</b>)</h4><div class="NLM_p last">The title compound was prepared according to the procedure described for <b>34b</b>from <i>tert</i>-butyl 2-methyl-1-(1-methyl-2-phenylhydrazinyl)-1-oxopropan-2-ylcarbamate (2.50 g, 8.1 mmol) to give 1.53 g (27% over 2 steps). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>19</sub>H<sub>25</sub>N<sub>3</sub>O<sub>5</sub>, 375.2; found, 376.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.40 (s, 9 H), 1.89 (s, 6 H), 3.67 (s, 3 H), 6.84 (br s, 1 H), 7.37–7.41 (m, 2 H), 7.46–7.51 (m, 1 H), 7.54–7.60 (m, 2 H).</div></div><div id="sec3_12_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> (F) 5-(2-Aminopropan-2-yl)-<i>N</i>-(3-fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>35a</b>)</h4><div class="NLM_p last">The title compound was prepared according to the general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines, followed by the removal of the Boc group (28 mg, 8% over 2 steps). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>30</sub>H<sub>28</sub>FN<sub>5</sub>O<sub>4</sub>, 541.2; found, 542.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.87 (s, 6 H), 3.59 (s, 3 H), 3.98 (s, 3 H), 6.42 (dd, <i>J</i> = 5.3, 0.8 Hz, 1 H), 7.18–7.27 (m, 2 H), 7.34 (d, <i>J</i> = 10.0 Hz, 1 H), 7.40–7.53 (m, 4 H), 7.55–7.61 (m, 2 H), 7.92 (dd, <i>J</i> = 12.3, 2.4 Hz, 1 H), 8.28 (d, <i>J</i> = 9.2 Hz, 1 H), 8.59 (d, <i>J</i> = 5.3 Hz, 1 H), 11.95 (s, 1 H).</div></div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> (<i>S</i>)-<i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-methyl-3-oxo-2-phenyl-5-(pyrrolidin-2-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>35b</b>)</h3><div id="sec3_13_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> (A) (<i>S</i>)-<i>tert</i>-Butyl 2-(2-Phenylhydrazinecarbonyl)pyrrolidine-1-carboxylate (<b>29b</b>)</h4><div class="NLM_p last">To a mixture of (<i>S</i>)-1-(<i>tert</i>-butoxycarbonyl)pyrrolidine-2-carboxylic acid (<b>28b</b>, 6.021 g, 27.97 mmol) and 1-hydroxybenzotriazole (5.156 g, 38.16 mmol) in DCM (100 mL) was added EDCI-HCl (6.462 g, 33.71 mmol), Et<sub>3</sub>N (4.70 mL, 33.7 mmol), and 1-phenylhydrazine (3.40 mL, 34.5 mmol). The mixture was stirred at rt under N<sub>2</sub> for 3 h and then was treated with H<sub>2</sub>O (100 mL) and HCl (1 N, 75 mL). The organic phase was separated, and the aqueous phase was filtered and the solid was washed with H<sub>2</sub>O and DCM. The layers of the filtrate were separated, and the combined organic phases were washed with HCl (1 N, 3 × 50 mL), saturated Na<sub>2</sub>CO<sub>3</sub> (75 mL), and brine (75 mL). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated, and dried under high vacuum to afford the title compound (8.50 g, 100%). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>16</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>, 305.2; found, 250.1 (M – C<sub>4</sub>H<sub>8</sub> + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.52 (s, 9 H), 1.88–2.08 (m, 3 H), 2.35–2.50 (m, 1 H), 3.30–3.60 (m, 2 H), 4.39 (br s, 1 H), 6.07 (d, <i>J</i> = 3.3 Hz, 1 H), 6.84 (d, <i>J</i> = 7.8 Hz, 2 H), 6.85–6.95 (m, 1 H), 7.23 (t, <i>J</i> = 7.6 Hz, 2 H), 8.76 (br s, 1 H).</div></div><div id="sec3_13_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> (B) (<i>S</i>)-<i>tert</i>-Butyl 2-(2-(Benzyloxycarbonyl)-2-phenylhydrazinecarbonyl)pyrrolidine-1-carboxylate (<b>30b</b>)</h4><div class="NLM_p last">To a solution of (<i>S</i>)-<i>tert</i>-butyl 2-(2-phenylhydrazinecarbonyl)pyrrolidine-1-carboxylate (8.50 g, 27.8 mmol) in THF (150 mL) was added aqueous NaOH (5.0 N, 14.0 mL, 70 mmol) and benzyl chloroformate (5.0 mL, 35 mmol). After the mixture was stirred at rt overnight, more NaOH (5 N, 13 mL, 65 mmol) and benzyl chloroformate (8.0 mL, 56 mmol) were added. After another 30 min, H<sub>2</sub>O (200 mL) was added, and the layers were separated. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was washed repeatedly with hexanes and then dried under high vacuum. The material was purified by chromatography on silica gel using MeOH–DCM (0–2.5%) as eluent to afford the title compound (5.31 g, 26%). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>29</sub>N<sub>3</sub>O<sub>5</sub>, 439.2; found, 462.1 (M + Na).</div></div><div id="sec3_13_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> (C) (<i>S</i>)-<i>tert</i>-Butyl 2-(2-(benzyloxycarbonyl)-1-methyl-2-phenylhydrazinecarbonyl)pyrrolidine-1-carboxylate (<b>31b</b>)</h4><div class="NLM_p last">To a solution of (<i>S</i>)-<i>tert</i>-butyl 2-(2-(benzyloxycarbonyl)-2-phenylhydrazinecarbonyl)pyrrolidine-1-carboxylate (5.31 g, 12.1 mmol) in DMF (50 mL), cooled in an ice–water bath under N<sub>2</sub>, was added NaH (683 mg, 60% in mineral oil). After 20 min, more DMF (40 mL) was added, and the reaction was allowed to warm to rt and stirred for 1 h. More DMF (10 mL) was added, followed by MeI (0.81 mL, 13 mmol). The resulting homogeneous mixture was stirred at rt for 15 min and then was poured into ice and allowed to warm to rt overnight. The aqueous phase was extracted with DCM, and the combined organic extracts were washed with H<sub>2</sub>O (4 × 200 mL) and brine (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under high vacuum to afford the title compound that was taken on to the next step. MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>31</sub>N<sub>3</sub>O<sub>5</sub>, 453.2; found, 354.1 (M-Boc + H).</div></div><div id="sec3_13_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> (D) (<i>S</i>)-<i>tert</i>-Butyl 2-(1-Methyl-2-phenylhydrazinecarbonyl)pyrrolidine-1-carboxylate (<b>32b</b>)</h4><div class="NLM_p last">A mixture of (<i>S</i>)-<i>tert</i>-butyl 2-(2-(benzyloxycarbonyl)-1-methyl-2-phenylhydrazinecarbonyl)pyrrolidine-1-carboxylate (5.275 g, 11.63 mmol) and Pd/C (5%, 505 mg) in MeOH (100 mL) was evacuated and backfilled with H<sub>2</sub> (balloon). The mixture was stirred at rt for 2 h and filtered through a pad of Celite. The filtrate was concentrated, and the residue was dried under high vacuum to afford the tile compound (3.890 g, 83% over 2 steps). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>17</sub>H<sub>25</sub>N<sub>3</sub>O<sub>3</sub>, 319.2; found, 220.1 (M-Boc + H).</div></div><div id="sec3_13_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> (E) (<i>S</i>)-5-(1-(<i>tert</i>-Butoxycarbonyl)pyrrolidin-2-yl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>34b</b>)</h4><div class="NLM_p last">To a solution of (<i>S</i>)-<i>tert</i>-butyl 2-(1-methyl-2-phenylhydrazinecarbonyl)pyrrolidine-1-carboxylate (3.890 g, 12.18 mmol) and DMAP (2.059 g, 16.85 mmol) in DCM (100 mL), cooled under N<sub>2</sub> in an ice water bath, was added ethyl malonoyl chloride (1.85 mL, 14.7 mmol). After 1 h at rt, more DMAP (889 mg, 7.29 mol) and ethyl malonylchloride (0.70 mL, 5.6 mmol) were added. After 30 min, the mixture was treated with H<sub>2</sub>O (100 mL). The aqueous phase was extracted with DCM. The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated, and purified by chromatography on silica gel with MeOH–DCM (0–3.5%). The purified material was dissolved in EtOH (54 mL), and sodium ethoxide (1.94 g, 28.5 mmol) was added. The mixture was stirred at rt under N<sub>2</sub> for 2.5 h and then heated at 90 °C–100 °C for 18 h. The mixture was allowed to cool to rt and then was diluted with H<sub>2</sub>O (25 mL) and partially concentrated. The residue was washed repeatedly with DCM. The DCM extracts were combined and washed with NaOH (1 N, 15 mL). The aqueous phases were combined, and the pH was adjusted to ∼4. The aqueous phase was concentrated and extracted with MeOH–DCM (1:3). The combined extracts were concentrated, and the residue was dried under high vacuum to afford the title compound (1.117 g, 21% over 2 steps). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>20</sub>H<sub>25</sub>N<sub>3</sub>O<sub>5</sub>, 387.2; found, 388.1 (M + H).</div></div><div id="sec3_13_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> (F) (<i>S</i>)-<i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-methyl-3-oxo-2-phenyl-5-(pyrrolidin-2-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>35b</b>)</h4><div class="NLM_p">The general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines was followed to prepare the Boc-protected derivative (<i>S</i>)-<i>tert</i>-butyl 2-(4-((3-fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)carbamoyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-5-yl)pyrrolidine-1-carboxylate. MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>36</sub>H<sub>36</sub>FN<sub>5</sub>O<sub>6</sub>, 653.3; found, 654.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.37–1.51 (m, 9 H), 2.00–2.15 (m, 4 H), 2.68 (br s, 2 H), 3.43 (s, 3 H), 3.48–3.56 (m, 1 H), 4.08 (s, 3 H), 6.76 (d, <i>J</i> = 6.6 Hz, 1 H), 7.18–7.25 (m, 1 H), 7.31–7.38 (m, 3 H), 7.45 (dd, <i>J</i> = 9.4, 2.4 Hz, 1 H), 7.46–7.63 (m, 3 H), 7.86 (d, <i>J</i> = 2.4 Hz, 1 H), 8.04 (dd, <i>J</i> = 12.5, 2.4 Hz, 1 H), 8.43 (d, <i>J</i> = 9.4 Hz, 1 H), 8.77 (d, <i>J</i> = 6.5 Hz, 1 H), 11.15 (s, 1 H).</div><div class="NLM_p last">(<i>S</i>)-<i>tert</i>-Butyl 2-(4-((3-fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)carbamoyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-5-yl)pyrrolidine-1-carboxylate (0.82 g, 1.3 mmol) was dissolved in DCM and TFA (0.77 mL, 10 mmol) was added. After 23 h, the mixture was treated with NH<sub>3</sub> in MeOH (2 N) and then concentrated. The residue was filtered through a silica gel plug [MeOH–DCM (2–10%); (2 N NH<sub>3</sub> in MeOH)–DCM (5%)]. The fractions with the desired product were collected, concentrated, and purified on HPLC (10–95% MeCN/H<sub>2</sub>O with 0.1% TFA) to afford the title compound (72 mg, 11% over 2 steps). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>31</sub>H<sub>28</sub>FN<sub>5</sub>O<sub>4</sub>, 553.2; found, 554.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.81–2.11 (m, 3 H), 2.42 (dtd, <i>J</i> = 12.0, 7.9,4.0 Hz, 1 H), 3.05–3.12 (m, 1 H), 3.19–3.26 (m, 1 H), 3.66 (s, 3 H), 3.97 (s, 3 H), 5.38 (t, <i>J</i> = 8.6 Hz, 1 H), 6.40 (dd, <i>J</i> = 5.3, 0.8 Hz, 1 H), 7.12–7.20 (m, 1 H), 7.22 (dd, <i>J</i> = 9.1, 2.4 Hz, 1 H), 7.27–7.31 (m, 1 H), 7.35–7.43 (m, 3 H), 7.46–7.53 (m, 1 H), 7.54–7.62 (m, 2 H), 7.91 (dd, <i>J</i> = 12.4, 2.4 Hz, 1 H), 8.27 (d, <i>J</i> = 9.2 Hz, 1 H), 8.59 (d, <i>J</i> = 5.1 Hz, 1 H), 11.22 (s, 1 H).</div></div></div><div id="sec3_13_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> (<i>S</i>)-<i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-methyl-3-oxo-2-phenyl-5-(pyrrolidin-2-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>36</b>)</h3><div class="NLM_p">The Boc-protected derivative (<i>S</i>)-<i>tert</i>-butyl 2-(4-((5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)carbamoyl)-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-5-yl)pyrrolidine-1-carboxylate was prepared according to the general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines. MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>35</sub>H<sub>36</sub>N<sub>6</sub>O<sub>6</sub>, 636.3; found, 637.2 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.36–1.53 (m, 9 H), 2.02–2.16 (m, 4 H), 2.65–2.73 (m, 2 H), 3.43 (s, 3 H), 3.45–3.52 (m, 1 H), 4.08 (s, 3 H), 6.76 (d, <i>J</i> = 6.6 Hz, 1 H), 7.36 (d, <i>J</i> = 7.2 Hz, 2 H), 7.47 (dd, <i>J</i> = 9.3, 2.2 Hz, 1 H), 7.51–7.64 (m, 4 H), 7.85 (d, <i>J</i> = 2.4 Hz, 1 H), 8.31 (d, <i>J</i> = 2.7 Hz, 1 H), 8.42 (d, <i>J</i> = 9.4 Hz, 1 H), 8.49 (d, <i>J</i> = 8.4 Hz, 1 H), 8.81 (d, <i>J</i> = 6.3 Hz, 1 H), 11.49 (s, 1 H).</div><div class="NLM_p last">The intermediate from previous step was dissolved in DCM (8 mL), and TFA (0.60 mL, 7.8 mmol) was added. The mixture was stirred at rt overnight. More TFA (0.55 mL) was added, and stirring was continued for 3 h. The reaction mixture was treated with a solution of NH<sub>3</sub> in MeOH (2 N) and stirred for 1 h. The mixture was concentrated, and the residue was purified on a silica gel column [(2 N NH<sub>3</sub> in MeOH)–DCM (5–10%)] to afford the title compound (175 mg, 28% over 2 steps). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>30</sub>H<sub>28</sub>N<sub>6</sub>O<sub>4</sub>, 536.2; found, 537.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.02–2.28 (m, 3 H), 2.48 (qd, <i>J</i> = 7.8, 3.5 Hz, 1 H), 3.30–3.39 (m, 1 H), 3.42–3.51 (m, 1 H), 3.63 (s, 3 H), 3.98 (s, 3 H), 5.28–5.32 (m, 1 H), 6.44 (d, <i>J</i> = 5.3 Hz, 1 H), 7.24 (dd, <i>J</i> = 9.3, 2.4 Hz, 1 H), 7.37–7.44 (m, 3 H), 7.48–7.60 (m, 4 H), 8.21–8.28 (m, 3 H), 8.62 (d, <i>J</i> = 5.3 Hz, 1 H), 11.70 (s, 1 H).</div></div><div id="sec3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> (±)-<i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-methyl-3-oxo-2-phenyl-5-(tetrahydrofuran-2-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>42a</b>)</h3><div id="sec3_14_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> (A) (±)-Methyl 3-Oxo-3-(tetrahydrofuran-2-yl)propanoate (<b>38a</b>)</h4><div class="NLM_p last">In a 100 mL round-bottomed flask under N<sub>2</sub> was mixed tetrahydro-2-furoic acid (2.0 mL, 20.7 mmol), CDI (4.02 g, 24.8 mmol), and THF (50 mL). The mixture was stirred at rt for 1.5 h before magnesium chloride (1.97 g, 20.7 mmol) and methyl potassium malonate (3.23 g, 20.7 mmol) were added. After stirring at rt overnight, the reaction mixture was carefully neutralized with HCl (2 N) (exothermic, gas evolution). The aqueous phase was extracted with DCM (3×). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude mixture was purified by chromatography on silica gel with DCM–MeOH (100:0 to 90:10) to afford the title compound (3.29 g, 92.4% yield) as colorless oil. MS (ESI pos ion) calcd for C<sub>8</sub>H<sub>12</sub>O<sub>4</sub>, 172.1; found, 173.1 (M + H).</div></div><div id="sec3_14_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> (B) (±)-1-Methyl-2-phenyl-5-(tetrahydrofuran-2-yl)-1<i>H</i>-pyrazol-3(2<i>H</i>)-one (<b>39a</b>)</h4><div class="NLM_p last">A mixture of methyl 3-oxo-3-(tetrahydrofuran-2-yl)propanoate (1973 mg, 11460 μmol) and 1-methyl-2-phenylhydrazine (700 mg, 5730 μmol) in PhMe (2 mL) in a 25 mL sealed tube under N<sub>2</sub> were stirred at rt for 2 d. After 48 h, the reaction mixture was directly purified by chromatography on silica gel with MeOH/EtOAc (10:90) to afford the title compound (255 mg, 18.2%) as a white solid. MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>16</sub>N<sub>2</sub>O<sub>2</sub>, 244.1; found, 245.1(M + H).</div></div><div id="sec3_14_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> (C) (±)-1-Methyl-3-oxo-2-phenyl-5-(tetrahydrofuran-2-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carbaldehyde (<b>40a</b>)</h4><div class="NLM_p last">In a 10 mL round-bottomed flask under N<sub>2</sub> was added POCl<sub>3</sub> (389 μL, 4175 μmol) to DMF (2021 μL, 26096 μmol) at 0 °C. After 45 min, the Vilsmeier reagent was transferred via cannula to solid 1-methyl-2-phenyl-5-(tetrahydrofuran-2-yl)-1,2-dihydropyrazol-3-one (255 mg, 1044 μmol) and the mixture was stirred at rt for 48 h. The reaction mixture was poured into a mixture of ice and NaOH (2 N). The aqueous phase was extracted with DCM (5×), and the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give the aldehyde. MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>16</sub>N<sub>2</sub>O<sub>3</sub>, 272.1; found, 273.1 (M + H).</div></div><div id="sec3_14_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> (D) (±)-1-Methyl-3-oxo-2-phenyl-5-(tetrahydrofuran-2-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic (<b>41a</b>)</h4><div class="NLM_p last">In a 100 -mL round-bottomed flask cooled to 0 °C was added 1-methyl-3-oxo-2-phenyl-5-(tetrahydrofuran-2-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carbaldehyde (284 mg, 1043 μmol), <i>t</i>-BuOH (5 mL), and then 2-methyl-2-butene (2210 μL, 20859 μmol). A solution of sodium chlorite (377 mg, 4172 μmol) in H<sub>2</sub>O (4 mL) was added dropwise followed by slow addition of KH<sub>2</sub>PO<sub>4</sub>(1135 mg, 8344 μmol) in H<sub>2</sub>O (4 mL). The biphasic mixture was warmed to rt and stirred vigorously for 48 h to give, after acidic workup, the title compound. MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>16</sub>N<sub>2</sub>O<sub>4</sub>, 288.1; found, 289.1(M + H).</div></div><div id="sec3_14_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> (E) (±)-<i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-methyl-3-oxo-2-phenyl-5-(tetrahydrofuran-2-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>42a</b>)</h4><div class="NLM_p last">The title compound was prepared using 3-fluoro-4-(7-methoxyquinolin-4-yloxy)aniline according to the general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines to give a white solid (325 mg, 86%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>5</sub>, 554.2; found, 555.2 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.01–2.16 (m, 3 H), 2.42–2.48 (m, 1 H), 3.50 (s, 3 H), 3.85–3.92 (m, 1 H), 3.95 (s, 3 H), 4.05–4.13 (m, 1 H), 5.94–6.03 (m, 1 H), 6.49 (d, <i>J</i> = 5.3 Hz, 1 H), 7.31 (dd, <i>J</i> = 9.2, 2.5 Hz, 1 H), 7.33–7.38 (m, 1 H), 7.40–7.45 (m, 2 H), 7.49 (d, <i>J</i> = 7.2 Hz, 2 H), 7.53–7.59 (m, 1 H), 7.59–7.66 (m, 2 H), 7.99 (dd, <i>J</i> = 13.0, 2.3 Hz, 1 H), 8.24 (d, <i>J</i> = 9.1 Hz, 1 H), 8.62 (d, <i>J</i> = 5.2 Hz, 1 H), 11.11 (s, 1 H).</div></div></div><div id="sec3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> (±)-<i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-methyl-3-oxo-2-phenyl-5-(tetrahydrofuran-3-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>42b</b>)</h3><div class="NLM_p">(A) 1-Methyl-3-oxo-2-phenyl-5-(tetrahydrofuran-2-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (<b>41b</b>) was prepared according to the procedure for the preparation of <b>41a</b>.</div><div class="NLM_p last">(B) The title compound was prepared using using 3-fluoro-4-(7-methoxyquinolin-4-yloxy)aniline according to the general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines to give a white solid (492 mg, 70%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>5</sub>, 554.2; found, 555.2 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.26–2.40 (m, 2 H), 3.47 (s, 3 H), 3.77 (q, <i>J</i> = 7.8 Hz, 1 H), 3.94 (s, 3 H), 3.96–4.01 (m, 1 H), 4.13 (t, <i>J</i> = 7.5 Hz, 1 H), 4.19 (td, <i>J</i> = 8.0, 4.0 Hz, 1 H), 4.55–4.66 (m, 1 H), 6.48 (d, <i>J</i> = 5.2 Hz, 1 H), 7.31 (dd, <i>J</i> = 9.2, 2.3 Hz, 1 H), 7.33–7.38 (m, 1 H), 7.40–7.46 (m, 2 H), 7.49 (d, <i>J</i> = 7.8 Hz, 2 H), 7.52–7.57 (m, 1 H), 7.58–7.65 (m, 2 H), 7.99 (dd, <i>J</i> = 13.1, 2.0 Hz, 1 H), 8.23 (d, <i>J</i> = 9.2 Hz, 1 H), 8.61 (d, <i>J</i> = 5.2 Hz, 1 H), 11.34 (s, 1 H).</div></div><div id="sec3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> <i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-methyl-3-oxo-2-phenyl-5-(tetrahydro-2<i>H</i>-pyran-4-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>42c</b>)</h3><div id="sec3_16_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> (A) Tetrahydro-2<i>H</i>-pyran-4-carboxylic Acid (<b>37c</b>)</h4><div class="NLM_p last">To a 100 mL round-bottomed flask was added methyl tetrahydro-2<i>H</i>-pyran-4-carboxylate (10 mL, 69 mmol) and MeOH (25 mL, 618 mmol). The mixture was chilled to −10 °C in a dry ice/acetone bath and allowed to stir for 10 min. KOH (12 g, 208 mmol) was added, and the mixture was allowed to stir at −10 °C for 5 h under inert atmosphere. The ice bath was removed, and the mixture was allowed to slowly warm to rt. After 20 min of stirring, the mixture was concentrated in vacuo. The residue was diluted with H<sub>2</sub>O and DCM, and the mixture was cooled in an ice bath. The chilled mixture was treated HCl (concd) until pH ∼ 2–3. The aqueous layer was extracted with DCM (3 × 50 mL). The combined organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to give the title compound (7.40 g, 57 mmol, 82%) as white solid. MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>6</sub>H<sub>10</sub>O<sub>3</sub>, 130.1; found, 131.2 (M + H). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.73–1.93 (m, 4 H), 2.53–2.64 (m, 1 H), 3.40–3.52 (m, 2 H), 3.99 (dt, <i>J</i> = 11.7, 3.6 Hz, 2 H), 5.30 (s, 1 H).</div></div><div id="sec3_16_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> (B) Methyl 3-Oxo-3-(tetrahydro-2<i>H</i>-pyran-4-yl) Propanoate (<b>38c</b>)</h4><div class="NLM_p last">The title compound was prepared from tetrahydro-2<i>H</i>-pyran-4-carboxylic acid (3.905 g, 30 mmol) according to the procedure for the preparation of <b>38a</b> to give the product as tan oil (2.80 g). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>9</sub>H<sub>14</sub>O<sub>4</sub>, 186.2; found, 187.1(M + H). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.62–1.85 (m, 5 H), 2.66–2.77 (m, 1 H), 3.43 (td, <i>J</i> = 11.5, 2.6 Hz, 2 H), 3.53 (s, 2 H), 3.74 (s, 3 H), 4.00 (ddd, <i>J</i> = 11.5, 3.9, 2.8 Hz, 2 H).</div></div><div id="sec3_16_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> (C) 1-Methyl-2-phenyl-5-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,2-dihydropyrazol-3-one (<b>39c</b>)</h4><div class="NLM_p last">To a 250 mL round-bottomed flask was added ethyl 3-oxo-3-(tetrahydro-2<i>H</i>-pyran-4-yl)propanoate (1.8 g, 9.1 mmol), HOAc (0.52 mL, 9.1 mmol), H<sub>2</sub>O (0.70 mL, 121 mmol), and pyridine (0.73 mL, 9.1 mmol). After 5 min, 1-methyl-2-phenylhydrazine (0.740 g, 6.1 mmol) was added. The mixture was placed in a preheated (105 °C) oil bath and stirred for 2 h. The reaction mixture was allowed to cool to rt and then was diluted with H<sub>2</sub>O, saturated NaHCO<sub>3</sub>, and DCM. The aqueous layer was extracted with DCM–MeOH (10:2, 3 × 24 mL), and the combined extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude mixture was purified by by chromatography on a prepacked amino-propyl silica-gel column (40 g) with MeOH–DCM (1–5%) as eluent to provide the title compound (0.430 g, 1.7 mmol, 27%) as tan solid. MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub>, 258.3; found, 259.1 (M + H).</div></div><div id="sec3_16_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> (D) 1-Methyl-3-oxo-2-phenyl-5-(tetrahydro-2<i>H</i>-pyran-4-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carbaldehyde (<b>40c</b>)</h4><div class="NLM_p last">The title compound was prepared according to the procedure for the preparation of <b>40a</b> to give, starting with 1-methyl-2-phenyl-5-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,2-dihydropyrazol-3-one (0.421 g, 1.6 mmol), the final compound as tan oil (0.380 g, 81%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub>, 286.3; found, 287.1 (M + H).</div></div><div id="sec3_16_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> (E) 1-Methyl-3-oxo-2-phenyl-5-(tetrahydro-2<i>H</i>-pyran-4-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>41c</b>)</h4><div class="NLM_p last">Starting with 1-methyl-3-oxo-2-phenyl-5-(tetrahydro-2<i>H</i>-pyran-4-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carbaldehyde (0.380 g, 1.3 mmol), the title compound was prepared using the procedure similar to that for the preparation of <b>41a</b> to give a light-yellow oil (0.400 g, 98%). To prevent decomposition, this material was carried into the next step of the synthesis without further purification. MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>18</sub>N<sub>2</sub>O<sub>4</sub>, 302.3; found, 303.1(M + H).</div></div><div id="sec3_16_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> (F) <i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-methyl-3-oxo-2-phenyl-5-(tetrahydro-2<i>H</i>-pyran-4-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>42c</b>)</h4><div class="NLM_p last">Starting with 3-fluoro-4-(7-methoxyquinolin-4-yloxy)aniline and 1-methyl-3-oxo-2-phenyl-5-(tetrahydro-2<i>H</i>-pyran-4-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (0.200 g, 0.66 mmol), the title compound was prepared using the general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines to give a tan solid (0.072 g, 19%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>29</sub>FN<sub>4</sub>O<sub>5</sub>, 568.5; found, 569.2 (M + H). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.83 (d, <i>J</i> = 11.0 Hz, 2 H), 2.33 (qd, <i>J</i> = 12.6, 4.4 Hz, 2 H), 3.49 (s, 3 H), 3.63 (t, <i>J</i> = 11.0 Hz, 2 H), 3.96 (s, 3 H), 4.15 (dd, <i>J</i> = 11.4, 3.8 Hz, 2 H), 4.47–4.60 (m, 1 H), 5.29 (s, 1 H), 6.40 (dd, <i>J</i> = 5.2, 0.8 Hz, 1 H), 7.14–7.42 (m, 4 H), 7.46–7.60 (m, 3 H), 7.92 (dd, <i>J</i> = 12.5, 2.3 Hz, 1 H), 8.27 (d, <i>J</i> = 9.2 Hz, 1 H), 8.59 (d, <i>J</i> = 5.3 Hz, 1 H), 11.25 (s, 1 H).</div></div></div><div id="sec3_16_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> <i>N</i>-(5-(7-Methoxyquinolin-4-yloxy)pyridin-2-yl)-1-methyl-3-oxo-2-phenyl-5-(tetrahydro-2<i>H</i>-pyran-4-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>43c</b>)</h3><div class="NLM_p last">Starting with 5-(7-methoxyquinolin-4-yloxy)pyridin-2-amine and 1-methyl-3-oxo-2-phenyl-5-(tetrahydro-2<i>H</i>-pyran-4-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (0.200 g, 0.66 mmol), the title compound was prepared using the general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines to give a colorless solid (0.050 g, 14%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>29</sub>N<sub>5</sub>O<sub>5</sub>, 551.5; found, 552.2 (M + H). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.76 (d, <i>J</i> = 10.7 Hz, 2 H), 2.19–2.35 (m, 2 H), 3.42 (s, 3 H), 3.50–3.60 (m, 2 H), 3.89 (s, 3 H), 4.07 (dd, <i>J</i> = 11.6, 3.8 Hz, 2 H), 4.37–4.49 (m, 1 H), 5.22 (s, 1 H), 6.34 (d, <i>J</i> = 5.3 Hz, 1 H), 7.15 (dd, <i>J</i> = 9.2, 2.5 Hz, 1 H), 7.28–7.50 (m, 5 H), 8.15 (d, <i>J</i> = 6.1 Hz, 1 H), 8.17 (s, 1 H), 8.29 (d, <i>J</i> = 9.1 Hz, 1 H), 8.52 (d, <i>J</i> = 5.3 Hz, 1 H), 11.55 (s, 1 H).</div></div><div id="sec3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> <i>N</i>-(5-(7-Methoxyquinolin-4-yloxy)pyridin-2-yl)-1-methyl-3-oxo-2-phenyl-5-(pyridin-4-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>43d</b>)</h3><div id="sec3_17_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> (A) 1-Methyl-2-phenyl-5-(pyridin-4-yl)-1,2-dihydropyrazol-3-one (<b>39d</b>)</h4><div class="NLM_p last">The title compound was prepared from ethyl isonicotinoylacetate (3.01 g, 16 mmol) according to the procedure for the preparation of <b>39c</b> to give the product (3.31 g). MS (ESI pos ion) calcd for C<sub>15</sub>H<sub>13</sub>N<sub>3</sub>O, 251.1; found, 252.1 (M + H). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 3.04 (s, 3 H), 5.98 (s, 1 H), 7.40–7.60 (m, 7 H), 8.80 (d, <i>J</i> = 6.1 Hz, 2 H).</div></div><div id="sec3_17_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> (B) 1-Methyl-3-oxo-2-phenyl-5-(pyridin-4-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carbaldehyde (<b>40d</b>)</h4><div class="NLM_p last">Prepared according to the procedure for the preparation of <b>40a</b>, from 1-methyl-2-phenyl-5-(pyridin-4-yl)-1,2-dihydropyrazol-3-one (3.31 g, 13 mmol) to yield the title compound that was taken to the next step without further purification. MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>16</sub>H<sub>13</sub>N<sub>3</sub>O<sub>2</sub>, 279.1; found, 280.1 (M + H).</div></div><div id="sec3_17_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> (C) 1-Methyl-3-oxo-2-phenyl-5-(pyridin-4-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>41d</b>)</h4><div class="NLM_p last">The title compound was prepared using the procedure similar to that for the preparation of <b>41a</b> (1.98 g, 52% over 2 steps). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>16</sub>H<sub>13</sub>N<sub>3</sub>O<sub>3</sub>, 295.1; found, 296.1 (M + H). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 3.18 (s, 3 H), 7.30–7.49 (m, 7 H), 8.69 (d, <i>J</i> = 6.0 Hz, 2 H).</div></div><div id="sec3_17_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> (D) <i>N</i>-(5-(7-Methoxyquinolin-4-yloxy)pyridin-2-yl)-1-methyl-3-oxo-2-phenyl-5-(pyridin-4-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>43d</b>)</h4><div class="NLM_p last">Starting with 5-(7-methoxyquinolin-4-yloxy)pyridin-2-amine and 1-methyl-3-oxo-2-phenyl-5-(pyridin-4-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid, the title compound was prepared using the general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines (285 mg, 45%). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>31</sub>H<sub>24</sub>N<sub>6</sub>O<sub>4</sub>, 544.2; found, 545.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.20 (s, 3 H), 3.98 (s, 3 H), 6.41 (d, <i>J</i> = 5.3 Hz, 1 H), 7.23 (d, <i>J</i> = 9.2 Hz, 1 H), 7.39–7.67 (m, 9 H), 8.21–8.27 (m, 3 H), 8.60 (d, <i>J</i> = 5.1 Hz, 1 H), 8.89 (d, <i>J</i> = 5.3 Hz, 2 H), 11.33 (s, 1 H).</div></div></div><div id="sec3_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> <i>N</i>-(5-(7-Methoxyquinolin-4-yloxy)pyridin-2-yl)-1-methyl-3-oxo-2-phenyl-5-(pyridin-2-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>43e</b>)</h3><div id="sec3_18_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> (A) 1-Methyl-2-phenyl-5-(pyridin-2-yl)-1<i>H</i>-pyrazol-3(2<i>H</i>)-one (<b>39e</b>)</h4><div class="NLM_p last">The title compound was prepared from ethyl picolinoylacetate (0.924 g, 4.8 mmol) according to the procedure for the preparation of <b>39c</b> to give the product as a tan solid (0.455 g, ∼70% pure at 254 nm). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>13</sub>N<sub>3</sub>O, 251.1; found, 252.1 (M + H). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 3.37 (s, 3 H), 7.36–7.45 (m, 2 H), 7.50–7.58 (m, 2 H), 7.87 (dd, <i>J</i> = 8.6, 1.0 Hz, 2 H), 7.93 (td, <i>J</i> = 7.7, 1.8 Hz, 2 H), 8.10 (d, <i>J</i> = 8.0 Hz, 1 H), 8.61 (d, <i>J</i> = 3.4 Hz, 1 H).</div></div><div id="sec3_18_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> (B) 1-Methyl-3-oxo-2-phenyl-5-(pyridin-2-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carbaldehyde (<b>40e</b>)</h4><div class="NLM_p last">Prepared according to the procedure for the preparation of <b>40a</b>, from 1-methyl-2-phenyl-5-(pyridin-2-yl)-1<i>H</i>-pyrazol-3(2<i>H</i>)-one (0.40 g, 1.6 mmol), to yield the title compound as a dark-brown oil (0.429 g). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>13</sub>N<sub>3</sub>O<sub>2</sub>, 279.2; found, 280.1 (M + H). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.88 (s, 3 H), 2.95 (s, 3 H), 3.39–3.45 (m, 3 H), 7.42–7.60 (m, 4 H), 7.83–7.96 (m, 2 H), 8.02 (s, 1 H), 8.78 (d, <i>J</i> = 4.7 Hz, 1 H), 9.91 (s, 1 H).</div></div><div id="sec3_18_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> (C) 1-Methyl-3-oxo-2-phenyl-5-(pyridin-2-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>41e</b>)</h4><div class="NLM_p last">Starting with 1-methyl-3-oxo-2-phenyl-5-(pyridin-2-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carbaldehyde (0.429 g, 1.5 mmol), the title compound was prepared using the procedure similar to that for the preparation of <b>41a</b> to yield a tan oil (0.390 g). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>13</sub>N<sub>3</sub>O<sub>3</sub>, 295.2; found, 296.1 (M + H).</div></div><div id="sec3_18_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> (D) <i>N</i>-(5-(7-Methoxyquinolin-4-yloxy)pyridin-2-yl)-1-methyl-3-oxo-2-phenyl-5-(pyridin-2-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>43e</b>)</h4><div class="NLM_p last">Starting with 5-(7-methoxyquinolin-4-yloxy)pyridin-2-amine and 1-methyl-3-oxo-2-phenyl-5-(pyridin-2-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (0.40 g, 1.4 mmol), the title compound was prepared using the general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines to give a tan solid (0.15 g, 20%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>24</sub>N<sub>6</sub>O<sub>4</sub>, 544.5; found, 545.2 (M + H). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 2.12 (s, 1 H), 3.24 (s, 3 H), 3.88 (s, 3 H), 6.32 (d, <i>J</i> = 5.3 Hz, 1 H), 7.13 (dd, <i>J</i> = 9.1, 2.4 Hz, 1 H), 7.20 (s, 1 H), 7.31–7.53 (m, 8 H), 7.80–7.90 (m, 2 H), 8.10–8.23 (m, 3 H), 8.50 (d, <i>J</i> = 5.3 Hz, 1 H), 8.72 (d, <i>J</i> = 4.8 Hz, 1 H), 11.39 (s, 1 H).</div></div></div><div id="sec3_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i116" class="anchor-spacer"></div><h3 class="article-section__title" id="_i116"> <i>N</i>-(5-(7-Methoxyquinolin-4-yloxy)pyridin-2-yl)-1-methyl-3-oxo-2-phenyl-5-(pyridin-3-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>43f</b>)</h3><div id="sec3_19_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> (A) 1-Methyl-2-phenyl-5-(pyridin-3-yl)-1,2-dihydropyrazol-3-one (<b>39f</b>)</h4><div class="NLM_p last">Starting with methyl nicotinoylacetate (1.3 g, 7.3 mmol), the title compound was prepared using a similar procedure for the preparation of <b>39a</b> to yield a tan solid (0.72 g, 39%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>13</sub>N<sub>3</sub>O, 251.1; found, 252.1 (M + H). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 3.02 (s, 3 H), 5.90 (s, 1 H), 7.26 (s, 2 H), 7.28–7.37 (m, 1 H), 7.45–7.58 (m, 3 H), 7.88 (dt, <i>J</i> = 7.9, 2.0 Hz, 1 H), 8.76 (dd, <i>J</i> = 4.8, 1.6 Hz, 1 H), 8.84 (d, <i>J</i> = 1.9 Hz, 1 H).</div></div><div id="sec3_19_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i118" class="anchor-spacer"></div><h4 class="article-section__title" id="_i118"> (B) 1-Methyl-3-oxo-2-phenyl-5-(pyridin-3-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carbaldehyde (<b>40f</b>)</h4><div class="NLM_p last">The title compound was prepared using a similar procedure for the preparation of <b>40a</b> to yield a brown oil. MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>13</sub>N<sub>3</sub>O<sub>2</sub>, 279.2; found, 280.1 (M + H).</div></div><div id="sec3_19_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i119" class="anchor-spacer"></div><h4 class="article-section__title" id="_i119"> (C) 1-Methyl-3-oxo-2-phenyl-5-(pyridin-3-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>41f</b>)</h4><div class="NLM_p last">The title compound was prepared using a similar procedure for the preparation of <b>41a</b> to yield a tan oil. MS (ESI pos ion) calcd for C<sub>16</sub>H<sub>13</sub>N<sub>3</sub>O<sub>3</sub>, 295.2; found, 296.1 (M + H).</div></div><div id="sec3_19_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i120" class="anchor-spacer"></div><h4 class="article-section__title" id="_i120"> (D) <i>N</i>-(5-(7-Methoxyquinolin-4-yloxy)pyridin-2-yl)-1-methyl-3-oxo-2-phenyl-5-(pyridin-3-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>43f</b>)</h4><div class="NLM_p last">Starting with 5-(7-methoxyquinolin-4-yloxy)pyridin-2-amine and 1-methyl-3-oxo-2-phenyl-5-(pyridin-3-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (0.230 g, 0.78 mmol), the title compound was prepared using the general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines to give a light-yellow solid (0.080 g, 19%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>24</sub>N<sub>6</sub>O<sub>4</sub>, 544.5; found, 545.2 (M + H). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 3.42 (s, 3 H), 3.89 (s, 3 H) 4.37–4.49 (m, 1 H), 5.22 (s, 1 H), 6.34 (d, <i>J</i> = 5.3 Hz, 1 H), 7.15 (dd, <i>J</i> = 9.2, 2.5 Hz, 1 H), 7.20 (s, 2 H), 7.28–7.50 (m, 7 H), 8.15 (d, <i>J</i> = 6.1 Hz, 1 H), 8.17 (s, 1 H), 8.29 (d, <i>J</i> = 9.1 Hz, 1 H), 8.52 (d, <i>J</i> = 5.3 Hz, 1 H), 11.55 (s, 1 H).</div></div></div><div id="sec3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i121" class="anchor-spacer"></div><h3 class="article-section__title" id="_i121"> <i>N</i>-(5-(7-Methoxyquinolin-4-yloxy)pyridin-2-yl)-1-methyl-3-oxo-2-phenyl-5-(pyrazin-2-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>43g</b>)</h3><div id="sec3_20_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i122" class="anchor-spacer"></div><h4 class="article-section__title" id="_i122"> (A) Methyl 3-oxo-3-(pyrazin-2-yl)propanoate (<b>38g</b>)</h4><div class="NLM_p last">The title compound was prepared from 2-pyrazinecarboxylic acid (1.00 g, 8.06 mmol) according to the procedure for the preparation of <b>38a</b> to give the product as a pale-yellow crystalline solid (1.28 g, 88.2%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>8</sub>H<sub>8</sub>N<sub>2</sub>O<sub>3</sub>, 180.2; found, 181.1 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.63 (s, 3 H), 4.21 (s, 2 H), 8.79–8.84 (m, 1 H), 8.94 (d, <i>J</i> = 2.5 Hz, 1 H), 9.16 (d, <i>J</i> = 1.4 Hz, 1 H).</div></div><div id="sec3_20_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i123" class="anchor-spacer"></div><h4 class="article-section__title" id="_i123"> (B) 1-Methyl-2-phenyl-5-(pyrazin-2-yl)-1,2-dihydropyrazol-3-one (<b>39g</b>)</h4><div class="NLM_p last">The title compound was prepared from methyl 3-oxo-3-(pyrazin-2-yl)propanoate (0.865 g, 4.8 mmol) according to the procedure for the preparation of <b>39c</b> to give the product as a yellowish–brown solid (0.378 g, 31%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>12</sub>N<sub>4</sub>O, 252.3; found, 253.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.32 (s, 3 H), 6.19 (s, 1 H), 7.33–7.40 (m, 1 H), 7.49–7.59 (m, 4 H), 8.67–8.71 (m, 1 H), 8.72–8.75 (m, 1 H), 8.96–9.00 (m, 1 H).</div></div><div id="sec3_20_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i124" class="anchor-spacer"></div><h4 class="article-section__title" id="_i124"> (C) 1-Methyl-3-oxo-2-phenyl-5-(pyrazin-2-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carbaldehyde (<b>40g</b>)</h4><div class="NLM_p last">Prepared according to the procedure for the preparation of <b>40a</b>, from 1-methyl-2-phenyl-5-(pyrazin-2-yl)-1,2-dihydropyrazol-3-one (0.263 g, 1.0 mmol), to yield the title compound as an orange solid (0.289 g, 99%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>12</sub>N<sub>4</sub>O<sub>2</sub>, 280.3; found, 281.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.43 (s, 3 H), 7.42–7.63 (m, 5 H), 8.76 (s, 2 H), 9.17 (s, 1 H), 9.96 (s, 1 H).</div></div><div id="sec3_20_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i125" class="anchor-spacer"></div><h4 class="article-section__title" id="_i125"> (D) 1-Methyl-3-oxo-2-phenyl-5-(pyrazin-2-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>41g</b>)</h4><div class="NLM_p last">Starting with 1-methyl-3-oxo-2-phenyl-5-(pyrazin-2-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carbaldehyde (0.390 g, 1.4 mmol), the title compound was prepared using the procedure similar to that for the preparation of <b>41a</b> to yield an off-white solid (0.300 g, 73%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>12</sub>N<sub>4</sub>O<sub>3</sub>, 296.3; found, 297.1 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.27 (s, 3 H), 7.52–7.59 (m, 3 H), 7.59–7.67 (m, 2 H), 8.82–8.86 (m, 1 H), 8.86–8.89 (m, 1 H), 9.03–9.07 (m, 1 H).</div></div><div id="sec3_20_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i126" class="anchor-spacer"></div><h4 class="article-section__title" id="_i126"> (E) <i>N</i>-(5-(7-Methoxyquinolin-4-yloxy)pyridin-2-yl)-1-methyl-3-oxo-2-phenyl-5-(pyrazin-2-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>43g</b>)</h4><div class="NLM_p last">A mixture of 1-methyl-3-oxo-2-phenyl-5-(pyrazin-2-yl)-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (0.100 g, 0.34 mmol), 5-(7-methoxyquinolin-4-yloxy)pyridin-2-amine (0.090 g, 0.34 mmol), EDCI-HCl (0.097 g, 0.51 mmol), and HOAt (0.046 g, 0.34 mmol) was suspended in DMF (1.7 mL). <i><sup>i</sup></i>Pr<sub>2</sub>NEt (0.21 mL, 1.2 mmol) was added, and the reaction mixture was stirred at rt for 2 d and then at 50 °C overnight. The reaction mixture was diluted with EtOAc and H<sub>2</sub>O. The aqueous layer was extracted with EtOAc. The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum. The crude material was purified by chromatography on silica gel eluting with MeOH–DCM (2–5%) to yield the title compound (0.046 g, 25%) as a light-orange solid. MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>23</sub>N<sub>7</sub>O<sub>4</sub>, 545.5; found, 546.2 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.30 (s, 3 H), 3.94 (s, 3 H), 6.52 (d, <i>J</i> = 5.3 Hz, 1 H), 7.30 (dd, <i>J</i> = 9.1, 2.4 Hz, 1 H), 7.41 (d, <i>J</i> = 2.4 Hz, 1 H), 7.57–7.70 (m, 5 H), 7.75 (dd, <i>J</i> = 9.0, 2.9 Hz, 1 H), 8.18–8.25 (m, 2 H), 8.35 (d, <i>J</i> = 2.6 Hz, 1 H), 8.61 (d, <i>J</i> = 5.2 Hz, 1 H), 8.85 (d, <i>J</i> = 2.5 Hz, 1 H), 8.87–8.91 (m, 1 H), 9.10–9.13 (m, 1 H), 11.29 (s, 1 H).</div></div></div><div id="sec3_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i127" class="anchor-spacer"></div><h3 class="article-section__title" id="_i127"> <i>N</i>-(5-(7-Methoxyquinolin-4-yloxy)pyridin-2-yl)-1-methyl-5-(5-methylisoxazol-3-yl)-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>43h</b>)</h3><div id="sec3_21_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i128" class="anchor-spacer"></div><h4 class="article-section__title" id="_i128"> (A) Methyl 3-(5-Methylisoxazol-3-yl)-3-oxopropanoate (<b>38h</b>)</h4><div class="NLM_p last">The title compound was prepared using a similar procedure for the preparation of <b>38a</b> to yield a white solid (3.25 g, 90%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>8</sub>H<sub>9</sub>NO<sub>4</sub>,: 183.2; found, 184.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.49 (s, 3 H), 3.82 (s, 3 H), 5.90 (s, 1 H), 6.28–6.32 (m, 1 H), 12.10 (s, 1 H).</div></div><div id="sec3_21_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i129" class="anchor-spacer"></div><h4 class="article-section__title" id="_i129"> (B) 1-Methyl-5-(5-methylisoxazol-3-yl)-2-phenyl-1,2-dihydropyrazol-3-one (<b>39h</b>)</h4><div class="NLM_p last">The title compound was prepared using a similar procedure for the preparation of <b>39a</b> to yield a light-yellow crystalline solid (1.71 g, 39%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>13</sub>N<sub>3</sub>O<sub>2</sub>, 255.3; found, 256.0 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.54 (s, 3 H), 3.38 (s, 3 H), 5.96 (s, 1 H), 6.29 (s, 1 H), 7.32–7.40 (m, 1 H), 7.49–7.53 (m, 4 H).</div></div><div id="sec3_21_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i130" class="anchor-spacer"></div><h4 class="article-section__title" id="_i130"> (C) 1-Methyl-5-(5-Methylisoxazol-3-yl)-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carbaldehyde(<b>40h</b>)</h4><div class="NLM_p last">The title compound was prepared using a similar procedure for the preparation of <b>40a</b> to yield a pale-orange oil (1.33 g, 74%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>13</sub>N<sub>3</sub>O<sub>3</sub>, 283.3; found, 284.0 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.58 (s, 3 H), 3.58 (s, 3 H), 6.79 (s, 1 H), 7.39–7.47 (m, 2 H), 7.47–7.54 (m, 1 H), 7.54–7.61 (m, 2 H), 9.96 (s, 1 H).</div></div><div id="sec3_21_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i131" class="anchor-spacer"></div><h4 class="article-section__title" id="_i131"> (D) 1-Methyl-5-(5-methylisoxazol-3-yl)-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>41h</b>)</h4><div class="NLM_p last">The title compound was prepared using a similar procedure for the preparation of <b>41a</b> to yield a pale-yellow solid (1.04 g, 74.0%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>13</sub>N<sub>3</sub>O<sub>4</sub>, 299.3; found, 300.0 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.55 (s, 3 H), 3.34 (s, 3 H), 6.75 (s, 1 H), 7.51–7.69 (m, 5 H), 12.43 (bs, 1 H).</div></div><div id="sec3_21_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i132" class="anchor-spacer"></div><h4 class="article-section__title" id="_i132"> (E) <i>N</i>-(5-(7-Methoxyquinolin-4-yloxy)pyridin-2-yl)-1-methyl-5-(5-methylisoxazol-3-yl)-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>43h</b>)</h4><div class="NLM_p last">The title compound was prepared using a similar procedure for the preparation of 43 g to yield a brown–yellow solid (0.065 g, 24%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>24</sub>N<sub>6</sub>O<sub>5</sub>, 548.5; found, 549.2 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.59 (s, 3 H), 3.49 (s, 3 H), 3.98 (s, 3 H), 6.44 (d, <i>J</i> = 5.2 Hz, 1 H), 6.74 (s, 1 H), 7.22–7.26 (m, 1 H), 7.43–7.55 (m, 5 H), 7.56–7.63 (m, 2 H), 8.21–8.28 (m, 2 H), 8.32 (d, <i>J</i> = 9.0 Hz, 1 H), 8.61 (d, <i>J</i> = 5.3 Hz, 1 H), 11.46 (s, 1 H).</div></div></div><div id="sec3_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i133" class="anchor-spacer"></div><h3 class="article-section__title" id="_i133"> <i>N</i>-(5-(7-Methoxyquinolin-4-yloxy)pyridin-2-yl)-1-methyl-5-(2-methylthiazol-4-yl)-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>43i</b>)</h3><div id="sec3_22_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i134" class="anchor-spacer"></div><h4 class="article-section__title" id="_i134"> (A) Methyl 3-(2-Methylthiazol-4-yl)-3-oxopropanoate (<b>38i</b>)</h4><div class="NLM_p last">The title compound was prepared using a similar procedure for the preparation of <b>38a</b> to yield an off-white crystalline solid (3.13 g, 90%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>8</sub>H<sub>9</sub>NO<sub>3</sub>S, 199.2; found, 200.1 (M + H). <sup>1</sup>H NMR indicated that the sample was an approximate 3:1 mixture of the diketo form and the enol form of the product. The diketo-form: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 2.75 (s, 3 H), 3.76 (s, 3 H), 4.10 (s, 2 H), 8.09 (s, 1 H). The enol-form: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.74 (s, 3 H), 3.81 (s, 3 H), 6.06 (s, 1 H), 7.73 (s, 1 H), 12.09 (s, 1 H).</div></div><div id="sec3_22_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i135" class="anchor-spacer"></div><h4 class="article-section__title" id="_i135"> (B) 1-Methyl-5-(2-methylthiazol-4-yl)-2-phenyl-1,2-dihydropyrazol-3-one (<b>39i</b>)</h4><div class="NLM_p last">The title compound was prepared using a similar procedure for the preparation of <b>39a</b> to yield a pale-orange foam (2.38 g, 62%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>13</sub>N<sub>3</sub>OS, 271.3; found, 272.0 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.82 (s, 3 H), 3.29 (s, 3 H), 5.94 (s, 1 H), 7.29–7.36 (m, 1 H), 7.46–7.52 (m, 2 H), 7.52–7.58 (m, 3 H).</div></div><div id="sec3_22_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i136" class="anchor-spacer"></div><h4 class="article-section__title" id="_i136"> (C) 1-Methyl-5-(2-methylthiazol-4-yl)-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carbaldehyde (<b>40i</b>)</h4><div class="NLM_p last">The title compound was prepared using a similar procedure for the preparation of <b>40a</b> to yield a light-yellow solid (2.44 g, 97%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>13</sub>N<sub>3</sub>O<sub>2</sub>S, 299.3; found, 300.0 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.81 (s, 3 H), 3.62 (s, 3 H), 7.42–7.49 (m, 3 H), 7.52–7.59 (m, 2 H), 8.76 (s, 1 H), 9.95 (s, 1 H).</div></div><div id="sec3_22_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i137" class="anchor-spacer"></div><h4 class="article-section__title" id="_i137"> (D) 1-Methyl-5-(2-methylthiazol-4-yl)-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>41i</b>)</h4><div class="NLM_p last">The title compound was prepared using a similar procedure for the preparation of <b>41a</b> to yield a pale-yellow solid (2.31 g, 90%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>13</sub>N<sub>3</sub>O<sub>3</sub>S, 315.3; found, 316.0 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.76 (s, 3 H), 3.43 (s, 3 H), 7.52–7.60 (m, 3 H), 7.60–7.66 (m, 2 H), 8.45 (s, 1 H), 12.79 (s, 1 H).</div></div><div id="sec3_22_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i138" class="anchor-spacer"></div><h4 class="article-section__title" id="_i138"> (E) <i>N</i>-(5-(7-Methoxyquinolin-4-yloxy)pyridin-2-yl)-1-methyl-5-(2-methylthiazol-4-yl)-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>43i</b>)</h4><div class="NLM_p last">The title compound was prepared using a similar procedure for the preparation of <b>43g</b> to yield a white solid (0.027 g, 10%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>24</sub>N<sub>6</sub>O<sub>4</sub>S, 564.6; found, 565.1 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.77 (s, 3 H), 3.34 (s, 3 H), 3.94 (s, 3 H), 6.53 (d, <i>J</i> = 5.2 Hz, 1 H), 7.30 (dd, <i>J</i> = 9.1, 2.4 Hz, 1 H), 7.42 (d, <i>J</i> = 2.4 Hz, 1 H), 7.53–7.61 (m, 3 H), 7.61–7.68 (m, 2 H), 7.77 (dd, <i>J</i> = 9.2, 2.8 Hz, 1 H), 8.22 (d, <i>J</i> = 9.1 Hz, 1 H), 8.29 (d, <i>J</i> = 9.1 Hz, 1 H), 8.32–8.37 (m, 2 H), 8.62 (d, <i>J</i> = 5.2 Hz, 1 H), 11.51 (s, 1 H).</div></div></div><div id="sec3_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i139" class="anchor-spacer"></div><h3 class="article-section__title" id="_i139"> 1-Ethyl-<i>N</i>-(3-fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>48a</b>)</h3><div id="sec3_23_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i140" class="anchor-spacer"></div><h4 class="article-section__title" id="_i140"> (A) 1-Ethyl-5-methyl-2-phenyl-1<i>H</i>-pyrazol-3(2<i>H</i>)-one (<b>45a</b>)</h4><div class="NLM_p last">A mixture of ethyl 4-methylbenzenesulfonate (1.26 g, 6 mmol) and 1-ethyl-5-methyl-2-phenyl-1<i>H</i>-pyrazol-3(2<i>H</i>)-one (1.00 g, 5.74 mmol) was heated at 160 °C for 16 h. The mixture was allowed to cool to rt and partitioned between DCM (80 mL) and NaOH (1 N, 10 mL). After 30 min, the mixture was diluted with H<sub>2</sub>O (40 mL). The organic phase was separated, washed with brine (50 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by chromatography on silica gel with MeOH/EtOAc (0 to 10%) to afford the desired product as light-yellow oil (1 g, 86%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>14</sub>N<sub>2</sub>O, 202.1; found, 203.1(M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.86 (t, <i>J</i> = 6.9 Hz, 3 H), 2.23 (s, 3 H), 3.56 (q, <i>J</i> = 7.0 Hz, 2 H), 5.42 (s, 1 H), 7.22–7.33 (m, 1 H), 7.35–7.42 (m, 14 H), 7.42–7.52 (m, 14 H).</div></div><div id="sec3_23_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i141" class="anchor-spacer"></div><h4 class="article-section__title" id="_i141"> (B) 1-Ethyl-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carbaldehyde (<b>46a</b>)</h4><div class="NLM_p last">To a solution of DMF (0.76 mL, 9.9 mmol) in a 50 mL round-bottomed flask cooled to 0 °C was added POCl<sub>3</sub>(0.69 mL, 7.4 mmol). After 30 min, the mixture was transferred to a 50 mL round-bottomed flask containing 1-ethyl-5-methyl-2-phenyl-1,2-dihydropyrazol-3-one (1.00 g, 4.9 mmol). The mixture was heated at 84 °C for 3 h and allowed to cool to rt. The mixture was poured into a mixture of ice, and the pH of the mixture was adjusted to ∼11 with NaOH (2 N). The mixture was then extracted with CHCl<sub>3</sub> (100 mL) twice. The combined organic phases were washed with brine (80 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by chromatography on silica gel with EtOAc/hexanes (50 to 100%) to the desired product as a white solid (0.95 g, 83%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>, 230.1; found, 231.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.09 (t, <i>J</i> = 7.1 Hz, 3 H), 2.66 (s, 3 H), 3.79 (q, <i>J</i> = 7.1 Hz, 2 H), 7.32 (dd, <i>J</i> = 8.2, 1.0 Hz, 2 H), 7.39–7.47 (m, 1 H), 7.48–7.57 (m, 2 H), 7.57–7.58 (m, 1 H), 9.89 (s, 1 H).</div></div><div id="sec3_23_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i142" class="anchor-spacer"></div><h4 class="article-section__title" id="_i142"> (C) 1-Ethyl-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>47a</b>)</h4><div class="NLM_p last">To a mixture of 1-ethyl-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carbaldehyde (5.0 g, 22 mmol) in <i><sup>t</sup></i>BuOH (82 mL, 869 mmol) was added 2-methyl-2-butene (23 mL, 217 mmol) at 0 °C, followed by sodium chlorite (5.9 g, 65 mmol) in H<sub>2</sub>O (25 mL). A solution of KH<sub>2</sub>PO<sub>4</sub> (15 g, 109 mmol) in H<sub>2</sub>O (25 mL)was added, and the mixture was allowed to warm to rt. After 18 h, the reaction mixture was extracted with EtOAc (2 × 100 mL). The organic phase was washed with brine (80 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude product was washed with small amount of EtOAc/hexanes (20%) to give the desired product as light-yellow solid (4.8 g, 90%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>14</sub>N<sub>2</sub>O<sub>3</sub>, 246.0; found, 247.0 (M + H). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.08 (t, <i>J</i> = 7.2 Hz, 3 H), 2.71 (s, 3 H), 3.86 (q, <i>J</i> = 7.0 Hz, 2 H), 7.30–7.41 (m, 2 H), 7.41–7.66 (m, 3 H).</div></div><div id="sec3_23_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i143" class="anchor-spacer"></div><h4 class="article-section__title" id="_i143"> (D) 1-Ethyl-<i>N</i>-(3-fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>48a</b>)</h4><div class="NLM_p last">The general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines was followed to prepare the title compound as white solid (0.50 g, 80%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>25</sub>FN<sub>4</sub>O<sub>4</sub>, 512.2; found, 513.1 (M + H). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 0.99–1.16 (m, 3 H), 2.81 (s, 3 H), 3.84 (q, <i>J</i> = 7.0 Hz, 2 H), 3.97 (s, 3 H), 6.42 (d, <i>J</i> = 5.3 Hz, 1 H), 7.13–7.63 (m, 9 H), 7.84–8.09 (m, 1 H), 8.27 (d, <i>J</i> = 9.0 Hz, 1 H), 8.59 (d, <i>J</i> = 5.3 Hz, 1 H), 10.91 (s, 1 H).</div></div></div><div id="sec3_23_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i144" class="anchor-spacer"></div><h3 class="article-section__title" id="_i144"> 1-Ethyl-<i>N</i>-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>49a</b>)</h3><div class="NLM_p last">The title compound was prepared similarly as <b>48a</b> (isolated after HPLC purification as the TFA salt, 0.30 g, 50%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>25</sub>N<sub>5</sub>O<sub>4</sub>, 495.2; found, 496.1 (M + H). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 1.08 (t, <i>J</i> = 7.1 Hz, 3 H), 2.80 (s, 3 H), 3.94 (q, <i>J</i> = 6.9 Hz, 2 H), 4.07 (s, 3 H), 6.98 (d, <i>J</i> = 6.8 Hz, 1 H), 7.40–7.65 (m, 7 H), 7.81 (dd, <i>J</i> = 9.0, 2.8 Hz, 1 H), 8.30 (d, <i>J</i> = 2.6 Hz, 1 H), 8.44 (d, <i>J</i> = 9.2 Hz, 1 H), 8.52 (d, <i>J</i> = 9.4 Hz, 1 H), 8.79 (d, <i>J</i> = 6.8 Hz, 1 H).</div></div><div id="sec3_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i145" class="anchor-spacer"></div><h3 class="article-section__title" id="_i145"> <i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-5-methyl-3-oxo-2-phenyl-1-propyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>48b</b>)</h3><div id="sec3_24_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i146" class="anchor-spacer"></div><h4 class="article-section__title" id="_i146"> (A) 5-Methyl-2-phenyl-1-propyl-1<i>H</i>-pyrazol-3(2<i>H</i>)-one (<b>45b</b>)</h4><div class="NLM_p last">A mixture of 1-phenyl-3-methyl-5-pyrazolone (10.0 g, 57 mmol) and 1-iodopropane (8.9 mL, 92 mmol) was heated in an oil bath at 110 °C overnight under inert atmosphere. The reaction mixture was allowed to cool to rt and was diluted with saturated NaHCO<sub>3</sub> and DCM. After 30 min, the mixture was treated with NaOH (5 N, 50 mL) while stirring. The aqueous layer was extracted with DCM (3 × 100 mL). The combined organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude material was recrystallized from warm EtOAc/hexanes to give a green crystalline solid as the desired product (3.2 g, 26%). MS (ESI pos ion)<i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>16</sub>N<sub>2</sub>O, 216.1; found, 217.1(M + H). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 0.75 (t, <i>J</i> = 7.4 Hz, 3 H), 1.35 (m, 2 H), 2.25 (s, 3 H), 3.39–3.57 (m, 2 H), 5.38 (s, 1 H), 7.25–7.33 (m, 1 H), 7.33–7.41 (m, 2 H), 7.41–7.52 (m, 2 H).</div></div><div id="sec3_24_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i147" class="anchor-spacer"></div><h4 class="article-section__title" id="_i147"> (B) 5-Methyl-3-oxo-2-phenyl-1-propyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carbaldehyde (<b>46b</b>)</h4><div class="NLM_p last">The same procedure that was used to prepare <b>46a</b> was followed to prepare the aldehyde (2.0 g, 63%) that was carried directly to the next step. MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>16</sub>N<sub>2</sub>O<sub>2</sub>, 244.1; found, 245.1 (M + H).</div></div><div id="sec3_24_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i148" class="anchor-spacer"></div><h4 class="article-section__title" id="_i148"> (C) 5-Methyl-3-oxo-2-phenyl-1-propyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>47b</b>)</h4><div class="NLM_p last">Method A. The same procedure that was used to prepare <b>47a</b> was followed to prepare the title compound. The crude product was recrystallized from DCM/hexanes to give the pure product as a tan colored crystalline solid. Method B. A mixture of 1-allyl-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (0.40 g, 1.5 mmol, prepared from allylation) and Pd/C (10%, 0.16 g) in EtOAc (50 mL) was stirred under H<sub>2</sub> (balloon) for 3 h. The mixture was filtered though a pad of Celite, and the filtrate was concentrated in vacuo. The residue was washed with EtOAc to give a white solid as the desired product (0.37 g, 92%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>16</sub>N<sub>2</sub>O<sub>3</sub>, 260.1; found, 261.1 (M + H). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 0.79 (t, <i>J</i> = 6.8 Hz, 3 H), 1.49 (d, <i>J</i> = 6.7 Hz, 2 H), 2.72 (bs, 3 H), 3.77 (t, <i>J</i> = 6.6 Hz, 2 H), 7.34 (d, <i>J</i> = 6.9 Hz, 2 H), 7.55 (d, <i>J</i> = 6.9 Hz, 3 H), 12.10 (s, 1 H).</div></div><div id="sec3_24_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i149" class="anchor-spacer"></div><h4 class="article-section__title" id="_i149"> (D) <i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-5-methyl-3-oxo-2-phenyl-1-propyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>48b</b>)</h4><div class="NLM_p last">The general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines was followed to prepare the title compound as white solid (0.65 g, 80%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>4</sub>, 526.2; found, 527.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.80 (t, <i>J</i> = 7.4 Hz, 3 H), 1.40–1.57 (m, 2 H), 2.81 (s, 3 H), 3.76 (t, <i>J</i> = 7.2 Hz, 2 H), 3.96 (s, 3 H), 6.42 (d, <i>J</i> = 5.3 Hz, 1 H), 7.17 (t, <i>J</i> = 8.7 Hz, 1 H), 7.23 (dd, <i>J</i> = 9.2, 2.4 Hz, 1 H), 7.25–7.33 (m, 1 H), 7.36 (d, <i>J</i> = 8.0 Hz, 2 H), 7.42 (d, <i>J</i> = 1.8 Hz, 1 H), 7.47 (t, <i>J</i> = 7.4 Hz, 1 H), 7.51–7.61 (m, 2 H), 7.92 (dd, <i>J</i> = 12.2, 1.7 Hz, 1 H), 8.27 (d, <i>J</i> = 9.0 Hz, 1 H), 8.59 (d, <i>J</i> = 5.3 Hz, 1 H), 10.90 (s, 1 H).</div></div></div><div id="sec3_24_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i150" class="anchor-spacer"></div><h3 class="article-section__title" id="_i150"> <i>N</i>-(5-(7-Methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-1-propyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>50b</b>)</h3><div class="NLM_p last">The same procedure that was used to prepare <b>48b</b> was followed to prepare the title compound as light-yellow solid (0.18 g, 86%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>27</sub>N<sub>5</sub>O<sub>4</sub>, 509.2; found, 510.2 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.80 (t, <i>J</i> = 7.4 Hz, 3 H), 1.40–1.58 (m, 2 H), 2.81 (s, 3 H), 3.76 (t, <i>J</i> = 7.2 Hz, 2 H), 3.98 (s, 3 H), 6.46 (d, <i>J</i> = 5.5 Hz, 1 H), 7.22–7.26 (m, 1 H), 7.37 (d, <i>J</i> = 8.0 Hz, 2 H), 7.43–7.47 (m, 2 H), 7.47–7.59 (m, 3 H), 8.20–8.30 (m, 2 H), 8.38 (d, <i>J</i> = 9.0 Hz, 1 H), 8.61 (d, <i>J</i> = 5.5 Hz, 1 H), 11.29 (s, 1 H).</div></div><div id="sec3_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i151" class="anchor-spacer"></div><h3 class="article-section__title" id="_i151"> <i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-5-methyl-1-(2-methylallyl)-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>48c</b>)</h3><div id="sec3_25_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i152" class="anchor-spacer"></div><h4 class="article-section__title" id="_i152"> (A) 5-Methyl-1-(2-methylallyl)-2-phenyl-1<i>H</i>-pyrazol-3(2<i>H</i>)-one (<b>45c</b>)</h4><div class="NLM_p last">A mixture of 5-methyl-2-phenyl-1<i>H</i>-pyrazol-3(2<i>H</i>)-one (18.0 g, 103 mmol) and 2-(bromomethyl)prop-1-ene (14 g, 103 mmol) was heated at 120 °C for 16 h. The reaction mixture was allowed to cool to rt and partitioned between CHCl<sub>3</sub> (400 mL) and NaOH (0.5 N, 100 mL). After 30 min, the organic phase was separated and washed with NaHCO<sub>3</sub> (saturated, 100 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by chromatography on silica gel with EtOAc/hexanes (50 to 100%) to afford the desired product (6.6 g, 28%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>16</sub>N<sub>2</sub>O, 228.1; found, 229.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.52 (s, 3 H), 2.25 (s, 3 H), 4.05 (s, 2 H), 4.51 (s, 1 H), 4.79 (s, 1 H), 5.37 (s, 1 H), 7.25–7.36 (m, 4 H), 7.40–7.50 (m, 2 H).</div></div><div id="sec3_25_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i153" class="anchor-spacer"></div><h4 class="article-section__title" id="_i153"> (B) 5-Methyl-1-(2-methylallyl)-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carbaldehyde (<b>46c</b>)</h4><div class="NLM_p last">The same procedure that was used to prepare <b>46a</b> was followed to prepare the title compound as yellow solid (5.13 g, 89.6%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>16</sub>N<sub>2</sub>O<sub>2</sub>, 256.1; found, 257.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.56 (s, 3 H), 2.63 (d, <i>J</i> = 1.2 Hz, 3 H), 4.20 (s, 2 H), 4.50 (s, 1 H), 4.92 (s, 1 H), 7.13–7.35 (m, 2 H), 7.38–7.59 (m, 3 H), 9.93 (d, <i>J</i> = 1.4 Hz, 1 H).</div></div><div id="sec3_25_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i154" class="anchor-spacer"></div><h4 class="article-section__title" id="_i154"> (C) 5-Methyl-1-(2-methylallyl)-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>47c</b>)</h4><div class="NLM_p last">The same procedure that was used to prepare <b>47a</b> was followed to prepare the title compound as white solid (4.0 g, 93%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>16</sub>N<sub>2</sub>O<sub>3</sub>, 272.1; found, 273.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.56 (s, 3 H), 2.68 (s, 3 H), 4.26 (s, 2 H), 4.45 (s, 1 H), 4.93 (s, 1 H), 7.29–7.37 (m, 2 H), 7.46–7.58 (m, 3 H), 12.12 (bs, 1 H).</div></div><div id="sec3_25_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i155" class="anchor-spacer"></div><h4 class="article-section__title" id="_i155"> (D) <i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-5-methyl-1-(2-methylallyl)-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>48c</b>)</h4><div class="NLM_p last">The general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines was followed to prepare the title compound as light-yellow solid (0.90 g, 91%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>4</sub>, 538.2; found, 539.2 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.58 (s, 3 H), 2.74–2.81 (s, 3 H), 3.97 (s, 3 H), 4.27 (s, 2 H), 4.50 (s, 1 H), 4.92 (s, 1 H), 6.42 (d, <i>J</i> = 5.3 Hz, 1 H), 7.13–7.25 (m, 2 H), 7.28–7.37 (m, 3 H), 7.40–7.60 (m, 5 H), 7.92 (dd, <i>J</i> = 12.5, 2.4 Hz, 1 H), 8.27 (d, <i>J</i> = 9.2 Hz, 1 H), 8.60 (d, <i>J</i> = 5.3 Hz, 1 H), 10.93 (s, 1 H).</div></div></div><div id="sec3_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i156" class="anchor-spacer"></div><h3 class="article-section__title" id="_i156"> <i>N</i>-(3-Fluoro-4-((7-methoxyquinolin-4-yl)oxy)phenyl)-1-isobutyl-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>48d</b>)</h3><div id="sec3_26_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i157" class="anchor-spacer"></div><h4 class="article-section__title" id="_i157"> (A) 1-Isobutyl-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>47d</b>)</h4><div class="NLM_p last">A mixture of 5-methyl-1-(2-methylallyl)-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (<b>47c</b>, 0.20 g, 0.73 mmol) and Pd/C (10%, 0.016 g) in EtOAc (60 mL) was stirred under H<sub>2</sub> (balloon) for 3 h. The mixture was filtered though a pad of Celite, and the filtrate was concentrated in vacuo to give the product as yellow solid (0.15 g, 74%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub>, 274.1; found, 275.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.76 (d, <i>J</i> = 6.6 Hz, 6 H), 1.76–1.85 (m, 1 H), 2.71 (s, 3 H), 3.63 (d, <i>J</i> = 7.6 Hz, 2 H), 7.31 (d, <i>J</i> = 7.2 Hz, 2 H), 7.47–7.59 (m, 3 H).</div></div><div id="sec3_26_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i158" class="anchor-spacer"></div><h4 class="article-section__title" id="_i158"> (B) <i>N</i>-(3-Fluoro-4-((7-methoxyquinolin-4-yl)oxy)phenyl)-1-isobutyl-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>48d</b>)</h4><div class="NLM_p last">The general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines was followed to prepare the title compound as white solid (0.067 g, 10%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>29</sub>FN<sub>4</sub>O<sub>5</sub>, 540.2; found, 541.2 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.78 (d, <i>J</i> = 6.6 Hz, 6 H), 1.85 (dt, <i>J</i> = 13.9, 6.9 Hz, 1 H), 2.82 (s, 3 H), 3.64 (d, <i>J</i> = 7.6 Hz, 2 H), 3.97 (s, 3 H), 6.41 (d, <i>J</i> = 5.1 Hz, 1 H), 7.11–7.25 (m, 2 H), 7.27–7.37 (m, 3 H), 7.41 (d, <i>J</i> = 2.4 Hz, 1 H), 7.44–7.51 (m, 1 H), 7.52–7.60 (m, 2 H), 7.92 (dd, <i>J</i> = 12.3, 2.4 Hz, 1 H), 8.27 (d, <i>J</i> = 9.2 Hz, 1 H), 8.59 (d, <i>J</i> = 5.3 Hz, 1 H), 10.90 (s, 1 H).</div></div></div><div id="sec3_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i159" class="anchor-spacer"></div><h3 class="article-section__title" id="_i159"> <i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-(2-hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>53</b>) Method A</h3><div id="sec3_27_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i160" class="anchor-spacer"></div><h4 class="article-section__title" id="_i160"> (A) 1-(2,3-Dihydroxy-2-methylpropyl)-<i>N</i>-(3-fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>51</b>)</h4><div class="NLM_p last">To a solution of <i>N</i>-(3-fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-5-methyl-1-(2-methylallyl)-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (0.90 g, 1.7 mmol) in <i><sup>t</sup></i>BuOH/H<sub>2</sub>O (9:1, 20 mL) was added 4-methylmorpholine <i>N</i>-oxide (0.59 g, 5.0 mmol), followed by a solution of OsO<sub>4</sub> (0.098 M/toluene, 3.4 mL, 0.33 mmol) at rt. After16 h, the solution was diluted with H<sub>2</sub>O (10 mL) and EtOAc (40 mL). The organic phase was separated and washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was washed with 50% EtOAc/hexanes to give the desired product as white solid (0.95 g, 99%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>29</sub>FN<sub>4</sub>O<sub>6</sub>, 572.2; found, 573.2 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.07 (s, 3 H), 2.89 (s, 3 H), 3.34 (s, 2 H), 3.86 (d, <i>J</i> = 15.6 Hz, 1 H), 3.96 (s, 4 H), 4.09–4.21 (m, 1 H), 6.42 (d, <i>J</i> = 5.3 Hz, 1 H), 7.10–7.35 (m, 5 H), 7.36–7.48 (m, 2 H), 7.49–7.59 (m, 2 H), 7.90 (d, <i>J</i> = 12.5 Hz, 1 H), 8.27 (d, <i>J</i> = 9.2 Hz, 1 H), 8.56 (d, <i>J</i> = 5.3 Hz, 1 H), 10.85 (s, 1 H).</div></div><div id="sec3_27_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i161" class="anchor-spacer"></div><h4 class="article-section__title" id="_i161"> (B) <i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-5-methyl-3-oxo-1-(2-oxopropyl)-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>52</b>)</h4><div class="NLM_p last">To a solution of 1-(2,3-dihydroxy-2-methylpropyl)-<i>N</i>-(3-fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (0.95 g, 1.7 mmol) in <i><sup>t</sup></i>BuOH/H<sub>2</sub>O (9:1, 20 mL) was added a solution of sodium periodate (1.1 g, 5.0 mmol) in H<sub>2</sub>O (20 mL) at rt. The mixture was stirred for 4 h and was diluted with H<sub>2</sub>O (20 mL). The mixture was extracted with EtOAc (80 mL) and the organic phase was washed with saturated Na<sub>2</sub>SO<sub>3</sub> (30 mL) followed by brine. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was washed with MeOH (5 mL) to give the desired product as white solid (0.80 g, 89%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>25</sub>FN<sub>4</sub>O<sub>5</sub>, 540.1; found, 541.2 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.07 (s, 3 H), 2.69 (s, 3 H), 3.97 (s, 3 H), 4.52 (s, 2 H), 6.44 (d, <i>J</i> = 5.3 Hz, 1 H), 7.11–7.35 (m, 5 H), 7.40–7.62 (m, 4 H), 7.92 (dd, <i>J</i> = 12.4, 2.4 Hz, 1 H), 8.28 (d, <i>J</i> = 9.2 Hz, 1 H), 8.60 (d, <i>J</i> = 5.3 Hz, 1 H), 10.86 (s, 1 H).</div></div><div id="sec3_27_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i162" class="anchor-spacer"></div><h4 class="article-section__title" id="_i162"> (C) <i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-(2-hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>53</b>)</h4><div class="NLM_p last">To a solution of <i>N</i>-(3-fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-5-methyl-3-oxo-1-(2-oxopropyl)-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (0.15 g, 0.28 mmol) in MeOH (15 mL) was added NaBH<sub>4</sub> (0.021 g, 0.55 mmol) in portions. The mixture was stirred at rt for 2 h and was then quenched with a solution of NaH<sub>2</sub>PO<sub>4</sub> (1 M, 20 mL). The mixture was extracted with EtOAc (50 mL). The organic phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was washed with small amount of EtOAc–ether mixture to give the desired product as light-yellow solid (0.14 g, 93%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>5</sub>, 542.2; found, 543.2 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.09 (d, <i>J</i> = 5.9 Hz, 3 H), 2.85 (s, 3 H), 3.61–3.74 (m, 1 H), 3.79–3.94 (m, 2 H), 3.97 (s, 3 H), 6.48 (d, <i>J</i> = 5.5 Hz, 1 H), 7.12–7.22 (m, 1 H), 7.24–7.34 (m, 4 H), 7.38–7.49 (m, 2 H), 7.49–7.58 (m, 2 H), 7.93 (dd, <i>J</i> = 12.4, 2.2 Hz, 1 H), 8.30 (d, <i>J</i> = 9.2 Hz, 1 H), 8.53 (d, <i>J</i> = 5.5 Hz, 1 H), 10.90 (s, 1 H).</div></div></div><div id="sec3_27_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i163" class="anchor-spacer"></div><h3 class="article-section__title" id="_i163"> <i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-(2-hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>53</b>–<b>58a</b>) Method B</h3><div class="NLM_p last">Alternatively, the title compound was prepared from racemic <b>57a</b> and aniline <b>9d</b> through amide coupling.</div></div><div id="sec3_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i164" class="anchor-spacer"></div><h3 class="article-section__title" id="_i164"> (<i>R</i>)-<i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-(2-hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide ((<i>R</i>)-<b>58a</b>)</h3><div id="sec3_28_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i165" class="anchor-spacer"></div><h4 class="article-section__title" id="_i165"> (A) (<i>R</i>)-Benzyl 1-(2-Hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate ((<i>R</i>)-<b>56a</b>)<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></h4><div class="NLM_p last">To a stirred suspension of benzyl 5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (15.0 g, 49 mmol) in dry ACN (100 mL) at 0 °C was added magnesium perchlorate (33 g, 146 mmol) in 3 portions over 1 min. The suspension was allowed to warm to rt over 10 min and was returned to 0 °C. (<i>R</i>)-(+)-propylene oxide (17 mL, 243 mmol) was added and the reaction mixture was head at 37 °C for 2 h. The mixture was concentrated to a thick syrup under vacuum and was taken in CHCl<sub>3</sub> (100 mL). The mixture was chilled to 10 °C and quenched with ice-cold H<sub>2</sub>O (200 mL). After being stirred for 1 h, the biphasic system was separated and the aqueous was extracted with CHCl<sub>3</sub> (2 × 50 mL). The combined organics were washed with saturated NH<sub>4</sub>Cl, dried over MgSO<sub>4</sub>, filtered, and concentrated. The resulting foam was dissolved in hot MeOH (15–20 mL) and chilled at 4 °C overnight. The mother liquor was separated, and the solid was dried under vacuum to give (<i>R</i>)-benzyl 1-(2-hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (14.6 g, 82% yield) as a light-tan crystals.</div></div><div id="sec3_28_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i166" class="anchor-spacer"></div><h4 class="article-section__title" id="_i166"> (B) (<i>R</i>)-1-(2-Hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>57a</b>)</h4><div class="NLM_p last">A solution of (<i>R</i>)-benzyl 1-(2-hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (14.4 g, 39.3 mmol) in MeOH (200 mL) was sparged with Ar for 20 min. To this mixture was added Pd/C (10%, 2.09 g). The mixture was stirred overnight under H<sub>2</sub> (balloon). The reaction mixture was filtered through a bed of Celite and evaporated to a solid. This solid was recrystallized from a minimal amount of boiling MeOH. The crystals, readily formed after 1 h at rt, were collected by filtration and was washed with cold MeOH (2 × 10 mL) and ether (20 mL) to give a white solid (4.1 g). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>14</sub>H<sub>16</sub>N<sub>2</sub>O<sub>4</sub>, 276.3; found, 277.1 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.88 (d, <i>J</i> = 6.3 Hz, 3 H), 2.65 (s, 3 H), 3.37 (bs, 1 H), 3.61–3.70 (m, 1 H), 3.78–3.93 (m, 1 H), 7.42 (d, <i>J</i> = 7.4 Hz, 2 H), 7.46–7.65 (m, 3 H).</div></div><div id="sec3_28_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i167" class="anchor-spacer"></div><h4 class="article-section__title" id="_i167"> (C) (<i>R</i>)-<i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-(2-hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide ((<i>R</i>)-<b>58a</b>)</h4><div class="NLM_p last">To a stirring solution of (<i>R</i>)-1-(2-hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (3.0 g, 10.8 mmol) and <i><sup>i</sup></i>Pr<sub>2</sub>NEt (1.9 mL, 10.8 mmol) in DMF (10 mL) was added HATU (4.2 g, 10.9 mmol). The mixture was stirred at rt for 20 min before 3-fluoro-4-(7-methoxyquinolin-4-yloxy)benzenamine (3.1 g, 10.9 mmol) was added. The dark solution was heated at 40 °C overnight. The reaction mixture was diluted with MeOH/CHCl<sub>3</sub> (1:9, 200 mL) and aqueous NaHCO<sub>3</sub> (5%, 150 mL). The aqueous layer was extracted twice with CHCl<sub>3</sub>/MeOH (9:1; 50 mL). The combined organics were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The resulting oil was azeotroped with toluene until a solid formed. The solid was recrystallized with a minimal amount of MeOH (15–20 mL). After 2 h at rt, the solid was collected by filtration and washed twice with cold MeOH (10 mL) to give (<i>R</i>)-<i>N</i>-(3-fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-(2-hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (3.35 g, 57% yield) as a white solid. MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>30</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>5</sub>, 542.5; found, 543.2 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.10 (d, <i>J</i> = 6.1 Hz, 3 H), 2.85 (s, 3 H), 3.66 (dd, <i>J</i> = 14.7, 2.4 Hz, 1 H), 3.78–3.93 (m, 2 H), 3.95 (s, 3 H), 6.42 (d, <i>J</i> = 4.9 Hz, 1 H), 7.14–7.31 (m, 6 H), 7.37 (d, <i>J</i> = 2.4 Hz, 1 H), 7.39–7.46 (m, 1 H), 7.46–7.55 (m, 2 H), 7.94 (dd, <i>J</i> = 12.5, 2.4 Hz, 1 H), 8.29 (d, <i>J</i> = 9.0 Hz, 1 H), 8.51 (d, <i>J</i> = 5.3 Hz, 1 H), 10.88 (s, 1 H).</div></div></div><div id="sec3_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i168" class="anchor-spacer"></div><h3 class="article-section__title" id="_i168"> (<i>S</i>)-<i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-(2-hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide ((<i>S</i>)-<b>58a</b>)</h3><div id="sec3_29_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i169" class="anchor-spacer"></div><h4 class="article-section__title" id="_i169"> (A) (<i>S</i>)-Benzyl 1-(2-Hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate ((<i>S</i>)-<b>56a</b>)</h4><div class="NLM_p last">To a 250 mL round-bottomed flask was added benzyl 5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (9.2 g, 30.0 mmol) and ACN (60 mL). The solution was cooled in an ice bath, and magnesium perchlorate (27 g, 120 mmol) was added in 3 portions. Then (<i>S</i>)-2-methyloxirane (8.7 g, 150 mmol) was added, and the reaction mixture was heated at 35 °C in an oil bath for 5 h. The reaction mixture was concentrated, dissolved in CHCl<sub>3</sub>, washed with H<sub>2</sub>O, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude product was purified by chromatography on silica gel eluting with MeOH/CHCl<sub>3</sub> (0 to 2%) to give (<i>S</i>)-benzyl 1-(2-hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (8.7 g, 79% yield) as a solid.</div></div><div id="sec3_29_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i170" class="anchor-spacer"></div><h4 class="article-section__title" id="_i170"> (B) The Next Two Steps Were Carried Out Similar to That for the Preparation of (<i>R</i>)-<b>58a</b></h4><div class="NLM_p last">MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>30</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>5</sub>, 542.5; found, 543.2 (M + H). <sup><b>1</b></sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.90 (d, <i>J</i> = 6.1 Hz, 3 H), 2.76 (s, 3 H), 3.55–3.70 (m, 2 H), 3.88 (dd, <i>J</i> = 15.1, 8.6 Hz, 1 H), 3.94 (s, 3 H), 5.07 (d, <i>J</i> = 5.3 Hz, 1 H), 6.49 (d, <i>J</i> = 5.1 Hz, 1 H), 7.26–7.38 (m, 2 H), 7.38–7.47 (m, 3 H), 7.47–7.54 (m, 1 H), 7.54–7.64 (m, 2 H), 7.98 (dd, <i>J</i> = 13.1, 2.4 Hz, 1 H), 8.23 (d, <i>J</i> = 9.2 Hz, 1 H), 8.62 (d, <i>J</i> = 5.3 Hz, 1 H), 10.99 (s, 1 H). Anal. Calcd for: C, 66.41; H, 5.02; N, 10.33. Found: C, 65.39; H, 5.03; N, 10.21.</div></div></div><div id="sec3_29_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i171" class="anchor-spacer"></div><h3 class="article-section__title" id="_i171"> 1-(2-Hydroxypropyl)-<i>N</i>-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>59a</b>)</h3><div class="NLM_p last">Prepared from racemic <b>57a</b> and aniline <b>9d</b> through amide coupling. MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>29</sub>H<sub>27</sub>N<sub>5</sub>O<sub>5</sub>, 525.2; found, 526.2 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.86–0.93 (m, 3 H), 2.77 (s, 3 H), 3.56–3.69 (m, 2 H), 3.88 (dd, <i>J</i> = 15.2, 8.9 Hz, 1 H), 3.94 (s, 3 H), 5.08 (d, <i>J</i> = 5.3 Hz, 1 H), 6.54 (d, <i>J</i> = 5.3 Hz, 1 H), 7.30 (dd, <i>J</i> = 9.1, 2.4 Hz, 1 H), 7.39–7.45 (m, 3 H), 7.47–7.55 (m, 1 H), 7.55–7.64 (m, 2 H), 7.80 (dd, <i>J</i> = 9.0, 2.9 Hz, 1 H), 8.22 (d, <i>J</i> = 9.0 Hz, 1 H), 8.32 (d, <i>J</i> = 2.7 Hz, 1 H), 8.36 (d, <i>J</i> = 9.0 Hz, 1 H), 8.62 (d, <i>J</i> = 5.3 Hz, 1 H), 11.27 (s, 1 H).</div></div><div id="sec3_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i172" class="anchor-spacer"></div><h3 class="article-section__title" id="_i172"> <i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-(2-hydroxyethyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>58b</b>)</h3><div id="sec3_30_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i173" class="anchor-spacer"></div><h4 class="article-section__title" id="_i173"> (A) 1-(2-Hydroxyethyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>57b</b>)</h4><div class="NLM_p last">A mixture of benzyl 1-(2-hydroxyethyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (<b>56b</b>, 0.73 g, 2.1 mmol) and Pd/C (10%, 0.22 g) in EtOAc (40 mL) was stirred under H<sub>2</sub> (balloon) for 3 h. The mixture was filtered though a pad of Celite, and the filtrate was concentrated in vacuo. The residue was washed with MeOH to give the desired product as white solid (0.45 g, 83%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>14</sub>N<sub>2</sub>O<sub>4</sub>, 262.1; found, 263.1 (M + H). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 2.72 (s, 3 H), 3.48 (t, <i>J</i> = 5.1 Hz, 2 H), 4.01 (t, <i>J</i> = 5.2 Hz, 2 H), 7.37–7.49 (m, 2 H), 7.52–7.67 (m, 3 H).</div></div><div id="sec3_30_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i174" class="anchor-spacer"></div><h4 class="article-section__title" id="_i174"> (B) <i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-(2-hydroxyethyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>58b</b>)</h4><div class="NLM_p last">The general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines was followed to prepare the title compound, starting with 3-fluoro-4-(7-methoxyquinolin-4-yloxy)benzenamine-HCl salt (0.26 g, 0.92 mmol) and 1-(2-hydroxyethyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (0.40 g, 1.5 mmol), as white solid (0.43 g, 89%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>25</sub>FN<sub>4</sub>O<sub>5</sub>, 528.2; found, 529.2 (M + H). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 2.84 (s, 3 H), 3.52 (t, <i>J</i> = 5.1 Hz, 2 H), 3.99 (s, 3 H), 4.03 (t, <i>J</i> = 5.2 Hz, 2 H), 6.51 (dd, <i>J</i> = 5.37, 1.0 Hz, 1 H), 7.24–7.41 (m, 4 H), 7.43–7.51 (m, 2 H), 7.51–7.68 (m, 3 H), 7.89–8.00 (m, 1 H), 8.30 (d, <i>J</i> = 9.2 Hz, 1 H), 8.55 (d, <i>J</i> = 5.3 Hz, 1 H).</div></div></div><div id="sec3_30_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i175" class="anchor-spacer"></div><h3 class="article-section__title" id="_i175"> 1-(2-Hydroxyethyl)-<i>N</i>-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>59b</b>)</h3><div class="NLM_p last">The general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines was followed to prepare the title compound, starting with 1-(2-hydroxyethyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (0.30 g, 1.1 mmol) and 5-(7-methoxyquinolin-4-yloxy)pyridin-2-amine (0.31 g, 1.1 mmol), as white solid (TFA salt) (0.20 g, 34%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>25</sub>N<sub>5</sub>O<sub>5</sub>, 511.2.2; found, 512.2 (M + H). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 2.84 (s, 3 H), 3.43–3.58 (m, 2 H), 4.03 (t, <i>J</i> = 4.4 Hz, 2 H), 4.08 (s, 3 H), 7.00 (d, <i>J</i> = 6.6 Hz, 1 H), 7.38–7.68 (m, 8 H), 7.83 (d, <i>J</i> = 9.0 Hz, 1 H), 8.33 (bs, 1 H), 8.47 (d, <i>J</i> = 9.0 Hz, 1 H), 8.55 (d, <i>J</i> = 9.4 Hz, 1 H), 8.81 (d, <i>J</i> = 6.8 Hz, 1 H).</div></div><div id="sec3_30_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i176" class="anchor-spacer"></div><h3 class="article-section__title" id="_i176"> (<i>S</i>)-<i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-(2-hydroxybutyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>58c</b>)</h3><div class="NLM_p last">The general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines was followed to prepare the title compound. MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>31</sub>H<sub>29</sub>FN<sub>4</sub>O<sub>5</sub>, 556.2; found, 556.6 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.83 (t, <i>J</i> = 7.3 Hz, 3 H), 1.27–1.43 (m, 2 H), 1.60–1.82 (m, 1 H), 2.85 (s, 3 H), 3.56–3.66 (m, 1 H), 3.70 (dd, <i>J</i> = 1.6 Hz, 1 H), 3.79–3.90 (m, 1 H), 3.95 (s, 3 H),6.42 (d, <i>J</i> = 5.3 Hz, 3 H), 7.11–7.31 (m, 6 H), 7.36 (d, <i>J</i> = 2.2 Hz, 1 H), 7.39–7.53 (m, 3 H), 7.95 (dd, <i>J</i> = 12.5, 2.0 Hz, 1 H), 8.30 (d, <i>J</i> = 9.2 Hz, 1 H), 8.50 (d, <i>J</i> = 5.3 Hz, 1 H), 10.90 (s, 1 H).</div></div><div id="sec3_30_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i177" class="anchor-spacer"></div><h3 class="article-section__title" id="_i177"> <i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-(2-hydroxy-3-methylbutyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>58d</b>)</h3><div class="NLM_p">The general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines was followed to prepare the title compound. MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>32</sub>H<sub>31</sub>FN<sub>4</sub>O<sub>5</sub>, 570.2; found, 571.6 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.73 (d, <i>J</i> = 6.8 Hz, 3 H), 0.79 (d, <i>J</i> = 6.8 Hz, 3 H), 1.45–1.70 (m, 3H), 2.85 (s, 3 H), 3.39–3.48 (m, 1 H), 3.72–3.80 (m, 1 H), 3.83–3.92 (m, 1 H), 3.96 (s, 3 H), 6.38–6.44 (m, 1 H), 7.13–7.24 (m, 2 H), 7.28–7.33 (m, 2 H), 7.40 (d, <i>J</i> = 2.4 Hz, 1 H), 7.42–7.49 (m, 1 H), 7.49–7.58 (m, 2 H), 7.92 (dd, <i>J</i> = 12.4, 2.4 Hz, 1 H), 8.28 (d, <i>J</i> = 9.0 Hz, 1 H), 8.56 (d, <i>J</i> = 5.3 Hz, 1 H), 10.89 (s, 1 H).</div><div class="NLM_p last">Synthesis of <b>58e</b> and <b>59e</b> were described previously.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div></div><div id="sec3_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i178" class="anchor-spacer"></div><h3 class="article-section__title" id="_i178"> 1-(2-Aminoethyl)-<i>N</i>-(3-fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>61</b>)</h3><div id="sec3_31_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i179" class="anchor-spacer"></div><h4 class="article-section__title" id="_i179"> (A) 1-(2-(1,3-Dioxoisoindolin-2-yl)ethyl)-<i>N</i>-(3-fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>60</b>)</h4><div class="NLM_p last">To a solution of <i>N</i>-(3-fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-1-(2-hydroxyethyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (0.20 g, 0.38 mmol) and phthalimide (0.11 g, 0.76 mmol) in DCM (10 mL) was added Ph<sub>3</sub>P (0.15 g, 0.57 mmol), followed by diethyl azodicarboxylate (0.089 mL, 0.57 mmol) via a syringe. The mixture was stirred at rt for 16 h. The solution was concentrated in vacuo, and the residue was purified by chromatography on silica gel with MeOH/EtOAc (0 to 10%) to give the desired product as light-yellow solid (0.22 g, 88%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>37</sub>H<sub>28</sub>FN<sub>5</sub>O<sub>6</sub>, 657.2; found, 658.2 (M + H). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 2.61 (s, 3 H), 3.67 (t, <i>J</i> = 5.5 Hz, 2 H), 3.89 (s, 3 H), 4.20 (t, <i>J</i> = 5.5 Hz, 2 H), 6.41 (dd, <i>J</i> = 5.4, 1.0 Hz, 1 H), 7.15–7.31 (m, 6 H), 7.35–7.46 (m, 3 H), 7.70–7.85 (m, 5 H), 8.20 (d, <i>J</i> = 9.0 Hz, 1 H), 8.45 (d, <i>J</i> = 5.5 Hz, 1 H).</div></div><div id="sec3_31_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i180" class="anchor-spacer"></div><h4 class="article-section__title" id="_i180"> (B) 1-(2-Aminoethyl)-<i>N</i>-(3-fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>61</b>)</h4><div class="NLM_p last">To a solution of 1-(2-(1,3-dioxoisoindolin-2-yl)ethyl)-<i>N</i>-(3-fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (0.20 g, 0.30 mmol) in EtOH/H<sub>2</sub>O (1:1, 20 mL) was added H<sub>2</sub>N<sub>2</sub> (0.049 g, 1.5 mmol). The mixture was heated at 50 °C for 8 h and allowed to cool to rt. The mixture was diluted with NaHCO<sub>3</sub> (saturated, 20 mL) and EtOAc (60 mL). The organic phase was separated and washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was washed with hexanes/EtOAc (20%) to give desired product as light-yellow solid (0.13 g, 81%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>26</sub>FN<sub>5</sub>O<sub>4</sub>, 527.1; found, 528.1 (M + H). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 2.67 (t, <i>J</i> = 6.7 Hz, 3 H), 2.82 (s, 3 H), 3.86–4.04 (m, 6 H), 6.49 (dd, <i>J</i> = 5.5, 0.94 Hz, 1 H), 7.21–7.40 (m, 4 H), 7.40–7.50 (m, 2 H), 7.52–7.69 (m, 3 H), 7.89–8.00 (m, 1 H), 8.29 (d, <i>J</i> = 9.2 Hz, 1 H), 8.53 (d, <i>J</i> = 5.5 Hz, 1 H).</div></div></div><div id="sec3_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i181" class="anchor-spacer"></div><h3 class="article-section__title" id="_i181"> 1-(2-Methoxyethyl)-<i>N</i>-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>63</b>)</h3><div id="sec3_32_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i182" class="anchor-spacer"></div><h4 class="article-section__title" id="_i182"> (A) Benzyl 1-(2-Methoxyethyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (<b>62a</b>)</h4><div class="NLM_p last">To a solution of benzyl 1-(2-hydroxyethyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (5.0 g, 14 mmol) in DCM (50 mL) was added a solution of fluoroboric acid (50%, 14 mL, 284 mmol). A solution of trimethylsilyl diazomethane in hexanes (2.0 M, 32 mL, 284 mmol) was added to the mixture dropwise over 30 min. The reaction mixture was allowed to warm to rt and stirred for 1 h. The mixture was diluted with DCM (50 mL) and H<sub>2</sub>O (50 mL). The organic phase was separated and was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by chromatography on silica gel [EtOAc/hexanes (50 to 100%; then MeOH/EtOAc (2%)] to give the desired product as white solid (0.10 g, 2% yield). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>22</sub>N<sub>2</sub>O<sub>4</sub>, 366.2; found, 367.2 (M + H). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.66 (s, 3 H), 3.20 (s, 3 H), 3.30 (t, <i>J</i> = 5.0 Hz, 2 H), 3.90 (t, <i>J</i> = 4.9 Hz, 2 H), 5.33 (s, 2 H), 7.22–7.40 (m, 6 H), 7.42–7.57 (m, 4 H).</div></div><div id="sec3_32_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i183" class="anchor-spacer"></div><h4 class="article-section__title" id="_i183"> (B) 1-(2-Methoxyethyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>62b</b>)</h4><div class="NLM_p last">To a solution of benzyl 1-(2-methoxyethyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (0.80 g, 2.2 mmol) in EtOAc (50 mL) was added Pd/C (10%, 0.023 g). The mixture was stirred under H<sub>2</sub> (balloon) for 6 h. The catalyst was removed by filtration through a pad of Celite. The filtrate was concentrated in vacuo to give the desired product as a white solid (0.60 g, 99%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>16</sub>N<sub>2</sub>O<sub>4</sub>, 276.2; found, 277.1 (M + H). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.73 (s, 3 H), 3.23 (s, 3 H), 3.31 (t, <i>J</i> = 4.9 Hz, 2 H), 3.98 (t, <i>J</i> = 4.9 Hz, 2 H), 7.34 (d, <i>J</i> = 7.4 Hz, 2 H), 7.42–7.61 (m, 3 H), 12.10 (bs, 1H).</div></div><div id="sec3_32_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i184" class="anchor-spacer"></div><h4 class="article-section__title" id="_i184"> (C) 1-(2-Methoxyethyl)-<i>N</i>-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>63</b>)</h4><div class="NLM_p last">The general procedure for amide coupling between 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid and anilines was followed to prepare the title compound, starting with 5-(7-methoxyquinolin-4-yloxy)pyridin-2-amine (0.10 g, 0.4 mmol) and 1-(2-methoxyethyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (0.1 g, 0.4 mmol), as white solid (TFA slat) (0.08 g, 42%). MS (ESI pos ion) <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>27</sub>N<sub>5</sub>O<sub>5</sub>, 525.2; found, 526.2 (M + H). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 2.81 (s, 3 H), 3.26 (s, 3 H), 3.38 (t, <i>J</i> = 4.9 Hz, 2 H), 4.05–4.15 (m, 5 H), 7.00 (d, <i>J</i> = 6.8 Hz, 1 H), 7.39–7.67 (m, 7 H), 7.84 (dd, <i>J</i> = 9.2, 2.8 Hz, 1 H), 8.34 (d, <i>J</i> = 2.5 Hz, 1 H), 8.49 (d, <i>J</i> = 9.0 Hz, 1 H), 8.56 (d, <i>J</i> = 9.4 Hz, 1 H), 8.81 (d, <i>J</i> = 6.8 Hz, 1 H).</div></div></div><div id="sec3_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i185" class="anchor-spacer"></div><h3 class="article-section__title" id="_i185"> 1-(3-Amino-2-hydroxypropyl)-<i>N</i>-(3-fluoro-4-((7-methoxyquinolin-4-yl)oxy)phenyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>67</b>)</h3><div id="sec3_33_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i186" class="anchor-spacer"></div><h4 class="article-section__title" id="_i186"> (A) Benzyl 1-(3-Azido-2-hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (<b>65a</b>)</h4><div class="NLM_p last">A suspension of benzyl 1-(3-chloro-2-hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (2.0 g, 5.00 mmol) and NaN<sub>3</sub> (0.97 g, 15 mmol) were heated at 90 °C in DMF (15 mL) and H<sub>2</sub>O (5 mL) for 18 h. The reaction was diluted with CHCl<sub>3</sub> (100 mL) and saturated NH<sub>4</sub>Cl (10 mL). The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure to afford title compound as white solid. MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>21</sub>H<sub>21</sub>N<sub>5</sub>O<sub>4</sub>, 407.2; found, 408.2 (M + H).</div></div><div id="sec3_33_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i187" class="anchor-spacer"></div><h4 class="article-section__title" id="_i187"> (B) Benzyl 1-(3-Amino-2-hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (<b>65b</b>)</h4><div class="NLM_p last">To a stirred solution of benzyl 1-(3-azido-2-hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (1.80 g, 4.42 mmol) in dry MeOH (2 mL) was added <i><sup>i</sup></i>Pr<sub>2</sub>NEt<sub>2</sub> (3.8 mL, 22.1 mmol) and propane-1,3-dithiol (2.2 mL, 22.1 mmol). After 48 h, the mixture was concentrated under reduced pressure. The residue was purified by chromatography on silica gel [(2 N NH<sub>3</sub> in MeOH)–DCM (2–10%)] to afford the title compound (1.35 g, 80% yield) as white foam. MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>21</sub>H<sub>23</sub>N<sub>3</sub>O<sub>4</sub>, 381.2; found, 382.2 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl3) δ 2.40–2.28 (m, 1 H), 2.52–2.42 (m, 1 H), 2.68 (s, 3 H), 3.58–3.42 (m, 1 H), 3.75–3.64 (m, 1 H), 3.87–3.75 (m, 1 H), 5.25 (s, 2 H), 7.52–7.36 (m, 5 H), 7.35–7.28 (m, 5 H).</div></div><div id="sec3_33_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i188" class="anchor-spacer"></div><h4 class="article-section__title" id="_i188"> (C) Benzyl 1-(3-(<i>tert</i>-Butoxycarbonyl)-2-hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (<b>66a</b>)</h4><div class="NLM_p last">To a stirred solution of benzyl 1-(3-amino-2-hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (167 mg, 0.44 mmol) in DCM (1 mL) was added Boc<sub>2</sub>O (1 M/THF, 0.44 mL, 0.44 mmol). After 18 h at 23 °C, the mixture was diluted with CHCl<sub>3</sub> (15 mL) and washed with saturated NH<sub>4</sub>Cl (5 mL). The separated organic was dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure to afford the title compound as white solid (200 mg, 95% yield). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd exact mass for C<sub>26</sub>H<sub>31</sub>N<sub>3</sub>O<sub>6</sub>, 481.2; found, 482.3 (M + H).</div></div><div id="sec3_33_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i189" class="anchor-spacer"></div><h4 class="article-section__title" id="_i189"> (D) 1-(3-((<i>tert</i>-Butoxycarbonyl)amino)-2-hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (<b>66b</b>)</h4><div class="NLM_p last">A stirred solution of benzyl 1-(3-(<i>tert</i>-butoxycarbonyl)-2-hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (160 mg, 332 μmol) in MeOH (15 mL) was sparged with Ar for 10 min. To this mixture was added Pd/C (10%, 35 mg), and the mixture was stirred under H<sub>2</sub> (balloon) for 1 h. The reaction mixture was filtered through a bed of Celite and concentrated to give a solid. MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>19</sub>H<sub>25</sub>N<sub>3</sub>O<sub>6</sub>: 391.2; found: 392.2 (M + H).</div></div><div id="sec3_33_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i190" class="anchor-spacer"></div><h4 class="article-section__title" id="_i190"> (E) 1-(3-Amino-2-hydroxypropyl)-<i>N</i>-(3-fluoro-4-((7-methoxyquinolin-4-yl)oxy)phenyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>67</b>)</h4><div class="NLM_p last">To a stirred solution of 1-(3-(<i>tert</i>-butoxycarbonyl)-2-hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (90 mg, 230 μmol) and <i><sup>i</sup></i>Pr<sub>2</sub>NEt (40 μL, 230 μmol) in DMF (1 mL) was added HATU (87 mg, 230 μmol). The mixture was stirred at rt for 20 min before 3-fluoro-4-(7-methoxyquinolin-4-yloxy)benzenamine (65 mg, 230 μmol) was added. After overnight, the reaction mixture was partitioned between DCM and aqueous NaHCO<sub>3</sub> (5%). The aqueous layer was extracted with DCM (2 × 5 mL), and the combined organics were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude material was purified by chromatography on silica gel eluting with MeOH–DCM (0–4%). The resulting film was exposed to TFA (1 mL) in DCM (1 mL) for 15 min. The mixture was washed with NaOH (1 M) and purified by chromatography on silica gel [MeOH–DCM (5%), then 3–10% of (2 M NH<sub>3</sub> in MeOH)–DCM (3–10%)] to afford 1-(3-amino-2-hydroxypropyl)-<i>N</i>-(3-fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide as fluffy white powder (40 mg, 31% yd). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>30</sub>H<sub>28</sub>FN<sub>5</sub>O<sub>5</sub>, 557.2; found, 558.3 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.28 (dd, <i>J</i> = 5.4, 2.6 Hz, 2 H), 2.69 (s, 3 H), 3.87 (s, 5 H), 4.94–5.15 (m, 1 H), 6.42 (d, <i>J</i> = 5.1 Hz, 1 H), 7.19–7.31 (m, 2 H), 7.31–7.40 (m, 4 H), 7.43 (s, 1 H), 7.51 (d, <i>J</i> = 7.6 Hz, 2 H), 7.90 (d, <i>J</i> = 2.4 Hz, 1 H), 8.16 (d, <i>J</i> = 9.0 Hz, 1 H), 8.55 (d, <i>J</i> = 5.3 Hz, 1 H), 10.93 (s, 1 H)</div></div></div><div id="sec3_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i191" class="anchor-spacer"></div><h3 class="article-section__title" id="_i191"> <i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-5-methyl-3-oxo-1-((2-oxooxazolidin-5-yl)methyl)-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>69</b>)</h3><div id="sec3_34_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i192" class="anchor-spacer"></div><h4 class="article-section__title" id="_i192"> (A) Benzyl 5-Methyl-3-oxo-1-((2-oxooxazolidin-5-yl)methyl)-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (<b>68a</b>)</h4><div class="NLM_p last">To a stirred suspension of benzyl 1-(3-amino-2-hydroxypropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (345 mg, 0.91 mmol) in 1,4-dioxane (2 mL) was added disuccinimidyl carbonate (232 mg, 0.91 mmol). The mixture was stirred for 30 min at 23 °C. To this solution was added DBU (327 μL, 2.2 mmol), and stirring was continued for an additional 1 h at 23 °C. The reaction mixture was diluted with DCM (25 mL) and washed with HCl (1 N, 10 mL). The separated organic phase was dried over MgSO<sub>4</sub>, filtered, concentrated under reduced pressure. The residue was purified by chromatography on silica gel eluting with MeOH–DCM (1–4%) to afford the title compound as white solid (310 mg, 84%). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>22</sub>H<sub>21</sub>N<sub>3</sub>O<sub>5</sub>, 407.2; found, 408.2 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.61 (s, 3 H), 3.04 (dd, <i>J</i> = 5.6, 9.3 Hz, 1 H), 3.40 (t, <i>J</i> = 9.0 Hz, 1 H), 3.89 (dd, <i>J</i> = 2.7, 16.0 Hz, 1 H), 4.23 (dd, <i>J</i> = 9.1, 15.9 Hz, 1 H), 4.57 (ddt, <i>J</i> = 2.9, 5.5, 8.8 Hz, 1 H), 5.23 (s, 2 H), 7.49–7.25 (m, 8 H), 7.58–7.48 (m, 2 H), 7.63 (s, 1 H).</div></div><div id="sec3_34_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i193" class="anchor-spacer"></div><h4 class="article-section__title" id="_i193"> (B) 5-Methyl-3-oxo-1-((2-oxooxazolidin-5-yl)methyl)-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic Acid (<b>68b</b>)</h4><div class="NLM_p last">A stirred suspension of benzyl 5-methyl-3-oxo-1-((2-oxooxazolidin-5-yl)methyl)-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate (150 mg, 0.37 mmol) in MeOH (10 mL) was sparged with Ar for 20 min. To this suspension was added Pd/C (10%, 5 mg). After18 h at 23 °C under H<sub>2</sub> (balloon), the reaction was filtered through a bed of Celite and concentrated under reduced pressure to afford title compound as white solid in quantitative yield. MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>15</sub>H<sub>15</sub>N<sub>3</sub>O<sub>5</sub>, 317.1; found, 318.1 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.63 (s, 3 H), 3.04 (dd, <i>J</i> = 5.5, 9.2 Hz, 1 H), 3.44–3.37 (m, 1 H), 3.97 (dd, <i>J</i> = 2.7, 16.0 Hz, 1 H), 4.25 (dd, <i>J</i> = 9.2, 16.0 Hz, 1 H), 4.62–4.51 (m, 1 H), 7.40 (d, <i>J</i> = 7.2 Hz, 2 H), 7.52–7.46 (m, 1 H), 7.60–7.54 (m, 2 H), 7.64 (s, 1 H).</div></div><div id="sec3_34_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i194" class="anchor-spacer"></div><h4 class="article-section__title" id="_i194"> (C) <i>N</i>-(3-Fluoro-4-(7-methoxyquinolin-4-yloxy)phenyl)-5-methyl-3-oxo-1-((2-oxooxazolidin-5-yl)methyl)-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (<b>69</b>)</h4><div class="NLM_p last">A solution of 5-methyl-3-oxo-1-((2-oxooxazolidin-5-yl)methyl)-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylic acid (80 mg, 252 μmol), <i><sup>i</sup></i>Pr<sub>2</sub>NEt2 (44 μL, 252 μmol), and HATU (96 mg, 252 μmol) in DMF (1 mL) was stirred for 20 min at 23 °C before 3-fluoro-4-(7-methoxyquinolin-4-yloxy)benzenamine was added. After 18 h at 40 °C, the reaction was diluted with DCM (15 mL) and washed with 5% NaHCO<sub>3</sub> (50 mL). The separated aqueous layer was extracted with DCM (2 × 5 mL), and the combined organics were dried over MgSO<sub>4</sub>, filtered, concentrated under reduced pressure, and purified by chromatography on silica gel eluting with MeOH–DCM (1–5%) to afford title compound as colorless film which was subsequently lyophilized from 50% ACN/H<sub>2</sub>O (2 mL) to provide amorphous white powder (100 mg, 68%). MS (ESI pos ion) <i>m</i>/<i>z</i>: calcd for C<sub>31</sub>H<sub>26</sub>FN<sub>5</sub>O<sub>6</sub>, 583.2; found, 584.2 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.07 (dd, <i>J</i> = 9.4, 5.5 Hz, 1 H), 3.43 (t, <i>J</i> = 9.1 Hz, 1 H), 3.90–4.07 (m, 4 H), 4.30 (dd, <i>J</i> = 16.0, 9.2 Hz, 1 H), 4.52–4.67 (m, 1 H), 6.50 (d, <i>J</i> = 5.3 Hz, 1 H), 7.28–7.48 (m, 6 H), 7.48–7.53 (m, 1 H), 7.54–7.68 (m, 3 H), 7.99 (dd, <i>J</i> = 13.0, 2.2 Hz, 1 H), 8.24 (d, <i>J</i> = 9.0 Hz, 1 H), 8.63 (d, <i>J</i> = 5.1 Hz, 1 H), 10.90 (s, 1 H).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i195"><a href="/doi/suppl/10.1021/jm201331s">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01131" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01131" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Biological assays, standard deviations, and X-ray crystallographic data.  This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm201331s/suppl_file/jm201331s_si_001.pdf">jm201331s_si_001.pdf (233.91 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm201331s" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86215" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86215" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Longbin Liu</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Oncology Research, and §Molecular Structure, Amgen Inc., One Amgen Center Drive, Thousand Oaks,
California 91320, United States </span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Medicinal Chemistry and ⊥Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge,
Massachusetts 02142, United States </span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#99f5f5f0ecd9f8f4fefcf7b7faf6f4"><span class="__cf_email__" data-cfemail="721e1e1b0732131f15171c5c111d1f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark H. Norman</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Oncology Research, and §Molecular Structure, Amgen Inc., One Amgen Center Drive, Thousand Oaks,
California 91320, United States </span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Medicinal Chemistry and ⊥Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge,
Massachusetts 02142, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew Lee</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Oncology Research, and §Molecular Structure, Amgen Inc., One Amgen Center Drive, Thousand Oaks,
California 91320, United States </span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Medicinal Chemistry and ⊥Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge,
Massachusetts 02142, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ning Xi</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Oncology Research, and §Molecular Structure, Amgen Inc., One Amgen Center Drive, Thousand Oaks,
California 91320, United States </span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Medicinal Chemistry and ⊥Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge,
Massachusetts 02142, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aaron Siegmund</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Oncology Research, and §Molecular Structure, Amgen Inc., One Amgen Center Drive, Thousand Oaks,
California 91320, United States </span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Medicinal Chemistry and ⊥Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge,
Massachusetts 02142, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessandro A. Boezio</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Oncology Research, and §Molecular Structure, Amgen Inc., One Amgen Center Drive, Thousand Oaks,
California 91320, United States </span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Medicinal Chemistry and ⊥Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge,
Massachusetts 02142, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shon Booker</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Oncology Research, and §Molecular Structure, Amgen Inc., One Amgen Center Drive, Thousand Oaks,
California 91320, United States </span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Medicinal Chemistry and ⊥Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge,
Massachusetts 02142, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Debbie Choquette</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Oncology Research, and §Molecular Structure, Amgen Inc., One Amgen Center Drive, Thousand Oaks,
California 91320, United States </span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Medicinal Chemistry and ⊥Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge,
Massachusetts 02142, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Noel D. D’Angelo</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Oncology Research, and §Molecular Structure, Amgen Inc., One Amgen Center Drive, Thousand Oaks,
California 91320, United States </span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Medicinal Chemistry and ⊥Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge,
Massachusetts 02142, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julie Germain</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Oncology Research, and §Molecular Structure, Amgen Inc., One Amgen Center Drive, Thousand Oaks,
California 91320, United States </span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Medicinal Chemistry and ⊥Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge,
Massachusetts 02142, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Yang</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Oncology Research, and §Molecular Structure, Amgen Inc., One Amgen Center Drive, Thousand Oaks,
California 91320, United States </span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Medicinal Chemistry and ⊥Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge,
Massachusetts 02142, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yajing Yang</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Oncology Research, and §Molecular Structure, Amgen Inc., One Amgen Center Drive, Thousand Oaks,
California 91320, United States </span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Medicinal Chemistry and ⊥Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge,
Massachusetts 02142, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yihong Zhang</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Oncology Research, and §Molecular Structure, Amgen Inc., One Amgen Center Drive, Thousand Oaks,
California 91320, United States </span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Medicinal Chemistry and ⊥Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge,
Massachusetts 02142, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven F. Bellon</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Oncology Research, and §Molecular Structure, Amgen Inc., One Amgen Center Drive, Thousand Oaks,
California 91320, United States </span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Medicinal Chemistry and ⊥Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge,
Massachusetts 02142, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas A. Whittington</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Oncology Research, and §Molecular Structure, Amgen Inc., One Amgen Center Drive, Thousand Oaks,
California 91320, United States </span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Medicinal Chemistry and ⊥Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge,
Massachusetts 02142, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Christophe Harmange</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Oncology Research, and §Molecular Structure, Amgen Inc., One Amgen Center Drive, Thousand Oaks,
California 91320, United States </span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Medicinal Chemistry and ⊥Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge,
Massachusetts 02142, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Celia Dominguez</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Oncology Research, and §Molecular Structure, Amgen Inc., One Amgen Center Drive, Thousand Oaks,
California 91320, United States </span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Medicinal Chemistry and ⊥Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge,
Massachusetts 02142, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tae-Seong Kim</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Oncology Research, and §Molecular Structure, Amgen Inc., One Amgen Center Drive, Thousand Oaks,
California 91320, United States </span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Medicinal Chemistry and ⊥Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge,
Massachusetts 02142, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isabelle Dussault</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry, ‡Oncology Research, and §Molecular Structure, Amgen Inc., One Amgen Center Drive, Thousand Oaks,
California 91320, United States </span>; 
    <span class="hlFld-Affiliation affiliation">∥Departments of Medicinal Chemistry and ⊥Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge,
Massachusetts 02142, United States </span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><p class="inlineNote">Abbreviations for chemical reagents and experimental descriptions are adopted from the convention of <i>Journal of Organic Chemistry</i>.</p></div></li></ul></div><div class="ack" id="ACK-d1006e10621-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i197">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51767" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51767" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Randy Hungate, Terry Rosen, Rick Kendall, and Glenn Begley for their support of this research program; Dan Retz and James Rider for the preparation of compounds <b>58a</b> and <b>48d</b>, respectively; and Alex Long for the purification of proteins used in this study.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i198" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i198"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i199" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i199"> Abbreviations Used</h2><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine-5′-triphosphate</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl) carbodiimide)</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">2-(7-aza-1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HGF</td><td class="NLM_def"><p class="first last">hepatocyte growth factor</p></td></tr><tr><td class="NLM_term">HOAt</td><td class="NLM_def"><p class="first last">(1-hydroxy-7-azabenzotriazole)</p></td></tr><tr><td class="NLM_term">IGF-1R</td><td class="NLM_def"><p class="first last">insulin-like growth factor receptor 1</p></td></tr><tr><td class="NLM_term">RTK</td><td class="NLM_def"><p class="first last">receptor tyrosine kinase</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">VEGFR-2</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor receptor 2</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i200">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41442" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41442" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 40 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bottaro, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faletto, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kmiecik, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aaronson, S. A.</span><span> </span><span class="NLM_article-title">Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x">, </span> <span class="NLM_fpage">802</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1991&pages=802-4&author=D.+P.+Bottaroauthor=J.+S.+Rubinauthor=D.+L.+Falettoauthor=A.+M.+Chanauthor=T.+E.+Kmiecikauthor=G.+F.+Vande+Woudeauthor=S.+A.+Aaronson&title=Identification+of+the+hepatocyte+growth+factor+receptor+as+the+c-met+proto-oncogene+product"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBottaro%26aufirst%3DD.%2BP.%26aulast%3DRubin%26aufirst%3DJ.%2BS.%26aulast%3DFaletto%26aufirst%3DD.%2BL.%26aulast%3DChan%26aufirst%3DA.%2BM.%26aulast%3DKmiecik%26aufirst%3DT.%2BE.%26aulast%3DVande%2BWoude%26aufirst%3DG.%2BF.%26aulast%3DAaronson%26aufirst%3DS.%2BA.%26atitle%3DIdentification%2520of%2520the%2520hepatocyte%2520growth%2520factor%2520receptor%2520as%2520the%2520c-met%2520proto-oncogene%2520product%26jtitle%3DScience%26date%3D1991%26volume%3D251%26spage%3D802%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Naldini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weidner, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponzetto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narsimhan, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarnegar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalopoulos, G. K.</span><span> </span><span class="NLM_article-title">Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2867</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1991&pages=2867-78&author=L.+Naldiniauthor=K.+M.+Weidnerauthor=E.+Vignaauthor=G.+Gaudinoauthor=A.+Bardelliauthor=C.+Ponzettoauthor=R.+P.+Narsimhanauthor=G.+Hartmannauthor=R.+Zarnegarauthor=G.+K.+Michalopoulos&title=Scatter+factor+and+hepatocyte+growth+factor+are+indistinguishable+ligands+for+the+MET+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNaldini%26aufirst%3DL.%26aulast%3DWeidner%26aufirst%3DK.%2BM.%26aulast%3DVigna%26aufirst%3DE.%26aulast%3DGaudino%26aufirst%3DG.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DPonzetto%26aufirst%3DC.%26aulast%3DNarsimhan%26aufirst%3DR.%2BP.%26aulast%3DHartmann%26aufirst%3DG.%26aulast%3DZarnegar%26aufirst%3DR.%26aulast%3DMichalopoulos%26aufirst%3DG.%2BK.%26atitle%3DScatter%2520factor%2520and%2520hepatocyte%2520growth%2520factor%2520are%2520indistinguishable%2520ligands%2520for%2520the%2520MET%2520receptor%26jtitle%3DEMBO%2520J.%26date%3D1991%26volume%3D10%26spage%3D2867%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Longati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponzetto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naldini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span> </span><span class="NLM_article-title">Tyrosines 1234–1235 are critical for activation of the tyrosine kinase encoded by the MET protoocogene (HGF receptor)</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1994&pages=49-57&author=P.+Longatiauthor=A.+Bardelliauthor=C.+Ponzettoauthor=L.+Naldiniauthor=P.+M.+Comoglio&title=Tyrosines+1234%E2%80%931235+are+critical+for+activation+of+the+tyrosine+kinase+encoded+by+the+MET+protoocogene+%28HGF+receptor%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLongati%26aufirst%3DP.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DPonzetto%26aufirst%3DC.%26aulast%3DNaldini%26aufirst%3DL.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26atitle%3DTyrosines%25201234%25E2%2580%25931235%2520are%2520critical%2520for%2520activation%2520of%2520the%2520tyrosine%2520kinase%2520encoded%2520by%2520the%2520MET%2520protoocogene%2520%2528HGF%2520receptor%2529%26jtitle%3DOncogene%26date%3D1994%26volume%3D9%26spage%3D49%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span> </span><span class="NLM_article-title">Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">1511</span><span class="NLM_x">–</span> <span class="NLM_lpage">1519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2000&pages=1511-1519&author=T.+Nakamuraauthor=S.+Mizunoauthor=K.+Matsumotoauthor=Y.+Sawaauthor=H.+Matsudaauthor=T.+Nakamura&title=Myocardial+protection+from+ischemia%2Freperfusion+injury+by+endogenous+and+exogenous+HGF"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DMizuno%26aufirst%3DS.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DSawa%26aufirst%3DY.%26aulast%3DMatsuda%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DT.%26atitle%3DMyocardial%2520protection%2520from%2520ischemia%252Freperfusion%2520injury%2520by%2520endogenous%2520and%2520exogenous%2520HGF%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2000%26volume%3D106%26spage%3D1511%26epage%3D1519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Huh, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Factor, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Commer, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorgeirsson, S. S.</span><span> </span><span class="NLM_article-title">Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">4477</span><span class="NLM_x">–</span> <span class="NLM_lpage">4482</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=4477-4482&author=C.+G.+Huhauthor=V.+W.+Factorauthor=A.+Sanchezauthor=K.+Uchidaauthor=E.+A.+Commerauthor=S.+S.+Thorgeirsson&title=Hepatocyte+growth+factor%2Fc-met+signaling+pathway+is+required+for+efficient+liver+regeneration+and+repair"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuh%26aufirst%3DC.%2BG.%26aulast%3DFactor%26aufirst%3DV.%2BW.%26aulast%3DSanchez%26aufirst%3DA.%26aulast%3DUchida%26aufirst%3DK.%26aulast%3DCommer%26aufirst%3DE.%2BA.%26aulast%3DThorgeirsson%26aufirst%3DS.%2BS.%26atitle%3DHepatocyte%2520growth%2520factor%252Fc-met%2520signaling%2520pathway%2520is%2520required%2520for%2520efficient%2520liver%2520regeneration%2520and%2520repair%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D4477%26epage%3D4482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="note"><p class="first last">For reviews, see,</p></div><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sattler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy</span> <span class="citation_source-journal">Curr. Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1007%2Fs11912-007-0005-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=17288874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1GrurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=102-108&author=M.+Sattlerauthor=R.+Salgia&title=c-Met+and+hepatocyte+growth+factor%3A+potential+as+novel+targets+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy</span></div><div class="casAuthors">Sattler, Martin; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Current Oncology Reports</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">102-108</span>CODEN:
                <span class="NLM_cas:coden">CORUAT</span>;
        ISSN:<span class="NLM_cas:issn">1523-3790</span>.
    
            (<span class="NLM_cas:orgname">Current Science Inc.</span>)
        </div><div class="casAbstract">A review.  Receptor tyrosine kinases have come to fruition as therapeutic targets in a variety of malignancies.  In this group of targets, the c-Met receptor tyrosine kinase plays an important role in increased cell growth, reduced apoptosis, altered cytoskeletal function, increased metastasis, and other biol. changes.  The ligand for c-Met is hepatocyte growth factor (HGF), also known as scatter factor.  Met is overexpressed and mutated in a variety of malignancies, among which germline mutations are of particular interest.  Most mutations of Met have been found in the juxtamembrane, the tyrosine kinase, and the semaphorin domain.  Met gain-of-function mutations lead to deregulated or prolonged tyrosine kinase activity, which is instrumental to its transforming activity.  This review summarizes the biol. functions regulated by Met and its structural requirements as well as related developments in targeted therapy.  Treatment approaches, including antagonism of HGF binding to Met, targeting of RNA and the Met protein, and inhibition of the tyrosine kinase domain of Met, are highlighted.  Targeting of the HGF/Met pathway, alone or in combination with std. therapies, is likely to improve current therapies in Met-dependent malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfjcMNRn_47LVg90H21EOLACvtfcHk0liuj2NEr46jvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1GrurY%253D&md5=8ae4f573341e51c23b8fdc11c609768c</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1007%2Fs11912-007-0005-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11912-007-0005-4%26sid%3Dliteratum%253Aachs%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3Dc-Met%2520and%2520hepatocyte%2520growth%2520factor%253A%2520potential%2520as%2520novel%2520targets%2520in%2520cancer%2520therapy%26jtitle%3DCurr.%2520Oncol.%2520Rep.%26date%3D2007%26volume%3D9%26spage%3D102%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mazzone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span> </span><span class="NLM_article-title">The Met pathway: master switch and drug target in cancer progression</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1611</span><span class="NLM_x">–</span> <span class="NLM_lpage">1621</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=1611-1621&author=M.+Mazzoneauthor=P.+M.+Comoglio&title=The+Met+pathway%3A+master+switch+and+drug+target+in+cancer+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMazzone%26aufirst%3DM.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26atitle%3DThe%2520Met%2520pathway%253A%2520master%2520switch%2520and%2520drug%2520target%2520in%2520cancer%2520progression%26jtitle%3DFASEB%2520J.%26date%3D2006%26volume%3D20%26spage%3D1611%26epage%3D1621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span> </span><span class="NLM_article-title">NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1111%2Fj.1349-7006.2003.tb01440.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=12824898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkslCnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2003&pages=321-327&author=K.+Matsumotoauthor=T.+Nakamura&title=NK4+%28HGF-antagonist%2Fangiogenesis+inhibitor%29+in+cancer+biology+and+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics</span></div><div class="casAuthors">Matsumoto, Kunio; Nakamura, Toshikazu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">321-327</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Japanese Cancer Association</span>)
        </div><div class="casAbstract">A review.  Invasion and subsequent establishment of metastasis are devastating events for patients with cancer, but past therapeutic approaches have paid relatively little attention to these important issues.  Hepatocyte growth factor (HGF) and its receptor, the c-Met tyrosine kinase, play roles in cancer invasion and metastasis in a wide variety of tumor cells.  Activation of the c-Met receptor integrates multiple signal transduction pathways involved in cell-cell and cell-matrix interactions, cellular migration, and breakdown of the extracellular scaffold.  Paracrine activation of the c-Met receptor by stromal-derived HGF mediates tumor-stromal interactions that facilitate invasion and metastasis.  Likewise, aberrant expression of the c-Met receptor and autocrine or mutational activation of c-Met receptor tyrosine kinase are closely assocd. with the progression of malignant tumors.  Based on this background, NK4, a competitive antagonist of HGF-c-Met assocn. was prepd. so as to block cancer invasion and metastasis.  NK4, an internal fragment of HGF, binds to but does not activate the c-Met receptor, thereby competitively antagonizing the biol. activities of HGF.  Unexpectedly, NK4 was subsequently shown to be an angiogenesis inhibitor as well, and this angioinhibitory activity is independent of its action as an HGF-antagonist.  Importantly, NK4 protein or NK4 gene therapy have been shown to inhibit tumor invasion, metastasis and angiogenesis, effectively converting malignant tumors into benign tumors.  Targeting tumor invasion-metastasis and angiogenesis with NK4 seems to have considerable therapeutic potential for cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4hjqCHWKtk7Vg90H21EOLACvtfcHk0liuj2NEr46jvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkslCnsrs%253D&md5=e8a412995fd7960319604909d8b0a077</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2003.tb01440.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2003.tb01440.x%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DT.%26atitle%3DNK4%2520%2528HGF-antagonist%252Fangiogenesis%2520inhibitor%2529%2520in%2520cancer%2520biology%2520and%2520therapeutics%26jtitle%3DCancer%2520Sci.%26date%3D2003%26volume%3D94%26spage%3D321%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gherardi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G. F.</span><span> </span><span class="NLM_article-title">Met, metastasis, motility and more</span> <span class="citation_source-journal">Nature Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">925</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1038%2Fnrm1261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=14685170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvFeju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=915-925&author=C.+Birchmeierauthor=W.+Birchmeierauthor=E.+Gherardiauthor=G.+F.+Vande+Woude&title=Met%2C+metastasis%2C+motility+and+more"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4dR"><div class="casContent"><span class="casTitleNuber">4d</span><div class="casTitle"><span class="NLM_cas:atitle">Met, metastasis, motility and more</span></div><div class="casAuthors">Birchmeier, Carmen; Birhcmeier, Walter; Gherardi, Ermanno; Vande Woude, George F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">915-925</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatocyte growth factor. scatter factor and its receptor, the tyrosine kinase Met, arose late in evolution and are unique to vertebrates.  In spite of this, Met uses mols. such as Gab1 - homologues of which are present in Caenorhabditis elegans and Drosophila melanogaster - for downstream signalling. Pivotal roles for Met in development and cancer have been established: Met controls cell migration and growth in embryogenesis; it also controls growth, invasion and metastasis in cancer cells; and activating Met mutations predispose to human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG_-6XRpZ-sLVg90H21EOLACvtfcHk0lj4Y7BsE2v2Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvFeju7s%253D&md5=ff5a02c73415784480c628fe65299a81</span></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1038%2Fnrm1261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1261%26sid%3Dliteratum%253Aachs%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DBirchmeier%26aufirst%3DW.%26aulast%3DGherardi%26aufirst%3DE.%26aulast%3DVande%2BWoude%26aufirst%3DG.%2BF.%26atitle%3DMet%252C%2520metastasis%252C%2520motility%2520and%2520more%26jtitle%3DNature%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2003%26volume%3D4%26spage%3D915%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">and references cited therein.</p></div><div class="NLM_citation" id="cit4e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Trusolino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span> </span><span class="NLM_article-title">Scatter-factor and semaphorin receptors: cell signaling for invasive growth</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">300</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1038%2Fnrc779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=12001990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD38XivFGqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=289-300&author=L.+Trusolinoauthor=P.+M.+Comoglio&title=Scatter-factor+and+semaphorin+receptors%3A+cell+signaling+for+invasive+growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4eR"><div class="casContent"><span class="casTitleNuber">4e</span><div class="casTitle"><span class="NLM_cas:atitle">Scatter-factor and semaphorin receptors: cell signalling for invasive growth</span></div><div class="casAuthors">Trusolino, Livio; Comoglio, Paolo M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">289-300</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  Malignant disease occurs when neoplastic cells abandon their primary site of accretion, cross tissue boundaries and penetrate the vasculature to colonize distant sites.  This process - metastasis - is the aberrant counterpart of a physiol. program for organ regeneration and maintenance.  Scatter factors and semaphorins, together with their receptors, help to orchestrate this program.  What are the differences between physiol. and pathol. activation of these signalling mols., and can we exploit them therapeutically to prevent metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6w1EeLXg7ebVg90H21EOLACvtfcHk0lj4Y7BsE2v2Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivFGqt7g%253D&md5=4a35b0df8816e69246b40e181370d5dc</span></div><a href="/servlet/linkout?suffix=cit4e&amp;dbid=16384&amp;doi=10.1038%2Fnrc779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc779%26sid%3Dliteratum%253Aachs%26aulast%3DTrusolino%26aufirst%3DL.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26atitle%3DScatter-factor%2520and%2520semaphorin%2520receptors%253A%2520cell%2520signaling%2520for%2520invasive%2520growth%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D289%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention</span> <span class="citation_source-journal">Cancer Lett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">225</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1016%2Fj.canlet.2004.09.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=15922853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Ggs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=225&publication_year=2005&pages=1-25&author=J.+Christensenauthor=J.+Burrowsauthor=R.+Salgia&title=c-Met+as+a+target+for+human+cancer+and+characterization+of+inhibitors+for+therapeutic+intervention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention</span></div><div class="casAuthors">Christensen, James G.; Burrows, Jon; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">225</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-26</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Receptor tyrosine kinase (RTK) targeted agents such as trastuzumab, Imatinib, bevacizumab, and gefitinib inhibitors have illustrated the utility of targeting this protein class for treatment of selected cancers.  A unique member of the RTK family, c-Met, also represents an intriguing target for cancer therapy that is yet to be explored in a clin. setting.  The proto-oncogene, c-Met, encodes the high-affinity receptor for hepatocyte growth factor (HGF) or scatter factor (SF).  C-Met and HGF are each required for normal mammalian development and have been shown to be particularly important in cell migration, morphogenic differentiation, and organization of three-dimensional tubular structures (e.g. renal tubular cells, gland formation, etc.) as well as cell growth and angiogenesis.  Both c-Met and HGF have been shown to be deregulated in and to correlate with poor prognosis in a no. of major human cancers.  New data describing the constitutive phosphorylation of c-Met in a no. of human tumors is presented here along with a variety of mechanisms by which c-Met can become activated, including mutation and gene amplification.  In support of the clin. data implicating c-Met activation in the pathogenesis of human cancers, introduction of c-Met and HGF (or mutant c-Met) into cells conferred the properties of motility, invasiveness, and tumorigenicity to the transformed cells.  Conversely, the inhibition of c-Met with a variety of receptor antagonists inhibited the motility, invasiveness, and tumorigenicity of human tumor cell lines.  Consistent with this observation, small-mol. inhibitors of c-Met were developed that antagonized c-Met/HGF-dependent phenotypes and tumor growth in mouse models.  This review will address the potential for development of c-Met inhibitors for treatment of human cancers with particular emphasis on recent findings with small-mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojTbSn0ouMILVg90H21EOLACvtfcHk0lj4Y7BsE2v2Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Ggs7c%253D&md5=106b145cbf442e9fec9667817697658d</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2004.09.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2004.09.044%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3Dc-Met%2520as%2520a%2520target%2520for%2520human%2520cancer%2520and%2520characterization%2520of%2520inhibitors%2520for%2520therapeutic%2520intervention%26jtitle%3DCancer%2520Lett%26date%3D2005%26volume%3D225%26spage%3D1%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dussault, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jun, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T. L.</span><span> </span><span class="NLM_article-title">HGF- and c-Met-targeted drugs: hopes, challenges and their future in cancer therapy</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">819</span><span class="NLM_x">–</span> <span class="NLM_lpage">825</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1358%2Fdof.2006.031.09.1026670" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVKnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=819-825&author=I.+Dussaultauthor=P.+Kaplan-Lefkoauthor=T.+Junauthor=A.+Coxonauthor=T.+L.+Burgess&title=HGF-+and+c-Met-targeted+drugs%3A+hopes%2C+challenges+and+their+future+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">HGF- and c-Met-targeted drugs: hopes, challenges and their future in cancer therapy</span></div><div class="casAuthors">Dussault, Isabelle; Kaplan-Lefko, Paula; Jun, Tani; Coxon, Angela; Burgess, Teresa L.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">819-825</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Cancer remains a formidable disease, with 1,372,910 new cases and 570,280 deaths in the United States alone in 2005 (http://www.cancer.org/docroot/stt/stt_0.asp).  Many types of cancers are still difficult to treat using conventional therapies.  For example, chemotherapeutic drugs are widely used, but their side effects can be devastating to the quality of life of patients and their efficacy is limited in late-stage cancers.  Therefore, efforts have been undertaken for the past several years to develop targeted drugs in the hope of improving efficacy and tolerability.  As these new drugs are starting to make their mark in the clinic, what can we expect in the future with anticancer drugs.  Already we are seeing the benefits of targeted therapies, different drug modalities, including antibodies, and more convenient forms of drug delivery.  Moreover, much attention is now being placed not only on attacking the cancer cells themselves, but also on intervening in the microenvironment in which they reside.  In this review, we will discuss the promise behind novel targeted therapies under development to inhibit signaling via the oncogenic HGF/c-Met pathway.  HGF and c-Met are exciting therapeutic targets that play important roles both directly in tumor cells and in the tumor microenvironment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz1H3RCrcur7Vg90H21EOLACvtfcHk0lj4Y7BsE2v2Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVKnuw%253D%253D&md5=014dca5910768abf2478b0c7a6a29169</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1358%2Fdof.2006.031.09.1026670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2006.031.09.1026670%26sid%3Dliteratum%253Aachs%26aulast%3DDussault%26aufirst%3DI.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%26aulast%3DJun%26aufirst%3DT.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DBurgess%26aufirst%3DT.%2BL.%26atitle%3DHGF-%2520and%2520c-Met-targeted%2520drugs%253A%2520hopes%252C%2520challenges%2520and%2520their%2520future%2520in%2520cancer%2520therapy%26jtitle%3DDrugs%2520Future%26date%3D2006%26volume%3D31%26spage%3D819%26epage%3D825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Abidoye, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murukurthy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">Review of clinic trials: agents targeting c-Met</span> <span class="citation_source-journal">Rev. Recent Clin. Trials</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.2174%2F157488707780599357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=18473999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXms1Oisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=143-147&author=O.+Abidoyeauthor=N.+Murukurthyauthor=R.+Salgia&title=Review+of+clinic+trials%3A+agents+targeting+c-Met"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Review of clinic trials: agents targeting c-Met</span></div><div class="casAuthors">Abidoye, Oyewale; Murukurthy, Nadh; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Reviews on Recent Clinical Trials</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-147</span>CODEN:
                <span class="NLM_cas:coden">RRCTB2</span>;
        ISSN:<span class="NLM_cas:issn">1574-8871</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Receptor tyrosine kinases are a group of mols. that can enhance cellular proliferation, cell motility and migration, and eventual metastasis.  C-Met receptor tyrosine kinase has a significant biol. and biochem. effect on cancer cells, and appears to be an important therapeutic target.  In many cancers, c-Met (which can be activated by its ligand hepatocyte growth factor, HGF) can be overexpressed, activated, amplified, and/or mutated.  The mutations of c-Met had initially been described in the tyrosine kinase domain, and we have described them in other "hot-spots" such as the juxtamembrane and semaphorin domains.  Targeting c-Met has been very fruitful pre-clin., and currently, there are several clin. trials for advanced cancers.  Described in this review are some of the biol. and biochem. aspects of c-Met, and detailed are a no. of therapeutic strategies.  With our understanding of c-Met biol. and role in cancer, we should be able to arrive at a unique strategy to eradicate cancers in which c-Met plays a significant role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdmIx_p1ud1rVg90H21EOLACvtfcHk0lgzaNpIt7STig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXms1Oisrk%253D&md5=2478f449b80738346560c666d4899404</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.2174%2F157488707780599357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157488707780599357%26sid%3Dliteratum%253Aachs%26aulast%3DAbidoye%26aufirst%3DO.%26aulast%3DMurukurthy%26aufirst%3DN.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3DReview%2520of%2520clinic%2520trials%253A%2520agents%2520targeting%2520c-Met%26jtitle%3DRev.%2520Recent%2520Clin.%2520Trials%26date%3D2007%26volume%3D2%26spage%3D143%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Eder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boerner, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoRusso, P. M.</span><span> </span><span class="NLM_article-title">Novel therapeutic inhibitors of the c-Met signaling pathway in cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2207</span><span class="NLM_x">–</span> <span class="NLM_lpage">2214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1158%2F1078-0432.CCR-08-1306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=19318488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvVWltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=2207-2214&author=J.+P.+Ederauthor=G.+F.+Vande+Woudeauthor=S.+A.+Boernerauthor=P.+M.+LoRusso&title=Novel+therapeutic+inhibitors+of+the+c-Met+signaling+pathway+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer</span></div><div class="casAuthors">Eder, Joseph Paul; Vande Woude, George F.; Boerner, Scott A.; Lo Russo, Patricia M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2207-2214</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  A wide variety of human malignancies exhibit sustained c-Met stimulation, overexpression, or mutation, including carcinomas of the breast, liver, lung, ovary, kidney, and thyroid.  Notably, activating mutations in c-Met have been pos. identified in patients with a particular hereditary form of papillary renal cancer, directly implicating c-Met in human tumorigenesis.  Aberrant signaling of the c-Met signaling pathway due to dysregulation of the c-Met receptor or overexpression of its ligand, hepatocyte growth factor (HGF), has been assocd. with an aggressive phenotype.  Extensive evidence that c-Met signaling is involved in the progression and spread of several cancers and an enhanced understanding of its role in disease have generated considerable interest in c-Met and HGF as major targets in cancer drug development.  This has led to the development of a variety of c-Met pathway antagonists with potential clin. applications.  The three main approaches of pathway-selective anticancer drug development have included antagonism of ligand/receptor interaction, inhibition of the tyrosine kinase catalytic activity, and blockade of the receptor/effector interaction.  Several c-Met antagonists are now under clin. investigation.  Preliminary clin. results of several of these agents, including both monoclonal antibodies and small-mol. tyrosine kinase inhibitors, have been encouraging.  Several multitargeted therapies have also been under investigation in the clinic and have demonstrated promise, particularly with regard to tyrosine kinase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9QBC0vQz8BrVg90H21EOLACvtfcHk0lgzaNpIt7STig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvVWltrY%253D&md5=48b4fc788b2b2cab1ce523047e33721d</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-1306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-1306%26sid%3Dliteratum%253Aachs%26aulast%3DEder%26aufirst%3DJ.%2BP.%26aulast%3DVande%2BWoude%26aufirst%3DG.%2BF.%26aulast%3DBoerner%26aufirst%3DS.%2BA.%26aulast%3DLoRusso%26aufirst%3DP.%2BM.%26atitle%3DNovel%2520therapeutic%2520inhibitors%2520of%2520the%2520c-Met%2520signaling%2520pathway%2520in%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D2207%26epage%3D2214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cui, J. J.</span><span> </span><span class="NLM_article-title">Inhibitors targeting hepatocyte growth factor receptor and their potential therapeutic applications</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1045</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1517%2F13543776.17.9.1035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSgtL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1035-1045&author=J.+J.+Cui&title=Inhibitors+targeting+hepatocyte+growth+factor+receptor+and+their+potential+therapeutic+applications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors targeting hepatocyte growth factor receptor and their potential therapeutic applications</span></div><div class="casAuthors">Cui, Jingrong Jean</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1035-1045</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The hepatocyte growth factor (HGF)/c-Met signaling pathway is important in mediating a wide range of biol. activities, including embryol. development, wound healing, tissue regeneration, angiogenesis, proliferation, survival, scattering, motility, invasion and morphogenic differentiation.  HGF and/or c-Met are expressed at abnormally high levels in a large variety of solid tumors.  Various c-Met mutations have been described in many solid tumors and some hematol. malignancies.  Therefore, inhibition of the HGF/c-Met signaling pathway has great potential in mol. targeted cancer therapy.  Many patent applications assocd. with inhibition of the HGF/c-Met axis have been published in the past few years.  There are four small mol. c-Met inhibitors presently in clin. trials.  This review focuses on recent patent applications for small mol. c-Met inhibitors and their potential applications in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwCxL0QxmH-LVg90H21EOLACvtfcHk0lgzaNpIt7STig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSgtL7P&md5=11d01e76a70de95edd486293fd94b62d</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1517%2F13543776.17.9.1035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.17.9.1035%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26atitle%3DInhibitors%2520targeting%2520hepatocyte%2520growth%2520factor%2520receptor%2520and%2520their%2520potential%2520therapeutic%2520applications%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2007%26volume%3D17%26spage%3D1035%26epage%3D1045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Porter, J.</span><span> </span><span class="NLM_article-title">Small molecule c-Met kinase inhibitors: a review of recent patents</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1517%2F13543770903514137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=20100000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=159-177&author=J.+Porter&title=Small+molecule+c-Met+kinase+inhibitors%3A+a+review+of+recent+patents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule c-Met kinase inhibitors: a review of recent patents</span></div><div class="casAuthors">Porter, John</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-177</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: c-Met kinase is the receptor for hepatocyte growth factor.  Primarily expressed on epithelial and mesenchymal cells its normal function is assocd. with wound healing, liver regeneration and embryo development.  However, dysregulation of c-Met through overexpression, gene amplification, mutation or a ligand-dependent autocrine/paracrine loop is assocd. with tumorigenesis.  C-Met dysregulation in human cancer patients is typically assocd. with a poor prognosis, aggressive disease, increased metastasis and shortened patient survival.  Targeting the hepatocyte growth factor/c-Met signaling pathway as a means of cancer therapy has, therefore, become increasingly popular with a no. of different therapeutic approaches undergoing clin. trials.  Areas covered by this review: This review covers the patent applications for small mol.  C-Met kinase inhibitors since 2007, attempts to place them in context from a structural point of view and examines their potential applications in cancer therapy.  What the reader will gain: Readers will gain an overview of the structural types of c-Met inhibitors, the major players in the field and an insight into what is progressing into the clinic.  Take home message: This area is developing rapidly and the results of the various ongoing clin. trials will generate an increased understanding of the potential benefits and pitfalls of c-Met inhibitors as therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqJq_0dMgMLLVg90H21EOLACvtfcHk0lhDsfi90xjvPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGktb8%253D&md5=eac531f4b57558e8d5d51a008cc0c629</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1517%2F13543770903514137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903514137%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DJ.%26atitle%3DSmall%2520molecule%2520c-Met%2520kinase%2520inhibitors%253A%2520a%2520review%2520of%2520recent%2520patents%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D159%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Schroeder, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, L. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullo-Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeyaseelan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manne, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppenheimer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1251</span><span class="NLM_x">–</span> <span class="NLM_lpage">1254</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801586s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1251-1254&author=G.+M.+Schroederauthor=Y.+Anauthor=Z.-W.+Caiauthor=X.-T.+Chenauthor=C.+Clarkauthor=L.+A.+M.+Corneliusauthor=J.+Daiauthor=J.+Gullo-Brownauthor=A.+Guptaauthor=B.+Henleyauthor=J.+T.+Huntauthor=R.+Jeyaseelanauthor=A.+Kamathauthor=K.+Kimauthor=J.+Lippyauthor=L.+J.+Lombardoauthor=V.+Manneauthor=S.+Oppenheimerauthor=J.+S.+Sackauthor=R.+J.+Schmidtauthor=G.+Shenauthor=K.+Stefanskiauthor=J.+S.+Tokarskiauthor=G.+L.+Trainorauthor=B.+S.+Wautletauthor=D.+Weiauthor=D.+K.+Williamsauthor=Y.+Zhangauthor=Y.+Zhangauthor=J.+Fargnoliauthor=R.+M.+Borzilleri&title=Discovery+of+N-%284-%282-Amino-3-chloropyridin-4-yloxy%29-3-fluorophenyl%29-4-ethoxy-1-%284-fluorophenyl%29-2-oxo-1%2C2-dihydropyridine-3-carboxamide+%28BMS-777607%29%2C+a+selective+and+orally+efficacious+inhibitor+of+the+Met+kinase+superfamily"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm801586s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801586s%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeder%26aufirst%3DG.%2BM.%26aulast%3DAn%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DZ.-W.%26aulast%3DChen%26aufirst%3DX.-T.%26aulast%3DClark%26aufirst%3DC.%26aulast%3DCornelius%26aufirst%3DL.%2BA.%2BM.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DGullo-Brown%26aufirst%3DJ.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DHenley%26aufirst%3DB.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DJeyaseelan%26aufirst%3DR.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DLippy%26aufirst%3DJ.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DManne%26aufirst%3DV.%26aulast%3DOppenheimer%26aufirst%3DS.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DSchmidt%26aufirst%3DR.%2BJ.%26aulast%3DShen%26aufirst%3DG.%26aulast%3DStefanski%26aufirst%3DK.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26aulast%3DWautlet%26aufirst%3DB.%2BS.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DD.%2BK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520of%2520N-%25284-%25282-Amino-3-chloropyridin-4-yloxy%2529-3-fluorophenyl%2529-4-ethoxy-1-%25284-fluorophenyl%2529-2-oxo-1%252C2-dihydropyridine-3-carboxamide%2520%2528BMS-777607%2529%252C%2520a%2520selective%2520and%2520orally%2520efficacious%2520inhibitor%2520of%2520the%2520Met%2520kinase%2520superfamily%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1251%26epage%3D1254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Norman, M. H.; Liu, L.; Lee, M.; Xi, N.; Fellows, I.; D’Angelo, N.; Dominguez, C.; Rex, R.; Bellon, S. F.; Kim, T.-S.; Dussault, I.</span><span> </span><span class="NLM_article-title">Structure-based design of novel class II c-Met inhibitors: 1. Identification of pyrazolone-based derivatives</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span>DOI <span class="refDoi"> DOI: 10.1021/jm201330u</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm201330u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+H.+Norman&author=L.+Liu&author=M.+Lee&author=N.+Xi&author=I.+Fellows&author=N.+D%E2%80%99Angelo&author=C.+Dominguez&author=R.+Rex&author=S.+F.+Bellon&author=T.-S.+Kim&author=I.+Dussault&title=Structure-based+design+of+novel+class+II+c-Met+inhibitors%3A+1.+Identification+of+pyrazolone-based+derivatives&doi=10.1021%2Fjm201330u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm201330u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201330u%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DM.%2BH.%26atitle%3DStructure-based%2520design%2520of%2520novel%2520class%2520II%2520c-Met%2520inhibitors%253A%25201.%2520Identification%2520of%2520pyrazolone-based%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26doi%3D10.1021%2Fjm201330u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><div class="note"><p class="first last">For the work leading to a clinical candidate based on pyrazolones, see,</p></div><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegmund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimaanovich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T.-S.</span><span> </span><span class="NLM_article-title">Discovery of 1-(2-hydroxy-2-methylpropyl)-<i>N</i>-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (AMG 458): a potent, selective, and orally bioavailable c-Met Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3688</span><span class="NLM_x">–</span> <span class="NLM_lpage">3691</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800401t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3688-3691&author=L.+Liuauthor=A.+Siegmundauthor=N.+Xiauthor=P.+Kaplan-Lefkoauthor=K.+Rexauthor=A.+Chenauthor=J.+Linauthor=J.+Moriguchiauthor=L.+Berryauthor=L.+Huangauthor=Y.+Tefferaauthor=Y.+Yangauthor=Y.+Zhangauthor=S.+F.+Bellonauthor=M.+Leeauthor=R.+Shimaanovichauthor=A.+Bakauthor=C.+Dominguezauthor=M.+Normanauthor=J.+C.+Harmangeauthor=I.+Dussaultauthor=T.-S.+Kim&title=Discovery+of+1-%282-hydroxy-2-methylpropyl%29-N-%285-%287-methoxyquinolin-4-yloxy%29pyridin-2-yl%29-5-methyl-3-oxo-2-phenyl-2%2C3-dihydro-1H-pyrazole-4-carboxamide+%28AMG+458%29%3A+a+potent%2C+selective%2C+and+orally+bioavailable+c-Met+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm800401t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800401t%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSiegmund%26aufirst%3DA.%26aulast%3DXi%26aufirst%3DN.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DMoriguchi%26aufirst%3DJ.%26aulast%3DBerry%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DShimaanovich%26aufirst%3DR.%26aulast%3DBak%26aufirst%3DA.%26aulast%3DDominguez%26aufirst%3DC.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26aulast%3DDussault%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DT.-S.%26atitle%3DDiscovery%2520of%25201-%25282-hydroxy-2-methylpropyl%2529-N-%25285-%25287-methoxyquinolin-4-yloxy%2529pyridin-2-yl%2529-5-methyl-3-oxo-2-phenyl-2%252C3-dihydro-1H-pyrazole-4-carboxamide%2520%2528AMG%2520458%2529%253A%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520c-Met%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3688%26epage%3D3691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Dussault, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S. F.</span><span> </span><span class="NLM_article-title">From concept to reality: the long road to c-Met and RON receptor tyrosine kinase inhibitors for the treatment of cancer</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=221-229&author=I.+Dussaultauthor=S.+F.+Bellon&title=From+concept+to+reality%3A+the+long+road+to+c-Met+and+RON+receptor+tyrosine+kinase+inhibitors+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDussault%26aufirst%3DI.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26atitle%3DFrom%2520concept%2520to%2520reality%253A%2520the%2520long%2520road%2520to%2520c-Met%2520and%2520RON%2520receptor%2520tyrosine%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D221%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ronsin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muscatelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattei, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breathnach, R.</span><span> </span><span class="NLM_article-title">A novel putative receptor protein tyrosine kinase of the met family</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1195</span><span class="NLM_x">–</span> <span class="NLM_lpage">1202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1993&pages=1195-1202&author=C.+Ronsinauthor=F.+Muscatelliauthor=M.+G.+Matteiauthor=R.+Breathnach&title=A+novel+putative+receptor+protein+tyrosine+kinase+of+the+met+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRonsin%26aufirst%3DC.%26aulast%3DMuscatelli%26aufirst%3DF.%26aulast%3DMattei%26aufirst%3DM.%2BG.%26aulast%3DBreathnach%26aufirst%3DR.%26atitle%3DA%2520novel%2520putative%2520receptor%2520protein%2520tyrosine%2520kinase%2520of%2520the%2520met%2520family%26jtitle%3DOncogene%26date%3D1993%26volume%3D8%26spage%3D1195%26epage%3D1202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="note"><p class="first last">Complete kinase selectivity profile of compound <b>1</b> is available in the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Baka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clamp, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayson, G. C.</span><span> </span><span class="NLM_article-title">A review of the latest clinical compounds to inhibit VEGF in pathological angiogenesis</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">876</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1517%2F14728222.10.6.867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=17105373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Smt7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=867-876&author=S.+Bakaauthor=A.+R.+Clampauthor=G.+C.+Jayson&title=A+review+of+the+latest+clinical+compounds+to+inhibit+VEGF+in+pathological+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the latest clinical compounds to inhibit VEGF in pathological angiogenesis</span></div><div class="casAuthors">Baka, Sofia; Clamp, Andrew R.; Jayson, Gordon C.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">867-876</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Angiogenesis plays an important role in the formation of new blood vessels and is crucial for tumor development and progression.  Imbalance between pro- and antiangiogenesis factors regulates the biol. process of angiogenesis.  The best characterized of the proangiogenic factors and the most potent is vascular endothelial growth factor (VEGF).  The binding of VEGF to one of its transmembrane tyrosine kinase receptors, which are predominantly found on endothelial cells, results in receptor dimerization, activation and autophosphorylation of the tyrosine kinase domain.  This triggers a cascade of complex downstream signalling pathways.  Several strategies targeting the VEGF signalling pathway have been developed.  These include neutralizing antibodies to VEGF (bevacizumab) or VEGF receptors (VEGFRs) (DC101), sol. VEGFR/VEGFR hybrids (VEGF-Trap), and tyrosine kinase inhibitors of VEGFRs (BAY43-9006, SU11248, ZD6474, AZD2171, PTK/ZK and others).  Several of these agents are now being investigated in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozY3D8lNZOqLVg90H21EOLACvtfcHk0liKhfgHsD-CkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Smt7zO&md5=3cba31f6365fd5ef2749fe401c4a0406</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1517%2F14728222.10.6.867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.10.6.867%26sid%3Dliteratum%253Aachs%26aulast%3DBaka%26aufirst%3DS.%26aulast%3DClamp%26aufirst%3DA.%2BR.%26aulast%3DJayson%26aufirst%3DG.%2BC.%26atitle%3DA%2520review%2520of%2520the%2520latest%2520clinical%2520compounds%2520to%2520inhibit%2520VEGF%2520in%2520pathological%2520angiogenesis%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2006%26volume%3D10%26spage%3D867%26epage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gasparini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, N.</span><span> </span><span class="NLM_article-title">Angiogenic inhibitors: a new therapeutic strategy in oncology</span> <span class="citation_source-journal">Nature Clin. Pract. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">562</span><span class="NLM_x">–</span> <span class="NLM_lpage">577</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1038%2Fncponc0342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=16270097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Ghu77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=562-577&author=G.+Gaspariniauthor=R.+Longoauthor=M.+Toiauthor=N.+Ferrara&title=Angiogenic+inhibitors%3A+a+new+therapeutic+strategy+in+oncology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenic inhibitors: a new therapeutic strategy in oncology</span></div><div class="casAuthors">Gasparini, Giampietro; Longo, Raffaele; Toi, Masakazu; Ferrara, Napoleone</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">562-577</span>CODEN:
                <span class="NLM_cas:coden">NCPOB5</span>;
        ISSN:<span class="NLM_cas:issn">1743-4254</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Angiogenesis is a multistep, complex and tightly regulated process that is necessary for tumor growth and metastasis.  Based on data of preclin. models, several antiangiogenic compds. has been shown to modify activated tumor endothelium, which suggests that these compds. can improve cytotoxic drug delivery.  Such agents have entered clin. trials as single agents or in combination with cytotoxic drugs, and have shown promising antitumor activity.  The pharmacodynamic and pharmacokinetic characteristics of antiangiogenic drugs are reviewed here.  Most of the early clin. testing of these agents was conducted in patients with advanced disease resistant to std. therapies.  Phase III trials compared the efficacy of std. chemotherapy alone with std. chemotherapy in combination with an exptl. angiogenesis inhibitor.  Although some of these studies were neg. or controversial, recent studies validated in large clin. trials with an anti-vascular endothelial growth factor antibody demonstrated significant clin. benefit and renewed enthusiasm for this therapeutic strategy.  This review describes the clin. studies of antiangiogenic agents and highlights the challenges related to choosing appropriate strategies for the selection of patients, study design and choice of appropriate endpoints for the studies' development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomP2ZoMwl49LVg90H21EOLACvtfcHk0liKhfgHsD-CkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Ghu77F&md5=5773a1514b2331de7cf2450fb27bd0a5</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1038%2Fncponc0342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncponc0342%26sid%3Dliteratum%253Aachs%26aulast%3DGasparini%26aufirst%3DG.%26aulast%3DLongo%26aufirst%3DR.%26aulast%3DToi%26aufirst%3DM.%26aulast%3DFerrara%26aufirst%3DN.%26atitle%3DAngiogenic%2520inhibitors%253A%2520a%2520new%2520therapeutic%2520strategy%2520in%2520oncology%26jtitle%3DNature%2520Clin.%2520Pract.%2520Oncol.%26date%3D2005%26volume%3D2%26spage%3D562%26epage%3D577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rochester, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedemann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellawell, G. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brewster, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macaulay, V. M.</span><span> </span><span class="NLM_article-title">Silencing of the IGF-1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer</span> <span class="citation_source-journal">Cancer Gene Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1038%2Fsj.cgt.7700775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=15499378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOht77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=90-100&author=M.+A.+Rochesterauthor=J.+Riedemannauthor=G.+O.+Hellawellauthor=S.+F.+Brewsterauthor=V.+M.+Macaulay&title=Silencing+of+the+IGF-1R+gene+enhances+sensitivity+to+DNA-damaging+agents+in+both+PTEN+wild-type+and+mutant+human+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer</span></div><div class="casAuthors">Rochester, Mark A.; Riedemann, Johann; Hellawell, Giles O.; Brewster, Simon F.; Macaulay, Valentine M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Gene Therapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-100</span>CODEN:
                <span class="NLM_cas:coden">CGTHEG</span>;
        ISSN:<span class="NLM_cas:issn">0929-1903</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The type 1 insulin-like growth factor receptor (IGF1R) is overexpressed in prostate cancer, and mediates proliferation, motility, and survival.  Many prostate cancers harbor inactivating PTEN mutations, enhancing Akt phosphorylation.  This activates the principal anti-apoptotic pathway downstream of the IGF1R, calling into question the value of IGF1R targeting in this tumor.  The aim of the current study was to assess the effect of IGF1R gene silencing in prostate cancer cells that lack functional PTEN protein.  In human DU145, LNCaP and PC3 prostate cancer cells, transfection with IGF1R small interfering RNA induced significant enhancement of apoptosis and inhibition of survival, not only in PTEN wild-type DU145 but also in PTEN mutant LNCaP and PC3.  This was attributed to attenuation of IGF signaling via Akt, ERKs and p38.  In both DU145 and PC3, IGF1R knockdown led to enhancement of sensitivity to mitoxantrone, etoposide, nitrogen mustard and ionizing radiation.  There was no sensitization to paclitaxel or 5-fluorouracil, which do not damage DNA, suggesting that chemosensitization results from impairment of the DNA damage response, in addn. to removal of apoptosis protection.  These results support the concept of IGF1R targeting in prostate cancer, and indicate that PTEN loss does not render tumor cells refractory to this strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgLDxqQOHN3bVg90H21EOLACvtfcHk0lhfvomwHU0YkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOht77O&md5=765655d6a8ef655355355fd1f9927130</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1038%2Fsj.cgt.7700775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cgt.7700775%26sid%3Dliteratum%253Aachs%26aulast%3DRochester%26aufirst%3DM.%2BA.%26aulast%3DRiedemann%26aufirst%3DJ.%26aulast%3DHellawell%26aufirst%3DG.%2BO.%26aulast%3DBrewster%26aufirst%3DS.%2BF.%26aulast%3DMacaulay%26aufirst%3DV.%2BM.%26atitle%3DSilencing%2520of%2520the%2520IGF-1R%2520gene%2520enhances%2520sensitivity%2520to%2520DNA-damaging%2520agents%2520in%2520both%2520PTEN%2520wild-type%2520and%2520mutant%2520human%2520prostate%2520cancer%26jtitle%3DCancer%2520Gene%2520Ther.%26date%3D2005%26volume%3D12%26spage%3D90%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Baserga, R.</span><span> </span><span class="NLM_article-title">The insulin-like growth factor-1 receptor as a target for cancer therapy</span> <span class="citation_source-journal">Expert. Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1517%2F14728222.9.4.753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=16083341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFels7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2005&pages=753-768&author=R.+Baserga&title=The+insulin-like+growth+factor-1+receptor+as+a+target+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">The insulin-like growth factor-I receptor as a target for cancer therapy</span></div><div class="casAuthors">Baserga, Renato</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">753-768</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">This review examines the rationale for targeting the insulin-like growth factor (IGF)-I receptor in the therapy of human tumors and their metastases.  The rationale is based on two crucial findings: (1) in exptl. animals, normal cells are only partially affected by the deletion of the IGF-I receptor, whereas tumor cells undergo apoptosis when the IGF-I receptor is downregulated; and (2) cells with a deleted IGF-I receptor are refractory to transformation by viral and cellular oncogenes.  This review focuses on the mechanisms underlying the exptl. findings, and discusses the possibility of extrapolating the results obtained in animals to the cure of human tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOpjOKN3IsjbVg90H21EOLACvtfcHk0lhfvomwHU0YkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFels7w%253D&md5=f07d91258f90130e9cb023e9d7a79e03</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1517%2F14728222.9.4.753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.9.4.753%26sid%3Dliteratum%253Aachs%26aulast%3DBaserga%26aufirst%3DR.%26atitle%3DThe%2520insulin-like%2520growth%2520factor-1%2520receptor%2520as%2520a%2520target%2520for%2520cancer%2520therapy%26jtitle%3DExpert.%2520Opin.%2520Ther.%2520Targets%26date%3D2005%26volume%3D9%26spage%3D753%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Miller, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee, D.</span><span> </span><span class="NLM_article-title">Type I insulin-like growth factor receptor as a therapeutic target in cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">10123</span><span class="NLM_x">–</span> <span class="NLM_lpage">10127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=10123-10127&author=B.+S.+Millerauthor=D.+Yee&title=Type+I+insulin-like+growth+factor+receptor+as+a+therapeutic+target+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DB.%2BS.%26aulast%3DYee%26aufirst%3DD.%26atitle%3DType%2520I%2520insulin-like%2520growth%2520factor%2520receptor%2520as%2520a%2520therapeutic%2520target%2520in%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D10123%26epage%3D10127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ueda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatsuse1, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawarabayashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takigawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morita, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukatsu1, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsubara, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, H.</span><span> </span><span class="NLM_article-title">Potential crosstalk between insulin-like growth factor receptor type 1 and epidermal growth factor receptor in progression and metastasis of pancreatic cancer</span> <span class="citation_source-journal">Mod. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">788</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=16575403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkslelsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2006&pages=788-796&author=S.+Uedaauthor=K.+Hatsuse1author=H.+Tsudaauthor=S.+Ogataauthor=N.+Kawarabayashiauthor=T.+Takigawaauthor=T.+Einamaauthor=D.+Moritaauthor=K.+Fukatsu1author=Y.+Sugiuraauthor=O.+Matsubaraauthor=H.+Mochizuki&title=Potential+crosstalk+between+insulin-like+growth+factor+receptor+type+1+and+epidermal+growth+factor+receptor+in+progression+and+metastasis+of+pancreatic+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14dR"><div class="casContent"><span class="casTitleNuber">14d</span><div class="casTitle"><span class="NLM_cas:atitle">Potential crosstalk between insulin-like growth factor receptor type 1 and epidermal growth factor receptor in progression and metastasis of pancreatic cancer</span></div><div class="casAuthors">Ueda, Shigeto; Hatsuse, Kazuo; Tsuda, Hitoshi; Ogata, Sho; Kawarabayashi, Nobuaki; Takigawa, Toshimichi; Einama, Takahiro; Morita, Daisaku; Fukatsu, Kazuhiko; Sugiura, Yoshiaki; Matsubara, Osamu; Mochizuki, Hidetaka</div><div class="citationInfo"><span class="NLM_cas:title">Modern Pathology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">788-796</span>CODEN:
                <span class="NLM_cas:coden">MODPEO</span>;
        ISSN:<span class="NLM_cas:issn">0893-3952</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The insulin-like growth factor receptor type 1 (IGF1R) and epidermal growth factor receptor (EGFR) are reportedly overexpressed in pancreatic cancer.  However, the correlation between activated EGFR and IGF1R and their clinicopathol. implications still remain unclear.  The cellular localization and overexpression of IGF1R and EGFR were investigated immunohistochem. in primary invasive ductal pancreatic carcinomas obtained from 74 patients who underwent radical surgical resection.  We also compared the status of IGF1R and EGFR overexpression between primary tumors and hepatic metastatic tumors obtained from 44 autopsied patients.  Among the 74 surgically resected primary tumors, cytoplasm- and membrane-dominant EGFR overexpression was detected in 22 (30%) and 7 (9%), resp., whereas cytoplasm- and membrane-dominant IGF1R overexpression was detected in 8 (11%) and 28 (38%), resp.  Membrane-dominant EGFR and cytoplasm-dominant IGF1R were more frequent in lower-grade tumors and correlated with favorable prognosis, whereas cytoplasm-dominant EGFR and membrane-dominant IGF1R were more frequent in higher-grade tumors and correlated with poor prognosis.  In 36 autopsy specimens of pancreatic tumor with concurrent overexpression of IGF1R and EGFR, there was an inverse correlation between the IGF1R and EGFR localization patterns (P=0.001).  In the hepatic metastatic tumors obtained by autopsy, the incidences of both IGF1R and EGFR overexpression were much higher than in the surgically resected primary tumors.  More than half of the autopsy cases consistently showed membrane-dominant EGFR expression in both the primary tumor and hepatic metastases, whereas IGF1R expression showed considerable variation.  Crosstalk between differently localized IGF1R and EGFR might play a role in detg. the biol. aggressiveness of pancreatic cancer, although their cellular localization may often alter during the process of metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom6sA2tMHEabVg90H21EOLACvtfcHk0lhfvomwHU0YkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkslelsr4%253D&md5=7ac42fec7836d17ba52dc22028854ee9</span></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DS.%26aulast%3DHatsuse1%26aufirst%3DK.%26aulast%3DTsuda%26aufirst%3DH.%26aulast%3DOgata%26aufirst%3DS.%26aulast%3DKawarabayashi%26aufirst%3DN.%26aulast%3DTakigawa%26aufirst%3DT.%26aulast%3DEinama%26aufirst%3DT.%26aulast%3DMorita%26aufirst%3DD.%26aulast%3DFukatsu1%26aufirst%3DK.%26aulast%3DSugiura%26aufirst%3DY.%26aulast%3DMatsubara%26aufirst%3DO.%26aulast%3DMochizuki%26aufirst%3DH.%26atitle%3DPotential%2520crosstalk%2520between%2520insulin-like%2520growth%2520factor%2520receptor%2520type%25201%2520and%2520epidermal%2520growth%2520factor%2520receptor%2520in%2520progression%2520and%2520metastasis%2520of%2520pancreatic%2520cancer%26jtitle%3DMod.%2520Pathol.%26date%3D2006%26volume%3D19%26spage%3D788%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><div class="note"><p class="first last">A previously described hierarchical molecular modeling method was used for generating the docked models:</p></div><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span> </span><span class="NLM_article-title">Improving Docking Accuracy through Molecular Mechanics Generalized Born Optimization and Scoring</span> <span class="citation_source-journal">J. Chem. Theory Comput.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1106</span></span><div class="citationLinks">[<a href="/doi/10.1021/ct6003406" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisFGqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=1106&author=M.+R.+Leeauthor=Y.+Sun&title=Improving+Docking+Accuracy+through+Molecular+Mechanics+Generalized+Born+Optimization+and+Scoring"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Improving Docking Accuracy through Molecular Mechanics Generalized Born Optimization and Scoring</span></div><div class="casAuthors">Lee, Matthew R.; Sun, Yaxiong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1106-1119</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Docking methods are typically used within the biopharmaceutical industry for the challenging purposes of suggesting putative binding modes of new chemotypes and for virtual screening.  When attempting to satisfy the far more simplistic yet fundamentally important goal of reproducing and identifying the correct binding mode from a cocrystal, all docking methods fail at a rather significant rate, demonstrating room for further improvement in docking methodol.  We report a hierarchical method that yields results comparable to the industry-leading docking packages GOLD, Glide, and Surflex.  By first using a fast, simple, well-established method, UCSF DOCK 4.0, to rigidly dock conformational ensembles, we successfully generate the correct binding mode in all but 4 of a std., publicly available set of 79 cocrystals from the PDB.  Among these 4 failures (1glq, 1tmn, 1rds, and 8gch), all are highly flexible, highly charged, and not druglike.  Subsequently, all resultant docking poses were optimized and scored in the protein with mol. mechanics, using a std. MMGB energy function.  In total, this hierarchical method identified the correct binding in 71 of 79 cases (90%), an unprecedented level of accuracy on this highly benchmarked test set.  Furthermore, the publicly available energy functions employ only phys. based force fields without parameter fitting from this or any other docking test sets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI_SFPZ-SW2LVg90H21EOLACvtfcHk0lgbw7Up9xJrHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisFGqsb4%253D&md5=087d99fe151f0cfeb5c0bb56f4f23257</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fct6003406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct6003406%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DSun%26aufirst%3DY.%26atitle%3DImproving%2520Docking%2520Accuracy%2520through%2520Molecular%2520Mechanics%2520Generalized%2520Born%2520Optimization%2520and%2520Scoring%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2007%26volume%3D3%26spage%3D1106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">Unpublished results. Published DFG-out X-ray structures of c-Met inhibitors include:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Unpublished+results.+Published+DFG-out+X-ray+structures+of+c-Met+inhibitors+include%3A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kim, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darienzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeyaseelan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullo-Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manne, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span> </span><span class="NLM_article-title">Discovery of pyrrolopyridine-pyridone based inhibitors of Met kinase: synthesis, X-ray crystallographic analysis, and biological Activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5330</span><span class="NLM_x">–</span> <span class="NLM_lpage">5341</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800476q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5330-5341&author=K.+S.+Kimauthor=L.+Zhangauthor=R.+Schmidtauthor=Z.+W.+Caiauthor=D.+Weiauthor=D.+K.+Williamsauthor=L.+J.+Lombardoauthor=G.+L.+Trainorauthor=D.+Xieauthor=Y.+Zhangauthor=Y.+Anauthor=J.+S.+Sackauthor=J.+S.+Tokarskiauthor=C.+Darienzoauthor=A.+Kamathauthor=P.+Maratheauthor=Y.+Zhangauthor=J.+Lippyauthor=R.+Jeyaseelanauthor=B.+Wautletauthor=B.+Henleyauthor=J.+Gullo-Brownauthor=V.+Manneauthor=J.+T.+Huntauthor=J.+Fargnoliauthor=R.+M.+Borzilleri&title=Discovery+of+pyrrolopyridine-pyridone+based+inhibitors+of+Met+kinase%3A+synthesis%2C+X-ray+crystallographic+analysis%2C+and+biological+Activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fjm800476q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800476q%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSchmidt%26aufirst%3DR.%26aulast%3DCai%26aufirst%3DZ.%2BW.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DD.%2BK.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26aulast%3DXie%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DAn%26aufirst%3DY.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DDarienzo%26aufirst%3DC.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLippy%26aufirst%3DJ.%26aulast%3DJeyaseelan%26aufirst%3DR.%26aulast%3DWautlet%26aufirst%3DB.%26aulast%3DHenley%26aufirst%3DB.%26aulast%3DGullo-Brown%26aufirst%3DJ.%26aulast%3DManne%26aufirst%3DV.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520of%2520pyrrolopyridine-pyridone%2520based%2520inhibitors%2520of%2520Met%2520kinase%253A%2520synthesis%252C%2520X-ray%2520crystallographic%2520analysis%252C%2520and%2520biological%2520Activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5330%26epage%3D5341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Qian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, K.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mock, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lougheed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakes, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentzien, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaks, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wooster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greshock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holy, A. H.</span><span> </span><span class="NLM_article-title">Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">8009</span><span class="NLM_x">–</span> <span class="NLM_lpage">8016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=8009-8016&author=F.+Qianauthor=S.+Engstauthor=K.+Yamaguchiauthor=P.+Yuauthor=K.-A.+Wonauthor=L.+Mockauthor=T.+Louauthor=J.+Tanauthor=C.+Liauthor=D.+Tamauthor=J.+Lougheedauthor=F.+M.+Yakesauthor=F.+Bentzienauthor=W.+Xuauthor=T.+Zaksauthor=R.+Woosterauthor=J.+Greshockauthor=A.+H.+Holy&title=Inhibition+of+tumor+cell+growth%2C+invasion%2C+and+metastasis+by+EXEL-2880+%28XL880%2C+GSK1363089%29%2C+a+novel+inhibitor+of+HGF+and+VEGF+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DF.%26aulast%3DEngst%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DWon%26aufirst%3DK.-A.%26aulast%3DMock%26aufirst%3DL.%26aulast%3DLou%26aufirst%3DT.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DLougheed%26aufirst%3DJ.%26aulast%3DYakes%26aufirst%3DF.%2BM.%26aulast%3DBentzien%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DZaks%26aufirst%3DT.%26aulast%3DWooster%26aufirst%3DR.%26aulast%3DGreshock%26aufirst%3DJ.%26aulast%3DHoly%26aufirst%3DA.%2BH.%26atitle%3DInhibition%2520of%2520tumor%2520cell%2520growth%252C%2520invasion%252C%2520and%2520metastasis%2520by%2520EXEL-2880%2520%2528XL880%252C%2520GSK1363089%2529%252C%2520a%2520novel%2520inhibitor%2520of%2520HGF%2520and%2520VEGF%2520receptor%2520tyrosine%2520kinases%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D8009%26epage%3D8016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Lin, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, T. L.</span><span> </span><span class="NLM_article-title">Synthesis and antitumor activity of halogen-substituted 4-(3,3-dimethyl-1-triazeno)quinolines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=268-272&author=A.+J.+Linauthor=T.+L.+Loo&title=Synthesis+and+antitumor+activity+of+halogen-substituted+4-%283%2C3-dimethyl-1-triazeno%29quinolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DA.%2BJ.%26aulast%3DLoo%26aufirst%3DT.%2BL.%26atitle%3DSynthesis%2520and%2520antitumor%2520activity%2520of%2520halogen-substituted%25204-%25283%252C3-dimethyl-1-triazeno%2529quinolines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D21%26spage%3D268%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Samizu, K.; Hisamichi, H.; Matsuhisa, A.; Kinoyama, I.; Hayakawa, M.; Taniguchi, N.; Ideyama, Y.; Kuromitsu, S.; Yahiro, K.; Okada, M.</span><span> </span><span class="NLM_article-title">Preparation of 3-quinoline-2(1<i>H</i>)-ylideneindolin-2-one derivatives as vascular endothelial growth factor (VEGF) inhibitors</span>. Patent WO 2002/094809A1,<span class="NLM_x"> </span><span class="NLM_year">2002.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002.&author=K.+Samizu&author=H.+Hisamichi&author=A.+Matsuhisa&author=I.+Kinoyama&author=M.+Hayakawa&author=N.+Taniguchi&author=Y.+Ideyama&author=S.+Kuromitsu&author=K.+Yahiro&author=M.+Okada&title=Preparation+of+3-quinoline-2%281H%29-ylideneindolin-2-one+derivatives+as+vascular+endothelial+growth+factor+%28VEGF%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSamizu%26aufirst%3DK.%26atitle%3DPreparation%2520of%25203-quinoline-2%25281H%2529-ylideneindolin-2-one%2520derivatives%2520as%2520vascular%2520endothelial%2520growth%2520factor%2520%2528VEGF%2529%2520inhibitors%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Herbert, J. M.</span><span> </span><span class="NLM_article-title">Negishi-type coupling of bromoarenes with dimethylzinc</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">819</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1016%2Fj.tetlet.2003.11.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVSiurfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=817-819&author=J.+M.+Herbert&title=Negishi-type+coupling+of+bromoarenes+with+dimethylzinc"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Negishi-type coupling of bromoarenes with dimethylzinc</span></div><div class="casAuthors">Herbert, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-819</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Treatment of bromoarenes with dimethylzinc in the presence of a Pd catalyst provides a high-yielding route to methylarenes.  The process accommodates a wide range of arom. substituents and, in the majority of cases, is free of side reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVl5qEJc56yLVg90H21EOLACvtfcHk0liWA8DCKpwagA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVSiurfE&md5=560b19106de1cc373afc0853c1fb5f09</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2003.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2003.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DHerbert%26aufirst%3DJ.%2BM.%26atitle%3DNegishi-type%2520coupling%2520of%2520bromoarenes%2520with%2520dimethylzinc%26jtitle%3DTetrahedron%2520Lett.%26date%3D2004%26volume%3D45%26spage%3D817%26epage%3D819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Molander, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivero, M. R.</span><span> </span><span class="NLM_article-title">Suzuki Cross-coupling reactions of potassium alkenyltrifluoroborates</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0169729" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovV2gurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=107-109&author=G.+A.+Molanderauthor=M.+R.+Rivero&title=Suzuki+Cross-coupling+reactions+of+potassium+alkenyltrifluoroborates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Suzuki Cross-Coupling Reactions of Potassium Alkenyltrifluoroborates</span></div><div class="casAuthors">Molander, Gary A.; Rivero, Marta Rodriguez</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">107-109</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The palladium-catalyzed coupling reaction of potassium alkenyltrifluoroborates with aryl or alkenyl halides or triflates proceeds readily with good yields.  The trifluoroborates are air- and moisture-stable solids that can be stored indefinitely.  The cross-coupling can be effected using PdCl2(dppf)·CH2Cl2 as the catalyst in n-PrOH in the presence of Et3N.  A variety of functional groups are tolerated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrueGc4zcgdjLVg90H21EOLACvtfcHk0liWA8DCKpwagA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovV2gurs%253D&md5=519063b115d6433b880ed809bf392f4b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fol0169729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0169729%26sid%3Dliteratum%253Aachs%26aulast%3DMolander%26aufirst%3DG.%2BA.%26aulast%3DRivero%26aufirst%3DM.%2BR.%26atitle%3DSuzuki%2520Cross-coupling%2520reactions%2520of%2520potassium%2520alkenyltrifluoroborates%26jtitle%3DOrg.%2520Lett.%26date%3D2002%26volume%3D4%26spage%3D107%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Kubo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyama, S.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murooka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isoe, T.</span><span> </span><span class="NLM_article-title">Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors: synthesis, structure–activity relationships, and antitumor activities of <i>N</i>-phenyl-<i>N</i>′-{4-(4-quinolyloxy)phenyl}ureas</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">–</span> <span class="NLM_lpage">1366</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030427r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1359-1366&author=K.+Kuboauthor=T.+Shimizuauthor=S.-I.+Ohyamaauthor=H.+Murookaauthor=A.+Iwaiauthor=K.+Nakamuraauthor=K.+Hasegawaauthor=Y.+Kobayashiauthor=N.+Takahashiauthor=K.+Takahashiauthor=S.+Katoauthor=T.+Izawaauthor=T.+Isoe&title=Novel+potent+orally+active+selective+VEGFR-2+tyrosine+kinase+inhibitors%3A+synthesis%2C+structure%E2%80%93activity+relationships%2C+and+antitumor+activities+of+N-phenyl-N%E2%80%B2-%7B4-%284-quinolyloxy%29phenyl%7Dureas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm030427r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030427r%26sid%3Dliteratum%253Aachs%26aulast%3DKubo%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DOhyama%26aufirst%3DS.-I.%26aulast%3DMurooka%26aufirst%3DH.%26aulast%3DIwai%26aufirst%3DA.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DHasegawa%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DS.%26aulast%3DIzawa%26aufirst%3DT.%26aulast%3DIsoe%26aufirst%3DT.%26atitle%3DNovel%2520potent%2520orally%2520active%2520selective%2520VEGFR-2%2520tyrosine%2520kinase%2520inhibitors%253A%2520synthesis%252C%2520structure%25E2%2580%2593activity%2520relationships%252C%2520and%2520antitumor%2520activities%2520of%2520N-phenyl-N%25E2%2580%25B2-%257B4-%25284-quinolyloxy%2529phenyl%257Dureas%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1359%26epage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Bannen, L. C.; Chan, D. S.-m.; Chen, J.; Dalrymple, L. E.; Forsyth, T. P.; Huynh, T. P.; Jammalamadaka, V.; Khoury, R. G.; Leahy, J. W.; Mac, M. B.; Mann, G.; Mann, L. W.; Nuss, J. M.; Parks, J. J.; Takeuchi, C. S.; Wang, Y.; Xu, W.</span><span> </span><span class="NLM_article-title">Preparation of quinolines and quinazolines as inhibitors of c-Met and other tyrosine kinases and therapeutic uses against proliferative diseases</span>. Patent WO 2005/030140,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=L.+C.+Bannen&author=D.+S.-m.+Chan&author=J.+Chen&author=L.+E.+Dalrymple&author=T.+P.+Forsyth&author=T.+P.+Huynh&author=V.+Jammalamadaka&author=R.+G.+Khoury&author=J.+W.+Leahy&author=M.+B.+Mac&author=G.+Mann&author=L.+W.+Mann&author=J.+M.+Nuss&author=J.+J.+Parks&author=C.+S.+Takeuchi&author=Y.+Wang&author=W.+Xu&title=Preparation+of+quinolines+and+quinazolines+as+inhibitors+of+c-Met+and+other+tyrosine+kinases+and+therapeutic+uses+against+proliferative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBannen%26aufirst%3DL.%2BC.%26atitle%3DPreparation%2520of%2520quinolines%2520and%2520quinazolines%2520as%2520inhibitors%2520of%2520c-Met%2520and%2520other%2520tyrosine%2520kinases%2520and%2520therapeutic%2520uses%2520against%2520proliferative%2520diseases%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Kung, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padrique, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span> </span><span class="NLM_article-title">Structure activity relationships of quinoline-containing c-Met inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1321</span><span class="NLM_x">–</span> <span class="NLM_lpage">1329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=1321-1329&author=P.+P.+Kungauthor=L.+Funkauthor=J.+Mengauthor=G.+Altonauthor=E.+Padriqueauthor=B.+Mroczkowski&title=Structure+activity+relationships+of+quinoline-containing+c-Met+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DP.%2BP.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DPadrique%26aufirst%3DE.%26aulast%3DMroczkowski%26aufirst%3DB.%26atitle%3DStructure%2520activity%2520relationships%2520of%2520quinoline-containing%2520c-Met%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26spage%3D1321%26epage%3D1329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Lauer, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiffany, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinker, J.</span><span> </span><span class="NLM_article-title">Synthesis of some chloromethoxyquinolines</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1946</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1268</span><span class="NLM_x">–</span> <span class="NLM_lpage">1269</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01211a040" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1946&pages=1268-1269&author=W.+M.+Lauerauthor=R.+T.+Arnoldauthor=B.+Tiffanyauthor=J.+Tinker&title=Synthesis+of+some+chloromethoxyquinolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fja01211a040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01211a040%26sid%3Dliteratum%253Aachs%26aulast%3DLauer%26aufirst%3DW.%2BM.%26aulast%3DArnold%26aufirst%3DR.%2BT.%26aulast%3DTiffany%26aufirst%3DB.%26aulast%3DTinker%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520some%2520chloromethoxyquinolines%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1946%26volume%3D68%26spage%3D1268%26epage%3D1269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Nara, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkhorst, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zemanek, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, D. A.</span><span> </span><span class="NLM_article-title">A simple Cu-catalyzed coupling approach to substituted 3-pyridinol and 5-opyrimidinol antioxidants</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">9326</span><span class="NLM_x">–</span> <span class="NLM_lpage">9333</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo801501e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=9326-9333&author=S.+J.+Naraauthor=M.+Jhaauthor=J.+Brinkhorstauthor=T.+J.+Zemanekauthor=D.+A.+Pratt&title=A+simple+Cu-catalyzed+coupling+approach+to+substituted+3-pyridinol+and+5-opyrimidinol+antioxidants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo801501e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo801501e%26sid%3Dliteratum%253Aachs%26aulast%3DNara%26aufirst%3DS.%2BJ.%26aulast%3DJha%26aufirst%3DM.%26aulast%3DBrinkhorst%26aufirst%3DJ.%26aulast%3DZemanek%26aufirst%3DT.%2BJ.%26aulast%3DPratt%26aufirst%3DD.%2BA.%26atitle%3DA%2520simple%2520Cu-catalyzed%2520coupling%2520approach%2520to%2520substituted%25203-pyridinol%2520and%25205-opyrimidinol%2520antioxidants%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26spage%3D9326%26epage%3D9333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ledrut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combes, G.</span><span> </span><span class="NLM_article-title">Reaction of <i>N</i>-bromosuccinamide with pyrazolones</span> <span class="citation_source-journal">Comptes Rendus</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1950</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">1513</span><span class="NLM_x">–</span> <span class="NLM_lpage">1515</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADyaG3sXisFeksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=1950&pages=1513-1515&author=J.+Ledrutauthor=G.+Combes&title=Reaction+of+N-bromosuccinamide+with+pyrazolones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">Reactions of N-bromosuccinimide with pyrazolones</span></div><div class="casAuthors">Ledrut, Jules; Combes, Georges</div><div class="citationInfo"><span class="NLM_cas:title"></span>
        (<span class="NLM_cas:date">1950</span>),
    <span class="NLM_cas:volume">231</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1513-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Heating equimolar amts. of antipyrine and N-bromosuccinimide (I) in CCl4 gave 4-brormoantipyrine (II).  With 2 mols. I, a mixt. of II and 2-phenyl-1-methyl-5-bromomethyl-4-bromo-3-pyrazolone (C.A. numbering) (III), m. 134° (from EtOH), was obtained.  III with hexamethylenetetramine gave a compd., m. 220-3°.  III could also be prepd. by treating I with II.  Bz2O2 did not affect the reactions, hydroquinone inhibited the formation of II. 4-methylantipyrine with I yielded 2-phenyl-1,5-bisbromomethyl-3-pyrazolone, m. 175° (from EtOH).  I with 4-hydroxymethylantipyrine gave II to the exclusion of any aldehyde, and I with 4-carboxyantipyrine, yielded II almost quantitatively.  I and 4-formylantipyrine (IV) gave a small amt. of III after prolonged heating in CCl4 or CHCl3; most of the aldehyde remaining unaffected.  IV with Br in cold CHCl3, however, gave II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcnlll7egjarVg90H21EOLACvtfcHk0lhV4fm9C0_wCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG3sXisFeksg%253D%253D&md5=5296b4b023f6943cc8305a535c20d3c3</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLedrut%26aufirst%3DJ.%26aulast%3DCombes%26aufirst%3DG.%26atitle%3DReaction%2520of%2520N-bromosuccinamide%2520with%2520pyrazolones%26jtitle%3DComptes%2520Rendus%26date%3D1950%26volume%3D231%26spage%3D1513%26epage%3D1515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">de Graef, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledrut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combes, G.</span><span> </span><span class="NLM_article-title">Prazolone series. XI. Reaction of <i>N</i>-halo imides with antipyrine and derivatives</span> <span class="citation_source-journal">Bull. Soc. Chim. Belges</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1952</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1002%2Fbscb.19520610702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADyaG3sXnt1Orsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1952&pages=331-351&author=H.+de+Graefauthor=J.+Ledrutauthor=G.+Combes&title=Prazolone+series.+XI.+Reaction+of+N-halo+imides+with+antipyrine+and+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazolone series. XI. Reactions of N-halo imides with antipyrine and derivatives</span></div><div class="casAuthors">de Graef, H.; Ledrut, J.; Combes, G.</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin des Societes Chimiques Belges</span>
        (<span class="NLM_cas:date">1952</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">331-51</span>CODEN:
                <span class="NLM_cas:coden">BSCBAG</span>;
        ISSN:<span class="NLM_cas:issn">0037-9646</span>.
    </div><div class="casAbstract">cf. C.A. 47, 4334c.  Antipyrine (1-phenyl-2,3-dimethyl-3-pyrazolin-5-one) (I) (1.88 g.) heated 30 min. with an equimolar amt. of N-bromosuccinimide (IA) in 50 cc. CCl4 gives 92%, 4-Br deriv. (II), m. 115°, and also some 1-phenyl-2-methyl-3-bromomethyl-4-bromo-3-pyrazolin-5-one (III), m. 135°; the sol. is filtered hot from the succinimide, cooled, evapd. to dryness, the less sol. III sepd. by fractional crystn. in alc., II recovered from the liquors and recrystd. from water.  Increasing amts. of IA give higher proportions of III.  III, an irritant, was prepd. in 77% yield (7 g.) by heating 6.7 g. II in 100 cc. CCl4 with 4.3 g. IA 45 min. on the water bath, and recrystg. the product from alc.  Both preparative reactions are unaffected by Bz2O2.  In the presence of excess IA (3 moles) I yields 33% III (isolated by fractional crystn. in alc.), and a compd. C11H9N2OBr3 (IV), m. 154°.  IV (0.75 g.) is also obtained by heating 0.01 mole III with 0.01 mole IA 90 min., 23% III being recovered.  IV is stable toward heating in aq. alc. Na2CO3 soln., conditions under which III is hydrolyzed to the 3-HOCH2 compd. (vide infra).  When heated with 10% NaOH IV is decompd. and totally debrominated; it does not react with (O2N)2C6H4NHNH2, and with AgNO3 in aq. alc. it forms 1 mole AgBr.  III forms a urotropine deriv. (1-phenyl-2-methy1-4-bromopyrazolin-5-one-3-methylhexamethylenetetrammonium bromide) (V), decompg. 220-5°, sol. in cold water, slightly sol. in alc.; 0.347 g. III and 0.140 g. hexamethylenetetramine in 10 cc. CHCl3 heated 15 min. and the mixt. evapd. yield 0.45 g. (94%) V.  V heated a few minutes on a water bath is hydrolyzed to an impure substance, m. 180-200°; the soln. yields with 2,4-(O2N)2C6H3NHNH2 a ppt. with the same m.p. as the HCHO deriv. of the latter (156°) and showing no depression.  1-Phenyl-2-methyl-3-hydroxymethyl-4-bromo-2-pyrazolin-5-one, m. 181° (3.4 g., 85%), is prepd. by heating 5.1 g. III, and 3 g. Na2CO3 1 hr. in 100 cc. 50% alc. on the water bath concg. the soln., and recrystg. the product from alc. or dioxane; exactly 1 equiv. of bromide ion is thereby produced.  5,5-Dimethyl-1,3-dichlorohydantoin (VA) (3 g., 0.015 mole) refluxed 30 min. with 5.64 g. (0.03 mole) I and 1 millimole Bz2O2 in CCl4 soln. and filtered hot yields 89% 5,5-dimethylhydantoin, m. 173-5°, and, upon cooling, 5.8 g. 4-chloroantipyrine (VI), m. 125-6° (from 50% alc.), also obtained (80%) when the Bz2O2 is omitted.  Use of the double amount of VA yields 38% VI and an oil.  On heating 2.22 g. VI 30 min. with 1 g. VA in CCl4, 90% of the dimethylhydantoin is isolated, and 27% VI recovered unchanged, and 2 g. of an unidentified oil obtained.  4-Methylantipyrine (VII), m. 82-3°, is prepd. in 50% yield by heating 1-phenyl-3,4-dimethyl-3-pyrazolin-5-one and Me2SO4 at 180° and recrystg. the product from Et2O-C6H6.  Bromination of VII and treatment with Na2CO3 yields 1-phenyl-2,4-dimethyl-3-bromomethyl-2-pyrazolin-5-one (VIII), m. 110°, which forms a hexamethylenetetrammonium salt m. 218-20° (from alc.); hydrolysis of the latter yields HCHO.  1-Phenyl-2-methyl-3,4-bis(dibromomethyl)-2-pyrazolin-5-one (IX), m. 175°, is the only product (35%) from 2.02 g. (0.01 mole) VII and 1.76 g. (0.01 mole) IA, suspended in 30 cc. CCl4, heated slowly to 60°, allowed to react 20 min., the soln. concd., and the product recrystd. repeatedly from alc.  Bz2O2 does not affect the reaction, but the yield is doubled by using twice the amt. of IA.  IX (.090 g., 74%) is also obtained from (0.100 g.) VIII and 0.063 g. IA refluxed 15 min. in 5 cc. CCl4.  In attempts to transform 4-(hydroxymethyl)antipyrine into the corresponding aldehyde with IA and VA in pyridine or water, only HCHO and the 4-halo compds. (II and VI, resp.) were isolated; Br yielded HCHO and a compd.  C23H24O2N4Br2, m. 205-8°, which was also obtained by the reaction of bromine with diantipyrinemethane.  4-Formylantipyrine and IA (0.01 mole each) heated in CCl4 lose CO and yield some III; VA gives VI and tars; Br yields 80% II.  Antipyric acid with IA (0.01 mole each) heated 15 min. in 35 cc. CCl4 lose CO2 and give 95% II; in the absence of IA the starting material remains unchanged after 20 min.; no reaction is observed with VA instead of IA; a satd. soln. of 2.32 g. antipyric acid in CHCl3 treated 12 hrs. at room temp. with 0.01 mole Br in CHCl3 (16% soln.) yields an oil from which can be isolated crystals, m. 130-5°, decompd. in boiling water into HBr, CO2, and II.  4-Acetylantipyrine (2.30 g., 0.01 mole) and 1.70 g. (0.01 mole) IA in 40 cc. CCl4 heated 30 min. on the water bath, the soln. filtered hot from the succinimide, and the crystals which sep. recrystd. from 25% alc, yield 0.6 g. 4-(bromoacetyl)antipyrine, m. 135°, identified by conversion (3 hrs. in aq. Na2CO3) to the α-hydroxymethyl ketone, m. 121° (from CHCl3-petr. ether).  1-Phenyl-2-methyl-3-hydroxymethyl-4-bromo-2-pyrazolin-5-one (X) (1 g.) in 40 cc. cold CHCl3 and 15 cc. 8% Br in CHCl3 let stand 36 hrs. in the dark and extd. with water and NaHCO3 yield 1.1 g. of the 3-bromomethyl analog, m. 170-2°, also obtained from 1.08 g. X, 35 cc. CCl4, and 0.90 g. IA heated 90 min. on the water bath (some starting material is recovered).  The product gives a 2,4-dinitrophenylhydrazone, m. 185-7°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPmvFBDV0gSLVg90H21EOLACvtfcHk0lhV4fm9C0_wCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG3sXnt1Orsg%253D%253D&md5=0db5cb2e480bb44c933117dc6a43e538</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1002%2Fbscb.19520610702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbscb.19520610702%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BGraef%26aufirst%3DH.%26aulast%3DLedrut%26aufirst%3DJ.%26aulast%3DCombes%26aufirst%3DG.%26atitle%3DPrazolone%2520series.%2520XI.%2520Reaction%2520of%2520N-halo%2520imides%2520with%2520antipyrine%2520and%2520derivatives%26jtitle%3DBull.%2520Soc.%2520Chim.%2520Belges%26date%3D1952%26volume%3D61%26spage%3D331%26epage%3D351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ito, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, N.</span><span> </span><span class="NLM_article-title">Synthesis of pyrazolone derivatives. XI. Synthesis of 6-substituted 1,2,6,7-tetrahydro-3<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span><div class="note"><p class="first last">and references cited therein.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1966&pages=297-298&author=I.+Itoauthor=N.+Oda&title=Synthesis+of+pyrazolone+derivatives.+XI.+Synthesis+of+6-substituted+1%2C2%2C6%2C7-tetrahydro-3H-pyrazolo%5B4%2C3-c%5Dpyridine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DI.%26aulast%3DOda%26aufirst%3DN.%26atitle%3DSynthesis%2520of%2520pyrazolone%2520derivatives.%2520XI.%2520Synthesis%2520of%25206-substituted%25201%252C2%252C6%252C7-tetrahydro-3H-pyrazolo%255B4%252C3-c%255Dpyridine%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1966%26volume%3D14%26spage%3D297%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Bodendorf, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mildner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, T.</span><span> </span><span class="NLM_article-title">Über Antipyrinaldehyd und Antipyrinsaure</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1949</span><span class="NLM_x">, </span> <span class="NLM_volume">563</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=563&publication_year=1949&pages=1-11&author=K.+Bodendorfauthor=J.+Mildnerauthor=T.+Lehmann&title=%C3%9Cber+Antipyrinaldehyd+und+Antipyrinsaure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBodendorf%26aufirst%3DK.%26aulast%3DMildner%26aufirst%3DJ.%26aulast%3DLehmann%26aufirst%3DT.%26atitle%3D%25C3%259Cber%2520Antipyrinaldehyd%2520und%2520Antipyrinsaure%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D1949%26volume%3D563%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Brooks, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L. D.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masamune, S.</span><span> </span><span class="NLM_article-title">C-Acylation under virtually neutral conditions</span> <span class="citation_source-journal">Angew. Chem. Int Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1979&pages=72-74&author=D.+W.+Brooksauthor=L.+D.-L.+Luauthor=S.+Masamune&title=C-Acylation+under+virtually+neutral+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DD.%2BW.%26aulast%3DLu%26aufirst%3DL.%2BD.-L.%26aulast%3DMasamune%26aufirst%3DS.%26atitle%3DC-Acylation%2520under%2520virtually%2520neutral%2520conditions%26jtitle%3DAngew.%2520Chem.%2520Int%2520Ed.%26date%3D1979%26volume%3D18%26spage%3D72%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Barluenga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merino, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viña, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palacios, F.</span><span> </span><span class="NLM_article-title">Regioselective synthesis of 1-alkyl-1-phenylhydrazines, 2-alkyl-1-phenylhydrazines, and 1,2-dialkyl-1-phenylhydrazines</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_fpage">398</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1055%2Fs-1990-26885" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADyaK3cXlsFWqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&pages=398-400&author=J.+Barluengaauthor=I.+Merinoauthor=S.+Vi%C3%B1aauthor=F.+Palacios&title=Regioselective+synthesis+of+1-alkyl-1-phenylhydrazines%2C+2-alkyl-1-phenylhydrazines%2C+and+1%2C2-dialkyl-1-phenylhydrazines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Regioselective synthesis of 1-alkyl-1-phenylhydrazines, 2-alkyl-1-phenylhydrazines, and 1,2-dialkyl-1-phenylhydrazines</span></div><div class="casAuthors">Barluenga, Jose; Merino, Isabel; Vina, Sara; Palacios, Francisco</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">398-400</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">The title compds. were prepd. in 82-95% yields by treating PhNHNHP+Ph3 Br- (I) with BuLi in THF, followed by alkyl halides and alk. hydrolysis.  E.g., treating I with 1 equiv BuLi and then with RX (R = Me, Et; X = iodo; R = allyl, PhCH2, X = Br) followed by aq. NaOH gave PhNHNHR.  Treating I with 2 equiv BuLi and then with 1 equiv RX gave PhNRNH2.  Treating I sequentially with 2 equiv BuLi, RX, and R1I (R1 = Et, Me) gave PhNRNHR1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm7v8qW13GFLVg90H21EOLACvtfcHk0lgbWHTpViYEJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXlsFWqsL4%253D&md5=1b7f4c5c7203e9ae19b874b4c464b66f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1055%2Fs-1990-26885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1990-26885%26sid%3Dliteratum%253Aachs%26aulast%3DBarluenga%26aufirst%3DJ.%26aulast%3DMerino%26aufirst%3DI.%26aulast%3DVi%25C3%25B1a%26aufirst%3DS.%26aulast%3DPalacios%26aufirst%3DF.%26atitle%3DRegioselective%2520synthesis%2520of%25201-alkyl-1-phenylhydrazines%252C%25202-alkyl-1-phenylhydrazines%252C%2520and%25201%252C2-dialkyl-1-phenylhydrazines%26jtitle%3DSynthesis%26date%3D1990%26spage%3D398%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Rockley, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summers, L. A.</span><span> </span><span class="NLM_article-title">Structures of 5-Methyl-4-((arylamino)methylene)-2,4-dihydro-3<i>H</i>-pyrazol-3-ones</span> <span class="citation_source-journal">Aust. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1981&pages=1117-1124&author=J.+E.+Rockleyauthor=L.+A.+Summers&title=Structures+of+5-Methyl-4-%28%28arylamino%29methylene%29-2%2C4-dihydro-3H-pyrazol-3-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRockley%26aufirst%3DJ.%2BE.%26aulast%3DSummers%26aufirst%3DL.%2BA.%26atitle%3DStructures%2520of%25205-Methyl-4-%2528%2528arylamino%2529methylene%2529-2%252C4-dihydro-3H-pyrazol-3-ones%26jtitle%3DAust.%2520J.%2520Chem.%26date%3D1981%26volume%3D34%26spage%3D1117%26epage%3D1124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Bal, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, W. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinnick, H. W.</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2091</span><span class="NLM_x">–</span> <span class="NLM_lpage">2096</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1016%2FS0040-4020%2801%2997963-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADyaL3MXlsFSjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bal%2C+B.+S.%3B+Childers%2C+W.+E.%2C+Jr.%3B+Pinnick%2C+H.+W.Tetrahedron+1981%2C+37%2C+2091%E2%80%932096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation of α,β-unsaturated aldehydes</span></div><div class="casAuthors">Bal, Balkrishna S.; Childers, Wayne E., Jr.; Pinnick, Harold W.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2091-6</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    </div><div class="casAbstract">Three methods for the oxidn. of α,β-unsatd. aldehydes to the corresponding acids were studied.  These were MnO2 oxidn. of the cyanohydrin deriv., treatment with Caro's acid, and reaction with NaClO2.  The last was the best method, giving pure acid in high yield.  E.g., propenal I (R = H) with NaClO2 (Me3COH, MeCH:CMe2, aq. NaH2PO4, room temp., overnight) gave 90% I (R = OH).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy3LIBi4Dq7LVg90H21EOLACvtfcHk0lgbWHTpViYEJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXlsFSjs74%253D&md5=1cea4c957f6032c660027bcd98e35e19</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2997963-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252997963-3%26sid%3Dliteratum%253Aachs%26aulast%3DBal%26aufirst%3DB.%2BS.%26aulast%3DChilders%26aufirst%3DW.%2BE.%26aulast%3DPinnick%26aufirst%3DH.%2BW.%26jtitle%3DTetrahedron%26date%3D1981%26volume%3D37%26spage%3D2091%26epage%3D2096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Siegmund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Retz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span> </span><span class="NLM_article-title">Selective β-hydroxyethylation at the N-1 position of a pyrazolone: synthesis of benzyl 1-(β-hydroxyethyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=1005-1008&author=A.+Siegmundauthor=D.+Retzauthor=N.+Xiauthor=C.+Dominguezauthor=R.+Burliauthor=L.+Liu&title=Selective+%CE%B2-hydroxyethylation+at+the+N-1+position+of+a+pyrazolone%3A+synthesis+of+benzyl+1-%28%CE%B2-hydroxyethyl%29-5-methyl-3-oxo-2-phenyl-2%2C3-dihydro-1H-pyrazole-4-carboxylate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiegmund%26aufirst%3DA.%26aulast%3DRetz%26aufirst%3DD.%26aulast%3DXi%26aufirst%3DN.%26aulast%3DDominguez%26aufirst%3DC.%26aulast%3DBurli%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DSelective%2520%25CE%25B2-hydroxyethylation%2520at%2520the%2520N-1%2520position%2520of%2520a%2520pyrazolone%253A%2520synthesis%2520of%2520benzyl%25201-%2528%25CE%25B2-hydroxyethyl%2529-5-methyl-3-oxo-2-phenyl-2%252C3-dihydro-1H-pyrazole-4-carboxylate%26jtitle%3DSynlett%26date%3D2008%26spage%3D1005%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="note"><p class="first last">For selected papers, see,</p></div><div class="NLM_citation" id="cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bridges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cody, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rewcastle, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMichael, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitors: unusually steep structure–activity relationship for analogs of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9503613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=267-76&author=A.+J.+Bridgesauthor=H.+Zhouauthor=D.+R.+Codyauthor=G.+W.+Rewcastleauthor=A.+McMichaelauthor=H.+D.+H.+Showalterauthor=D.+W.+Fryauthor=A.+J.+Krakerauthor=W.+A.+Denny&title=Tyrosine+kinase+inhibitors%3A+unusually+steep+structure%E2%80%93activity+relationship+for+analogs+of+4-%283-bromoanilino%29-6%2C7-dimethoxyquinazoline+%28PD+153035%29%2C+a+potent+inhibitor+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1021%2Fjm9503613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9503613%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DCody%26aufirst%3DD.%2BR.%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26aulast%3DMcMichael%26aufirst%3DA.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%2BH.%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DKraker%26aufirst%3DA.%2BJ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DTyrosine%2520kinase%2520inhibitors%253A%2520unusually%2520steep%2520structure%25E2%2580%2593activity%2520relationship%2520for%2520analogs%2520of%25204-%25283-bromoanilino%2529-6%252C7-dimethoxyquinazoline%2520%2528PD%2520153035%2529%252C%2520a%2520potent%2520inhibitor%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D267%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boschelli, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamuya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upeslacis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, N.</span><span> </span><span class="NLM_article-title">4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3244</span><span class="NLM_x">–</span> <span class="NLM_lpage">3256</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000206a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3244-3256&author=A.+Wissnerauthor=D.+M.+Bergerauthor=D.+H.+Boschelliauthor=M.+B.+Floydauthor=L.+M.+Greenbergerauthor=B.+C.+Gruberauthor=B.+D.+Johnsonauthor=N.+Mamuyaauthor=R.+Nilakantanauthor=M.+F.+Reichauthor=R.+Shenauthor=H.-R.+Tsouauthor=E.+Upeslacisauthor=Y.+F.+Wangauthor=B.+Wuauthor=F.+Yeauthor=N.+Zhang&title=4-Anilino-6%2C7-dialkoxyquinoline-3-carbonitrile+inhibitors+of+epidermal+growth+factor+receptor+kinase+and+their+bioisosteric+relationship+to+the+4-anilino-6%2C7-dialkoxyquinazoline+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1021%2Fjm000206a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000206a%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DD.%2BM.%26aulast%3DBoschelli%26aufirst%3DD.%2BH.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26aulast%3DGruber%26aufirst%3DB.%2BC.%26aulast%3DJohnson%26aufirst%3DB.%2BD.%26aulast%3DMamuya%26aufirst%3DN.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DReich%26aufirst%3DM.%2BF.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DTsou%26aufirst%3DH.-R.%26aulast%3DUpeslacis%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DY.%2BF.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DN.%26atitle%3D4-Anilino-6%252C7-dialkoxyquinoline-3-carbonitrile%2520inhibitors%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520kinase%2520and%2520their%2520bioisosteric%2520relationship%2520to%2520the%25204-anilino-6%252C7-dialkoxyquinazoline%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3244%26epage%3D3256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Scott, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balliet, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gero, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poondru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theoclitou, M.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyurin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinda, M. J.</span><span> </span><span class="NLM_article-title">Identification of 3-amido-4-anilinoquinolines as potent and selective inhibitors of CSF-1R kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">697</span><span class="NLM_x">–</span> <span class="NLM_lpage">700</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=697-700&author=D.+A.+Scottauthor=C.+L.+Ballietauthor=D.+J.+Cookauthor=A.+M.+Davisauthor=T.+W.+Geroauthor=C.+A.+Omerauthor=S.+Poondruauthor=M.-E.+Theoclitouauthor=B.+Tyurinauthor=M.+J.+Zinda&title=Identification+of+3-amido-4-anilinoquinolines+as+potent+and+selective+inhibitors+of+CSF-1R+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DD.%2BA.%26aulast%3DBalliet%26aufirst%3DC.%2BL.%26aulast%3DCook%26aufirst%3DD.%2BJ.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DGero%26aufirst%3DT.%2BW.%26aulast%3DOmer%26aufirst%3DC.%2BA.%26aulast%3DPoondru%26aufirst%3DS.%26aulast%3DTheoclitou%26aufirst%3DM.-E.%26aulast%3DTyurin%26aufirst%3DB.%26aulast%3DZinda%26aufirst%3DM.%2BJ.%26atitle%3DIdentification%2520of%25203-amido-4-anilinoquinolines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520CSF-1R%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D697%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Cincinelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassinelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallavalle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuccinardi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunino, F.</span><span> </span><span class="NLM_article-title">Synthesis, modeling, and RET protein kinase inhibitory activity of 3- and 4-substituted b-Carbolin-1-ones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7777</span><span class="NLM_x">–</span> <span class="NLM_lpage">7787</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8007823" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7777-7787&author=R.+Cincinelliauthor=G.+Cassinelliauthor=S.+Dallavalleauthor=C.+Lanziauthor=L.+Merliniauthor=M.+Bottaauthor=T.+Tuccinardiauthor=A.+Martinelliauthor=S.+Pencoauthor=F.+Zunino&title=Synthesis%2C+modeling%2C+and+RET+protein+kinase+inhibitory+activity+of+3-+and+4-substituted+b-Carbolin-1-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33d&amp;dbid=16384&amp;doi=10.1021%2Fjm8007823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8007823%26sid%3Dliteratum%253Aachs%26aulast%3DCincinelli%26aufirst%3DR.%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DDallavalle%26aufirst%3DS.%26aulast%3DLanzi%26aufirst%3DC.%26aulast%3DMerlini%26aufirst%3DL.%26aulast%3DBotta%26aufirst%3DM.%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DPenco%26aufirst%3DS.%26aulast%3DZunino%26aufirst%3DF.%26atitle%3DSynthesis%252C%2520modeling%252C%2520and%2520RET%2520protein%2520kinase%2520inhibitory%2520activity%2520of%25203-%2520and%25204-substituted%2520b-Carbolin-1-ones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7777%26epage%3D7787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kim, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dushin, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arndt, K.</span><span> </span><span class="NLM_article-title">Benzo[<i>c</i>][2,7]naphthyridines as inhibitors of PDK-1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5225</span><span class="NLM_x">–</span> <span class="NLM_lpage">5228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5225-5228&author=K.-H.+Kimauthor=A.+Wissnerauthor=M.+B.+Floydauthor=H.+L.+Fraserauthor=Y.+D.+Wangauthor=R.+G.+Dushinauthor=Y.+Huauthor=A.+Ollandauthor=B.+Guoauthor=K.+Arndt&title=Benzo%5Bc%5D%5B2%2C7%5Dnaphthyridines+as+inhibitors+of+PDK-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.-H.%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DFraser%26aufirst%3DH.%2BL.%26aulast%3DWang%26aufirst%3DY.%2BD.%26aulast%3DDushin%26aufirst%3DR.%2BG.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DB.%26aulast%3DArndt%26aufirst%3DK.%26atitle%3DBenzo%255Bc%255D%255B2%252C7%255Dnaphthyridines%2520as%2520inhibitors%2520of%2520PDK-1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5225%26epage%3D5228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Flowers-Geary, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penning, T. M.</span><span> </span><span class="NLM_article-title">Cytotoxicity of polycyclic aromatic hydrocarbon <i>o</i>-quinones in rats and human hepatoma cells</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx00033a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1993&pages=252-260&author=L.+Flowers-Gearyauthor=R.+G.+Harveyauthor=T.+M.+Penning&title=Cytotoxicity+of+polycyclic+aromatic+hydrocarbon+o-quinones+in+rats+and+human+hepatoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Ftx00033a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx00033a002%26sid%3Dliteratum%253Aachs%26aulast%3DFlowers-Geary%26aufirst%3DL.%26aulast%3DHarvey%26aufirst%3DR.%2BG.%26aulast%3DPenning%26aufirst%3DT.%2BM.%26atitle%3DCytotoxicity%2520of%2520polycyclic%2520aromatic%2520hydrocarbon%2520o-quinones%2520in%2520rats%2520and%2520human%2520hepatoma%2520cells%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D1993%26volume%3D6%26spage%3D252%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="note"><p class="first last">In a related system where the N(1) was substituted with a 2-hydroxy propyl group, removing the 7-methoxyl group resulted in 12-fold loss of potency relative to the 6.7-dimethoxyl analogue.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Evans, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span> </span><span class="NLM_article-title">Drug–protein adducts: an industry prespective on minimizing the potential for drug bioactivation in drug discovery and development</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx034170b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=3-16&author=D.+C.+Evansauthor=A.+P.+Wattauthor=D.+A.+Nicoll-Griffithauthor=T.+A.+Baillie&title=Drug%E2%80%93protein+adducts%3A+an+industry+prespective+on+minimizing+the+potential+for+drug+bioactivation+in+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Ftx034170b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx034170b%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BC.%26aulast%3DWatt%26aufirst%3DA.%2BP.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DDrug%25E2%2580%2593protein%2520adducts%253A%2520an%2520industry%2520prespective%2520on%2520minimizing%2520the%2520potential%2520for%2520drug%2520bioactivation%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2004%26volume%3D17%26spage%3D3%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nelson, S. D.</span><span> </span><span class="NLM_article-title">Metabolic activation and drug toxicity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">765</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00349a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADyaL38XktVSjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1982&pages=753-765&author=S.+D.+Nelson&title=Metabolic+activation+and+drug+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37aR"><div class="casContent"><span class="casTitleNuber">37a</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic activation and drug toxicity</span></div><div class="casAuthors">Nelson, Sidney D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">753-65</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A review with 128 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzUsG75cxLYLVg90H21EOLACvtfcHk0lhk_IFVjKxZ8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XktVSjsL8%253D&md5=89c759fff948a83bb8edebef1c8cdbad</span></div><a href="/servlet/linkout?suffix=cit37a&amp;dbid=16384&amp;doi=10.1021%2Fjm00349a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00349a001%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DS.%2BD.%26atitle%3DMetabolic%2520activation%2520and%2520drug%2520toxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1982%26volume%3D25%26spage%3D753%26epage%3D765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit37b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">This strategy was recently applied to an acylthiourea series:</p></div><span class="NLM_contrib-group">Kung, P.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padrique, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of quinoline-containing c-Met inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1321</span><span class="NLM_x">–</span> <span class="NLM_lpage">1329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=1321-1329&author=P.-P.+Kungauthor=L.+Funkauthor=J.+Mengauthor=G.+Altonauthor=E.+Padriqueauthor=B.+Mroczkowski&title=Structure%E2%80%93activity+relationships+of+quinoline-containing+c-Met+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DP.-P.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DPadrique%26aufirst%3DE.%26aulast%3DMroczkowski%26aufirst%3DB.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520quinoline-containing%2520c-Met%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26spage%3D1321%26epage%3D1329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reese, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span> </span><span class="NLM_article-title">Identification of a novel Recepteur d’Origine Nantais/c-Met small molecule kinase inhibitor with antitumor activity in vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">6680</span><span class="NLM_x">–</span> <span class="NLM_lpage">6687</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=6680-6687&author=Y.+Zhangauthor=P.+J.+Kaplan-Lefkoauthor=K.+Rexauthor=Y.+Yangauthor=J.+Moriguchiauthor=T.+Osgoodauthor=B.+Mattsonauthor=A.+Coxonauthor=M.+Reeseauthor=T.-S.+Kimauthor=J.+Linauthor=A.+Chenauthor=T.+L.+Burgessauthor=I.+Dussault&title=Identification+of+a+novel+Recepteur+d%E2%80%99Origine+Nantais%2Fc-Met+small+molecule+kinase+inhibitor+with+antitumor+activity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%2BJ.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DMoriguchi%26aufirst%3DJ.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DMattson%26aufirst%3DB.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DReese%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DT.-S.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DBurgess%26aufirst%3DT.%2BL.%26aulast%3DDussault%26aufirst%3DI.%26atitle%3DIdentification%2520of%2520a%2520novel%2520Recepteur%2520d%25E2%2580%2599Origine%2520Nantais%252Fc-Met%2520small%2520molecule%2520kinase%2520inhibitor%2520with%2520antitumor%2520activity%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D6680%26epage%3D6687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span>Part of the synthesis and characterization of compounds have been described in: <span class="NLM_contrib-group">Kim, T.-S.; Bauer, D.; Bellon, S.; Boezio, A.; Booker, S.; Choquette, D.; D’Amico, D. C.; D’Angelo, N.; Dominguez, C.; Fellows, I. M.; Germain, J.; Graceffa, R.; Harmange, J.-C.; Hirai, S.; La, D.; Lee, M.; Liu, L.; Norman, M. H.; Potashman, M.; Rovet, P.; Siegmund, A. C.; Xi, N.; Yang, K.</span><div class="note"><p class="first last">(Amgen Inc)</p></div>. Patent WO 2006/116713A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Part+of+the+synthesis+and+characterization+of+compounds+have+been+described+in%3A+Kim%2C+T.-S.%3B+Bauer%2C+D.%3B+Bellon%2C+S.%3B+Boezio%2C+A.%3B+Booker%2C+S.%3B+Choquette%2C+D.%3B+D%E2%80%99Amico%2C+D.+C.%3B+D%E2%80%99Angelo%2C+N.%3B+Dominguez%2C+C.%3B+Fellows%2C+I.+M.%3B+Germain%2C+J.%3B+Graceffa%2C+R.%3B+Harmange%2C+J.-C.%3B+Hirai%2C+S.%3B+La%2C+D.%3B+Lee%2C+M.%3B+Liu%2C+L.%3B+Norman%2C+M.+H.%3B+Potashman%2C+M.%3B+Rovet%2C+P.%3B+Siegmund%2C+A.+C.%3B+Xi%2C+N.%3B+Yang%2C+K.%28Amgen+Inc%29.+Patent+WO+2006%2F116713A1%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DT.-S.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Kubo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyama, S.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murooka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isoe, T.</span><span> </span><span class="NLM_article-title">Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors: synthesis, structure–activity relationships, and antitumor activities of <i>N</i>-phenyl-<i>N</i>′-{4-(4-quinolyloxy)phenyl}ureas</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">–</span> <span class="NLM_lpage">1366</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030427r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1359-1366&author=K.+Kuboauthor=T.+Shimizuauthor=S.-I.+Ohyamaauthor=H.+Murookaauthor=A.+Iwaiauthor=K.+Nakamuraauthor=K.+Hasegawaauthor=Y.+Kobayashiauthor=N.+Takahashiauthor=K.+Takahashiauthor=S.+Katoauthor=T.+Izawaauthor=T.+Isoe&title=Novel+potent+orally+active+selective+VEGFR-2+tyrosine+kinase+inhibitors%3A+synthesis%2C+structure%E2%80%93activity+relationships%2C+and+antitumor+activities+of+N-phenyl-N%E2%80%B2-%7B4-%284-quinolyloxy%29phenyl%7Dureas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm030427r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030427r%26sid%3Dliteratum%253Aachs%26aulast%3DKubo%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DOhyama%26aufirst%3DS.-I.%26aulast%3DMurooka%26aufirst%3DH.%26aulast%3DIwai%26aufirst%3DA.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DHasegawa%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DS.%26aulast%3DIzawa%26aufirst%3DT.%26aulast%3DIsoe%26aufirst%3DT.%26atitle%3DNovel%2520potent%2520orally%2520active%2520selective%2520VEGFR-2%2520tyrosine%2520kinase%2520inhibitors%253A%2520synthesis%252C%2520structure%25E2%2580%2593activity%2520relationships%252C%2520and%2520antitumor%2520activities%2520of%2520N-phenyl-N%25E2%2580%25B2-%257B4-%25284-quinolyloxy%2529phenyl%257Dureas%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1359%26epage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b','cit4c','cit4d','cit4e'],'ref5':['cit5a','cit5b','cit5c','cit5d'],'ref6':['cit6a','cit6b'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':[],'ref13':['cit13a','cit13b'],'ref14':['cit14a','cit14b','cit14c','cit14d'],'ref15':['cit15'],'ref16':['cit16a','cit16b','cit16c'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26a','cit26b','cit26c'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33a','cit33b','cit33c','cit33d','cit33e'],'ref34':['cit34'],'ref35':[],'ref36':['cit36'],'ref37':['cit37a','cit37b'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 53 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaifan  Zhang</span>, <span class="hlFld-ContribAuthor ">Chi  Yang</span>, <span class="hlFld-ContribAuthor ">Hequan  Yao</span>, and <span class="hlFld-ContribAuthor ">Aijun  Lin</span>  . </span><span class="cited-content_cbyCitation_article-title">[3 + 2] Cycloaddition Reaction of in Situ Formed Azaoxyallyl Cations with Aldehydes: An Approach to Oxazolidin-4-ones. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2016,</strong> <em>18 </em>
                                    (18)
                                     , 4618-4621. <a href="https://doi.org/10.1021/acs.orglett.6b02254" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b02254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b02254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b02254%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3D%25255B3%252B%25252B%252B2%25255D%252BCycloaddition%252BReaction%252Bof%252Bin%252BSitu%252BFormed%252BAzaoxyallyl%252BCations%252Bwith%252BAldehydes%25253A%252BAn%252BApproach%252Bto%252BOxazolidin-4-ones%26aulast%3DZhang%26aufirst%3DKaifan%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D30072016%26date%3D29082016%26date%3D16092016%26volume%3D18%26issue%3D18%26spage%3D4618%26epage%3D4621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro A.  Boezio</span>, <span class="hlFld-ContribAuthor ">Katrina W.  Copeland</span>, <span class="hlFld-ContribAuthor ">Karen  Rex</span>, <span class="hlFld-ContribAuthor ">Brian  K. Albrecht</span>, <span class="hlFld-ContribAuthor ">David  Bauer</span>, <span class="hlFld-ContribAuthor ">Steven F.  Bellon</span>, <span class="hlFld-ContribAuthor ">Christiane  Boezio</span>, <span class="hlFld-ContribAuthor ">Martin A.  Broome</span>, <span class="hlFld-ContribAuthor ">Deborah  Choquette</span>, <span class="hlFld-ContribAuthor ">Angela  Coxon</span>, <span class="hlFld-ContribAuthor ">Isabelle  Dussault</span>, <span class="hlFld-ContribAuthor ">Satoko  Hirai</span>, <span class="hlFld-ContribAuthor ">Richard  Lewis</span>, <span class="hlFld-ContribAuthor ">Min-Hwa Jasmine  Lin</span>, <span class="hlFld-ContribAuthor ">Julia  Lohman</span>, <span class="hlFld-ContribAuthor ">Jingzhou  Liu</span>, <span class="hlFld-ContribAuthor ">Emily A.  Peterson</span>, <span class="hlFld-ContribAuthor ">Michele  Potashman</span>, <span class="hlFld-ContribAuthor ">Roman  Shimanovich</span>, <span class="hlFld-ContribAuthor ">Yohannes  Teffera</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Karina R.  Vaida</span>, and <span class="hlFld-ContribAuthor ">Jean-Christophe  Harmange</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of (R)-6-(1-(8-Fluoro-6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one (AMG 337), a Potent and Selective Inhibitor of MET with High Unbound Target Coverage and Robust In Vivo Antitumor Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (6)
                                     , 2328-2342. <a href="https://doi.org/10.1021/acs.jmedchem.5b01716" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01716%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%252528R%252529-6-%2525281-%2525288-Fluoro-6-%2525281-methyl-1H-pyrazol-4-yl%252529-%25255B1%25252C2%25252C4%25255Dtriazolo%25255B4%25252C3-a%25255Dpyridin-3-yl%252529ethyl%252529-3-%2525282-methoxyethoxy%252529-1%25252C6-naphthyridin-5%2525286H%252529-one%252B%252528AMG%252B337%252529%25252C%252Ba%252BPotent%252Band%252BSelective%252BInhibitor%252Bof%252BMET%252Bwith%252BHigh%252BUnbound%252BTarget%252BCoverage%252Band%252BRobust%252BIn%252BVivo%252BAntitumor%252BActivity%26aulast%3DBoezio%26aufirst%3DAlessandro%2BA.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D04112015%26date%3D11022016%26date%3D24032016%26date%3D26012016%26volume%3D59%26issue%3D6%26spage%3D2328%26epage%3D2342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adrian L.  Smith</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Holger  Beckmann</span>, <span class="hlFld-ContribAuthor ">Steven F.  Bellon</span>, <span class="hlFld-ContribAuthor ">Pedro J.  Beltran</span>, <span class="hlFld-ContribAuthor ">Shon  Booker</span>, <span class="hlFld-ContribAuthor ">Hao  Chen</span>, <span class="hlFld-ContribAuthor ">Young-Ah  Chung</span>, <span class="hlFld-ContribAuthor ">Noel D.  D’Angelo</span>, <span class="hlFld-ContribAuthor ">Jennifer  Dao</span>, <span class="hlFld-ContribAuthor ">Kenneth R.  Dellamaggiore</span>, <span class="hlFld-ContribAuthor ">Peter  Jaeckel</span>, <span class="hlFld-ContribAuthor ">Richard  Kendall</span>, <span class="hlFld-ContribAuthor ">Katja  Labitzke</span>, <span class="hlFld-ContribAuthor ">Alexander M.  Long</span>, <span class="hlFld-ContribAuthor ">Silvia  Materna-Reichelt</span>, <span class="hlFld-ContribAuthor ">Petia  Mitchell</span>, <span class="hlFld-ContribAuthor ">Mark H.  Norman</span>, <span class="hlFld-ContribAuthor ">David  Powers</span>, <span class="hlFld-ContribAuthor ">Mark  Rose</span>, <span class="hlFld-ContribAuthor ">Paul L.  Shaffer</span>, <span class="hlFld-ContribAuthor ">Michelle M.  Wu</span>, and <span class="hlFld-ContribAuthor ">J. Russell  Lipford</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 1H-Pyrazol-3(2H)-ones as Potent and Selective Inhibitors of Protein Kinase R-like Endoplasmic Reticulum Kinase (PERK). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (3)
                                     , 1426-1441. <a href="https://doi.org/10.1021/jm5017494" title="DOI URL">https://doi.org/10.1021/jm5017494</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5017494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5017494%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B1H-Pyrazol-3%2525282H%252529-ones%252Bas%252BPotent%252Band%252BSelective%252BInhibitors%252Bof%252BProtein%252BKinase%252BR-like%252BEndoplasmic%252BReticulum%252BKinase%252B%252528PERK%252529%26aulast%3DSmith%26aufirst%3DAdrian%2BL.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D11112014%26date%3D14012015%26date%3D12022015%26volume%3D58%26issue%3D3%26spage%3D1426%26epage%3D1441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J. Jean  Cui</span>  . </span><span class="cited-content_cbyCitation_article-title">Targeting Receptor Tyrosine Kinase MET in Cancer: Small Molecule Inhibitors and Clinical Progress. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (11)
                                     , 4427-4453. <a href="https://doi.org/10.1021/jm401427c" title="DOI URL">https://doi.org/10.1021/jm401427c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401427c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401427c%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BReceptor%252BTyrosine%252BKinase%252BMET%252Bin%252BCancer%25253A%252BSmall%252BMolecule%252BInhibitors%252Band%252BClinical%252BProgress%26aulast%3DCui%26aufirst%3DJ.%2BJean%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D16092013%26date%3D18122013%26date%3D12062014%26date%3D09122013%26volume%3D57%26issue%3D11%26spage%3D4427%26epage%3D4453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James  Solowiej</span>, <span class="hlFld-ContribAuthor ">Jeffrey H.  Chen</span>, <span class="hlFld-ContribAuthor ">Helen Y.  Zou</span>, <span class="hlFld-ContribAuthor ">Stephan K.  Grant</span>, and <span class="hlFld-ContribAuthor ">Brion W.  Murray</span>  . </span><span class="cited-content_cbyCitation_article-title">Substrate-Specific Conformational Regulation of the Receptor Tyrosine Kinase VEGFR2 Catalytic Domain. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2013,</strong> <em>8 </em>
                                    (5)
                                     , 978-986. <a href="https://doi.org/10.1021/cb400040z" title="DOI URL">https://doi.org/10.1021/cb400040z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb400040z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb400040z%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DSubstrate-Specific%252BConformational%252BRegulation%252Bof%252Bthe%252BReceptor%252BTyrosine%252BKinase%252BVEGFR2%252BCatalytic%252BDomain%26aulast%3DSolowiej%26aufirst%3DJames%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D17012013%26date%3D26022013%26date%3D06032013%26date%3D17052013%26date%3D26022013%26volume%3D8%26issue%3D5%26spage%3D978%26epage%3D986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark H.  Norman</span>, <span class="hlFld-ContribAuthor ">Longbin  Liu</span>, <span class="hlFld-ContribAuthor ">Matthew  Lee</span>, <span class="hlFld-ContribAuthor ">Ning  Xi</span>, <span class="hlFld-ContribAuthor ">Ingrid  Fellows</span>, <span class="hlFld-ContribAuthor ">Noel D.  D’Angelo</span>, <span class="hlFld-ContribAuthor ">Celia  Dominguez</span>, <span class="hlFld-ContribAuthor ">Karen  Rex</span>, <span class="hlFld-ContribAuthor ">Steven F.  Bellon</span>, <span class="hlFld-ContribAuthor ">Tae-Seong  Kim</span>, and <span class="hlFld-ContribAuthor ">Isabelle  Dussault</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Novel Class II c-Met Inhibitors: 1. Identification of Pyrazolone-Based Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (5)
                                     , 1858-1867. <a href="https://doi.org/10.1021/jm201330u" title="DOI URL">https://doi.org/10.1021/jm201330u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201330u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201330u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BNovel%252BClass%252BII%252Bc-Met%252BInhibitors%25253A%252B1.%252BIdentification%252Bof%252BPyrazolone-Based%252BDerivatives%26aulast%3DNorman%26aufirst%3DMark%2BH.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D06102011%26date%3D24022012%26date%3D08032012%26date%3D09022012%26volume%3D55%26issue%3D5%26spage%3D1858%26epage%3D1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vrushabendra  Basavanna</span>, <span class="hlFld-ContribAuthor ">Srikantamurthy  Ningaiah</span>, <span class="hlFld-ContribAuthor ">Manasa  Chandramouli</span>, <span class="hlFld-ContribAuthor ">Anjali  Sobha</span>, <span class="hlFld-ContribAuthor ">Shridevi  Doddamani</span>. </span><span class="cited-content_cbyCitation_article-title">Quinolinyl-pyrazoles: synthesis and pharmacological evolution in the recent decennial. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Iranian Chemical Society</span><span> <strong>2021,</strong> <em>18 </em>
                                    (7)
                                     , 1479-1522. <a href="https://doi.org/10.1007/s13738-020-02152-1" title="DOI URL">https://doi.org/10.1007/s13738-020-02152-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13738-020-02152-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13738-020-02152-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Iranian%2520Chemical%2520Society%26atitle%3DQuinolinyl-pyrazoles%25253A%252Bsynthesis%252Band%252Bpharmacological%252Bevolution%252Bin%252Bthe%252Brecent%252Bdecennial%26aulast%3DBasavanna%26aufirst%3DVrushabendra%26date%3D2021%26date%3D2021%26volume%3D18%26issue%3D7%26spage%3D1479%26epage%3D1522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin-Sheng  Zhuo</span>, <span class="hlFld-ContribAuthor ">Feng-Xu  Wu</span>, <span class="hlFld-ContribAuthor ">Ming-Shu  Wang</span>, <span class="hlFld-ContribAuthor ">Hong-Chuang  Xu</span>, <span class="hlFld-ContribAuthor ">Fan-Peng  Yang</span>, <span class="hlFld-ContribAuthor ">Yan-Guang  Tian</span>, <span class="hlFld-ContribAuthor ">Xing-E.  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhi-Hui  Ming</span>, <span class="hlFld-ContribAuthor ">Xiao-Lei  Zhu</span>, <span class="hlFld-ContribAuthor ">Ge-Fei  Hao</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–activity relationship study of novel quinazoline-based 1,6-naphthyridinones as MET inhibitors with potent antitumor efficacy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>208 </em>, 112785. <a href="https://doi.org/10.1016/j.ejmech.2020.112785" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112785</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112785%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593activity%252Brelationship%252Bstudy%252Bof%252Bnovel%252Bquinazoline-based%252B1%25252C6-naphthyridinones%252Bas%252BMET%252Binhibitors%252Bwith%252Bpotent%252Bantitumor%252Befficacy%26aulast%3DZhuo%26aufirst%3DLin-Sheng%26date%3D2020%26volume%3D208%26spage%3D112785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingming  Sun</span>, <span class="hlFld-ContribAuthor ">Wuhong  Chen</span>, <span class="hlFld-ContribAuthor ">Tao  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhenjun  Liu</span>, <span class="hlFld-ContribAuthor ">Junchao  Wei</span>, <span class="hlFld-ContribAuthor ">Ning  Xi</span>. </span><span class="cited-content_cbyCitation_article-title">19F NMR spectroscopy as a tool to detect rotations in fluorine substituted phenyl compounds. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (48)
                                     , 131679. <a href="https://doi.org/10.1016/j.tet.2020.131679" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131679</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131679%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3D19F%252BNMR%252Bspectroscopy%252Bas%252Ba%252Btool%252Bto%252Bdetect%252Brotations%252Bin%252Bfluorine%252Bsubstituted%252Bphenyl%252Bcompounds%26aulast%3DSun%26aufirst%3DMingming%26date%3D2020%26volume%3D76%26issue%3D48%26spage%3D131679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth Qian Xu  Mulcahy</span>, <span class="hlFld-ContribAuthor ">Rossymar Rivera  Colόn</span>, <span class="hlFld-ContribAuthor ">Roger  Abounader</span>. </span><span class="cited-content_cbyCitation_article-title">HGF/MET Signaling in Malignant Brain Tumors. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (20)
                                     , 7546. <a href="https://doi.org/10.3390/ijms21207546" title="DOI URL">https://doi.org/10.3390/ijms21207546</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21207546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21207546%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DHGF%25252FMET%252BSignaling%252Bin%252BMalignant%252BBrain%252BTumors%26aulast%3DMulcahy%26aufirst%3DElizabeth%2BQian%2BXu%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D20%26spage%3D7546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiang  Nan</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Hui-Jing  Li</span>, <span class="hlFld-ContribAuthor ">Rui  Wu</span>, <span class="hlFld-ContribAuthor ">Sen-Biao  Fang</span>, <span class="hlFld-ContribAuthor ">Zhi-Zhou  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan-Chao  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel N-sulfonylamidine-based derivatives as c-Met inhibitors via Cu-catalyzed three-component reaction. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>200 </em>, 112470. <a href="https://doi.org/10.1016/j.ejmech.2020.112470" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112470</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112470%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252BN-sulfonylamidine-based%252Bderivatives%252Bas%252Bc-Met%252Binhibitors%252Bvia%252BCu-catalyzed%252Bthree-component%252Breaction%26aulast%3DNan%26aufirst%3DXiang%26date%3D2020%26volume%3D200%26spage%3D112470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongchuang  Xu</span>, <span class="hlFld-ContribAuthor ">Minshu  Wang</span>, <span class="hlFld-ContribAuthor ">Fengxu  Wu</span>, <span class="hlFld-ContribAuthor ">Linsheng  Zhuo</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Nengfang  She</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-substituted-3-phenyl-1,6-naphthyridinone derivatives bearing quinoline moiety as selective type II c-Met kinase inhibitors against VEGFR-2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (12)
                                     , 115555. <a href="https://doi.org/10.1016/j.bmc.2020.115555" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115555</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115555%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-substituted-3-phenyl-1%25252C6-naphthyridinone%252Bderivatives%252Bbearing%252Bquinoline%252Bmoiety%252Bas%252Bselective%252Btype%252BII%252Bc-Met%252Bkinase%252Binhibitors%252Bagainst%252BVEGFR-2%26aulast%3DXu%26aufirst%3DHongchuang%26date%3D2020%26volume%3D28%26issue%3D12%26spage%3D115555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Binliang  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaobo  Liu</span>, <span class="hlFld-ContribAuthor ">Hehua  Xiong</span>, <span class="hlFld-ContribAuthor ">Qian  Zhang</span>, <span class="hlFld-ContribAuthor ">Xin  Sun</span>, <span class="hlFld-ContribAuthor ">Zunhua  Yang</span>, <span class="hlFld-ContribAuthor ">Shan  Xu</span>, <span class="hlFld-ContribAuthor ">Pengwu  Zheng</span>, <span class="hlFld-ContribAuthor ">Wufu  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of [1,2,4]triazolo[4,3-
              a
              ]pyrazine derivatives bearing a 4-oxo-pyridazinone moiety as potential c-Met kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2020,</strong> <em>44 </em>
                                    (21)
                                     , 9053-9063. <a href="https://doi.org/10.1039/D0NJ00575D" title="DOI URL">https://doi.org/10.1039/D0NJ00575D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NJ00575D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NJ00575D%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%25255B1%25252C2%25252C4%25255Dtriazolo%25255B4%25252C3-%252Ba%252B%25255Dpyrazine%252Bderivatives%252Bbearing%252Ba%252B4-oxo-pyridazinone%252Bmoiety%252Bas%252Bpotential%252Bc-Met%252Bkinase%252Binhibitors%26aulast%3DZhang%26aufirst%3DBinliang%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D21%26spage%3D9053%26epage%3D9063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiang  Nan</span>, <span class="hlFld-ContribAuthor ">Hui-Jing  Li</span>, <span class="hlFld-ContribAuthor ">Sen-Biao  Fang</span>, <span class="hlFld-ContribAuthor ">Qin-Ying  Li</span>, <span class="hlFld-ContribAuthor ">Yan-Chao  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based discovery of novel 4-(2-fluorophenoxy)quinoline derivatives as c-Met inhibitors using isocyanide-involved multicomponent reactions. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>193 </em>, 112241. <a href="https://doi.org/10.1016/j.ejmech.2020.112241" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112241</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112241%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bdiscovery%252Bof%252Bnovel%252B4-%2525282-fluorophenoxy%252529quinoline%252Bderivatives%252Bas%252Bc-Met%252Binhibitors%252Busing%252Bisocyanide-involved%252Bmulticomponent%252Breactions%26aulast%3DNan%26aufirst%3DXiang%26date%3D2020%26volume%3D193%26spage%3D112241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zefeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Xufen  Dai</span>, <span class="hlFld-ContribAuthor ">Chenyang  Li</span>, <span class="hlFld-ContribAuthor ">Xiao  Wang</span>, <span class="hlFld-ContribAuthor ">Jiale  Tian</span>, <span class="hlFld-ContribAuthor ">Ying  Feng</span>, <span class="hlFld-ContribAuthor ">Jing  Xie</span>, <span class="hlFld-ContribAuthor ">Cong  Ma</span>, <span class="hlFld-ContribAuthor ">Zhuang  Nie</span>, <span class="hlFld-ContribAuthor ">Peinan  Fan</span>, <span class="hlFld-ContribAuthor ">Mingcheng  Qian</span>, <span class="hlFld-ContribAuthor ">Xirui  He</span>, <span class="hlFld-ContribAuthor ">Shaoping  Wu</span>, <span class="hlFld-ContribAuthor ">Yongmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazolone structural motif in medicinal chemistry: Retrospect and prospect. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>186 </em>, 111893. <a href="https://doi.org/10.1016/j.ejmech.2019.111893" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111893</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111893%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrazolone%252Bstructural%252Bmotif%252Bin%252Bmedicinal%252Bchemistry%25253A%252BRetrospect%252Band%252Bprospect%26aulast%3DZhao%26aufirst%3DZefeng%26date%3D2020%26volume%3D186%26spage%3D111893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yifeng  Yang</span>, <span class="hlFld-ContribAuthor ">Yingxiu  Li</span>, <span class="hlFld-ContribAuthor ">Yunlei  Hou</span>, <span class="hlFld-ContribAuthor ">Mingze  Qin</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Ju  Liu</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of 4-phenoxyquinoline derivatives as potent c-Met kinase inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (23)
                                     , 126666. <a href="https://doi.org/10.1016/j.bmcl.2019.126666" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126666</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126666%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252B4-phenoxyquinoline%252Bderivatives%252Bas%252Bpotent%252Bc-Met%252Bkinase%252Binhibitor%26aulast%3DYang%26aufirst%3DYifeng%26date%3D2019%26volume%3D29%26issue%3D23%26spage%3D126666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabio  Marchetti</span>, <span class="hlFld-ContribAuthor ">Claudio  Pettinari</span>, <span class="hlFld-ContribAuthor ">Corrado  Di Nicola</span>, <span class="hlFld-ContribAuthor ">Alessia  Tombesi</span>, <span class="hlFld-ContribAuthor ">Riccardo  Pettinari</span>. </span><span class="cited-content_cbyCitation_article-title">Coordination chemistry of pyrazolone-based ligands and applications of their metal complexes. </span><span class="cited-content_cbyCitation_journal-name">Coordination Chemistry Reviews</span><span> <strong>2019,</strong> <em>401 </em>, 213069. <a href="https://doi.org/10.1016/j.ccr.2019.213069" title="DOI URL">https://doi.org/10.1016/j.ccr.2019.213069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccr.2019.213069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccr.2019.213069%26sid%3Dliteratum%253Aachs%26jtitle%3DCoordination%2520Chemistry%2520Reviews%26atitle%3DCoordination%252Bchemistry%252Bof%252Bpyrazolone-based%252Bligands%252Band%252Bapplications%252Bof%252Btheir%252Bmetal%252Bcomplexes%26aulast%3DMarchetti%26aufirst%3DFabio%26date%3D2019%26volume%3D401%26spage%3D213069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng-Cheng  Lv</span>, <span class="hlFld-ContribAuthor ">Yu-Shun  Yang</span>, <span class="hlFld-ContribAuthor ">Zhong-Chang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress in the Development of Small Molecule c-Met Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (15)
                                     , 1276-1288. <a href="https://doi.org/10.2174/1568026619666190712205353" title="DOI URL">https://doi.org/10.2174/1568026619666190712205353</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190712205353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190712205353%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BProgress%252Bin%252Bthe%252BDevelopment%252Bof%252BSmall%252BMolecule%252Bc-Met%252BInhibitors%26aulast%3DLv%26aufirst%3DPeng-Cheng%26date%3D2019%26volume%3D19%26issue%3D15%26spage%3D1276%26epage%3D1288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vegard Torp  Lien</span>, <span class="hlFld-ContribAuthor ">Solveig  Pettersen</span>, <span class="hlFld-ContribAuthor ">Mads Haugland  Haugen</span>, <span class="hlFld-ContribAuthor ">Dag Erlend  Olberg</span>, <span class="hlFld-ContribAuthor ">Gunhild M.  Mælandsmo</span>, <span class="hlFld-ContribAuthor ">Jo  Klaveness</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 6‐substituted quinolines derived from cabozantinib as c‐Met inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2019,</strong> <em>352 </em>
                                    (9)
                                     , 1900101. <a href="https://doi.org/10.1002/ardp.201900101" title="DOI URL">https://doi.org/10.1002/ardp.201900101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201900101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201900101%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B6%2525E2%252580%252590substituted%252Bquinolines%252Bderived%252Bfrom%252Bcabozantinib%252Bas%252Bc%2525E2%252580%252590Met%252Binhibitors%26aulast%3DLien%26aufirst%3DVegard%2BTorp%26date%3D2019%26date%3D2019%26volume%3D352%26issue%3D9%26spage%3D1900101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andreas  Luxenburger</span>, <span class="hlFld-ContribAuthor ">Dorian  Schmidt</span>, <span class="hlFld-ContribAuthor ">Chiara  Ianes</span>, <span class="hlFld-ContribAuthor ">Christian  Pichlo</span>, <span class="hlFld-ContribAuthor ">Marc  Krüger</span>, <span class="hlFld-ContribAuthor ">Thorsten  von Drathen</span>, <span class="hlFld-ContribAuthor ">Elena  Brunstein</span>, <span class="hlFld-ContribAuthor ">Graeme  Gainsford</span>, <span class="hlFld-ContribAuthor ">Ulrich  Baumann</span>, <span class="hlFld-ContribAuthor ">Uwe  Knippschild</span>, <span class="hlFld-ContribAuthor ">Christian  Peifer</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Biological Evaluation of Isoxazole-Based CK1 Inhibitors Modified with Chiral Pyrrolidine Scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (5)
                                     , 873. <a href="https://doi.org/10.3390/molecules24050873" title="DOI URL">https://doi.org/10.3390/molecules24050873</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24050873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24050873%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BIsoxazole-Based%252BCK1%252BInhibitors%252BModified%252Bwith%252BChiral%252BPyrrolidine%252BScaffolds%26aulast%3DLuxenburger%26aufirst%3DAndreas%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D5%26spage%3D873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deboshikha  Bhattacharjee</span>, <span class="hlFld-ContribAuthor ">Sanjoy Kumar  Sheet</span>, <span class="hlFld-ContribAuthor ">Snehadrinarayan  Khatua</span>, <span class="hlFld-ContribAuthor ">Koel  Biswas</span>, <span class="hlFld-ContribAuthor ">Santaram  Joshi</span>, <span class="hlFld-ContribAuthor ">Bekington  Myrboh</span>. </span><span class="cited-content_cbyCitation_article-title">A reusable magnetic nickel nanoparticle based catalyst for the aqueous synthesis of diverse heterocycles and their evaluation as potential anti-bacterial agent. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (18)
                                     , 5018-5028. <a href="https://doi.org/10.1016/j.bmc.2018.08.033" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.08.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.08.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.08.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DA%252Breusable%252Bmagnetic%252Bnickel%252Bnanoparticle%252Bbased%252Bcatalyst%252Bfor%252Bthe%252Baqueous%252Bsynthesis%252Bof%252Bdiverse%252Bheterocycles%252Band%252Btheir%252Bevaluation%252Bas%252Bpotential%252Banti-bacterial%252Bagent%26aulast%3DBhattacharjee%26aufirst%3DDeboshikha%26date%3D2018%26volume%3D26%26issue%3D18%26spage%3D5018%26epage%3D5028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Palak K.  Parikh</span>, <span class="hlFld-ContribAuthor ">Manjunath D.  Ghate</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the discovery of small molecule c-Met Kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>143 </em>, 1103-1138. <a href="https://doi.org/10.1016/j.ejmech.2017.08.044" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.08.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.08.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.08.044%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdiscovery%252Bof%252Bsmall%252Bmolecule%252Bc-Met%252BKinase%252Binhibitors%26aulast%3DParikh%26aufirst%3DPalak%2BK.%26date%3D2018%26volume%3D143%26spage%3D1103%26epage%3D1138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">De  Kang</span>, <span class="hlFld-ContribAuthor ">Xiaocong  Pang</span>, <span class="hlFld-ContribAuthor ">Wenwen  Lian</span>, <span class="hlFld-ContribAuthor ">Lvjie  Xu</span>, <span class="hlFld-ContribAuthor ">Jinhua  Wang</span>, <span class="hlFld-ContribAuthor ">Hao  Jia</span>, <span class="hlFld-ContribAuthor ">Baoyue  Zhang</span>, <span class="hlFld-ContribAuthor ">Ai-Lin  Liu</span>, <span class="hlFld-ContribAuthor ">Guan-Hua  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of VEGFR2 inhibitors by integrating naïve Bayesian classification, molecular docking and drug screening approaches. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (10)
                                     , 5286-5297. <a href="https://doi.org/10.1039/C7RA12259D" title="DOI URL">https://doi.org/10.1039/C7RA12259D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7RA12259D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7RA12259D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDiscovery%252Bof%252BVEGFR2%252Binhibitors%252Bby%252Bintegrating%252Bna%2525C3%2525AFve%252BBayesian%252Bclassification%25252C%252Bmolecular%252Bdocking%252Band%252Bdrug%252Bscreening%252Bapproaches%26aulast%3DKang%26aufirst%3DDe%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D10%26spage%3D5286%26epage%3D5297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nichola  Cruickshanks</span>, <span class="hlFld-ContribAuthor ">Ying  Zhang</span>, <span class="hlFld-ContribAuthor ">Fang  Yuan</span>, <span class="hlFld-ContribAuthor ">Mary  Pahuski</span>, <span class="hlFld-ContribAuthor ">Myron  Gibert</span>, <span class="hlFld-ContribAuthor ">Roger  Abounader</span>. </span><span class="cited-content_cbyCitation_article-title">Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2017,</strong> <em>9 </em>
                                    (12)
                                     , 87. <a href="https://doi.org/10.3390/cancers9070087" title="DOI URL">https://doi.org/10.3390/cancers9070087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers9070087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers9070087%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DRole%252Band%252BTherapeutic%252BTargeting%252Bof%252Bthe%252BHGF%25252FMET%252BPathway%252Bin%252BGlioblastoma%26aulast%3DCruickshanks%26aufirst%3DNichola%26date%3D2017%26date%3D2017%26volume%3D9%26issue%3D12%26spage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ju  Liu</span>, <span class="hlFld-ContribAuthor ">Di  Yang</span>, <span class="hlFld-ContribAuthor ">Xiuxiu  Yang</span>, <span class="hlFld-ContribAuthor ">Minhua  Nie</span>, <span class="hlFld-ContribAuthor ">Guodong  Wu</span>, <span class="hlFld-ContribAuthor ">Zhunchao  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Yajing  Liu</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 4-phenoxyquinoline derivatives containing 3-oxo-3,4-dihydroquinoxaline moiety as c-Met kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (16)
                                     , 4475-4486. <a href="https://doi.org/10.1016/j.bmc.2017.06.037" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.06.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.06.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.06.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B4-phenoxyquinoline%252Bderivatives%252Bcontaining%252B3-oxo-3%25252C4-dihydroquinoxaline%252Bmoiety%252Bas%252Bc-Met%252Bkinase%252Binhibitors%26aulast%3DLiu%26aufirst%3DJu%26date%3D2017%26volume%3D25%26issue%3D16%26spage%3D4475%26epage%3D4486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Xuan</span>, <span class="hlFld-ContribAuthor ">Xiao  Cheng</span>, <span class="hlFld-ContribAuthor ">Xia  Cao</span>. </span><span class="cited-content_cbyCitation_article-title">[3+3] Cycloaddition of
              in Situ
              Formed Azaoxyallyl Cations with Nitrones: Synthesis of 1,2,4-Oxadiazinan-5-one Derivatives. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2017,</strong> <em>2 </em>
                                    (16)
                                     , 4364-4367. <a href="https://doi.org/10.1002/slct.201700826" title="DOI URL">https://doi.org/10.1002/slct.201700826</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201700826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201700826%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3D%25255B3%25252B3%25255D%252BCycloaddition%252Bof%252Bin%252BSitu%252BFormed%252BAzaoxyallyl%252BCations%252Bwith%252BNitrones%25253A%252BSynthesis%252Bof%252B1%25252C2%25252C4-Oxadiazinan-5-one%252BDerivatives%26aulast%3DXuan%26aufirst%3DJun%26date%3D2017%26date%3D2017%26volume%3D2%26issue%3D16%26spage%3D4364%26epage%3D4367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiao  Wang</span>, <span class="hlFld-ContribAuthor ">Lijun  Xie</span>, <span class="hlFld-ContribAuthor ">Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Shuancheng  Xi</span>, <span class="hlFld-ContribAuthor ">Tianfang  Zeng</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Novel 4-Phenoxyquinolines Bearing 3-Hydrosulfonylacrylamido or 1
              H
              -Imidazole-4-carboxamido Scaffolds as c-Met Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2017,</strong> <em>350 </em>
                                    (2)
                                     , 1600307. <a href="https://doi.org/10.1002/ardp.201600307" title="DOI URL">https://doi.org/10.1002/ardp.201600307</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201600307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201600307%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BNovel%252B4-Phenoxyquinolines%252BBearing%252B3-Hydrosulfonylacrylamido%252Bor%252B1%252BH%252B-Imidazole-4-carboxamido%252BScaffolds%252Bas%252Bc-Met%252BKinase%252BInhibitors%26aulast%3DWang%26aufirst%3DJiao%26date%3D2017%26date%3D2017%26volume%3D350%26issue%3D2%26spage%3D1600307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Nan  Jiang</span>, <span class="hlFld-ContribAuthor ">Sijia  Zhao</span>, <span class="hlFld-ContribAuthor ">Shuancheng  Xi</span>, <span class="hlFld-ContribAuthor ">Jiao  Wang</span>, <span class="hlFld-ContribAuthor ">Tongfei  Jing</span>, <span class="hlFld-ContribAuthor ">Wenyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Ming  Guo</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 4-(2-fluorophenoxy)quinoline derivatives as selective c-Met inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (3)
                                     , 886-896. <a href="https://doi.org/10.1016/j.bmc.2016.12.002" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.12.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.12.002%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B4-%2525282-fluorophenoxy%252529quinoline%252Bderivatives%252Bas%252Bselective%252Bc-Met%252Binhibitors%26aulast%3DWang%26aufirst%3DXiaoqiang%26date%3D2017%26volume%3D25%26issue%3D3%26spage%3D886%26epage%3D896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.A.  Boezio</span>, <span class="hlFld-ContribAuthor ">E.A.  Peterson</span>, <span class="hlFld-ContribAuthor ">J.-C.  Harmange</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of AMG 337: Using Structure Guided Scaffold Hybridization to Optimize Physicochemical Properties and Target Coverage of a MET Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 138-160. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12462-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12462-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12462-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12462-X%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Bof%252BAMG%252B337%25253A%252BUsing%252BStructure%252BGuided%252BScaffold%252BHybridization%252Bto%252BOptimize%252BPhysicochemical%252BProperties%252Band%252BTarget%252BCoverage%252Bof%252Ba%252BMET%252BKinase%252BInhibitor%26aulast%3DBoezio%26aufirst%3DA.A.%26date%3D2017%26spage%3D138%26epage%3D160%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ju  Liu</span>, <span class="hlFld-ContribAuthor ">Minhua  Nie</span>, <span class="hlFld-ContribAuthor ">Yanjing  Wang</span>, <span class="hlFld-ContribAuthor ">Jinxing  Hu</span>, <span class="hlFld-ContribAuthor ">Feng  Zhang</span>, <span class="hlFld-ContribAuthor ">Yanlin  Gao</span>, <span class="hlFld-ContribAuthor ">Yajing  Liu</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and structure-activity relationships of novel 4-phenoxyquinoline derivatives containing 1,2,4-triazolone moiety as c-Met kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>123 </em>, 431-446. <a href="https://doi.org/10.1016/j.ejmech.2016.07.059" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.07.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.07.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.07.059%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bstructure-activity%252Brelationships%252Bof%252Bnovel%252B4-phenoxyquinoline%252Bderivatives%252Bcontaining%252B1%25252C2%25252C4-triazolone%252Bmoiety%252Bas%252Bc-Met%252Bkinase%252Binhibitors%26aulast%3DLiu%26aufirst%3DJu%26date%3D2016%26volume%3D123%26spage%3D431%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong  Lu</span>, <span class="hlFld-ContribAuthor ">Aijun  Shen</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Weiqiang  Xing</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Youhong  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel benzo[d]oxazol-2(3H)-one derivatives bearing 7-substituted-4-enthoxyquinoline moieties as c-Met kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>115 </em>, 191-200. <a href="https://doi.org/10.1016/j.ejmech.2016.03.027" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.03.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.03.027%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252Bbenzo%25255Bd%25255Doxazol-2%2525283H%252529-one%252Bderivatives%252Bbearing%252B7-substituted-4-enthoxyquinoline%252Bmoieties%252Bas%252Bc-Met%252Bkinase%252Binhibitors%26aulast%3DLu%26aufirst%3DDong%26date%3D2016%26volume%3D115%26spage%3D191%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yingnan  Jiang</span>, <span class="hlFld-ContribAuthor ">Ke  Zhang</span>, <span class="hlFld-ContribAuthor ">Suyu  Gao</span>, <span class="hlFld-ContribAuthor ">Guihua  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Huang</span>, <span class="hlFld-ContribAuthor ">Jinhui  Wang</span>, <span class="hlFld-ContribAuthor ">Lixia  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent c-MET Inhibitors with New Scaffold Having Different Quinazoline, Pyridine and Tetrahydro-Pyridothienopyrimidine Headgroups. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (5)
                                     , 612. <a href="https://doi.org/10.3390/molecules21050612" title="DOI URL">https://doi.org/10.3390/molecules21050612</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21050612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21050612%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDiscovery%252Bof%252BPotent%252Bc-MET%252BInhibitors%252Bwith%252BNew%252BScaffold%252BHaving%252BDifferent%252BQuinazoline%25252C%252BPyridine%252Band%252BTetrahydro-Pyridothienopyrimidine%252BHeadgroups%26aulast%3DJiang%26aufirst%3DYingnan%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D5%26spage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Shiyu  Jin</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Dong  Lu</span>, <span class="hlFld-ContribAuthor ">Limin  Zeng</span>, <span class="hlFld-ContribAuthor ">Yiming  Sun</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Youhong  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Pyridazinone derivatives displaying highly potent and selective inhibitory activities against c-Met tyrosine kinase. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>108 </em>, 322-333. <a href="https://doi.org/10.1016/j.ejmech.2015.11.042" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.11.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.11.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.11.042%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyridazinone%252Bderivatives%252Bdisplaying%252Bhighly%252Bpotent%252Band%252Bselective%252Binhibitory%252Bactivities%252Bagainst%252Bc-Met%252Btyrosine%252Bkinase%26aulast%3DLiu%26aufirst%3DYang%26date%3D2016%26volume%3D108%26spage%3D322%26epage%3D333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Palak  Parikh</span>, <span class="hlFld-ContribAuthor ">Manjunath  Ghate</span>, <span class="hlFld-ContribAuthor ">Vivek K.  Vyas</span>. </span><span class="cited-content_cbyCitation_article-title">CoMFA and CoMSIA studies on 6,7-disubstituted-4-phenoxyquinoline derivatives as c-Met kinase inhibitors and anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2015,</strong> <em>24 </em>
                                    (12)
                                     , 4078-4092. <a href="https://doi.org/10.1007/s00044-015-1450-5" title="DOI URL">https://doi.org/10.1007/s00044-015-1450-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-015-1450-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-015-1450-5%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DCoMFA%252Band%252BCoMSIA%252Bstudies%252Bon%252B6%25252C7-disubstituted-4-phenoxyquinoline%252Bderivatives%252Bas%252Bc-Met%252Bkinase%252Binhibitors%252Band%252Banticancer%252Bagents%26aulast%3DParikh%26aufirst%3DPalak%26date%3D2015%26date%3D2015%26volume%3D24%26issue%3D12%26spage%3D4078%26epage%3D4092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manisha  Bihani</span>, <span class="hlFld-ContribAuthor ">Pranjal P.  Bora</span>, <span class="hlFld-ContribAuthor ">Alakesh K.  Verma</span>, <span class="hlFld-ContribAuthor ">Reshita  Baruah</span>, <span class="hlFld-ContribAuthor ">Hari Prasanna Deka  Boruah</span>, <span class="hlFld-ContribAuthor ">Ghanashyam  Bez</span>. </span><span class="cited-content_cbyCitation_article-title">PPL catalyzed four-component PASE synthesis of 5-monosubstituted barbiturates: Structure and pharmacological properties. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (24)
                                     , 5732-5736. <a href="https://doi.org/10.1016/j.bmcl.2015.10.088" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.10.088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.10.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.10.088%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPPL%252Bcatalyzed%252Bfour-component%252BPASE%252Bsynthesis%252Bof%252B5-monosubstituted%252Bbarbiturates%25253A%252BStructure%252Band%252Bpharmacological%252Bproperties%26aulast%3DBihani%26aufirst%3DManisha%26date%3D2015%26volume%3D25%26issue%3D24%26spage%3D5732%26epage%3D5736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yaşar  Dürüst</span>, <span class="hlFld-ContribAuthor ">Eda  Sağırlı</span>, <span class="hlFld-ContribAuthor ">Akın  Sağırlı</span>. </span><span class="cited-content_cbyCitation_article-title">Reactions of 3-methyl-2-oxopyrazolidinium ylides with phenylsulfonylacrylonitriles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2015,</strong> <em>71 </em>
                                    (49)
                                     , 9307-9312. <a href="https://doi.org/10.1016/j.tet.2015.10.022" title="DOI URL">https://doi.org/10.1016/j.tet.2015.10.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2015.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2015.10.022%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DReactions%252Bof%252B3-methyl-2-oxopyrazolidinium%252Bylides%252Bwith%252Bphenylsulfonylacrylonitriles%26aulast%3DD%25C3%25BCr%25C3%25BCst%26aufirst%3DYa%25C5%259Far%26date%3D2015%26volume%3D71%26issue%3D49%26spage%3D9307%26epage%3D9312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Hu</span>, <span class="hlFld-ContribAuthor ">Mingyan  Jiang</span>, <span class="hlFld-ContribAuthor ">Lijun  Xie</span>, <span class="hlFld-ContribAuthor ">Gang  Hu</span>, <span class="hlFld-ContribAuthor ">Cuirong  Zhang</span>, <span class="hlFld-ContribAuthor ">Lixia  Zhang</span>, <span class="hlFld-ContribAuthor ">Shunguang  Zhou</span>, <span class="hlFld-ContribAuthor ">Meihui  Zhang</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and pharmacological evaluation of novel 4-phenoxyquinoline derivatives as potential antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Chinese Universities</span><span> <strong>2015,</strong> <em>31 </em>
                                    (5)
                                     , 746-755. <a href="https://doi.org/10.1007/s40242-015-5166-3" title="DOI URL">https://doi.org/10.1007/s40242-015-5166-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40242-015-5166-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40242-015-5166-3%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Chinese%2520Universities%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bpharmacological%252Bevaluation%252Bof%252Bnovel%252B4-phenoxyquinoline%252Bderivatives%252Bas%252Bpotential%252Bantitumor%252Bagents%26aulast%3DHu%26aufirst%3DHao%26date%3D2015%26date%3D2015%26volume%3D31%26issue%3D5%26spage%3D746%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stéphane L.  Raeppel</span>, <span class="hlFld-ContribAuthor ">Eric  Therrien</span>, <span class="hlFld-ContribAuthor ">Franck  Raeppel</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of constrained analogs of LCRF-0004 as potent RON tyrosine kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (17)
                                     , 3706-3710. <a href="https://doi.org/10.1016/j.bmcl.2015.06.034" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.06.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.06.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.06.034%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bconstrained%252Banalogs%252Bof%252BLCRF-0004%252Bas%252Bpotent%252BRON%252Btyrosine%252Bkinase%252Binhibitors%26aulast%3DRaeppel%26aufirst%3DSt%25C3%25A9phane%2BL.%26date%3D2015%26volume%3D25%26issue%3D17%26spage%3D3706%26epage%3D3710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Franck  Raeppel</span>, <span class="hlFld-ContribAuthor ">Stéphane L.  Raeppel</span>, <span class="hlFld-ContribAuthor ">Eric  Therrien</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and RON receptor tyrosine kinase inhibitory activity of new head groups analogs of LCRF-0004. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (18)
                                     , 3810-3815. <a href="https://doi.org/10.1016/j.bmcl.2015.07.080" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.07.080</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.07.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.07.080%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252BRON%252Breceptor%252Btyrosine%252Bkinase%252Binhibitory%252Bactivity%252Bof%252Bnew%252Bhead%252Bgroups%252Banalogs%252Bof%252BLCRF-0004%26aulast%3DRaeppel%26aufirst%3DFranck%26date%3D2015%26volume%3D25%26issue%3D18%26spage%3D3810%26epage%3D3815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiqiang  Xing</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Shiyu  Jin</span>, <span class="hlFld-ContribAuthor ">Zhangxing  Shi</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Lang  Wang</span>, <span class="hlFld-ContribAuthor ">Yinchun  Ji</span>, <span class="hlFld-ContribAuthor ">Dong  Lu</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Youhong  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Enhancing the cellular anti-proliferation activity of pyridazinones as c-met inhibitors using docking analysis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>95 </em>, 302-312. <a href="https://doi.org/10.1016/j.ejmech.2015.03.041" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.03.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.03.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.03.041%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEnhancing%252Bthe%252Bcellular%252Banti-proliferation%252Bactivity%252Bof%252Bpyridazinones%252Bas%252Bc-met%252Binhibitors%252Busing%252Bdocking%252Banalysis%26aulast%3DXing%26aufirst%3DWeiqiang%26date%3D2015%26volume%3D95%26spage%3D302%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandip R.  Khobare</span>, <span class="hlFld-ContribAuthor ">Vikas S.  Gajare</span>, <span class="hlFld-ContribAuthor ">Nagaraju  Rajana</span>, <span class="hlFld-ContribAuthor ">Rajender  Datrika</span>, <span class="hlFld-ContribAuthor ">K.  Srinivasa Reddy</span>, <span class="hlFld-ContribAuthor ">U.K.  Syam Kumar</span>, <span class="hlFld-ContribAuthor ">Vidavalur  Siddaiah</span>. </span><span class="cited-content_cbyCitation_article-title">Diastereoselective total synthesis of piperidine alkaloids: (2R,5R)-5-hydroxyhomopipecolic acid and (2R,5R,8R)-5-hydroxysedamine. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2015,</strong> <em>56 </em>
                                    (17)
                                     , 2207-2210. <a href="https://doi.org/10.1016/j.tetlet.2015.02.042" title="DOI URL">https://doi.org/10.1016/j.tetlet.2015.02.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2015.02.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2015.02.042%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DDiastereoselective%252Btotal%252Bsynthesis%252Bof%252Bpiperidine%252Balkaloids%25253A%252B%2525282R%25252C5R%252529-5-hydroxyhomopipecolic%252Bacid%252Band%252B%2525282R%25252C5R%25252C8R%252529-5-hydroxysedamine%26aulast%3DKhobare%26aufirst%3DSandip%2BR.%26date%3D2015%26volume%3D56%26issue%3D17%26spage%3D2207%26epage%3D2210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David K.  Johnson</span>, <span class="hlFld-ContribAuthor ">John  Karanicolas</span>, . </span><span class="cited-content_cbyCitation_article-title">Selectivity by Small-Molecule Inhibitors of Protein Interactions Can Be Driven by Protein Surface Fluctuations. </span><span class="cited-content_cbyCitation_journal-name">PLOS Computational Biology</span><span> <strong>2015,</strong> <em>11 </em>
                                    (2)
                                     , e1004081. <a href="https://doi.org/10.1371/journal.pcbi.1004081" title="DOI URL">https://doi.org/10.1371/journal.pcbi.1004081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pcbi.1004081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pcbi.1004081%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Computational%2520Biology%26atitle%3DSelectivity%252Bby%252BSmall-Molecule%252BInhibitors%252Bof%252BProtein%252BInteractions%252BCan%252BBe%252BDriven%252Bby%252BProtein%252BSurface%252BFluctuations%26aulast%3DJohnson%26aufirst%3DDavid%2BK.%26date%3D2015%26date%3D2015%26volume%3D11%26issue%3D2%26spage%3De1004081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manisha  Bihani</span>, <span class="hlFld-ContribAuthor ">Pranjal P.  Bora</span>, <span class="hlFld-ContribAuthor ">Ghanashyam  Bez</span>, <span class="hlFld-ContribAuthor ">Hassan  Askari</span>. </span><span class="cited-content_cbyCitation_article-title">A green four-component synthesis of zwitterionic alkyl/benzyl pyrazolyl barbiturates and their photophysical studies. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2014,</strong> <em>18 </em>
                                    (4)
                                     , 745-757. <a href="https://doi.org/10.1007/s11030-014-9532-8" title="DOI URL">https://doi.org/10.1007/s11030-014-9532-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-014-9532-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-014-9532-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DA%252Bgreen%252Bfour-component%252Bsynthesis%252Bof%252Bzwitterionic%252Balkyl%25252Fbenzyl%252Bpyrazolyl%252Bbarbiturates%252Band%252Btheir%252Bphotophysical%252Bstudies%26aulast%3DBihani%26aufirst%3DManisha%26date%3D2014%26date%3D2014%26volume%3D18%26issue%3D4%26spage%3D745%26epage%3D757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan  Gianatassio</span>, <span class="hlFld-ContribAuthor ">Shuhei  Kawamura</span>, <span class="hlFld-ContribAuthor ">Cecil L  Eprile</span>, <span class="hlFld-ContribAuthor ">Klement  Foo</span>, <span class="hlFld-ContribAuthor ">Jason  Ge</span>, <span class="hlFld-ContribAuthor ">Aaron C.  Burns</span>, <span class="hlFld-ContribAuthor ">Michael R.  Collins</span>, <span class="hlFld-ContribAuthor ">Phil S.  Baran</span>. </span><span class="cited-content_cbyCitation_article-title">Simple Sulfinate Synthesis Enables CH Trifluoromethylcyclopropanation. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2014,</strong> <em>126 </em>
                                    (37)
                                     , 10009-10013. <a href="https://doi.org/10.1002/ange.201406622" title="DOI URL">https://doi.org/10.1002/ange.201406622</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201406622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201406622%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DSimple%252BSulfinate%252BSynthesis%252BEnables%252BC%2525EF%2525A3%2525BFH%252BTrifluoromethylcyclopropanation%26aulast%3DGianatassio%26aufirst%3DRyan%26date%3D2014%26date%3D2014%26volume%3D126%26issue%3D37%26spage%3D10009%26epage%3D10013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan  Gianatassio</span>, <span class="hlFld-ContribAuthor ">Shuhei  Kawamura</span>, <span class="hlFld-ContribAuthor ">Cecil L  Eprile</span>, <span class="hlFld-ContribAuthor ">Klement  Foo</span>, <span class="hlFld-ContribAuthor ">Jason  Ge</span>, <span class="hlFld-ContribAuthor ">Aaron C.  Burns</span>, <span class="hlFld-ContribAuthor ">Michael R.  Collins</span>, <span class="hlFld-ContribAuthor ">Phil S.  Baran</span>. </span><span class="cited-content_cbyCitation_article-title">Simple Sulfinate Synthesis Enables CH Trifluoromethylcyclopropanation. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2014,</strong> <em>53 </em>
                                    (37)
                                     , 9851-9855. <a href="https://doi.org/10.1002/anie.201406622" title="DOI URL">https://doi.org/10.1002/anie.201406622</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201406622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201406622%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DSimple%252BSulfinate%252BSynthesis%252BEnables%252BC%2525EF%2525A3%2525BFH%252BTrifluoromethylcyclopropanation%26aulast%3DGianatassio%26aufirst%3DRyan%26date%3D2014%26date%3D2014%26volume%3D53%26issue%3D37%26spage%3D9851%26epage%3D9855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zijian  Liu</span>, <span class="hlFld-ContribAuthor ">Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Ruiming  Guo</span>, <span class="hlFld-ContribAuthor ">Jinxing  Hu</span>, <span class="hlFld-ContribAuthor ">Ruijuan  Li</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 6,7-disubstituted-4-phenoxyquinoline derivatives bearing 4-oxo-3,4-dihydrophthalazine-1-carboxamide moieties as c-Met kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (14)
                                     , 3642-3653. <a href="https://doi.org/10.1016/j.bmc.2014.05.013" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.05.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.05.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B6%25252C7-disubstituted-4-phenoxyquinoline%252Bderivatives%252Bbearing%252B4-oxo-3%25252C4-dihydrophthalazine-1-carboxamide%252Bmoieties%252Bas%252Bc-Met%252Bkinase%252Binhibitors%26aulast%3DLiu%26aufirst%3DZijian%26date%3D2014%26volume%3D22%26issue%3D14%26spage%3D3642%26epage%3D3653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhoulong  Fan</span>, <span class="hlFld-ContribAuthor ">Kui  Wu</span>, <span class="hlFld-ContribAuthor ">Li  Xing</span>, <span class="hlFld-ContribAuthor ">Qizheng  Yao</span>, <span class="hlFld-ContribAuthor ">Ao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-catalyzed double C–H activation: one-pot synthesis of benzo[c]pyrazolo[1,2-a]cinnolin-1-ones from 5-pyrazolones and aryl iodides. </span><span class="cited-content_cbyCitation_journal-name">Chem. Commun.</span><span> <strong>2014,</strong> <em>50 </em>
                                    (14)
                                     , 1682-1684. <a href="https://doi.org/10.1039/C3CC47989G" title="DOI URL">https://doi.org/10.1039/C3CC47989G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C3CC47989G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC3CC47989G%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Commun.%26atitle%3DPalladium-catalyzed%252Bdouble%252BC%2525E2%252580%252593H%252Bactivation%25253A%252Bone-pot%252Bsynthesis%252Bof%252Bbenzo%25255Bc%25255Dpyrazolo%25255B1%25252C2-a%25255Dcinnolin-1-ones%252Bfrom%252B5-pyrazolones%252Band%252Baryl%252Biodides%26aulast%3DFan%26aufirst%3DZhoulong%26date%3D2014%26date%3D2014%26volume%3D50%26issue%3D14%26spage%3D1682%26epage%3D1684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiyou  Li</span>, <span class="hlFld-ContribAuthor ">Lamei  Wu</span>, <span class="hlFld-ContribAuthor ">Tao  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhengxi  Huang</span>, <span class="hlFld-ContribAuthor ">Guofu  Qiu</span>, <span class="hlFld-ContribAuthor ">Zhongqiang  Zhou</span>, <span class="hlFld-ContribAuthor ">Longfei  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">N-2-Hydroxybenzaldehyde acylhydrazone–Fe(
              iii
              ) complex: synthesis, crystal structure and its efficient and selective N-methylation. </span><span class="cited-content_cbyCitation_journal-name">Dalton Trans.</span><span> <strong>2014,</strong> <em>43 </em>
                                    (20)
                                     , 7554-7560. <a href="https://doi.org/10.1039/C4DT00121D" title="DOI URL">https://doi.org/10.1039/C4DT00121D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4DT00121D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4DT00121D%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Trans.%26atitle%3DN-2-Hydroxybenzaldehyde%252Bacylhydrazone%2525E2%252580%252593Fe%252528%252Biii%252B%252529%252Bcomplex%25253A%252Bsynthesis%25252C%252Bcrystal%252Bstructure%252Band%252Bits%252Befficient%252Band%252Bselective%252BN-methylation%26aulast%3DLi%26aufirst%3DZhiyou%26date%3D2014%26date%3D2014%26volume%3D43%26issue%3D20%26spage%3D7554%26epage%3D7560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yiwen  Yang</span>, <span class="hlFld-ContribAuthor ">Hao  Gong</span>, <span class="hlFld-ContribAuthor ">Chunxiang  Kuang</span>. </span><span class="cited-content_cbyCitation_article-title">Room-Temperature Direct Alkenylation of 5-Pyrazolones. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>2013 </em>
                                    (24)
                                     , 5276-5281. <a href="https://doi.org/10.1002/ejoc.201300765" title="DOI URL">https://doi.org/10.1002/ejoc.201300765</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201300765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201300765%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRoom-Temperature%252BDirect%252BAlkenylation%252Bof%252B5-Pyrazolones%26aulast%3DYang%26aufirst%3DYiwen%26date%3D2013%26date%3D2013%26volume%3D2013%26issue%3D24%26spage%3D5276%26epage%3D5281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sai  Li</span>, <span class="hlFld-ContribAuthor ">Rui  Jiang</span>, <span class="hlFld-ContribAuthor ">Mingze  Qin</span>, <span class="hlFld-ContribAuthor ">Haicheng  Liu</span>, <span class="hlFld-ContribAuthor ">Guangyan  Zhang</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Antitumor Activity of Novel 4-(2-Fluorophenoxy)quinoline Derivatives Bearing the 4-Oxo-1,4-dihydroquinoline-3-carboxamide Moiety. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2013,</strong> <em>346 </em>
                                    (7)
                                     , 521-533. <a href="https://doi.org/10.1002/ardp.201300029" title="DOI URL">https://doi.org/10.1002/ardp.201300029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201300029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201300029%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%252Band%252BAntitumor%252BActivity%252Bof%252BNovel%252B4-%2525282-Fluorophenoxy%252529quinoline%252BDerivatives%252BBearing%252Bthe%252B4-Oxo-1%25252C4-dihydroquinoline-3-carboxamide%252BMoiety%26aulast%3DLi%26aufirst%3DSai%26date%3D2013%26date%3D2013%26volume%3D346%26issue%3D7%26spage%3D521%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Wang</span>, <span class="hlFld-ContribAuthor ">Zhong-Liang  Xu</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Jian-Ping  Lin</span>, <span class="hlFld-ContribAuthor ">Yin-Chun  Ji</span>, <span class="hlFld-ContribAuthor ">Mei-Yu  Geng</span>, <span class="hlFld-ContribAuthor ">Ya-Qiu  Long</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation on the 1,6-naphthyridine motif: discovery and SAR study of 1H-imidazo[4,5-h][1,6]naphthyridin-2(3H)-one-based c-Met kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2013,</strong> <em>11 </em>
                                    (9)
                                     , 1545-1562. <a href="https://doi.org/10.1039/C2OB26710A" title="DOI URL">https://doi.org/10.1039/C2OB26710A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C2OB26710A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC2OB26710A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DInvestigation%252Bon%252Bthe%252B1%25252C6-naphthyridine%252Bmotif%25253A%252Bdiscovery%252Band%252BSAR%252Bstudy%252Bof%252B1H-imidazo%25255B4%25252C5-h%25255D%25255B1%25252C6%25255Dnaphthyridin-2%2525283H%252529-one-based%252Bc-Met%252Bkinase%252Binhibitors%26aulast%3DWang%26aufirst%3DYong%26date%3D2013%26date%3D2013%26volume%3D11%26issue%3D9%26spage%3D1545%26epage%3D1562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fuchao  Yu</span>, <span class="hlFld-ContribAuthor ">Zhiqiong  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaopan  Hao</span>, <span class="hlFld-ContribAuthor ">Xiuyang  Jiang</span>, <span class="hlFld-ContribAuthor ">Shengjiao  Yan</span>, <span class="hlFld-ContribAuthor ">Jun  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Three component solvent-free synthesis of 1H-pyrazol-5(4H)-one-based heterocyclic ketene aminal derivatives. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2013,</strong> <em>3 </em>
                                    (32)
                                     , 13183. <a href="https://doi.org/10.1039/c3ra41547c" title="DOI URL">https://doi.org/10.1039/c3ra41547c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ra41547c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ra41547c%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DThree%252Bcomponent%252Bsolvent-free%252Bsynthesis%252Bof%252B1H-pyrazol-5%2525284H%252529-one-based%252Bheterocyclic%252Bketene%252Baminal%252Bderivatives%26aulast%3DYu%26aufirst%3DFuchao%26date%3D2013%26volume%3D3%26issue%3D32%26spage%3D13183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Gong</span>, <span class="hlFld-ContribAuthor ">Yiwen  Yang</span>, <span class="hlFld-ContribAuthor ">Zechao  Wang</span>, <span class="hlFld-ContribAuthor ">Chunxiang  Kuang</span>. </span><span class="cited-content_cbyCitation_article-title">An easy direct arylation of 5-pyrazolones. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>9 </em>, 2033-2039. <a href="https://doi.org/10.3762/bjoc.9.240" title="DOI URL">https://doi.org/10.3762/bjoc.9.240</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.9.240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.9.240%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAn%252Beasy%252Bdirect%252Barylation%252Bof%252B5-pyrazolones%26aulast%3DGong%26aufirst%3DHao%26date%3D2013%26date%3D2013%26volume%3D9%26spage%3D2033%26epage%3D2039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure and activity of compound <b>1</b>, a pyrazolone-based class II c-Met inhibitor (numbering conventions used in the text for the quinoline and the pyrazolone rings are shown).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Model of <b>1</b> in VEGFR-2 indicating key contacts. Hydrogen bonds are colored in green and key van der Waals contacts in black. Distances are in Å. (B) X-ray cocrystal structure of <b>1</b> in VEGFR-2 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3U6J">3U6J</a>). Phe1047 of the DFG-motif adopts a DFG-out conformation as predicted. (C) Overlay of c-Met (blue) and VEGFR-2 (gray) cocrystal structures showing the relative orientations of <b>1</b> and the 3–4 Å “movement” of the C-helix.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0016.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) diethyl ethoxymethylenemalonate, 100 °C, 17 h, (2) Ph<sub>2</sub>O, 245 °C, 2 h; (b) (1) NaOH (aq), 100 °C, 50 min, HCl, (2) Ph<sub>2</sub>O, reflux, 30 min; (c) POCl<sub>3</sub>, 110 °C, 2 h; (d) PhCl, 140 °C, 16 h; (e) Me<sub>2</sub>Zn, Pd(dppf)Cl<sub>2</sub>, dioxane, 105 °C; (f) (CH<sub>2</sub>═CH)BF<sub>3</sub>K, Pd(dppf)Cl<sub>2</sub>, PrOH, 95 °C; (g) SnCl<sub>2</sub>, EtOH, 70 °C; (h) H<sub>2</sub>, Pd(OH)<sub>2</sub>/C (20%), EtOH; (i) HATU, DCM.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0017.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>10</b>, HATU, Et<sub>3</sub>N, DCM; (b) <b>10</b>, (CO)<sub>2</sub>Cl<sub>2</sub>, DMF, DCM; (c) 3-methoxy-4-nitrophenol, PhCl, reflux; (d) H<sub>2</sub>, Pd/C (20%), EtOAc; (e) BnOH, Cs<sub>2</sub>CO<sub>3</sub>, CuI, 1,10-phenanthroline, 110 °C; (f) BzCl, pyridine, DCM; (g) H<sub>2</sub>, Pd/C (10%), MeOH; (h) <b>17</b>, PPTS, 2-BuOH, 100 °C; (i) NaOH, MeOH, 70 °C.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0018.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, CHCl<sub>3</sub>; (b) (1) NaN<sub>3</sub>, DMF, (2) PPh<sub>3</sub>, THF, H<sub>2</sub>O; (3) Boc<sub>2</sub>O, DCM; (c) R<sub>1</sub>R<sub>2</sub>NH, DCM; (d) NaOH, H<sub>2</sub>O, MeOH, 80 °C; (e) HATU, <b>9d</b> or <b>16</b>, DMF or DCM.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0019.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HOBt, EDCI, Et<sub>3</sub>N, PhNHNH<sub>2</sub>, DCM; (b) BnOC(O)Cl, NaOH (aq), THF; (c) NaH, DMF; MeI, 0 °C → rt; (d) H<sub>2</sub>, Pd/C, MeOH; (e) DMAP, ethyl malonoyl chloride, DCM, 0 °C → rt; (f) NaOEt, EtOH, 90 °C; NaOH, MeOH, 90 °C; (g) <b>9d</b> or <b>16</b>, <sup><i>i</i></sup>Pr<sub>2</sub>NEt, HATU, DMF or DCM; (h) TFA, DCM.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0020.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CDI, methyl malonate potassium salt, MgCl<sub>2</sub>, THF; (b) PhNHNHMe, HOAc, pyridine, 100 °C; (c) DMF, POCl<sub>3</sub>; (d) NaClO<sub>2</sub>, 2-methylbut-2-ene, NaH<sub>2</sub>PO<sub>4</sub>, <sup><i>t</i></sup>BuOH, 0→20 °C; (e) <b>9d</b> or <b>16,</b> HATU or EDCI-HOAt, DMF, or DCM.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0021.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) RX (X = I, OTs, or Br), Δ; (b) POCl<sub>3</sub>, DMF, 50 °C; (c) NaClO<sub>2</sub>, KH<sub>2</sub>PO<sub>4</sub>, 2-methyl-2-butene, <sup><i>t</i></sup>BuOH, H<sub>2</sub>O, 0 °C → rt; (d) H<sub>2</sub>, Pd/C, EtOAc; (e) <b>9d</b> or <b>16</b>, Et<sub>3</sub>N, HATU, DMF; (f) OsO<sub>4</sub>, NMO, <sup><i>t</i></sup>BuOH–H<sub>2</sub>O; (g) NaIO<sub>4</sub>, <sup><i>t</i></sup>BuOH–H<sub>2</sub>O; (h) NaBH<sub>4</sub>, MeOH.</p></p></figure><figure data-id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0022.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Mg(ClO<sub>4</sub>)<sub>2</sub> or AlCl<sub>3</sub>, ACN; (b) Pd/C, H<sub>2</sub>, EtOAc; (c) <b>9d</b> or <b>16</b>, HATU, Et<sub>3</sub>N, DMF; (d) phthalimide, Ph<sub>3</sub>P, DEAD, DCM; (e) hydrazine, EtOH/H<sub>2</sub>O, 50 °C.</p></p></figure><figure data-id="sch8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0023.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) TMSCHN<sub>2</sub>, HBF<sub>4</sub>, DCM; (b) H<sub>2</sub>, Pd/C, EtOAc; (c) <b>9b</b> or <b>16</b>, HATU, Et<sub>3</sub>N, DMF; (d) NaN<sub>3</sub>, DMF/water, 90 °C, 18 h; (e) HSC<sub>3</sub>H<sub>6</sub>SH, DIEA, MeOH, 23 °C, 48 h; (f) Boc<sub>2</sub>O, DCM; (g) disuccinimidyl carbonate (DSC), DBU, 1,4-dioxane, 23 °C, 2 h; (h) TFA, DCM.</p></p></figure><figure data-id="fig3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray structure of <b>1</b> bound to c-Met highlighting key interactions of the 6- (right-hand side) and 7- (left-hand side) methoxyl groups of the quinoline ring (A-region). Hydrogen bonds are colored in green and key van der Waals contacts in black. Distances are in Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray structure of <b>1</b> bound to c-Met highlighting key interactions of the central fluorophenyl ring (B-region). Hydrogen bonds are colored in green and key van der Waals contacts in black. Distances are in Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0011.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. C-region of X-ray structure of <b>1</b> bound to c-Met, with three distinct areas annotated. Note that the side chain of Glu1127, between the solvent channel and Ile1145 pocket, was not resolved and is treated artificially in this surface representation as an alanine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0012.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Impact of α-branching of C(5)-substitution on conformational preferences. The conformation of the α-<i>unbranched</i> fragment is dictated by the strong preference of the sp<sup>3</sup> carbon to place the nitrogen atom <i>orthogonal</i> to the pyrazolone plane. In contrast, the ground state conformer for the α-branched fragment forms an intramolecular H-bond between the β-NH and the amide carbonyl, thereby interrupting its ability to satisfy the DFG motif-Asp1222 backbone amide-NH and rendering it incompatible with binding to c-Met. α-Branched molecules presumably pay a conformational penalty to bind in a different higher energy conformation that does not interfere with DFG-out binding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0013.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. X-ray cocrystal structure of (<i>R</i>)-<b>58a</b> bound to c-Met (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3U6I">3U6I</a>). (A) Key interactions of the pyrazolone region with the protein. Hydrogen bond (green dashed lines) distances are in Å; (B) surface of the c-Met active site pocket. The surfaces of Phe1089, Asp1222, Phe1223, and Gly1224 are not depicted for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0014.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Heat map of kinase activity (IC<sub>50</sub>) of compounds <b>1</b> and <b>59e</b> (activity units are in micromolar).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/medium/jm-2011-01331s_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0015.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structural evolution from <b>1</b> to <b>59e</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201331s/production/images/large/jm-2011-01331s_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201331s&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i200">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01713" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01713" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 40 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bottaro, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faletto, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kmiecik, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aaronson, S. A.</span><span> </span><span class="NLM_article-title">Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x">, </span> <span class="NLM_fpage">802</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1991&pages=802-4&author=D.+P.+Bottaroauthor=J.+S.+Rubinauthor=D.+L.+Falettoauthor=A.+M.+Chanauthor=T.+E.+Kmiecikauthor=G.+F.+Vande+Woudeauthor=S.+A.+Aaronson&title=Identification+of+the+hepatocyte+growth+factor+receptor+as+the+c-met+proto-oncogene+product"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBottaro%26aufirst%3DD.%2BP.%26aulast%3DRubin%26aufirst%3DJ.%2BS.%26aulast%3DFaletto%26aufirst%3DD.%2BL.%26aulast%3DChan%26aufirst%3DA.%2BM.%26aulast%3DKmiecik%26aufirst%3DT.%2BE.%26aulast%3DVande%2BWoude%26aufirst%3DG.%2BF.%26aulast%3DAaronson%26aufirst%3DS.%2BA.%26atitle%3DIdentification%2520of%2520the%2520hepatocyte%2520growth%2520factor%2520receptor%2520as%2520the%2520c-met%2520proto-oncogene%2520product%26jtitle%3DScience%26date%3D1991%26volume%3D251%26spage%3D802%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Naldini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weidner, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponzetto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narsimhan, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarnegar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalopoulos, G. K.</span><span> </span><span class="NLM_article-title">Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2867</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1991&pages=2867-78&author=L.+Naldiniauthor=K.+M.+Weidnerauthor=E.+Vignaauthor=G.+Gaudinoauthor=A.+Bardelliauthor=C.+Ponzettoauthor=R.+P.+Narsimhanauthor=G.+Hartmannauthor=R.+Zarnegarauthor=G.+K.+Michalopoulos&title=Scatter+factor+and+hepatocyte+growth+factor+are+indistinguishable+ligands+for+the+MET+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNaldini%26aufirst%3DL.%26aulast%3DWeidner%26aufirst%3DK.%2BM.%26aulast%3DVigna%26aufirst%3DE.%26aulast%3DGaudino%26aufirst%3DG.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DPonzetto%26aufirst%3DC.%26aulast%3DNarsimhan%26aufirst%3DR.%2BP.%26aulast%3DHartmann%26aufirst%3DG.%26aulast%3DZarnegar%26aufirst%3DR.%26aulast%3DMichalopoulos%26aufirst%3DG.%2BK.%26atitle%3DScatter%2520factor%2520and%2520hepatocyte%2520growth%2520factor%2520are%2520indistinguishable%2520ligands%2520for%2520the%2520MET%2520receptor%26jtitle%3DEMBO%2520J.%26date%3D1991%26volume%3D10%26spage%3D2867%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Longati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponzetto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naldini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span> </span><span class="NLM_article-title">Tyrosines 1234–1235 are critical for activation of the tyrosine kinase encoded by the MET protoocogene (HGF receptor)</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1994&pages=49-57&author=P.+Longatiauthor=A.+Bardelliauthor=C.+Ponzettoauthor=L.+Naldiniauthor=P.+M.+Comoglio&title=Tyrosines+1234%E2%80%931235+are+critical+for+activation+of+the+tyrosine+kinase+encoded+by+the+MET+protoocogene+%28HGF+receptor%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLongati%26aufirst%3DP.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DPonzetto%26aufirst%3DC.%26aulast%3DNaldini%26aufirst%3DL.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26atitle%3DTyrosines%25201234%25E2%2580%25931235%2520are%2520critical%2520for%2520activation%2520of%2520the%2520tyrosine%2520kinase%2520encoded%2520by%2520the%2520MET%2520protoocogene%2520%2528HGF%2520receptor%2529%26jtitle%3DOncogene%26date%3D1994%26volume%3D9%26spage%3D49%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span> </span><span class="NLM_article-title">Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">1511</span><span class="NLM_x">–</span> <span class="NLM_lpage">1519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2000&pages=1511-1519&author=T.+Nakamuraauthor=S.+Mizunoauthor=K.+Matsumotoauthor=Y.+Sawaauthor=H.+Matsudaauthor=T.+Nakamura&title=Myocardial+protection+from+ischemia%2Freperfusion+injury+by+endogenous+and+exogenous+HGF"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DMizuno%26aufirst%3DS.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DSawa%26aufirst%3DY.%26aulast%3DMatsuda%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DT.%26atitle%3DMyocardial%2520protection%2520from%2520ischemia%252Freperfusion%2520injury%2520by%2520endogenous%2520and%2520exogenous%2520HGF%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2000%26volume%3D106%26spage%3D1511%26epage%3D1519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Huh, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Factor, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Commer, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorgeirsson, S. S.</span><span> </span><span class="NLM_article-title">Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">4477</span><span class="NLM_x">–</span> <span class="NLM_lpage">4482</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=4477-4482&author=C.+G.+Huhauthor=V.+W.+Factorauthor=A.+Sanchezauthor=K.+Uchidaauthor=E.+A.+Commerauthor=S.+S.+Thorgeirsson&title=Hepatocyte+growth+factor%2Fc-met+signaling+pathway+is+required+for+efficient+liver+regeneration+and+repair"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuh%26aufirst%3DC.%2BG.%26aulast%3DFactor%26aufirst%3DV.%2BW.%26aulast%3DSanchez%26aufirst%3DA.%26aulast%3DUchida%26aufirst%3DK.%26aulast%3DCommer%26aufirst%3DE.%2BA.%26aulast%3DThorgeirsson%26aufirst%3DS.%2BS.%26atitle%3DHepatocyte%2520growth%2520factor%252Fc-met%2520signaling%2520pathway%2520is%2520required%2520for%2520efficient%2520liver%2520regeneration%2520and%2520repair%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D4477%26epage%3D4482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="note"><p class="first last">For reviews, see,</p></div><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sattler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy</span> <span class="citation_source-journal">Curr. Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1007%2Fs11912-007-0005-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=17288874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1GrurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=102-108&author=M.+Sattlerauthor=R.+Salgia&title=c-Met+and+hepatocyte+growth+factor%3A+potential+as+novel+targets+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy</span></div><div class="casAuthors">Sattler, Martin; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Current Oncology Reports</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">102-108</span>CODEN:
                <span class="NLM_cas:coden">CORUAT</span>;
        ISSN:<span class="NLM_cas:issn">1523-3790</span>.
    
            (<span class="NLM_cas:orgname">Current Science Inc.</span>)
        </div><div class="casAbstract">A review.  Receptor tyrosine kinases have come to fruition as therapeutic targets in a variety of malignancies.  In this group of targets, the c-Met receptor tyrosine kinase plays an important role in increased cell growth, reduced apoptosis, altered cytoskeletal function, increased metastasis, and other biol. changes.  The ligand for c-Met is hepatocyte growth factor (HGF), also known as scatter factor.  Met is overexpressed and mutated in a variety of malignancies, among which germline mutations are of particular interest.  Most mutations of Met have been found in the juxtamembrane, the tyrosine kinase, and the semaphorin domain.  Met gain-of-function mutations lead to deregulated or prolonged tyrosine kinase activity, which is instrumental to its transforming activity.  This review summarizes the biol. functions regulated by Met and its structural requirements as well as related developments in targeted therapy.  Treatment approaches, including antagonism of HGF binding to Met, targeting of RNA and the Met protein, and inhibition of the tyrosine kinase domain of Met, are highlighted.  Targeting of the HGF/Met pathway, alone or in combination with std. therapies, is likely to improve current therapies in Met-dependent malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfjcMNRn_47LVg90H21EOLACvtfcHk0lis1aW_-F1TrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1GrurY%253D&md5=8ae4f573341e51c23b8fdc11c609768c</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1007%2Fs11912-007-0005-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11912-007-0005-4%26sid%3Dliteratum%253Aachs%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3Dc-Met%2520and%2520hepatocyte%2520growth%2520factor%253A%2520potential%2520as%2520novel%2520targets%2520in%2520cancer%2520therapy%26jtitle%3DCurr.%2520Oncol.%2520Rep.%26date%3D2007%26volume%3D9%26spage%3D102%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mazzone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span> </span><span class="NLM_article-title">The Met pathway: master switch and drug target in cancer progression</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1611</span><span class="NLM_x">–</span> <span class="NLM_lpage">1621</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=1611-1621&author=M.+Mazzoneauthor=P.+M.+Comoglio&title=The+Met+pathway%3A+master+switch+and+drug+target+in+cancer+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMazzone%26aufirst%3DM.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26atitle%3DThe%2520Met%2520pathway%253A%2520master%2520switch%2520and%2520drug%2520target%2520in%2520cancer%2520progression%26jtitle%3DFASEB%2520J.%26date%3D2006%26volume%3D20%26spage%3D1611%26epage%3D1621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span> </span><span class="NLM_article-title">NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1111%2Fj.1349-7006.2003.tb01440.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=12824898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkslCnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2003&pages=321-327&author=K.+Matsumotoauthor=T.+Nakamura&title=NK4+%28HGF-antagonist%2Fangiogenesis+inhibitor%29+in+cancer+biology+and+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics</span></div><div class="casAuthors">Matsumoto, Kunio; Nakamura, Toshikazu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">321-327</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Japanese Cancer Association</span>)
        </div><div class="casAbstract">A review.  Invasion and subsequent establishment of metastasis are devastating events for patients with cancer, but past therapeutic approaches have paid relatively little attention to these important issues.  Hepatocyte growth factor (HGF) and its receptor, the c-Met tyrosine kinase, play roles in cancer invasion and metastasis in a wide variety of tumor cells.  Activation of the c-Met receptor integrates multiple signal transduction pathways involved in cell-cell and cell-matrix interactions, cellular migration, and breakdown of the extracellular scaffold.  Paracrine activation of the c-Met receptor by stromal-derived HGF mediates tumor-stromal interactions that facilitate invasion and metastasis.  Likewise, aberrant expression of the c-Met receptor and autocrine or mutational activation of c-Met receptor tyrosine kinase are closely assocd. with the progression of malignant tumors.  Based on this background, NK4, a competitive antagonist of HGF-c-Met assocn. was prepd. so as to block cancer invasion and metastasis.  NK4, an internal fragment of HGF, binds to but does not activate the c-Met receptor, thereby competitively antagonizing the biol. activities of HGF.  Unexpectedly, NK4 was subsequently shown to be an angiogenesis inhibitor as well, and this angioinhibitory activity is independent of its action as an HGF-antagonist.  Importantly, NK4 protein or NK4 gene therapy have been shown to inhibit tumor invasion, metastasis and angiogenesis, effectively converting malignant tumors into benign tumors.  Targeting tumor invasion-metastasis and angiogenesis with NK4 seems to have considerable therapeutic potential for cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4hjqCHWKtk7Vg90H21EOLACvtfcHk0lis1aW_-F1TrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkslCnsrs%253D&md5=e8a412995fd7960319604909d8b0a077</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2003.tb01440.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2003.tb01440.x%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DT.%26atitle%3DNK4%2520%2528HGF-antagonist%252Fangiogenesis%2520inhibitor%2529%2520in%2520cancer%2520biology%2520and%2520therapeutics%26jtitle%3DCancer%2520Sci.%26date%3D2003%26volume%3D94%26spage%3D321%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gherardi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G. F.</span><span> </span><span class="NLM_article-title">Met, metastasis, motility and more</span> <span class="citation_source-journal">Nature Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">915</span><span class="NLM_x">–</span> <span class="NLM_lpage">925</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1038%2Fnrm1261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=14685170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvFeju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=915-925&author=C.+Birchmeierauthor=W.+Birchmeierauthor=E.+Gherardiauthor=G.+F.+Vande+Woude&title=Met%2C+metastasis%2C+motility+and+more"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4dR"><div class="casContent"><span class="casTitleNuber">4d</span><div class="casTitle"><span class="NLM_cas:atitle">Met, metastasis, motility and more</span></div><div class="casAuthors">Birchmeier, Carmen; Birhcmeier, Walter; Gherardi, Ermanno; Vande Woude, George F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">915-925</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatocyte growth factor. scatter factor and its receptor, the tyrosine kinase Met, arose late in evolution and are unique to vertebrates.  In spite of this, Met uses mols. such as Gab1 - homologues of which are present in Caenorhabditis elegans and Drosophila melanogaster - for downstream signalling. Pivotal roles for Met in development and cancer have been established: Met controls cell migration and growth in embryogenesis; it also controls growth, invasion and metastasis in cancer cells; and activating Met mutations predispose to human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG_-6XRpZ-sLVg90H21EOLACvtfcHk0lis1aW_-F1TrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvFeju7s%253D&md5=ff5a02c73415784480c628fe65299a81</span></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1038%2Fnrm1261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1261%26sid%3Dliteratum%253Aachs%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DBirchmeier%26aufirst%3DW.%26aulast%3DGherardi%26aufirst%3DE.%26aulast%3DVande%2BWoude%26aufirst%3DG.%2BF.%26atitle%3DMet%252C%2520metastasis%252C%2520motility%2520and%2520more%26jtitle%3DNature%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2003%26volume%3D4%26spage%3D915%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">and references cited therein.</p></div><div class="NLM_citation" id="rightTab-cit4e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Trusolino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comoglio, P. M.</span><span> </span><span class="NLM_article-title">Scatter-factor and semaphorin receptors: cell signaling for invasive growth</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">300</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1038%2Fnrc779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=12001990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD38XivFGqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=289-300&author=L.+Trusolinoauthor=P.+M.+Comoglio&title=Scatter-factor+and+semaphorin+receptors%3A+cell+signaling+for+invasive+growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4eR"><div class="casContent"><span class="casTitleNuber">4e</span><div class="casTitle"><span class="NLM_cas:atitle">Scatter-factor and semaphorin receptors: cell signalling for invasive growth</span></div><div class="casAuthors">Trusolino, Livio; Comoglio, Paolo M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">289-300</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  Malignant disease occurs when neoplastic cells abandon their primary site of accretion, cross tissue boundaries and penetrate the vasculature to colonize distant sites.  This process - metastasis - is the aberrant counterpart of a physiol. program for organ regeneration and maintenance.  Scatter factors and semaphorins, together with their receptors, help to orchestrate this program.  What are the differences between physiol. and pathol. activation of these signalling mols., and can we exploit them therapeutically to prevent metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6w1EeLXg7ebVg90H21EOLACvtfcHk0lgdgcfoeFSU4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivFGqt7g%253D&md5=4a35b0df8816e69246b40e181370d5dc</span></div><a href="/servlet/linkout?suffix=cit4e&amp;dbid=16384&amp;doi=10.1038%2Fnrc779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc779%26sid%3Dliteratum%253Aachs%26aulast%3DTrusolino%26aufirst%3DL.%26aulast%3DComoglio%26aufirst%3DP.%2BM.%26atitle%3DScatter-factor%2520and%2520semaphorin%2520receptors%253A%2520cell%2520signaling%2520for%2520invasive%2520growth%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D289%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention</span> <span class="citation_source-journal">Cancer Lett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">225</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1016%2Fj.canlet.2004.09.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=15922853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Ggs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=225&publication_year=2005&pages=1-25&author=J.+Christensenauthor=J.+Burrowsauthor=R.+Salgia&title=c-Met+as+a+target+for+human+cancer+and+characterization+of+inhibitors+for+therapeutic+intervention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention</span></div><div class="casAuthors">Christensen, James G.; Burrows, Jon; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">225</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-26</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Receptor tyrosine kinase (RTK) targeted agents such as trastuzumab, Imatinib, bevacizumab, and gefitinib inhibitors have illustrated the utility of targeting this protein class for treatment of selected cancers.  A unique member of the RTK family, c-Met, also represents an intriguing target for cancer therapy that is yet to be explored in a clin. setting.  The proto-oncogene, c-Met, encodes the high-affinity receptor for hepatocyte growth factor (HGF) or scatter factor (SF).  C-Met and HGF are each required for normal mammalian development and have been shown to be particularly important in cell migration, morphogenic differentiation, and organization of three-dimensional tubular structures (e.g. renal tubular cells, gland formation, etc.) as well as cell growth and angiogenesis.  Both c-Met and HGF have been shown to be deregulated in and to correlate with poor prognosis in a no. of major human cancers.  New data describing the constitutive phosphorylation of c-Met in a no. of human tumors is presented here along with a variety of mechanisms by which c-Met can become activated, including mutation and gene amplification.  In support of the clin. data implicating c-Met activation in the pathogenesis of human cancers, introduction of c-Met and HGF (or mutant c-Met) into cells conferred the properties of motility, invasiveness, and tumorigenicity to the transformed cells.  Conversely, the inhibition of c-Met with a variety of receptor antagonists inhibited the motility, invasiveness, and tumorigenicity of human tumor cell lines.  Consistent with this observation, small-mol. inhibitors of c-Met were developed that antagonized c-Met/HGF-dependent phenotypes and tumor growth in mouse models.  This review will address the potential for development of c-Met inhibitors for treatment of human cancers with particular emphasis on recent findings with small-mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojTbSn0ouMILVg90H21EOLACvtfcHk0lgdgcfoeFSU4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Ggs7c%253D&md5=106b145cbf442e9fec9667817697658d</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2004.09.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2004.09.044%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3Dc-Met%2520as%2520a%2520target%2520for%2520human%2520cancer%2520and%2520characterization%2520of%2520inhibitors%2520for%2520therapeutic%2520intervention%26jtitle%3DCancer%2520Lett%26date%3D2005%26volume%3D225%26spage%3D1%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dussault, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jun, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T. L.</span><span> </span><span class="NLM_article-title">HGF- and c-Met-targeted drugs: hopes, challenges and their future in cancer therapy</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">819</span><span class="NLM_x">–</span> <span class="NLM_lpage">825</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1358%2Fdof.2006.031.09.1026670" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVKnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=819-825&author=I.+Dussaultauthor=P.+Kaplan-Lefkoauthor=T.+Junauthor=A.+Coxonauthor=T.+L.+Burgess&title=HGF-+and+c-Met-targeted+drugs%3A+hopes%2C+challenges+and+their+future+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">HGF- and c-Met-targeted drugs: hopes, challenges and their future in cancer therapy</span></div><div class="casAuthors">Dussault, Isabelle; Kaplan-Lefko, Paula; Jun, Tani; Coxon, Angela; Burgess, Teresa L.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">819-825</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Cancer remains a formidable disease, with 1,372,910 new cases and 570,280 deaths in the United States alone in 2005 (http://www.cancer.org/docroot/stt/stt_0.asp).  Many types of cancers are still difficult to treat using conventional therapies.  For example, chemotherapeutic drugs are widely used, but their side effects can be devastating to the quality of life of patients and their efficacy is limited in late-stage cancers.  Therefore, efforts have been undertaken for the past several years to develop targeted drugs in the hope of improving efficacy and tolerability.  As these new drugs are starting to make their mark in the clinic, what can we expect in the future with anticancer drugs.  Already we are seeing the benefits of targeted therapies, different drug modalities, including antibodies, and more convenient forms of drug delivery.  Moreover, much attention is now being placed not only on attacking the cancer cells themselves, but also on intervening in the microenvironment in which they reside.  In this review, we will discuss the promise behind novel targeted therapies under development to inhibit signaling via the oncogenic HGF/c-Met pathway.  HGF and c-Met are exciting therapeutic targets that play important roles both directly in tumor cells and in the tumor microenvironment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz1H3RCrcur7Vg90H21EOLACvtfcHk0lgdgcfoeFSU4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVKnuw%253D%253D&md5=014dca5910768abf2478b0c7a6a29169</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1358%2Fdof.2006.031.09.1026670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2006.031.09.1026670%26sid%3Dliteratum%253Aachs%26aulast%3DDussault%26aufirst%3DI.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%26aulast%3DJun%26aufirst%3DT.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DBurgess%26aufirst%3DT.%2BL.%26atitle%3DHGF-%2520and%2520c-Met-targeted%2520drugs%253A%2520hopes%252C%2520challenges%2520and%2520their%2520future%2520in%2520cancer%2520therapy%26jtitle%3DDrugs%2520Future%26date%3D2006%26volume%3D31%26spage%3D819%26epage%3D825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Abidoye, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murukurthy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">Review of clinic trials: agents targeting c-Met</span> <span class="citation_source-journal">Rev. Recent Clin. Trials</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.2174%2F157488707780599357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=18473999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXms1Oisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=143-147&author=O.+Abidoyeauthor=N.+Murukurthyauthor=R.+Salgia&title=Review+of+clinic+trials%3A+agents+targeting+c-Met"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Review of clinic trials: agents targeting c-Met</span></div><div class="casAuthors">Abidoye, Oyewale; Murukurthy, Nadh; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Reviews on Recent Clinical Trials</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-147</span>CODEN:
                <span class="NLM_cas:coden">RRCTB2</span>;
        ISSN:<span class="NLM_cas:issn">1574-8871</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Receptor tyrosine kinases are a group of mols. that can enhance cellular proliferation, cell motility and migration, and eventual metastasis.  C-Met receptor tyrosine kinase has a significant biol. and biochem. effect on cancer cells, and appears to be an important therapeutic target.  In many cancers, c-Met (which can be activated by its ligand hepatocyte growth factor, HGF) can be overexpressed, activated, amplified, and/or mutated.  The mutations of c-Met had initially been described in the tyrosine kinase domain, and we have described them in other "hot-spots" such as the juxtamembrane and semaphorin domains.  Targeting c-Met has been very fruitful pre-clin., and currently, there are several clin. trials for advanced cancers.  Described in this review are some of the biol. and biochem. aspects of c-Met, and detailed are a no. of therapeutic strategies.  With our understanding of c-Met biol. and role in cancer, we should be able to arrive at a unique strategy to eradicate cancers in which c-Met plays a significant role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdmIx_p1ud1rVg90H21EOLACvtfcHk0lgwpr2FtOOUmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXms1Oisrk%253D&md5=2478f449b80738346560c666d4899404</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.2174%2F157488707780599357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157488707780599357%26sid%3Dliteratum%253Aachs%26aulast%3DAbidoye%26aufirst%3DO.%26aulast%3DMurukurthy%26aufirst%3DN.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3DReview%2520of%2520clinic%2520trials%253A%2520agents%2520targeting%2520c-Met%26jtitle%3DRev.%2520Recent%2520Clin.%2520Trials%26date%3D2007%26volume%3D2%26spage%3D143%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Eder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vande Woude, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boerner, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoRusso, P. M.</span><span> </span><span class="NLM_article-title">Novel therapeutic inhibitors of the c-Met signaling pathway in cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2207</span><span class="NLM_x">–</span> <span class="NLM_lpage">2214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1158%2F1078-0432.CCR-08-1306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=19318488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvVWltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=2207-2214&author=J.+P.+Ederauthor=G.+F.+Vande+Woudeauthor=S.+A.+Boernerauthor=P.+M.+LoRusso&title=Novel+therapeutic+inhibitors+of+the+c-Met+signaling+pathway+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer</span></div><div class="casAuthors">Eder, Joseph Paul; Vande Woude, George F.; Boerner, Scott A.; Lo Russo, Patricia M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2207-2214</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  A wide variety of human malignancies exhibit sustained c-Met stimulation, overexpression, or mutation, including carcinomas of the breast, liver, lung, ovary, kidney, and thyroid.  Notably, activating mutations in c-Met have been pos. identified in patients with a particular hereditary form of papillary renal cancer, directly implicating c-Met in human tumorigenesis.  Aberrant signaling of the c-Met signaling pathway due to dysregulation of the c-Met receptor or overexpression of its ligand, hepatocyte growth factor (HGF), has been assocd. with an aggressive phenotype.  Extensive evidence that c-Met signaling is involved in the progression and spread of several cancers and an enhanced understanding of its role in disease have generated considerable interest in c-Met and HGF as major targets in cancer drug development.  This has led to the development of a variety of c-Met pathway antagonists with potential clin. applications.  The three main approaches of pathway-selective anticancer drug development have included antagonism of ligand/receptor interaction, inhibition of the tyrosine kinase catalytic activity, and blockade of the receptor/effector interaction.  Several c-Met antagonists are now under clin. investigation.  Preliminary clin. results of several of these agents, including both monoclonal antibodies and small-mol. tyrosine kinase inhibitors, have been encouraging.  Several multitargeted therapies have also been under investigation in the clinic and have demonstrated promise, particularly with regard to tyrosine kinase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9QBC0vQz8BrVg90H21EOLACvtfcHk0lgwpr2FtOOUmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvVWltrY%253D&md5=48b4fc788b2b2cab1ce523047e33721d</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-1306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-1306%26sid%3Dliteratum%253Aachs%26aulast%3DEder%26aufirst%3DJ.%2BP.%26aulast%3DVande%2BWoude%26aufirst%3DG.%2BF.%26aulast%3DBoerner%26aufirst%3DS.%2BA.%26aulast%3DLoRusso%26aufirst%3DP.%2BM.%26atitle%3DNovel%2520therapeutic%2520inhibitors%2520of%2520the%2520c-Met%2520signaling%2520pathway%2520in%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D2207%26epage%3D2214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cui, J. J.</span><span> </span><span class="NLM_article-title">Inhibitors targeting hepatocyte growth factor receptor and their potential therapeutic applications</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1045</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1517%2F13543776.17.9.1035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSgtL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1035-1045&author=J.+J.+Cui&title=Inhibitors+targeting+hepatocyte+growth+factor+receptor+and+their+potential+therapeutic+applications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors targeting hepatocyte growth factor receptor and their potential therapeutic applications</span></div><div class="casAuthors">Cui, Jingrong Jean</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1035-1045</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The hepatocyte growth factor (HGF)/c-Met signaling pathway is important in mediating a wide range of biol. activities, including embryol. development, wound healing, tissue regeneration, angiogenesis, proliferation, survival, scattering, motility, invasion and morphogenic differentiation.  HGF and/or c-Met are expressed at abnormally high levels in a large variety of solid tumors.  Various c-Met mutations have been described in many solid tumors and some hematol. malignancies.  Therefore, inhibition of the HGF/c-Met signaling pathway has great potential in mol. targeted cancer therapy.  Many patent applications assocd. with inhibition of the HGF/c-Met axis have been published in the past few years.  There are four small mol. c-Met inhibitors presently in clin. trials.  This review focuses on recent patent applications for small mol. c-Met inhibitors and their potential applications in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwCxL0QxmH-LVg90H21EOLACvtfcHk0lgwpr2FtOOUmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSgtL7P&md5=11d01e76a70de95edd486293fd94b62d</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1517%2F13543776.17.9.1035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.17.9.1035%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26atitle%3DInhibitors%2520targeting%2520hepatocyte%2520growth%2520factor%2520receptor%2520and%2520their%2520potential%2520therapeutic%2520applications%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2007%26volume%3D17%26spage%3D1035%26epage%3D1045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Porter, J.</span><span> </span><span class="NLM_article-title">Small molecule c-Met kinase inhibitors: a review of recent patents</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1517%2F13543770903514137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=20100000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=159-177&author=J.+Porter&title=Small+molecule+c-Met+kinase+inhibitors%3A+a+review+of+recent+patents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule c-Met kinase inhibitors: a review of recent patents</span></div><div class="casAuthors">Porter, John</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-177</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: c-Met kinase is the receptor for hepatocyte growth factor.  Primarily expressed on epithelial and mesenchymal cells its normal function is assocd. with wound healing, liver regeneration and embryo development.  However, dysregulation of c-Met through overexpression, gene amplification, mutation or a ligand-dependent autocrine/paracrine loop is assocd. with tumorigenesis.  C-Met dysregulation in human cancer patients is typically assocd. with a poor prognosis, aggressive disease, increased metastasis and shortened patient survival.  Targeting the hepatocyte growth factor/c-Met signaling pathway as a means of cancer therapy has, therefore, become increasingly popular with a no. of different therapeutic approaches undergoing clin. trials.  Areas covered by this review: This review covers the patent applications for small mol.  C-Met kinase inhibitors since 2007, attempts to place them in context from a structural point of view and examines their potential applications in cancer therapy.  What the reader will gain: Readers will gain an overview of the structural types of c-Met inhibitors, the major players in the field and an insight into what is progressing into the clinic.  Take home message: This area is developing rapidly and the results of the various ongoing clin. trials will generate an increased understanding of the potential benefits and pitfalls of c-Met inhibitors as therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqJq_0dMgMLLVg90H21EOLACvtfcHk0lgwpr2FtOOUmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGktb8%253D&md5=eac531f4b57558e8d5d51a008cc0c629</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1517%2F13543770903514137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903514137%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DJ.%26atitle%3DSmall%2520molecule%2520c-Met%2520kinase%2520inhibitors%253A%2520a%2520review%2520of%2520recent%2520patents%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D159%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Schroeder, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, L. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullo-Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeyaseelan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manne, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppenheimer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1251</span><span class="NLM_x">–</span> <span class="NLM_lpage">1254</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801586s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1251-1254&author=G.+M.+Schroederauthor=Y.+Anauthor=Z.-W.+Caiauthor=X.-T.+Chenauthor=C.+Clarkauthor=L.+A.+M.+Corneliusauthor=J.+Daiauthor=J.+Gullo-Brownauthor=A.+Guptaauthor=B.+Henleyauthor=J.+T.+Huntauthor=R.+Jeyaseelanauthor=A.+Kamathauthor=K.+Kimauthor=J.+Lippyauthor=L.+J.+Lombardoauthor=V.+Manneauthor=S.+Oppenheimerauthor=J.+S.+Sackauthor=R.+J.+Schmidtauthor=G.+Shenauthor=K.+Stefanskiauthor=J.+S.+Tokarskiauthor=G.+L.+Trainorauthor=B.+S.+Wautletauthor=D.+Weiauthor=D.+K.+Williamsauthor=Y.+Zhangauthor=Y.+Zhangauthor=J.+Fargnoliauthor=R.+M.+Borzilleri&title=Discovery+of+N-%284-%282-Amino-3-chloropyridin-4-yloxy%29-3-fluorophenyl%29-4-ethoxy-1-%284-fluorophenyl%29-2-oxo-1%2C2-dihydropyridine-3-carboxamide+%28BMS-777607%29%2C+a+selective+and+orally+efficacious+inhibitor+of+the+Met+kinase+superfamily"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm801586s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801586s%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeder%26aufirst%3DG.%2BM.%26aulast%3DAn%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DZ.-W.%26aulast%3DChen%26aufirst%3DX.-T.%26aulast%3DClark%26aufirst%3DC.%26aulast%3DCornelius%26aufirst%3DL.%2BA.%2BM.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DGullo-Brown%26aufirst%3DJ.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DHenley%26aufirst%3DB.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DJeyaseelan%26aufirst%3DR.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DLippy%26aufirst%3DJ.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DManne%26aufirst%3DV.%26aulast%3DOppenheimer%26aufirst%3DS.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DSchmidt%26aufirst%3DR.%2BJ.%26aulast%3DShen%26aufirst%3DG.%26aulast%3DStefanski%26aufirst%3DK.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26aulast%3DWautlet%26aufirst%3DB.%2BS.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DD.%2BK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520of%2520N-%25284-%25282-Amino-3-chloropyridin-4-yloxy%2529-3-fluorophenyl%2529-4-ethoxy-1-%25284-fluorophenyl%2529-2-oxo-1%252C2-dihydropyridine-3-carboxamide%2520%2528BMS-777607%2529%252C%2520a%2520selective%2520and%2520orally%2520efficacious%2520inhibitor%2520of%2520the%2520Met%2520kinase%2520superfamily%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1251%26epage%3D1254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Norman, M. H.; Liu, L.; Lee, M.; Xi, N.; Fellows, I.; D’Angelo, N.; Dominguez, C.; Rex, R.; Bellon, S. F.; Kim, T.-S.; Dussault, I.</span><span> </span><span class="NLM_article-title">Structure-based design of novel class II c-Met inhibitors: 1. Identification of pyrazolone-based derivatives</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span>DOI <span class="refDoi"> DOI: 10.1021/jm201330u</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm201330u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+H.+Norman&author=L.+Liu&author=M.+Lee&author=N.+Xi&author=I.+Fellows&author=N.+D%E2%80%99Angelo&author=C.+Dominguez&author=R.+Rex&author=S.+F.+Bellon&author=T.-S.+Kim&author=I.+Dussault&title=Structure-based+design+of+novel+class+II+c-Met+inhibitors%3A+1.+Identification+of+pyrazolone-based+derivatives&doi=10.1021%2Fjm201330u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm201330u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201330u%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DM.%2BH.%26atitle%3DStructure-based%2520design%2520of%2520novel%2520class%2520II%2520c-Met%2520inhibitors%253A%25201.%2520Identification%2520of%2520pyrazolone-based%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26doi%3D10.1021%2Fjm201330u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><div class="note"><p class="first last">For the work leading to a clinical candidate based on pyrazolones, see,</p></div><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegmund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimaanovich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T.-S.</span><span> </span><span class="NLM_article-title">Discovery of 1-(2-hydroxy-2-methylpropyl)-<i>N</i>-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (AMG 458): a potent, selective, and orally bioavailable c-Met Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3688</span><span class="NLM_x">–</span> <span class="NLM_lpage">3691</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800401t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3688-3691&author=L.+Liuauthor=A.+Siegmundauthor=N.+Xiauthor=P.+Kaplan-Lefkoauthor=K.+Rexauthor=A.+Chenauthor=J.+Linauthor=J.+Moriguchiauthor=L.+Berryauthor=L.+Huangauthor=Y.+Tefferaauthor=Y.+Yangauthor=Y.+Zhangauthor=S.+F.+Bellonauthor=M.+Leeauthor=R.+Shimaanovichauthor=A.+Bakauthor=C.+Dominguezauthor=M.+Normanauthor=J.+C.+Harmangeauthor=I.+Dussaultauthor=T.-S.+Kim&title=Discovery+of+1-%282-hydroxy-2-methylpropyl%29-N-%285-%287-methoxyquinolin-4-yloxy%29pyridin-2-yl%29-5-methyl-3-oxo-2-phenyl-2%2C3-dihydro-1H-pyrazole-4-carboxamide+%28AMG+458%29%3A+a+potent%2C+selective%2C+and+orally+bioavailable+c-Met+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm800401t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800401t%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSiegmund%26aufirst%3DA.%26aulast%3DXi%26aufirst%3DN.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DMoriguchi%26aufirst%3DJ.%26aulast%3DBerry%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DShimaanovich%26aufirst%3DR.%26aulast%3DBak%26aufirst%3DA.%26aulast%3DDominguez%26aufirst%3DC.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26aulast%3DDussault%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DT.-S.%26atitle%3DDiscovery%2520of%25201-%25282-hydroxy-2-methylpropyl%2529-N-%25285-%25287-methoxyquinolin-4-yloxy%2529pyridin-2-yl%2529-5-methyl-3-oxo-2-phenyl-2%252C3-dihydro-1H-pyrazole-4-carboxamide%2520%2528AMG%2520458%2529%253A%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520c-Met%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3688%26epage%3D3691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Dussault, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S. F.</span><span> </span><span class="NLM_article-title">From concept to reality: the long road to c-Met and RON receptor tyrosine kinase inhibitors for the treatment of cancer</span> <span class="citation_source-journal">Anti-Cancer Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=221-229&author=I.+Dussaultauthor=S.+F.+Bellon&title=From+concept+to+reality%3A+the+long+road+to+c-Met+and+RON+receptor+tyrosine+kinase+inhibitors+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDussault%26aufirst%3DI.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26atitle%3DFrom%2520concept%2520to%2520reality%253A%2520the%2520long%2520road%2520to%2520c-Met%2520and%2520RON%2520receptor%2520tyrosine%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D221%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ronsin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muscatelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattei, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breathnach, R.</span><span> </span><span class="NLM_article-title">A novel putative receptor protein tyrosine kinase of the met family</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1195</span><span class="NLM_x">–</span> <span class="NLM_lpage">1202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1993&pages=1195-1202&author=C.+Ronsinauthor=F.+Muscatelliauthor=M.+G.+Matteiauthor=R.+Breathnach&title=A+novel+putative+receptor+protein+tyrosine+kinase+of+the+met+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRonsin%26aufirst%3DC.%26aulast%3DMuscatelli%26aufirst%3DF.%26aulast%3DMattei%26aufirst%3DM.%2BG.%26aulast%3DBreathnach%26aufirst%3DR.%26atitle%3DA%2520novel%2520putative%2520receptor%2520protein%2520tyrosine%2520kinase%2520of%2520the%2520met%2520family%26jtitle%3DOncogene%26date%3D1993%26volume%3D8%26spage%3D1195%26epage%3D1202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="note"><p class="first last">Complete kinase selectivity profile of compound <b>1</b> is available in the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Baka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clamp, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayson, G. C.</span><span> </span><span class="NLM_article-title">A review of the latest clinical compounds to inhibit VEGF in pathological angiogenesis</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">876</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1517%2F14728222.10.6.867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=17105373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Smt7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=867-876&author=S.+Bakaauthor=A.+R.+Clampauthor=G.+C.+Jayson&title=A+review+of+the+latest+clinical+compounds+to+inhibit+VEGF+in+pathological+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the latest clinical compounds to inhibit VEGF in pathological angiogenesis</span></div><div class="casAuthors">Baka, Sofia; Clamp, Andrew R.; Jayson, Gordon C.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">867-876</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Angiogenesis plays an important role in the formation of new blood vessels and is crucial for tumor development and progression.  Imbalance between pro- and antiangiogenesis factors regulates the biol. process of angiogenesis.  The best characterized of the proangiogenic factors and the most potent is vascular endothelial growth factor (VEGF).  The binding of VEGF to one of its transmembrane tyrosine kinase receptors, which are predominantly found on endothelial cells, results in receptor dimerization, activation and autophosphorylation of the tyrosine kinase domain.  This triggers a cascade of complex downstream signalling pathways.  Several strategies targeting the VEGF signalling pathway have been developed.  These include neutralizing antibodies to VEGF (bevacizumab) or VEGF receptors (VEGFRs) (DC101), sol. VEGFR/VEGFR hybrids (VEGF-Trap), and tyrosine kinase inhibitors of VEGFRs (BAY43-9006, SU11248, ZD6474, AZD2171, PTK/ZK and others).  Several of these agents are now being investigated in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozY3D8lNZOqLVg90H21EOLACvtfcHk0ljBotmvIRy_gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Smt7zO&md5=3cba31f6365fd5ef2749fe401c4a0406</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1517%2F14728222.10.6.867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.10.6.867%26sid%3Dliteratum%253Aachs%26aulast%3DBaka%26aufirst%3DS.%26aulast%3DClamp%26aufirst%3DA.%2BR.%26aulast%3DJayson%26aufirst%3DG.%2BC.%26atitle%3DA%2520review%2520of%2520the%2520latest%2520clinical%2520compounds%2520to%2520inhibit%2520VEGF%2520in%2520pathological%2520angiogenesis%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2006%26volume%3D10%26spage%3D867%26epage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gasparini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, N.</span><span> </span><span class="NLM_article-title">Angiogenic inhibitors: a new therapeutic strategy in oncology</span> <span class="citation_source-journal">Nature Clin. Pract. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">562</span><span class="NLM_x">–</span> <span class="NLM_lpage">577</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1038%2Fncponc0342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=16270097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Ghu77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=562-577&author=G.+Gaspariniauthor=R.+Longoauthor=M.+Toiauthor=N.+Ferrara&title=Angiogenic+inhibitors%3A+a+new+therapeutic+strategy+in+oncology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenic inhibitors: a new therapeutic strategy in oncology</span></div><div class="casAuthors">Gasparini, Giampietro; Longo, Raffaele; Toi, Masakazu; Ferrara, Napoleone</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">562-577</span>CODEN:
                <span class="NLM_cas:coden">NCPOB5</span>;
        ISSN:<span class="NLM_cas:issn">1743-4254</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Angiogenesis is a multistep, complex and tightly regulated process that is necessary for tumor growth and metastasis.  Based on data of preclin. models, several antiangiogenic compds. has been shown to modify activated tumor endothelium, which suggests that these compds. can improve cytotoxic drug delivery.  Such agents have entered clin. trials as single agents or in combination with cytotoxic drugs, and have shown promising antitumor activity.  The pharmacodynamic and pharmacokinetic characteristics of antiangiogenic drugs are reviewed here.  Most of the early clin. testing of these agents was conducted in patients with advanced disease resistant to std. therapies.  Phase III trials compared the efficacy of std. chemotherapy alone with std. chemotherapy in combination with an exptl. angiogenesis inhibitor.  Although some of these studies were neg. or controversial, recent studies validated in large clin. trials with an anti-vascular endothelial growth factor antibody demonstrated significant clin. benefit and renewed enthusiasm for this therapeutic strategy.  This review describes the clin. studies of antiangiogenic agents and highlights the challenges related to choosing appropriate strategies for the selection of patients, study design and choice of appropriate endpoints for the studies' development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomP2ZoMwl49LVg90H21EOLACvtfcHk0ljBotmvIRy_gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Ghu77F&md5=5773a1514b2331de7cf2450fb27bd0a5</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1038%2Fncponc0342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncponc0342%26sid%3Dliteratum%253Aachs%26aulast%3DGasparini%26aufirst%3DG.%26aulast%3DLongo%26aufirst%3DR.%26aulast%3DToi%26aufirst%3DM.%26aulast%3DFerrara%26aufirst%3DN.%26atitle%3DAngiogenic%2520inhibitors%253A%2520a%2520new%2520therapeutic%2520strategy%2520in%2520oncology%26jtitle%3DNature%2520Clin.%2520Pract.%2520Oncol.%26date%3D2005%26volume%3D2%26spage%3D562%26epage%3D577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rochester, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedemann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellawell, G. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brewster, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macaulay, V. M.</span><span> </span><span class="NLM_article-title">Silencing of the IGF-1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer</span> <span class="citation_source-journal">Cancer Gene Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1038%2Fsj.cgt.7700775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=15499378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOht77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=90-100&author=M.+A.+Rochesterauthor=J.+Riedemannauthor=G.+O.+Hellawellauthor=S.+F.+Brewsterauthor=V.+M.+Macaulay&title=Silencing+of+the+IGF-1R+gene+enhances+sensitivity+to+DNA-damaging+agents+in+both+PTEN+wild-type+and+mutant+human+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer</span></div><div class="casAuthors">Rochester, Mark A.; Riedemann, Johann; Hellawell, Giles O.; Brewster, Simon F.; Macaulay, Valentine M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Gene Therapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-100</span>CODEN:
                <span class="NLM_cas:coden">CGTHEG</span>;
        ISSN:<span class="NLM_cas:issn">0929-1903</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The type 1 insulin-like growth factor receptor (IGF1R) is overexpressed in prostate cancer, and mediates proliferation, motility, and survival.  Many prostate cancers harbor inactivating PTEN mutations, enhancing Akt phosphorylation.  This activates the principal anti-apoptotic pathway downstream of the IGF1R, calling into question the value of IGF1R targeting in this tumor.  The aim of the current study was to assess the effect of IGF1R gene silencing in prostate cancer cells that lack functional PTEN protein.  In human DU145, LNCaP and PC3 prostate cancer cells, transfection with IGF1R small interfering RNA induced significant enhancement of apoptosis and inhibition of survival, not only in PTEN wild-type DU145 but also in PTEN mutant LNCaP and PC3.  This was attributed to attenuation of IGF signaling via Akt, ERKs and p38.  In both DU145 and PC3, IGF1R knockdown led to enhancement of sensitivity to mitoxantrone, etoposide, nitrogen mustard and ionizing radiation.  There was no sensitization to paclitaxel or 5-fluorouracil, which do not damage DNA, suggesting that chemosensitization results from impairment of the DNA damage response, in addn. to removal of apoptosis protection.  These results support the concept of IGF1R targeting in prostate cancer, and indicate that PTEN loss does not render tumor cells refractory to this strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgLDxqQOHN3bVg90H21EOLACvtfcHk0ljBotmvIRy_gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOht77O&md5=765655d6a8ef655355355fd1f9927130</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1038%2Fsj.cgt.7700775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cgt.7700775%26sid%3Dliteratum%253Aachs%26aulast%3DRochester%26aufirst%3DM.%2BA.%26aulast%3DRiedemann%26aufirst%3DJ.%26aulast%3DHellawell%26aufirst%3DG.%2BO.%26aulast%3DBrewster%26aufirst%3DS.%2BF.%26aulast%3DMacaulay%26aufirst%3DV.%2BM.%26atitle%3DSilencing%2520of%2520the%2520IGF-1R%2520gene%2520enhances%2520sensitivity%2520to%2520DNA-damaging%2520agents%2520in%2520both%2520PTEN%2520wild-type%2520and%2520mutant%2520human%2520prostate%2520cancer%26jtitle%3DCancer%2520Gene%2520Ther.%26date%3D2005%26volume%3D12%26spage%3D90%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Baserga, R.</span><span> </span><span class="NLM_article-title">The insulin-like growth factor-1 receptor as a target for cancer therapy</span> <span class="citation_source-journal">Expert. Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1517%2F14728222.9.4.753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=16083341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFels7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2005&pages=753-768&author=R.+Baserga&title=The+insulin-like+growth+factor-1+receptor+as+a+target+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">The insulin-like growth factor-I receptor as a target for cancer therapy</span></div><div class="casAuthors">Baserga, Renato</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">753-768</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">This review examines the rationale for targeting the insulin-like growth factor (IGF)-I receptor in the therapy of human tumors and their metastases.  The rationale is based on two crucial findings: (1) in exptl. animals, normal cells are only partially affected by the deletion of the IGF-I receptor, whereas tumor cells undergo apoptosis when the IGF-I receptor is downregulated; and (2) cells with a deleted IGF-I receptor are refractory to transformation by viral and cellular oncogenes.  This review focuses on the mechanisms underlying the exptl. findings, and discusses the possibility of extrapolating the results obtained in animals to the cure of human tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOpjOKN3IsjbVg90H21EOLACvtfcHk0lh_kTrQRt2_pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFels7w%253D&md5=f07d91258f90130e9cb023e9d7a79e03</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1517%2F14728222.9.4.753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.9.4.753%26sid%3Dliteratum%253Aachs%26aulast%3DBaserga%26aufirst%3DR.%26atitle%3DThe%2520insulin-like%2520growth%2520factor-1%2520receptor%2520as%2520a%2520target%2520for%2520cancer%2520therapy%26jtitle%3DExpert.%2520Opin.%2520Ther.%2520Targets%26date%3D2005%26volume%3D9%26spage%3D753%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Miller, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee, D.</span><span> </span><span class="NLM_article-title">Type I insulin-like growth factor receptor as a therapeutic target in cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">10123</span><span class="NLM_x">–</span> <span class="NLM_lpage">10127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=10123-10127&author=B.+S.+Millerauthor=D.+Yee&title=Type+I+insulin-like+growth+factor+receptor+as+a+therapeutic+target+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DB.%2BS.%26aulast%3DYee%26aufirst%3DD.%26atitle%3DType%2520I%2520insulin-like%2520growth%2520factor%2520receptor%2520as%2520a%2520therapeutic%2520target%2520in%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D10123%26epage%3D10127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ueda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatsuse1, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawarabayashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takigawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morita, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukatsu1, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsubara, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, H.</span><span> </span><span class="NLM_article-title">Potential crosstalk between insulin-like growth factor receptor type 1 and epidermal growth factor receptor in progression and metastasis of pancreatic cancer</span> <span class="citation_source-journal">Mod. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">788</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=8&amp;doi=10.1021%2Fjm201331s&amp;key=16575403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkslelsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2006&pages=788-796&author=S.+Uedaauthor=K.+Hatsuse1author=H.+Tsudaauthor=S.+Ogataauthor=N.+Kawarabayashiauthor=T.+Takigawaauthor=T.+Einamaauthor=D.+Moritaauthor=K.+Fukatsu1author=Y.+Sugiuraauthor=O.+Matsubaraauthor=H.+Mochizuki&title=Potential+crosstalk+between+insulin-like+growth+factor+receptor+type+1+and+epidermal+growth+factor+receptor+in+progression+and+metastasis+of+pancreatic+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14dR"><div class="casContent"><span class="casTitleNuber">14d</span><div class="casTitle"><span class="NLM_cas:atitle">Potential crosstalk between insulin-like growth factor receptor type 1 and epidermal growth factor receptor in progression and metastasis of pancreatic cancer</span></div><div class="casAuthors">Ueda, Shigeto; Hatsuse, Kazuo; Tsuda, Hitoshi; Ogata, Sho; Kawarabayashi, Nobuaki; Takigawa, Toshimichi; Einama, Takahiro; Morita, Daisaku; Fukatsu, Kazuhiko; Sugiura, Yoshiaki; Matsubara, Osamu; Mochizuki, Hidetaka</div><div class="citationInfo"><span class="NLM_cas:title">Modern Pathology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">788-796</span>CODEN:
                <span class="NLM_cas:coden">MODPEO</span>;
        ISSN:<span class="NLM_cas:issn">0893-3952</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The insulin-like growth factor receptor type 1 (IGF1R) and epidermal growth factor receptor (EGFR) are reportedly overexpressed in pancreatic cancer.  However, the correlation between activated EGFR and IGF1R and their clinicopathol. implications still remain unclear.  The cellular localization and overexpression of IGF1R and EGFR were investigated immunohistochem. in primary invasive ductal pancreatic carcinomas obtained from 74 patients who underwent radical surgical resection.  We also compared the status of IGF1R and EGFR overexpression between primary tumors and hepatic metastatic tumors obtained from 44 autopsied patients.  Among the 74 surgically resected primary tumors, cytoplasm- and membrane-dominant EGFR overexpression was detected in 22 (30%) and 7 (9%), resp., whereas cytoplasm- and membrane-dominant IGF1R overexpression was detected in 8 (11%) and 28 (38%), resp.  Membrane-dominant EGFR and cytoplasm-dominant IGF1R were more frequent in lower-grade tumors and correlated with favorable prognosis, whereas cytoplasm-dominant EGFR and membrane-dominant IGF1R were more frequent in higher-grade tumors and correlated with poor prognosis.  In 36 autopsy specimens of pancreatic tumor with concurrent overexpression of IGF1R and EGFR, there was an inverse correlation between the IGF1R and EGFR localization patterns (P=0.001).  In the hepatic metastatic tumors obtained by autopsy, the incidences of both IGF1R and EGFR overexpression were much higher than in the surgically resected primary tumors.  More than half of the autopsy cases consistently showed membrane-dominant EGFR expression in both the primary tumor and hepatic metastases, whereas IGF1R expression showed considerable variation.  Crosstalk between differently localized IGF1R and EGFR might play a role in detg. the biol. aggressiveness of pancreatic cancer, although their cellular localization may often alter during the process of metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom6sA2tMHEabVg90H21EOLACvtfcHk0lh_kTrQRt2_pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkslelsr4%253D&md5=7ac42fec7836d17ba52dc22028854ee9</span></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DS.%26aulast%3DHatsuse1%26aufirst%3DK.%26aulast%3DTsuda%26aufirst%3DH.%26aulast%3DOgata%26aufirst%3DS.%26aulast%3DKawarabayashi%26aufirst%3DN.%26aulast%3DTakigawa%26aufirst%3DT.%26aulast%3DEinama%26aufirst%3DT.%26aulast%3DMorita%26aufirst%3DD.%26aulast%3DFukatsu1%26aufirst%3DK.%26aulast%3DSugiura%26aufirst%3DY.%26aulast%3DMatsubara%26aufirst%3DO.%26aulast%3DMochizuki%26aufirst%3DH.%26atitle%3DPotential%2520crosstalk%2520between%2520insulin-like%2520growth%2520factor%2520receptor%2520type%25201%2520and%2520epidermal%2520growth%2520factor%2520receptor%2520in%2520progression%2520and%2520metastasis%2520of%2520pancreatic%2520cancer%26jtitle%3DMod.%2520Pathol.%26date%3D2006%26volume%3D19%26spage%3D788%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><div class="note"><p class="first last">A previously described hierarchical molecular modeling method was used for generating the docked models:</p></div><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span> </span><span class="NLM_article-title">Improving Docking Accuracy through Molecular Mechanics Generalized Born Optimization and Scoring</span> <span class="citation_source-journal">J. Chem. Theory Comput.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1106</span></span><div class="citationLinks">[<a href="/doi/10.1021/ct6003406" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisFGqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=1106&author=M.+R.+Leeauthor=Y.+Sun&title=Improving+Docking+Accuracy+through+Molecular+Mechanics+Generalized+Born+Optimization+and+Scoring"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Improving Docking Accuracy through Molecular Mechanics Generalized Born Optimization and Scoring</span></div><div class="casAuthors">Lee, Matthew R.; Sun, Yaxiong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1106-1119</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Docking methods are typically used within the biopharmaceutical industry for the challenging purposes of suggesting putative binding modes of new chemotypes and for virtual screening.  When attempting to satisfy the far more simplistic yet fundamentally important goal of reproducing and identifying the correct binding mode from a cocrystal, all docking methods fail at a rather significant rate, demonstrating room for further improvement in docking methodol.  We report a hierarchical method that yields results comparable to the industry-leading docking packages GOLD, Glide, and Surflex.  By first using a fast, simple, well-established method, UCSF DOCK 4.0, to rigidly dock conformational ensembles, we successfully generate the correct binding mode in all but 4 of a std., publicly available set of 79 cocrystals from the PDB.  Among these 4 failures (1glq, 1tmn, 1rds, and 8gch), all are highly flexible, highly charged, and not druglike.  Subsequently, all resultant docking poses were optimized and scored in the protein with mol. mechanics, using a std. MMGB energy function.  In total, this hierarchical method identified the correct binding in 71 of 79 cases (90%), an unprecedented level of accuracy on this highly benchmarked test set.  Furthermore, the publicly available energy functions employ only phys. based force fields without parameter fitting from this or any other docking test sets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI_SFPZ-SW2LVg90H21EOLACvtfcHk0lh_kTrQRt2_pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisFGqsb4%253D&md5=087d99fe151f0cfeb5c0bb56f4f23257</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fct6003406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct6003406%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DSun%26aufirst%3DY.%26atitle%3DImproving%2520Docking%2520Accuracy%2520through%2520Molecular%2520Mechanics%2520Generalized%2520Born%2520Optimization%2520and%2520Scoring%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2007%26volume%3D3%26spage%3D1106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">Unpublished results. Published DFG-out X-ray structures of c-Met inhibitors include:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Unpublished+results.+Published+DFG-out+X-ray+structures+of+c-Met+inhibitors+include%3A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kim, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darienzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeyaseelan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullo-Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manne, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span> </span><span class="NLM_article-title">Discovery of pyrrolopyridine-pyridone based inhibitors of Met kinase: synthesis, X-ray crystallographic analysis, and biological Activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5330</span><span class="NLM_x">–</span> <span class="NLM_lpage">5341</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800476q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5330-5341&author=K.+S.+Kimauthor=L.+Zhangauthor=R.+Schmidtauthor=Z.+W.+Caiauthor=D.+Weiauthor=D.+K.+Williamsauthor=L.+J.+Lombardoauthor=G.+L.+Trainorauthor=D.+Xieauthor=Y.+Zhangauthor=Y.+Anauthor=J.+S.+Sackauthor=J.+S.+Tokarskiauthor=C.+Darienzoauthor=A.+Kamathauthor=P.+Maratheauthor=Y.+Zhangauthor=J.+Lippyauthor=R.+Jeyaseelanauthor=B.+Wautletauthor=B.+Henleyauthor=J.+Gullo-Brownauthor=V.+Manneauthor=J.+T.+Huntauthor=J.+Fargnoliauthor=R.+M.+Borzilleri&title=Discovery+of+pyrrolopyridine-pyridone+based+inhibitors+of+Met+kinase%3A+synthesis%2C+X-ray+crystallographic+analysis%2C+and+biological+Activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fjm800476q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800476q%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSchmidt%26aufirst%3DR.%26aulast%3DCai%26aufirst%3DZ.%2BW.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DD.%2BK.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26aulast%3DXie%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DAn%26aufirst%3DY.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DDarienzo%26aufirst%3DC.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLippy%26aufirst%3DJ.%26aulast%3DJeyaseelan%26aufirst%3DR.%26aulast%3DWautlet%26aufirst%3DB.%26aulast%3DHenley%26aufirst%3DB.%26aulast%3DGullo-Brown%26aufirst%3DJ.%26aulast%3DManne%26aufirst%3DV.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520of%2520pyrrolopyridine-pyridone%2520based%2520inhibitors%2520of%2520Met%2520kinase%253A%2520synthesis%252C%2520X-ray%2520crystallographic%2520analysis%252C%2520and%2520biological%2520Activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5330%26epage%3D5341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Qian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, K.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mock, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lougheed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakes, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentzien, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaks, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wooster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greshock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holy, A. H.</span><span> </span><span class="NLM_article-title">Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">8009</span><span class="NLM_x">–</span> <span class="NLM_lpage">8016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=8009-8016&author=F.+Qianauthor=S.+Engstauthor=K.+Yamaguchiauthor=P.+Yuauthor=K.-A.+Wonauthor=L.+Mockauthor=T.+Louauthor=J.+Tanauthor=C.+Liauthor=D.+Tamauthor=J.+Lougheedauthor=F.+M.+Yakesauthor=F.+Bentzienauthor=W.+Xuauthor=T.+Zaksauthor=R.+Woosterauthor=J.+Greshockauthor=A.+H.+Holy&title=Inhibition+of+tumor+cell+growth%2C+invasion%2C+and+metastasis+by+EXEL-2880+%28XL880%2C+GSK1363089%29%2C+a+novel+inhibitor+of+HGF+and+VEGF+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DF.%26aulast%3DEngst%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DWon%26aufirst%3DK.-A.%26aulast%3DMock%26aufirst%3DL.%26aulast%3DLou%26aufirst%3DT.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DLougheed%26aufirst%3DJ.%26aulast%3DYakes%26aufirst%3DF.%2BM.%26aulast%3DBentzien%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DZaks%26aufirst%3DT.%26aulast%3DWooster%26aufirst%3DR.%26aulast%3DGreshock%26aufirst%3DJ.%26aulast%3DHoly%26aufirst%3DA.%2BH.%26atitle%3DInhibition%2520of%2520tumor%2520cell%2520growth%252C%2520invasion%252C%2520and%2520metastasis%2520by%2520EXEL-2880%2520%2528XL880%252C%2520GSK1363089%2529%252C%2520a%2520novel%2520inhibitor%2520of%2520HGF%2520and%2520VEGF%2520receptor%2520tyrosine%2520kinases%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D8009%26epage%3D8016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Lin, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, T. L.</span><span> </span><span class="NLM_article-title">Synthesis and antitumor activity of halogen-substituted 4-(3,3-dimethyl-1-triazeno)quinolines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=268-272&author=A.+J.+Linauthor=T.+L.+Loo&title=Synthesis+and+antitumor+activity+of+halogen-substituted+4-%283%2C3-dimethyl-1-triazeno%29quinolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DA.%2BJ.%26aulast%3DLoo%26aufirst%3DT.%2BL.%26atitle%3DSynthesis%2520and%2520antitumor%2520activity%2520of%2520halogen-substituted%25204-%25283%252C3-dimethyl-1-triazeno%2529quinolines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D21%26spage%3D268%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Samizu, K.; Hisamichi, H.; Matsuhisa, A.; Kinoyama, I.; Hayakawa, M.; Taniguchi, N.; Ideyama, Y.; Kuromitsu, S.; Yahiro, K.; Okada, M.</span><span> </span><span class="NLM_article-title">Preparation of 3-quinoline-2(1<i>H</i>)-ylideneindolin-2-one derivatives as vascular endothelial growth factor (VEGF) inhibitors</span>. Patent WO 2002/094809A1,<span class="NLM_x"> </span><span class="NLM_year">2002.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002.&author=K.+Samizu&author=H.+Hisamichi&author=A.+Matsuhisa&author=I.+Kinoyama&author=M.+Hayakawa&author=N.+Taniguchi&author=Y.+Ideyama&author=S.+Kuromitsu&author=K.+Yahiro&author=M.+Okada&title=Preparation+of+3-quinoline-2%281H%29-ylideneindolin-2-one+derivatives+as+vascular+endothelial+growth+factor+%28VEGF%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSamizu%26aufirst%3DK.%26atitle%3DPreparation%2520of%25203-quinoline-2%25281H%2529-ylideneindolin-2-one%2520derivatives%2520as%2520vascular%2520endothelial%2520growth%2520factor%2520%2528VEGF%2529%2520inhibitors%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Herbert, J. M.</span><span> </span><span class="NLM_article-title">Negishi-type coupling of bromoarenes with dimethylzinc</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">819</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1016%2Fj.tetlet.2003.11.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVSiurfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=817-819&author=J.+M.+Herbert&title=Negishi-type+coupling+of+bromoarenes+with+dimethylzinc"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Negishi-type coupling of bromoarenes with dimethylzinc</span></div><div class="casAuthors">Herbert, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-819</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Treatment of bromoarenes with dimethylzinc in the presence of a Pd catalyst provides a high-yielding route to methylarenes.  The process accommodates a wide range of arom. substituents and, in the majority of cases, is free of side reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVl5qEJc56yLVg90H21EOLACvtfcHk0lhxgQbCRuqEpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVSiurfE&md5=560b19106de1cc373afc0853c1fb5f09</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2003.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2003.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DHerbert%26aufirst%3DJ.%2BM.%26atitle%3DNegishi-type%2520coupling%2520of%2520bromoarenes%2520with%2520dimethylzinc%26jtitle%3DTetrahedron%2520Lett.%26date%3D2004%26volume%3D45%26spage%3D817%26epage%3D819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Molander, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivero, M. R.</span><span> </span><span class="NLM_article-title">Suzuki Cross-coupling reactions of potassium alkenyltrifluoroborates</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0169729" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovV2gurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=107-109&author=G.+A.+Molanderauthor=M.+R.+Rivero&title=Suzuki+Cross-coupling+reactions+of+potassium+alkenyltrifluoroborates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Suzuki Cross-Coupling Reactions of Potassium Alkenyltrifluoroborates</span></div><div class="casAuthors">Molander, Gary A.; Rivero, Marta Rodriguez</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">107-109</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The palladium-catalyzed coupling reaction of potassium alkenyltrifluoroborates with aryl or alkenyl halides or triflates proceeds readily with good yields.  The trifluoroborates are air- and moisture-stable solids that can be stored indefinitely.  The cross-coupling can be effected using PdCl2(dppf)·CH2Cl2 as the catalyst in n-PrOH in the presence of Et3N.  A variety of functional groups are tolerated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrueGc4zcgdjLVg90H21EOLACvtfcHk0liLCKXdyhv5Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovV2gurs%253D&md5=519063b115d6433b880ed809bf392f4b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fol0169729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0169729%26sid%3Dliteratum%253Aachs%26aulast%3DMolander%26aufirst%3DG.%2BA.%26aulast%3DRivero%26aufirst%3DM.%2BR.%26atitle%3DSuzuki%2520Cross-coupling%2520reactions%2520of%2520potassium%2520alkenyltrifluoroborates%26jtitle%3DOrg.%2520Lett.%26date%3D2002%26volume%3D4%26spage%3D107%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Kubo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyama, S.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murooka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isoe, T.</span><span> </span><span class="NLM_article-title">Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors: synthesis, structure–activity relationships, and antitumor activities of <i>N</i>-phenyl-<i>N</i>′-{4-(4-quinolyloxy)phenyl}ureas</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">–</span> <span class="NLM_lpage">1366</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030427r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1359-1366&author=K.+Kuboauthor=T.+Shimizuauthor=S.-I.+Ohyamaauthor=H.+Murookaauthor=A.+Iwaiauthor=K.+Nakamuraauthor=K.+Hasegawaauthor=Y.+Kobayashiauthor=N.+Takahashiauthor=K.+Takahashiauthor=S.+Katoauthor=T.+Izawaauthor=T.+Isoe&title=Novel+potent+orally+active+selective+VEGFR-2+tyrosine+kinase+inhibitors%3A+synthesis%2C+structure%E2%80%93activity+relationships%2C+and+antitumor+activities+of+N-phenyl-N%E2%80%B2-%7B4-%284-quinolyloxy%29phenyl%7Dureas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm030427r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030427r%26sid%3Dliteratum%253Aachs%26aulast%3DKubo%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DOhyama%26aufirst%3DS.-I.%26aulast%3DMurooka%26aufirst%3DH.%26aulast%3DIwai%26aufirst%3DA.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DHasegawa%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DS.%26aulast%3DIzawa%26aufirst%3DT.%26aulast%3DIsoe%26aufirst%3DT.%26atitle%3DNovel%2520potent%2520orally%2520active%2520selective%2520VEGFR-2%2520tyrosine%2520kinase%2520inhibitors%253A%2520synthesis%252C%2520structure%25E2%2580%2593activity%2520relationships%252C%2520and%2520antitumor%2520activities%2520of%2520N-phenyl-N%25E2%2580%25B2-%257B4-%25284-quinolyloxy%2529phenyl%257Dureas%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1359%26epage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Bannen, L. C.; Chan, D. S.-m.; Chen, J.; Dalrymple, L. E.; Forsyth, T. P.; Huynh, T. P.; Jammalamadaka, V.; Khoury, R. G.; Leahy, J. W.; Mac, M. B.; Mann, G.; Mann, L. W.; Nuss, J. M.; Parks, J. J.; Takeuchi, C. S.; Wang, Y.; Xu, W.</span><span> </span><span class="NLM_article-title">Preparation of quinolines and quinazolines as inhibitors of c-Met and other tyrosine kinases and therapeutic uses against proliferative diseases</span>. Patent WO 2005/030140,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=L.+C.+Bannen&author=D.+S.-m.+Chan&author=J.+Chen&author=L.+E.+Dalrymple&author=T.+P.+Forsyth&author=T.+P.+Huynh&author=V.+Jammalamadaka&author=R.+G.+Khoury&author=J.+W.+Leahy&author=M.+B.+Mac&author=G.+Mann&author=L.+W.+Mann&author=J.+M.+Nuss&author=J.+J.+Parks&author=C.+S.+Takeuchi&author=Y.+Wang&author=W.+Xu&title=Preparation+of+quinolines+and+quinazolines+as+inhibitors+of+c-Met+and+other+tyrosine+kinases+and+therapeutic+uses+against+proliferative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBannen%26aufirst%3DL.%2BC.%26atitle%3DPreparation%2520of%2520quinolines%2520and%2520quinazolines%2520as%2520inhibitors%2520of%2520c-Met%2520and%2520other%2520tyrosine%2520kinases%2520and%2520therapeutic%2520uses%2520against%2520proliferative%2520diseases%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Kung, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padrique, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span> </span><span class="NLM_article-title">Structure activity relationships of quinoline-containing c-Met inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1321</span><span class="NLM_x">–</span> <span class="NLM_lpage">1329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=1321-1329&author=P.+P.+Kungauthor=L.+Funkauthor=J.+Mengauthor=G.+Altonauthor=E.+Padriqueauthor=B.+Mroczkowski&title=Structure+activity+relationships+of+quinoline-containing+c-Met+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DP.%2BP.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DPadrique%26aufirst%3DE.%26aulast%3DMroczkowski%26aufirst%3DB.%26atitle%3DStructure%2520activity%2520relationships%2520of%2520quinoline-containing%2520c-Met%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26spage%3D1321%26epage%3D1329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Lauer, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiffany, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinker, J.</span><span> </span><span class="NLM_article-title">Synthesis of some chloromethoxyquinolines</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1946</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1268</span><span class="NLM_x">–</span> <span class="NLM_lpage">1269</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01211a040" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1946&pages=1268-1269&author=W.+M.+Lauerauthor=R.+T.+Arnoldauthor=B.+Tiffanyauthor=J.+Tinker&title=Synthesis+of+some+chloromethoxyquinolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fja01211a040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01211a040%26sid%3Dliteratum%253Aachs%26aulast%3DLauer%26aufirst%3DW.%2BM.%26aulast%3DArnold%26aufirst%3DR.%2BT.%26aulast%3DTiffany%26aufirst%3DB.%26aulast%3DTinker%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520some%2520chloromethoxyquinolines%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1946%26volume%3D68%26spage%3D1268%26epage%3D1269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Nara, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkhorst, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zemanek, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, D. A.</span><span> </span><span class="NLM_article-title">A simple Cu-catalyzed coupling approach to substituted 3-pyridinol and 5-opyrimidinol antioxidants</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">9326</span><span class="NLM_x">–</span> <span class="NLM_lpage">9333</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo801501e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=9326-9333&author=S.+J.+Naraauthor=M.+Jhaauthor=J.+Brinkhorstauthor=T.+J.+Zemanekauthor=D.+A.+Pratt&title=A+simple+Cu-catalyzed+coupling+approach+to+substituted+3-pyridinol+and+5-opyrimidinol+antioxidants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo801501e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo801501e%26sid%3Dliteratum%253Aachs%26aulast%3DNara%26aufirst%3DS.%2BJ.%26aulast%3DJha%26aufirst%3DM.%26aulast%3DBrinkhorst%26aufirst%3DJ.%26aulast%3DZemanek%26aufirst%3DT.%2BJ.%26aulast%3DPratt%26aufirst%3DD.%2BA.%26atitle%3DA%2520simple%2520Cu-catalyzed%2520coupling%2520approach%2520to%2520substituted%25203-pyridinol%2520and%25205-opyrimidinol%2520antioxidants%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26spage%3D9326%26epage%3D9333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ledrut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combes, G.</span><span> </span><span class="NLM_article-title">Reaction of <i>N</i>-bromosuccinamide with pyrazolones</span> <span class="citation_source-journal">Comptes Rendus</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1950</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">1513</span><span class="NLM_x">–</span> <span class="NLM_lpage">1515</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADyaG3sXisFeksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=1950&pages=1513-1515&author=J.+Ledrutauthor=G.+Combes&title=Reaction+of+N-bromosuccinamide+with+pyrazolones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">Reactions of N-bromosuccinimide with pyrazolones</span></div><div class="casAuthors">Ledrut, Jules; Combes, Georges</div><div class="citationInfo"><span class="NLM_cas:title"></span>
        (<span class="NLM_cas:date">1950</span>),
    <span class="NLM_cas:volume">231</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1513-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Heating equimolar amts. of antipyrine and N-bromosuccinimide (I) in CCl4 gave 4-brormoantipyrine (II).  With 2 mols. I, a mixt. of II and 2-phenyl-1-methyl-5-bromomethyl-4-bromo-3-pyrazolone (C.A. numbering) (III), m. 134° (from EtOH), was obtained.  III with hexamethylenetetramine gave a compd., m. 220-3°.  III could also be prepd. by treating I with II.  Bz2O2 did not affect the reactions, hydroquinone inhibited the formation of II. 4-methylantipyrine with I yielded 2-phenyl-1,5-bisbromomethyl-3-pyrazolone, m. 175° (from EtOH).  I with 4-hydroxymethylantipyrine gave II to the exclusion of any aldehyde, and I with 4-carboxyantipyrine, yielded II almost quantitatively.  I and 4-formylantipyrine (IV) gave a small amt. of III after prolonged heating in CCl4 or CHCl3; most of the aldehyde remaining unaffected.  IV with Br in cold CHCl3, however, gave II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcnlll7egjarVg90H21EOLACvtfcHk0lgEkPcfTsbxNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG3sXisFeksg%253D%253D&md5=5296b4b023f6943cc8305a535c20d3c3</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLedrut%26aufirst%3DJ.%26aulast%3DCombes%26aufirst%3DG.%26atitle%3DReaction%2520of%2520N-bromosuccinamide%2520with%2520pyrazolones%26jtitle%3DComptes%2520Rendus%26date%3D1950%26volume%3D231%26spage%3D1513%26epage%3D1515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">de Graef, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledrut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combes, G.</span><span> </span><span class="NLM_article-title">Prazolone series. XI. Reaction of <i>N</i>-halo imides with antipyrine and derivatives</span> <span class="citation_source-journal">Bull. Soc. Chim. Belges</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1952</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1002%2Fbscb.19520610702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADyaG3sXnt1Orsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1952&pages=331-351&author=H.+de+Graefauthor=J.+Ledrutauthor=G.+Combes&title=Prazolone+series.+XI.+Reaction+of+N-halo+imides+with+antipyrine+and+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazolone series. XI. Reactions of N-halo imides with antipyrine and derivatives</span></div><div class="casAuthors">de Graef, H.; Ledrut, J.; Combes, G.</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin des Societes Chimiques Belges</span>
        (<span class="NLM_cas:date">1952</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">331-51</span>CODEN:
                <span class="NLM_cas:coden">BSCBAG</span>;
        ISSN:<span class="NLM_cas:issn">0037-9646</span>.
    </div><div class="casAbstract">cf. C.A. 47, 4334c.  Antipyrine (1-phenyl-2,3-dimethyl-3-pyrazolin-5-one) (I) (1.88 g.) heated 30 min. with an equimolar amt. of N-bromosuccinimide (IA) in 50 cc. CCl4 gives 92%, 4-Br deriv. (II), m. 115°, and also some 1-phenyl-2-methyl-3-bromomethyl-4-bromo-3-pyrazolin-5-one (III), m. 135°; the sol. is filtered hot from the succinimide, cooled, evapd. to dryness, the less sol. III sepd. by fractional crystn. in alc., II recovered from the liquors and recrystd. from water.  Increasing amts. of IA give higher proportions of III.  III, an irritant, was prepd. in 77% yield (7 g.) by heating 6.7 g. II in 100 cc. CCl4 with 4.3 g. IA 45 min. on the water bath, and recrystg. the product from alc.  Both preparative reactions are unaffected by Bz2O2.  In the presence of excess IA (3 moles) I yields 33% III (isolated by fractional crystn. in alc.), and a compd. C11H9N2OBr3 (IV), m. 154°.  IV (0.75 g.) is also obtained by heating 0.01 mole III with 0.01 mole IA 90 min., 23% III being recovered.  IV is stable toward heating in aq. alc. Na2CO3 soln., conditions under which III is hydrolyzed to the 3-HOCH2 compd. (vide infra).  When heated with 10% NaOH IV is decompd. and totally debrominated; it does not react with (O2N)2C6H4NHNH2, and with AgNO3 in aq. alc. it forms 1 mole AgBr.  III forms a urotropine deriv. (1-phenyl-2-methy1-4-bromopyrazolin-5-one-3-methylhexamethylenetetrammonium bromide) (V), decompg. 220-5°, sol. in cold water, slightly sol. in alc.; 0.347 g. III and 0.140 g. hexamethylenetetramine in 10 cc. CHCl3 heated 15 min. and the mixt. evapd. yield 0.45 g. (94%) V.  V heated a few minutes on a water bath is hydrolyzed to an impure substance, m. 180-200°; the soln. yields with 2,4-(O2N)2C6H3NHNH2 a ppt. with the same m.p. as the HCHO deriv. of the latter (156°) and showing no depression.  1-Phenyl-2-methyl-3-hydroxymethyl-4-bromo-2-pyrazolin-5-one, m. 181° (3.4 g., 85%), is prepd. by heating 5.1 g. III, and 3 g. Na2CO3 1 hr. in 100 cc. 50% alc. on the water bath concg. the soln., and recrystg. the product from alc. or dioxane; exactly 1 equiv. of bromide ion is thereby produced.  5,5-Dimethyl-1,3-dichlorohydantoin (VA) (3 g., 0.015 mole) refluxed 30 min. with 5.64 g. (0.03 mole) I and 1 millimole Bz2O2 in CCl4 soln. and filtered hot yields 89% 5,5-dimethylhydantoin, m. 173-5°, and, upon cooling, 5.8 g. 4-chloroantipyrine (VI), m. 125-6° (from 50% alc.), also obtained (80%) when the Bz2O2 is omitted.  Use of the double amount of VA yields 38% VI and an oil.  On heating 2.22 g. VI 30 min. with 1 g. VA in CCl4, 90% of the dimethylhydantoin is isolated, and 27% VI recovered unchanged, and 2 g. of an unidentified oil obtained.  4-Methylantipyrine (VII), m. 82-3°, is prepd. in 50% yield by heating 1-phenyl-3,4-dimethyl-3-pyrazolin-5-one and Me2SO4 at 180° and recrystg. the product from Et2O-C6H6.  Bromination of VII and treatment with Na2CO3 yields 1-phenyl-2,4-dimethyl-3-bromomethyl-2-pyrazolin-5-one (VIII), m. 110°, which forms a hexamethylenetetrammonium salt m. 218-20° (from alc.); hydrolysis of the latter yields HCHO.  1-Phenyl-2-methyl-3,4-bis(dibromomethyl)-2-pyrazolin-5-one (IX), m. 175°, is the only product (35%) from 2.02 g. (0.01 mole) VII and 1.76 g. (0.01 mole) IA, suspended in 30 cc. CCl4, heated slowly to 60°, allowed to react 20 min., the soln. concd., and the product recrystd. repeatedly from alc.  Bz2O2 does not affect the reaction, but the yield is doubled by using twice the amt. of IA.  IX (.090 g., 74%) is also obtained from (0.100 g.) VIII and 0.063 g. IA refluxed 15 min. in 5 cc. CCl4.  In attempts to transform 4-(hydroxymethyl)antipyrine into the corresponding aldehyde with IA and VA in pyridine or water, only HCHO and the 4-halo compds. (II and VI, resp.) were isolated; Br yielded HCHO and a compd.  C23H24O2N4Br2, m. 205-8°, which was also obtained by the reaction of bromine with diantipyrinemethane.  4-Formylantipyrine and IA (0.01 mole each) heated in CCl4 lose CO and yield some III; VA gives VI and tars; Br yields 80% II.  Antipyric acid with IA (0.01 mole each) heated 15 min. in 35 cc. CCl4 lose CO2 and give 95% II; in the absence of IA the starting material remains unchanged after 20 min.; no reaction is observed with VA instead of IA; a satd. soln. of 2.32 g. antipyric acid in CHCl3 treated 12 hrs. at room temp. with 0.01 mole Br in CHCl3 (16% soln.) yields an oil from which can be isolated crystals, m. 130-5°, decompd. in boiling water into HBr, CO2, and II.  4-Acetylantipyrine (2.30 g., 0.01 mole) and 1.70 g. (0.01 mole) IA in 40 cc. CCl4 heated 30 min. on the water bath, the soln. filtered hot from the succinimide, and the crystals which sep. recrystd. from 25% alc, yield 0.6 g. 4-(bromoacetyl)antipyrine, m. 135°, identified by conversion (3 hrs. in aq. Na2CO3) to the α-hydroxymethyl ketone, m. 121° (from CHCl3-petr. ether).  1-Phenyl-2-methyl-3-hydroxymethyl-4-bromo-2-pyrazolin-5-one (X) (1 g.) in 40 cc. cold CHCl3 and 15 cc. 8% Br in CHCl3 let stand 36 hrs. in the dark and extd. with water and NaHCO3 yield 1.1 g. of the 3-bromomethyl analog, m. 170-2°, also obtained from 1.08 g. X, 35 cc. CCl4, and 0.90 g. IA heated 90 min. on the water bath (some starting material is recovered).  The product gives a 2,4-dinitrophenylhydrazone, m. 185-7°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPmvFBDV0gSLVg90H21EOLACvtfcHk0lgEkPcfTsbxNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG3sXnt1Orsg%253D%253D&md5=0db5cb2e480bb44c933117dc6a43e538</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1002%2Fbscb.19520610702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbscb.19520610702%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BGraef%26aufirst%3DH.%26aulast%3DLedrut%26aufirst%3DJ.%26aulast%3DCombes%26aufirst%3DG.%26atitle%3DPrazolone%2520series.%2520XI.%2520Reaction%2520of%2520N-halo%2520imides%2520with%2520antipyrine%2520and%2520derivatives%26jtitle%3DBull.%2520Soc.%2520Chim.%2520Belges%26date%3D1952%26volume%3D61%26spage%3D331%26epage%3D351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ito, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, N.</span><span> </span><span class="NLM_article-title">Synthesis of pyrazolone derivatives. XI. Synthesis of 6-substituted 1,2,6,7-tetrahydro-3<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span><div class="note"><p class="first last">and references cited therein.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1966&pages=297-298&author=I.+Itoauthor=N.+Oda&title=Synthesis+of+pyrazolone+derivatives.+XI.+Synthesis+of+6-substituted+1%2C2%2C6%2C7-tetrahydro-3H-pyrazolo%5B4%2C3-c%5Dpyridine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DI.%26aulast%3DOda%26aufirst%3DN.%26atitle%3DSynthesis%2520of%2520pyrazolone%2520derivatives.%2520XI.%2520Synthesis%2520of%25206-substituted%25201%252C2%252C6%252C7-tetrahydro-3H-pyrazolo%255B4%252C3-c%255Dpyridine%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1966%26volume%3D14%26spage%3D297%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Bodendorf, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mildner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, T.</span><span> </span><span class="NLM_article-title">Über Antipyrinaldehyd und Antipyrinsaure</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1949</span><span class="NLM_x">, </span> <span class="NLM_volume">563</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=563&publication_year=1949&pages=1-11&author=K.+Bodendorfauthor=J.+Mildnerauthor=T.+Lehmann&title=%C3%9Cber+Antipyrinaldehyd+und+Antipyrinsaure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBodendorf%26aufirst%3DK.%26aulast%3DMildner%26aufirst%3DJ.%26aulast%3DLehmann%26aufirst%3DT.%26atitle%3D%25C3%259Cber%2520Antipyrinaldehyd%2520und%2520Antipyrinsaure%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D1949%26volume%3D563%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Brooks, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L. D.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masamune, S.</span><span> </span><span class="NLM_article-title">C-Acylation under virtually neutral conditions</span> <span class="citation_source-journal">Angew. Chem. Int Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1979&pages=72-74&author=D.+W.+Brooksauthor=L.+D.-L.+Luauthor=S.+Masamune&title=C-Acylation+under+virtually+neutral+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DD.%2BW.%26aulast%3DLu%26aufirst%3DL.%2BD.-L.%26aulast%3DMasamune%26aufirst%3DS.%26atitle%3DC-Acylation%2520under%2520virtually%2520neutral%2520conditions%26jtitle%3DAngew.%2520Chem.%2520Int%2520Ed.%26date%3D1979%26volume%3D18%26spage%3D72%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Barluenga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merino, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viña, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palacios, F.</span><span> </span><span class="NLM_article-title">Regioselective synthesis of 1-alkyl-1-phenylhydrazines, 2-alkyl-1-phenylhydrazines, and 1,2-dialkyl-1-phenylhydrazines</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_fpage">398</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1055%2Fs-1990-26885" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADyaK3cXlsFWqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&pages=398-400&author=J.+Barluengaauthor=I.+Merinoauthor=S.+Vi%C3%B1aauthor=F.+Palacios&title=Regioselective+synthesis+of+1-alkyl-1-phenylhydrazines%2C+2-alkyl-1-phenylhydrazines%2C+and+1%2C2-dialkyl-1-phenylhydrazines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Regioselective synthesis of 1-alkyl-1-phenylhydrazines, 2-alkyl-1-phenylhydrazines, and 1,2-dialkyl-1-phenylhydrazines</span></div><div class="casAuthors">Barluenga, Jose; Merino, Isabel; Vina, Sara; Palacios, Francisco</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">398-400</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">The title compds. were prepd. in 82-95% yields by treating PhNHNHP+Ph3 Br- (I) with BuLi in THF, followed by alkyl halides and alk. hydrolysis.  E.g., treating I with 1 equiv BuLi and then with RX (R = Me, Et; X = iodo; R = allyl, PhCH2, X = Br) followed by aq. NaOH gave PhNHNHR.  Treating I with 2 equiv BuLi and then with 1 equiv RX gave PhNRNH2.  Treating I sequentially with 2 equiv BuLi, RX, and R1I (R1 = Et, Me) gave PhNRNHR1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm7v8qW13GFLVg90H21EOLACvtfcHk0lj8XUiWLz7cPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXlsFWqsL4%253D&md5=1b7f4c5c7203e9ae19b874b4c464b66f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1055%2Fs-1990-26885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1990-26885%26sid%3Dliteratum%253Aachs%26aulast%3DBarluenga%26aufirst%3DJ.%26aulast%3DMerino%26aufirst%3DI.%26aulast%3DVi%25C3%25B1a%26aufirst%3DS.%26aulast%3DPalacios%26aufirst%3DF.%26atitle%3DRegioselective%2520synthesis%2520of%25201-alkyl-1-phenylhydrazines%252C%25202-alkyl-1-phenylhydrazines%252C%2520and%25201%252C2-dialkyl-1-phenylhydrazines%26jtitle%3DSynthesis%26date%3D1990%26spage%3D398%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Rockley, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summers, L. A.</span><span> </span><span class="NLM_article-title">Structures of 5-Methyl-4-((arylamino)methylene)-2,4-dihydro-3<i>H</i>-pyrazol-3-ones</span> <span class="citation_source-journal">Aust. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1981&pages=1117-1124&author=J.+E.+Rockleyauthor=L.+A.+Summers&title=Structures+of+5-Methyl-4-%28%28arylamino%29methylene%29-2%2C4-dihydro-3H-pyrazol-3-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRockley%26aufirst%3DJ.%2BE.%26aulast%3DSummers%26aufirst%3DL.%2BA.%26atitle%3DStructures%2520of%25205-Methyl-4-%2528%2528arylamino%2529methylene%2529-2%252C4-dihydro-3H-pyrazol-3-ones%26jtitle%3DAust.%2520J.%2520Chem.%26date%3D1981%26volume%3D34%26spage%3D1117%26epage%3D1124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Bal, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, W. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinnick, H. W.</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2091</span><span class="NLM_x">–</span> <span class="NLM_lpage">2096</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm201331s&amp;key=10.1016%2FS0040-4020%2801%2997963-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADyaL3MXlsFSjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bal%2C+B.+S.%3B+Childers%2C+W.+E.%2C+Jr.%3B+Pinnick%2C+H.+W.Tetrahedron+1981%2C+37%2C+2091%E2%80%932096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation of α,β-unsaturated aldehydes</span></div><div class="casAuthors">Bal, Balkrishna S.; Childers, Wayne E., Jr.; Pinnick, Harold W.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2091-6</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    </div><div class="casAbstract">Three methods for the oxidn. of α,β-unsatd. aldehydes to the corresponding acids were studied.  These were MnO2 oxidn. of the cyanohydrin deriv., treatment with Caro's acid, and reaction with NaClO2.  The last was the best method, giving pure acid in high yield.  E.g., propenal I (R = H) with NaClO2 (Me3COH, MeCH:CMe2, aq. NaH2PO4, room temp., overnight) gave 90% I (R = OH).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy3LIBi4Dq7LVg90H21EOLACvtfcHk0lj8XUiWLz7cPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXlsFSjs74%253D&md5=1cea4c957f6032c660027bcd98e35e19</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2997963-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252997963-3%26sid%3Dliteratum%253Aachs%26aulast%3DBal%26aufirst%3DB.%2BS.%26aulast%3DChilders%26aufirst%3DW.%2BE.%26aulast%3DPinnick%26aufirst%3DH.%2BW.%26jtitle%3DTetrahedron%26date%3D1981%26volume%3D37%26spage%3D2091%26epage%3D2096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Siegmund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Retz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span> </span><span class="NLM_article-title">Selective β-hydroxyethylation at the N-1 position of a pyrazolone: synthesis of benzyl 1-(β-hydroxyethyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxylate</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=1005-1008&author=A.+Siegmundauthor=D.+Retzauthor=N.+Xiauthor=C.+Dominguezauthor=R.+Burliauthor=L.+Liu&title=Selective+%CE%B2-hydroxyethylation+at+the+N-1+position+of+a+pyrazolone%3A+synthesis+of+benzyl+1-%28%CE%B2-hydroxyethyl%29-5-methyl-3-oxo-2-phenyl-2%2C3-dihydro-1H-pyrazole-4-carboxylate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiegmund%26aufirst%3DA.%26aulast%3DRetz%26aufirst%3DD.%26aulast%3DXi%26aufirst%3DN.%26aulast%3DDominguez%26aufirst%3DC.%26aulast%3DBurli%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DSelective%2520%25CE%25B2-hydroxyethylation%2520at%2520the%2520N-1%2520position%2520of%2520a%2520pyrazolone%253A%2520synthesis%2520of%2520benzyl%25201-%2528%25CE%25B2-hydroxyethyl%2529-5-methyl-3-oxo-2-phenyl-2%252C3-dihydro-1H-pyrazole-4-carboxylate%26jtitle%3DSynlett%26date%3D2008%26spage%3D1005%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="note"><p class="first last">For selected papers, see,</p></div><div class="NLM_citation" id="rightTab-cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bridges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cody, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rewcastle, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMichael, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitors: unusually steep structure–activity relationship for analogs of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9503613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=267-76&author=A.+J.+Bridgesauthor=H.+Zhouauthor=D.+R.+Codyauthor=G.+W.+Rewcastleauthor=A.+McMichaelauthor=H.+D.+H.+Showalterauthor=D.+W.+Fryauthor=A.+J.+Krakerauthor=W.+A.+Denny&title=Tyrosine+kinase+inhibitors%3A+unusually+steep+structure%E2%80%93activity+relationship+for+analogs+of+4-%283-bromoanilino%29-6%2C7-dimethoxyquinazoline+%28PD+153035%29%2C+a+potent+inhibitor+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1021%2Fjm9503613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9503613%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DCody%26aufirst%3DD.%2BR.%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26aulast%3DMcMichael%26aufirst%3DA.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%2BH.%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DKraker%26aufirst%3DA.%2BJ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DTyrosine%2520kinase%2520inhibitors%253A%2520unusually%2520steep%2520structure%25E2%2580%2593activity%2520relationship%2520for%2520analogs%2520of%25204-%25283-bromoanilino%2529-6%252C7-dimethoxyquinazoline%2520%2528PD%2520153035%2529%252C%2520a%2520potent%2520inhibitor%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D267%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boschelli, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamuya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upeslacis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, N.</span><span> </span><span class="NLM_article-title">4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3244</span><span class="NLM_x">–</span> <span class="NLM_lpage">3256</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000206a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3244-3256&author=A.+Wissnerauthor=D.+M.+Bergerauthor=D.+H.+Boschelliauthor=M.+B.+Floydauthor=L.+M.+Greenbergerauthor=B.+C.+Gruberauthor=B.+D.+Johnsonauthor=N.+Mamuyaauthor=R.+Nilakantanauthor=M.+F.+Reichauthor=R.+Shenauthor=H.-R.+Tsouauthor=E.+Upeslacisauthor=Y.+F.+Wangauthor=B.+Wuauthor=F.+Yeauthor=N.+Zhang&title=4-Anilino-6%2C7-dialkoxyquinoline-3-carbonitrile+inhibitors+of+epidermal+growth+factor+receptor+kinase+and+their+bioisosteric+relationship+to+the+4-anilino-6%2C7-dialkoxyquinazoline+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1021%2Fjm000206a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000206a%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DD.%2BM.%26aulast%3DBoschelli%26aufirst%3DD.%2BH.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26aulast%3DGruber%26aufirst%3DB.%2BC.%26aulast%3DJohnson%26aufirst%3DB.%2BD.%26aulast%3DMamuya%26aufirst%3DN.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DReich%26aufirst%3DM.%2BF.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DTsou%26aufirst%3DH.-R.%26aulast%3DUpeslacis%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DY.%2BF.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DN.%26atitle%3D4-Anilino-6%252C7-dialkoxyquinoline-3-carbonitrile%2520inhibitors%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520kinase%2520and%2520their%2520bioisosteric%2520relationship%2520to%2520the%25204-anilino-6%252C7-dialkoxyquinazoline%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3244%26epage%3D3256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Scott, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balliet, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gero, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poondru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theoclitou, M.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyurin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinda, M. J.</span><span> </span><span class="NLM_article-title">Identification of 3-amido-4-anilinoquinolines as potent and selective inhibitors of CSF-1R kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">697</span><span class="NLM_x">–</span> <span class="NLM_lpage">700</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=697-700&author=D.+A.+Scottauthor=C.+L.+Ballietauthor=D.+J.+Cookauthor=A.+M.+Davisauthor=T.+W.+Geroauthor=C.+A.+Omerauthor=S.+Poondruauthor=M.-E.+Theoclitouauthor=B.+Tyurinauthor=M.+J.+Zinda&title=Identification+of+3-amido-4-anilinoquinolines+as+potent+and+selective+inhibitors+of+CSF-1R+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DD.%2BA.%26aulast%3DBalliet%26aufirst%3DC.%2BL.%26aulast%3DCook%26aufirst%3DD.%2BJ.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DGero%26aufirst%3DT.%2BW.%26aulast%3DOmer%26aufirst%3DC.%2BA.%26aulast%3DPoondru%26aufirst%3DS.%26aulast%3DTheoclitou%26aufirst%3DM.-E.%26aulast%3DTyurin%26aufirst%3DB.%26aulast%3DZinda%26aufirst%3DM.%2BJ.%26atitle%3DIdentification%2520of%25203-amido-4-anilinoquinolines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520CSF-1R%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D697%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Cincinelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassinelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallavalle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuccinardi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunino, F.</span><span> </span><span class="NLM_article-title">Synthesis, modeling, and RET protein kinase inhibitory activity of 3- and 4-substituted b-Carbolin-1-ones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7777</span><span class="NLM_x">–</span> <span class="NLM_lpage">7787</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8007823" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7777-7787&author=R.+Cincinelliauthor=G.+Cassinelliauthor=S.+Dallavalleauthor=C.+Lanziauthor=L.+Merliniauthor=M.+Bottaauthor=T.+Tuccinardiauthor=A.+Martinelliauthor=S.+Pencoauthor=F.+Zunino&title=Synthesis%2C+modeling%2C+and+RET+protein+kinase+inhibitory+activity+of+3-+and+4-substituted+b-Carbolin-1-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33d&amp;dbid=16384&amp;doi=10.1021%2Fjm8007823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8007823%26sid%3Dliteratum%253Aachs%26aulast%3DCincinelli%26aufirst%3DR.%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DDallavalle%26aufirst%3DS.%26aulast%3DLanzi%26aufirst%3DC.%26aulast%3DMerlini%26aufirst%3DL.%26aulast%3DBotta%26aufirst%3DM.%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DPenco%26aufirst%3DS.%26aulast%3DZunino%26aufirst%3DF.%26atitle%3DSynthesis%252C%2520modeling%252C%2520and%2520RET%2520protein%2520kinase%2520inhibitory%2520activity%2520of%25203-%2520and%25204-substituted%2520b-Carbolin-1-ones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7777%26epage%3D7787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kim, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dushin, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arndt, K.</span><span> </span><span class="NLM_article-title">Benzo[<i>c</i>][2,7]naphthyridines as inhibitors of PDK-1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5225</span><span class="NLM_x">–</span> <span class="NLM_lpage">5228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5225-5228&author=K.-H.+Kimauthor=A.+Wissnerauthor=M.+B.+Floydauthor=H.+L.+Fraserauthor=Y.+D.+Wangauthor=R.+G.+Dushinauthor=Y.+Huauthor=A.+Ollandauthor=B.+Guoauthor=K.+Arndt&title=Benzo%5Bc%5D%5B2%2C7%5Dnaphthyridines+as+inhibitors+of+PDK-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.-H.%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DFraser%26aufirst%3DH.%2BL.%26aulast%3DWang%26aufirst%3DY.%2BD.%26aulast%3DDushin%26aufirst%3DR.%2BG.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DB.%26aulast%3DArndt%26aufirst%3DK.%26atitle%3DBenzo%255Bc%255D%255B2%252C7%255Dnaphthyridines%2520as%2520inhibitors%2520of%2520PDK-1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5225%26epage%3D5228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Flowers-Geary, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penning, T. M.</span><span> </span><span class="NLM_article-title">Cytotoxicity of polycyclic aromatic hydrocarbon <i>o</i>-quinones in rats and human hepatoma cells</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx00033a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1993&pages=252-260&author=L.+Flowers-Gearyauthor=R.+G.+Harveyauthor=T.+M.+Penning&title=Cytotoxicity+of+polycyclic+aromatic+hydrocarbon+o-quinones+in+rats+and+human+hepatoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Ftx00033a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx00033a002%26sid%3Dliteratum%253Aachs%26aulast%3DFlowers-Geary%26aufirst%3DL.%26aulast%3DHarvey%26aufirst%3DR.%2BG.%26aulast%3DPenning%26aufirst%3DT.%2BM.%26atitle%3DCytotoxicity%2520of%2520polycyclic%2520aromatic%2520hydrocarbon%2520o-quinones%2520in%2520rats%2520and%2520human%2520hepatoma%2520cells%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D1993%26volume%3D6%26spage%3D252%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="note"><p class="first last">In a related system where the N(1) was substituted with a 2-hydroxy propyl group, removing the 7-methoxyl group resulted in 12-fold loss of potency relative to the 6.7-dimethoxyl analogue.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Evans, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span> </span><span class="NLM_article-title">Drug–protein adducts: an industry prespective on minimizing the potential for drug bioactivation in drug discovery and development</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx034170b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=3-16&author=D.+C.+Evansauthor=A.+P.+Wattauthor=D.+A.+Nicoll-Griffithauthor=T.+A.+Baillie&title=Drug%E2%80%93protein+adducts%3A+an+industry+prespective+on+minimizing+the+potential+for+drug+bioactivation+in+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Ftx034170b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx034170b%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BC.%26aulast%3DWatt%26aufirst%3DA.%2BP.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DDrug%25E2%2580%2593protein%2520adducts%253A%2520an%2520industry%2520prespective%2520on%2520minimizing%2520the%2520potential%2520for%2520drug%2520bioactivation%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2004%26volume%3D17%26spage%3D3%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nelson, S. D.</span><span> </span><span class="NLM_article-title">Metabolic activation and drug toxicity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">765</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00349a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=32&amp;doi=10.1021%2Fjm201331s&amp;key=1%3ACAS%3A528%3ADyaL38XktVSjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1982&pages=753-765&author=S.+D.+Nelson&title=Metabolic+activation+and+drug+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37aR"><div class="casContent"><span class="casTitleNuber">37a</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic activation and drug toxicity</span></div><div class="casAuthors">Nelson, Sidney D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">753-65</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A review with 128 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzUsG75cxLYLVg90H21EOLACvtfcHk0lhz9QPslriU5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XktVSjsL8%253D&md5=89c759fff948a83bb8edebef1c8cdbad</span></div><a href="/servlet/linkout?suffix=cit37a&amp;dbid=16384&amp;doi=10.1021%2Fjm00349a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00349a001%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DS.%2BD.%26atitle%3DMetabolic%2520activation%2520and%2520drug%2520toxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1982%26volume%3D25%26spage%3D753%26epage%3D765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit37b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">This strategy was recently applied to an acylthiourea series:</p></div><span class="NLM_contrib-group">Kung, P.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padrique, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of quinoline-containing c-Met inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1321</span><span class="NLM_x">–</span> <span class="NLM_lpage">1329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=1321-1329&author=P.-P.+Kungauthor=L.+Funkauthor=J.+Mengauthor=G.+Altonauthor=E.+Padriqueauthor=B.+Mroczkowski&title=Structure%E2%80%93activity+relationships+of+quinoline-containing+c-Met+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DP.-P.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DPadrique%26aufirst%3DE.%26aulast%3DMroczkowski%26aufirst%3DB.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520quinoline-containing%2520c-Met%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26spage%3D1321%26epage%3D1329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan-Lefko, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rex, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reese, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dussault, I.</span><span> </span><span class="NLM_article-title">Identification of a novel Recepteur d’Origine Nantais/c-Met small molecule kinase inhibitor with antitumor activity in vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">6680</span><span class="NLM_x">–</span> <span class="NLM_lpage">6687</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=6680-6687&author=Y.+Zhangauthor=P.+J.+Kaplan-Lefkoauthor=K.+Rexauthor=Y.+Yangauthor=J.+Moriguchiauthor=T.+Osgoodauthor=B.+Mattsonauthor=A.+Coxonauthor=M.+Reeseauthor=T.-S.+Kimauthor=J.+Linauthor=A.+Chenauthor=T.+L.+Burgessauthor=I.+Dussault&title=Identification+of+a+novel+Recepteur+d%E2%80%99Origine+Nantais%2Fc-Met+small+molecule+kinase+inhibitor+with+antitumor+activity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKaplan-Lefko%26aufirst%3DP.%2BJ.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DMoriguchi%26aufirst%3DJ.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DMattson%26aufirst%3DB.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DReese%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DT.-S.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DBurgess%26aufirst%3DT.%2BL.%26aulast%3DDussault%26aufirst%3DI.%26atitle%3DIdentification%2520of%2520a%2520novel%2520Recepteur%2520d%25E2%2580%2599Origine%2520Nantais%252Fc-Met%2520small%2520molecule%2520kinase%2520inhibitor%2520with%2520antitumor%2520activity%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D6680%26epage%3D6687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span>Part of the synthesis and characterization of compounds have been described in: <span class="NLM_contrib-group">Kim, T.-S.; Bauer, D.; Bellon, S.; Boezio, A.; Booker, S.; Choquette, D.; D’Amico, D. C.; D’Angelo, N.; Dominguez, C.; Fellows, I. M.; Germain, J.; Graceffa, R.; Harmange, J.-C.; Hirai, S.; La, D.; Lee, M.; Liu, L.; Norman, M. H.; Potashman, M.; Rovet, P.; Siegmund, A. C.; Xi, N.; Yang, K.</span><div class="note"><p class="first last">(Amgen Inc)</p></div>. Patent WO 2006/116713A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Part+of+the+synthesis+and+characterization+of+compounds+have+been+described+in%3A+Kim%2C+T.-S.%3B+Bauer%2C+D.%3B+Bellon%2C+S.%3B+Boezio%2C+A.%3B+Booker%2C+S.%3B+Choquette%2C+D.%3B+D%E2%80%99Amico%2C+D.+C.%3B+D%E2%80%99Angelo%2C+N.%3B+Dominguez%2C+C.%3B+Fellows%2C+I.+M.%3B+Germain%2C+J.%3B+Graceffa%2C+R.%3B+Harmange%2C+J.-C.%3B+Hirai%2C+S.%3B+La%2C+D.%3B+Lee%2C+M.%3B+Liu%2C+L.%3B+Norman%2C+M.+H.%3B+Potashman%2C+M.%3B+Rovet%2C+P.%3B+Siegmund%2C+A.+C.%3B+Xi%2C+N.%3B+Yang%2C+K.%28Amgen+Inc%29.+Patent+WO+2006%2F116713A1%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DT.-S.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Kubo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohyama, S.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murooka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isoe, T.</span><span> </span><span class="NLM_article-title">Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors: synthesis, structure–activity relationships, and antitumor activities of <i>N</i>-phenyl-<i>N</i>′-{4-(4-quinolyloxy)phenyl}ureas</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">–</span> <span class="NLM_lpage">1366</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030427r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1359-1366&author=K.+Kuboauthor=T.+Shimizuauthor=S.-I.+Ohyamaauthor=H.+Murookaauthor=A.+Iwaiauthor=K.+Nakamuraauthor=K.+Hasegawaauthor=Y.+Kobayashiauthor=N.+Takahashiauthor=K.+Takahashiauthor=S.+Katoauthor=T.+Izawaauthor=T.+Isoe&title=Novel+potent+orally+active+selective+VEGFR-2+tyrosine+kinase+inhibitors%3A+synthesis%2C+structure%E2%80%93activity+relationships%2C+and+antitumor+activities+of+N-phenyl-N%E2%80%B2-%7B4-%284-quinolyloxy%29phenyl%7Dureas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm030427r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030427r%26sid%3Dliteratum%253Aachs%26aulast%3DKubo%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DOhyama%26aufirst%3DS.-I.%26aulast%3DMurooka%26aufirst%3DH.%26aulast%3DIwai%26aufirst%3DA.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DHasegawa%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DS.%26aulast%3DIzawa%26aufirst%3DT.%26aulast%3DIsoe%26aufirst%3DT.%26atitle%3DNovel%2520potent%2520orally%2520active%2520selective%2520VEGFR-2%2520tyrosine%2520kinase%2520inhibitors%253A%2520synthesis%252C%2520structure%25E2%2580%2593activity%2520relationships%252C%2520and%2520antitumor%2520activities%2520of%2520N-phenyl-N%25E2%2580%25B2-%257B4-%25284-quinolyloxy%2529phenyl%257Dureas%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1359%26epage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3U6J" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3U6J','PDB','3U6J'); return false;">PDB: 3U6J</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3U6I" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3U6I','PDB','3U6I'); return false;">PDB: 3U6I</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i195"><a href="/doi/suppl/10.1021/jm201331s">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_32421"></div></div></div></div></div><hr /></hr><p class="last">Biological assays, standard deviations, and X-ray crystallographic data.  This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm201331s/suppl_file/jm201331s_si_001.pdf">jm201331s_si_001.pdf (233.91 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm201331s&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm201331s%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-5" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm201331s" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e11fb71e86227f","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
